
<html lang="en"     class="pb-page"  data-request-id="b783df32-74c7-48cd-a89d-ba6750a8c797"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2017.60.issue-23;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.7b01062;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure–Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist" /></meta><meta name="dc.Creator" content="Salvatore  Di Maro" /></meta><meta name="dc.Creator" content="Francesco Saverio  Di Leva" /></meta><meta name="dc.Creator" content="Anna Maria  Trotta" /></meta><meta name="dc.Creator" content="Diego  Brancaccio" /></meta><meta name="dc.Creator" content="Luigi  Portella" /></meta><meta name="dc.Creator" content="Michela  Aurilio" /></meta><meta name="dc.Creator" content="Stefano  Tomassi" /></meta><meta name="dc.Creator" content="Anna  Messere" /></meta><meta name="dc.Creator" content="Deborah  Sementa" /></meta><meta name="dc.Creator" content="Secondo  Lastoria" /></meta><meta name="dc.Creator" content="Alfonso  Carotenuto" /></meta><meta name="dc.Creator" content="Ettore  Novellino" /></meta><meta name="dc.Creator" content="Stefania  Scala" /></meta><meta name="dc.Creator" content="Luciana  Marinelli" /></meta><meta name="dc.Description" content="In our ongoing pursuit of CXCR4 antagonists as potential anticancer agents, we recently developed a potent, selective, and plasma stable peptide, Ac-Arg-Ala-[d-Cys-Arg-Phe-Phe-Cys]-COOH (3). Nevert..." /></meta><meta name="Description" content="In our ongoing pursuit of CXCR4 antagonists as potential anticancer agents, we recently developed a potent, selective, and plasma stable peptide, Ac-Arg-Ala-[d-Cys-Arg-Phe-Phe-Cys]-COOH (3). Nevert..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 20, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01062" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01062" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01062" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01062" /></link>
        
    
    

<title>Structure–Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01062" /></meta><meta property="og:title" content="Structure–Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0009.jpeg" /></meta><meta property="og:description" content="In our ongoing pursuit of CXCR4 antagonists as potential anticancer agents, we recently developed a potent, selective, and plasma stable peptide, Ac-Arg-Ala-[d-Cys-Arg-Phe-Phe-Cys]-COOH (3). Nevertheless, this compound was still not potent enough (IC50 ≈ 53 nM) to enter preclinical studies. Thus, a lead-optimization campaign was here undertaken to further improve the binding affinity of 3 while preserving its selectivity and proteolytic stability. Specifically, extensive structure–activity relationships (SARs) investigations were carried out on both its aromatic and disulfide forming amino acids. One among the synthesized analogue, Ac-Arg-Ala-[d-Cys-Arg-Phe-His-Pen]-COOH (19), displayed subnanomolar affinity toward CXCR4, with a marked selectivity over CXCR3 and CXCR7. NMR and molecular modeling studies disclosed the molecular bases for the binding of 19 to CXCR4 and for its improved potency compared to the lead 3. Finally, biological assays on specific cancer cell lines showed that 19 can impair CXCL12-mediated cell migration and CXCR4 internalization more efficiently than the clinically approved CXCR4 antagonist plerixafor." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01062"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01062">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01062&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01062&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01062&amp;href=/doi/10.1021/acs.jmedchem.7b01062" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 9641-9652</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01064" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01028" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Salvatore++Di+Maro">Salvatore Di Maro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francesco+Saverio++Di+Leva">Francesco Saverio Di Leva</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna+Maria++Trotta">Anna Maria Trotta</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Diego++Brancaccio">Diego Brancaccio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luigi++Portella">Luigi Portella</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michela++Aurilio">Michela Aurilio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefano++Tomassi">Stefano Tomassi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Messere">Anna Messere</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deborah++Sementa">Deborah Sementa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Secondo++Lastoria">Secondo Lastoria</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alfonso++Carotenuto">Alfonso Carotenuto</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ettore++Novellino">Ettore Novellino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-2181-2142" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefania++Scala">Stefania Scala</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luciana++Marinelli">Luciana Marinelli</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-4084-8044" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">DiSTABiF, University of Campania “Luigi Vanvitelli”, Caserta 81100, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Pharmacy, University of Naples “Federico II”, Via D. Montesano 49, 80131 Naples, Italy</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Functional Genomics Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione Giovanni Pascale”, IRCCS, Via M. Semmola 52, 80131 Naples, Italy</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Nuclear Medicine Unit, Department of Diagnostic Imaging, Radiant and Metabolic Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione Giovanni Pascale”, IRCCS, Via M. Semmola 52, 80131 Naples, Italy</span></div><div class="corresp-info"><strong>*</strong>S.S.: phone, 0039-081-5903678, 0039-380-3140318; e-mail, <a href="/cdn-cgi/l/email-protection#e497ca9787858885a48d97908d9091908b9091898b968dca8a85ca8d90"><span class="__cf_email__" data-cfemail="bbc895c8d8dad7dafbd2c8cfd2cfcecfd4cfced6d4c9d295d5da95d2cf">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>L.M.: phone, 0039-328-6795645; e-mail, <a href="/cdn-cgi/l/email-protection#462a2b27342f28232a0633282f2827682f32"><span class="__cf_email__" data-cfemail="563a3b37243f38333a1623383f3837783f22">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01062&amp;href=/doi/10.1021%2Facs.jmedchem.7b01062" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 9641–9652</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 10, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 July 2017</li><li><span class="item_label"><b>Published</b> online</span>20 November 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 December 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01062" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01062</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9641%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSalvatore%2BDi%2BMaro%252C%2BFrancesco%2BSaverio%2BDi%2BLeva%252C%2BAnna%2BMaria%2BTrotta%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D23%26contentID%3Dacs.jmedchem.7b01062%26title%3DStructure%25E2%2580%2593Activity%2BRelationships%2Band%2BBiological%2BCharacterization%2Bof%2Ba%2BNovel%252C%2BPotent%252C%2Band%2BSerum%2BStable%2BC-X-C%2BChemokine%2BReceptor%2BType%2B4%2B%2528CXCR4%2529%2BAntagonist%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9652%26publicationDate%3DDecember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01062"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1650</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01062" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Salvatore&quot;,&quot;last_name&quot;:&quot;Di Maro&quot;},{&quot;first_name&quot;:&quot;Francesco&quot;,&quot;last_name&quot;:&quot;Saverio Di Leva&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Maria Trotta&quot;},{&quot;first_name&quot;:&quot;Diego&quot;,&quot;last_name&quot;:&quot;Brancaccio&quot;},{&quot;first_name&quot;:&quot;Luigi&quot;,&quot;last_name&quot;:&quot;Portella&quot;},{&quot;first_name&quot;:&quot;Michela&quot;,&quot;last_name&quot;:&quot;Aurilio&quot;},{&quot;first_name&quot;:&quot;Stefano&quot;,&quot;last_name&quot;:&quot;Tomassi&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Messere&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;Sementa&quot;},{&quot;first_name&quot;:&quot;Secondo&quot;,&quot;last_name&quot;:&quot;Lastoria&quot;},{&quot;first_name&quot;:&quot;Alfonso&quot;,&quot;last_name&quot;:&quot;Carotenuto&quot;},{&quot;first_name&quot;:&quot;Ettore&quot;,&quot;last_name&quot;:&quot;Novellino&quot;},{&quot;first_name&quot;:&quot;Stefania&quot;,&quot;last_name&quot;:&quot;Scala&quot;},{&quot;first_name&quot;:&quot;Luciana&quot;,&quot;last_name&quot;:&quot;Marinelli&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;9641-9652&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01062&quot;},&quot;abstract&quot;:&quot;In our ongoing pursuit of CXCR4 antagonists as potential anticancer agents, we recently developed a potent, selective, and plasma stable peptide, Ac-Arg-Ala-[d-Cys-Arg-Phe-Phe-Cys]-COOH (3). Nevertheless, this compound was still not potent enough (IC50 ≈ 53 nM) to enter preclinical studies. Thus, a lead-optimization campaign was here undertaken to further improve the binding affinity of 3 while preserving its selectivity and proteolytic stability. Specifically, extensive structure–activity relationships (SARs) investigations were carried out on both its aromatic and disulfide forming amino acids. One among the synthesized analogue, Ac-Arg-Ala-[d-Cys-Arg-Phe-His-Pen]-COOH (19), displayed subnanomolar affinity toward CXCR4, with a marked selectivity over CXCR3 and CXCR7. NMR and molecular modeling studies disclosed the molecular bases for the binding of 19 to CXCR4 and for its improved potency compared to the lead 3. Finally, biological assays on specific cancer cell lines showed that 19 can impair CXCL12-media&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01062&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01062" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01062&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01062" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01062&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01062" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01062&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01062&amp;href=/doi/10.1021/acs.jmedchem.7b01062" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01062" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01062" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01062%26sid%3Dliteratum%253Aachs%26pmid%3D29125295%26genre%3Darticle%26aulast%3DDi%2BMaro%26date%3D2017%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationships%2Band%2BBiological%2BCharacterization%2Bof%2Ba%2BNovel%252C%2BPotent%252C%2Band%2BSerum%2BStable%2BC-X-C%2BChemokine%2BReceptor%2BType%2B4%2B%2528CXCR4%2529%2BAntagonist%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D23%26spage%3D9641%26epage%3D9652%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/jmcmar.2017.60.issue-23/20171214/jmcmar.2017.60.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In our ongoing pursuit of CXCR4 antagonists as potential anticancer agents, we recently developed a potent, selective, and plasma stable peptide, Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d</span>-Cys-Arg-Phe-Phe-Cys]-COOH (<b>3</b>). Nevertheless, this compound was still not potent enough (IC<sub>50</sub> ≈ 53 nM) to enter preclinical studies. Thus, a lead-optimization campaign was here undertaken to further improve the binding affinity of <b>3</b> while preserving its selectivity and proteolytic stability. Specifically, extensive structure–activity relationships (SARs) investigations were carried out on both its aromatic and disulfide forming amino acids. One among the synthesized analogue, Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d</span>-Cys-Arg-Phe-His-Pen]-COOH (<b>19</b>), displayed subnanomolar affinity toward CXCR4, with a marked selectivity over CXCR3 and CXCR7. NMR and molecular modeling studies disclosed the molecular bases for the binding of <b>19</b> to CXCR4 and for its improved potency compared to the lead <b>3</b>. Finally, biological assays on specific cancer cell lines showed that <b>19</b> can impair CXCL12-mediated cell migration and CXCR4 internalization more efficiently than the clinically approved CXCR4 antagonist plerixafor.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35787" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35787" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The chemokine receptor CXCR4 plays a central role in multiple physiological and pathological processes including tumor growth and metastasis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> CXCR4 is indeed highly expressed in more than 20 different solid and hematological cancer types, characterized by high aggressiveness, and eager to metastasize toward secondary organs where the endogenous CXCR4 ligand CXCL12/SDF-1α (stromal-cell derived factor 1α) is produced.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Emerging evidence demonstrates that primary tumor releases soluble factors able to remodel the microenvironment in secondary organs predisposing “premetastatic niches” where neoplastic cells will seed. CXCL12 plays a pivotal role in this process through the recruitment of bone marrow derived cells and neuthrophils.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In fact, the clinically approved CXCR4 antagonist plerixafor (<b>1</b>),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> also known as AMD3100 (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>), inhibits the tissue inhibitor of metalloproteinases (TIMP-1) that controls the liver premetastatic niches in colorectal cancer patients.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Along the same line, an AMD3100 analogue had been previously shown to modulate oncogenic mediators such as MMP2, GSK3, cMYC, AKT, and STAT3, inhibiting the formation of a cancer nurturing microenvironment and in turn metastasis.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Moreover, it is now well established that, besides being a fertile soil for cancer growth, the microenvironment can facilitate immune escape of tumor cells. In this perspective, the aberrant recruitment of CXCR4 expressing cells together with an increment of CXCL12 in stroma represent key events in metastasis process via both tumor-specific and T-cell based mechanisms. At this regard, improved efficacy of targeting immune checkpoints receptors (ICRs) was recently demonstrated by some of us through coupling of immune checkpoints inhibitors with CXCR4 antagonists such as <b>1</b>.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Moreover, interactions between stromal cells producing CXCL12 such as cancer-associated fibroblasts (CAFs) and neoplastic cells have been demonstrated to have an impact on metabolic reprogramming of cancer cells.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Also, recent evidence demonstrates that CXCL12 plays a role in promoting a glycolytic shift, known as the “Warburg” effect, in leukemic cells through the CXCR4/mTOR signaling axis. Notably, plerixafor administration in acute myeloid leukemia cells markedly reduces glucose uptake, mTOR activation, and consequently basal glycolysis and glycolytic capacity.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Besides plerixafor and plerixafor-like derivatives, a number of peptidic and nonpeptidic CXCR4 antagonist have been discovered so far.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17">(10-17)</a> Among these, prominent examples are the protein epitope mimetic POL5551,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> the 14-mer peptides H-Arg-Arg-Nal-Cys-Tyr-Arg-Lys-<span class="smallcaps smallerCapital">d</span>-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-OH (T140),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and 4F-benzoyl-Arg-Arg-Nal-Cys-Tyr-Cit-Lys-<span class="smallcaps smallerCapital">d</span>-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-NH<sub>2</sub> (BKT140)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and their downsized cyclic derivatives such as cyclo[Arg<sup>1</sup>-Arg<sup>2</sup>-Nal<sup>3</sup>-Gly<sup>4</sup>-<span class="smallcaps smallerCapital">d</span>-Tyr<sup>5</sup>] (FC131),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> as well as cyclo[Phe-Tyr-Lys(iPr)-<span class="smallcaps smallerCapital">d</span>-Arg-2-Nal-Gly-<span class="smallcaps smallerCapital">d</span>-Glu]-Lys(iPr)-NH<sub>2</sub> (LY2510924).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Also, several CXCR4-targeting probes for molecular imaging were developed.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Indeed, the in vivo assessment of CXCR4 expression can provide relevant information on tumor biology and identify patients eligible for CXCR4-targeted therapies. In this perspective, AMD derivatives have been investigated for <sup>64</sup>Cu-,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a><sup>18</sup>F-,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and even <sup>11</sup>C-labeling.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Recently, a radiolabeled CXCR4-ligand ([<sup>68</sup>Ga]pentixafor) for PET imaging has been successfully utilized in patients with hematologic and solid malignancies.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> As a part of our continued effort to find effective CXCR4 antagonists,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> starting from a CXCL12-mimetic cyclic peptide (H-Arg-Ala-[Cys-Arg-Phe-Phe-Cys]-COOH)<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (<b>2</b>), we have recently reported the design and synthesis of a plasma stable CXCR4 peptide antagonist (Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d</span>-Cys-Arg-Phe-Phe-Cys]-COOH) (<b>3</b>) (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>), which was able to selectively bind the receptor with an IC<sub>50</sub> of 53 nM.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In spite of its promising pharmacological and pharmacokinetic profile, <b>3</b> was still not suited for comprehensive in vivo studies since a low nanomolar or picomolar IC<sub>50</sub> is generally required for such investigations.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Chemical Structures of <b>1</b> (plerixafor) and <b>3</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Therefore, a lead-optimization study was here undertaken to further improve the peptide binding potency, without affecting its stability in biological fluids, with the final aim to achieve an optimal CXCR4 response and minimize the potential side effects due to off-target interactions. To reach this goal, we have performed an extensive structure–activity relationship (SAR) study around both the overall cycle conformation and the two aromatic amino acids of <b>3</b>. The novel cyclic peptides were evaluated as CXCR4 antagonists through the inhibition of receptor binding of anti-CXCR4 PE-antibodies (clone 12G5), and for the most affine compound (<b>19</b>) the potency was further quantified through a iodine-125 CXCL12 competition test in human leukemic lymphoblast (CCRF-CEM cells). These assays showed that <b>19</b> is able to displace the labeled chemokine with an IC<sub>50</sub> of 20 ± 2 nM, thus representing a new potent CXCR4 antagonist. The selectivity of action of <b>19</b> was then demonstrated through binding assays on CXCR3 and CXCR7 overexpressing cell lines. NMR and molecular modeling disclosed the molecular bases for the binding of <b>19</b> to CXCR4, also explaining the structure–activity relationships of all the other newly synthesized peptides. Finally, the biological efficacy of <b>19</b> was demonstrated through the evaluation of CXCL12-dependent cell migration and CXCL12-mediated CXCR4 internalization in specific cancer cell lines.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05512" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05512" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design</h3><div class="NLM_p last">Our previous Ala-scan study on <b>3</b> pointed out that <span class="smallcaps smallerCapital">l-</span>Arg at both the 1 and 4 positions and the two <span class="smallcaps smallerCapital">l-</span>Phe at 5 and 6 positions were fundamental for the interaction with the CXCR4 receptor. In the attempt to improve the activity of <b>3</b>, a three-step structure–activity relationship study was designed. In the first step, we explored the cycle conformation of <b>3</b> by replacing either the <span class="smallcaps smallerCapital">l-</span>Cys (position 7) or the <span class="smallcaps smallerCapital">d-</span>Cys (position 3) or both with penicillamine (Pen) (compounds <b>4</b>–<b>6</b>). The most potent analogue (<b>4</b>) emerging from this first round of modifications entered the second phase of the study. In detail, the Phe residues at the 5 or 6 position were, one at a time, replaced by amino acids bearing smaller aromatic side chains, such as <span class="smallcaps smallerCapital">l-</span>His (<b>7</b>, <b>13</b>), or bulkier side chains, such as <span class="smallcaps smallerCapital">l-</span>1- and <span class="smallcaps smallerCapital">l-</span>2-naphthylalanine (<span class="smallcaps smallerCapital">l-</span>1-Nal, <span class="smallcaps smallerCapital">l-</span>2-Nal) (<b>11</b>, <b>17</b> and <b>12</b>, <b>18</b>, respectively), or substituted on the phenyl ring with electron withdrawing (4-Cl and 4-NO<sub>2</sub>) (<b>9</b>, <b>15</b> and <b>10</b>, <b>16</b>) or electron donor (4-OH) (<b>8</b>, <b>14</b>) groups. Finally, the most effective modifications (<b>4</b>, <b>12</b>, and <b>13</b>) were simultaneously applied into a single compound (<b>19</b>) to check whether their combination would result in a further increment of potency.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p last">All the linear heptapeptides were assembled in solid phase by standard Fmoc/<sup><i>t</i></sup>Bu protocol using 2-chlorotrityl resin as support in order to minimize the potential racemization of the first amino acid during the loading process.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Unfortunately, the replacement of <span class="smallcaps smallerCapital">l-</span>Cys (position 7) with a residue of <span class="smallcaps smallerCapital">l-</span>Pen produced linear final products in substantial lower yield, when the first amino acid was loaded by classical reported protocol (15% <span class="smallcaps smallerCapital">l-</span>Pen vs 60% <span class="smallcaps smallerCapital">l-</span>Cys). In our opinion, the observed lack of synthetic efficiency was probably due to the more hindered side chain of penicillamine compared with cysteine. Thus, to increase the yield of the coupling of the first amino acid, we used an excess of resin (2 equiv) with respect to the latter. This strategy indeed provides a larger number of the chlorine reactive groups involved in the loading of the first amino acid. By using this alternative approach, we were able to increase the yield of the final linear compounds from 15% to about 55%. Once assembled on the solid support, all the linear heptapeptides were removed from the resin and the resulting free thiol groups were eventually oxidized using <i>N</i>-chlorosuccinimide to form the desired disulfide bridge.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> CXCR4 Binding Assays</h3><div class="NLM_p">All the peptides were preliminarily assessed against CXCR4 measuring their ability to inhibit receptor binding of anti-CXCR4 PE-conjugated antibody (clone 12G5) in CEM-CCRF human T leukemia cells that overexpress CXCR4.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> First, we evaluated the effects of the replacement of <span class="smallcaps smallerCapital">d-</span>Cys<sup>3</sup> and <span class="smallcaps smallerCapital">l-</span>Cys<sup>7</sup> in the lead peptide <b>3</b> with <span class="smallcaps smallerCapital">d-</span> and <span class="smallcaps smallerCapital">l-</span>Pen, respectively.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> As reported in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, the latter modifications led to an enhancement of affinity toward CXCR4, with peptide <b>4</b> able to reduce the receptor/antibody interaction with an IC<sub>50</sub> of 40 ± 10 nM. Conversely, the introduction of a <span class="smallcaps smallerCapital">d-</span>Pen in place of <span class="smallcaps smallerCapital">d-</span>Cys<sup>3</sup> (<b>5</b>) completely abolished the binding. Also, a dramatic lack of affinity was observed when both <span class="smallcaps smallerCapital">d-</span> and <span class="smallcaps smallerCapital">l-</span>Pen were simultaneously inserted at the 3 and 7 positions, respectively, with compound <b>6</b> showing an IC<sub>50</sub> of about 1530 ± 40 nM. These results would thus indicate that the two methyl groups on the α-carbon of Pen modify the orientation of the pharmacophoric amino acid side chains, which is however favorable for the binding only in the case of <span class="smallcaps smallerCapital">l-</span>Cys<sup>7</sup> substitution. Next, further structure–activity relationship studies were performed by replacing the two <span class="smallcaps smallerCapital">l-</span>Phe residues of peptide <b>4</b>. Indeed, compound <b>7</b>, featuring <span class="smallcaps smallerCapital">l-</span>His in place of Phe<sup>5</sup>, turned out as totally inactive; conversely, <b>13</b>, obtained through the Phe<sup>6</sup>/His substitution, showed a remarkably higher affinity for the receptor (IC<sub>50</sub> = 6 ± 2 nM). Also, when either position 5 or position 6 was substituted with a <span class="smallcaps smallerCapital">l-</span>Tyr residue (<b>8</b> and <b>14</b>), we observed a marked drop in affinity for the receptor if compared to peptide <b>4</b>. On the other hand, the introduction of a chlorine in para position of the Phe<sup>5</sup> and Phe<sup>6</sup> aromatic ring (<b>9</b>–<b>15</b>) produced diametrically opposite results. In particular, the presence of a (4-Cl)-<span class="smallcaps smallerCapital">l-</span>Phe residue at the 5 position (<b>9</b>) was well tolerated, while the same group at the 6 position (<b>15</b>) dramatically reduced the affinity for the receptor. Negative results were also observed when we introduced alternative withdrawing groups such as a nitro group at the 5 (<b>10</b>, IC<sub>50</sub> = 210 ± 70 nM) and 6 positions (<b>16</b>, IC<sub>50</sub> > 10 000 nM). Next, the influence on peptide binding of bulkier side chain was investigated by inserting <span class="smallcaps smallerCapital">l-</span>1- and <span class="smallcaps smallerCapital">l-</span>2-Nal residues in place of Phe<sup>5</sup> and Phe<sup>6</sup>. Among the resulting analogues, <b>11</b> and <b>17</b>, bearing <span class="smallcaps smallerCapital">l-</span>1-Nal at 5 and 6 positions, respectively, and <b>18</b>, bearing <span class="smallcaps smallerCapital">l-</span>2-Nal at the 6 position, showed reduced receptor binding potency if compared to peptide <b>4</b>. Conversely, peptide <b>12</b>, obtained through the replacement of Phe<sup>5</sup> with 2-Nal, was about 2 times more potent than <b>4</b> (IC<sub>50</sub> = 22 ± 2 nM). Considering the good results achieved by introducing 2-Nal in place of Phe<sup>5</sup> and His in place of Phe<sup>6</sup>, we decided to combine these two modifications in a unique compound, namely, <b>19</b>. Noteworthy, this peptide showed the ability to inhibit the receptor binding of PE-conjugated 12G5 anti-CXCR4 antibody in the low nanomolar range (IC<sub>50</sub> = 1.5 ± 0.5 nM).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> Values (Mean ± SD) for CXCR4 Antagonist Peptides Obtained Measuring the Inhibition of Receptor Binding of Anti-CXCR4 PE-Antibodies (Clone 12G5)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">sequence</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">H-Arg-Ala-[Cys-Arg-Phe-Phe-Cys]-COOH</td><td class="colsep0 rowsep0" align="left">6200 ± 1300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d-</span>Cys-Arg-Phe-Phe-Cys]-COOH</td><td class="colsep0 rowsep0" align="left">53 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d-</span>Cys-Arg-Phe-Phe-<b>Pen</b>]-COOH</td><td class="colsep0 rowsep0" align="left">40 ± 10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">Ac-Arg-Ala-[<b><span class="smallcaps smallerCapital">d-</span>Pen</b>-Arg-Phe-Phe-Cys]-COOH</td><td class="colsep0 rowsep0" align="left">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">Ac-Arg-Ala-[<b><span class="smallcaps smallerCapital">d-</span>Pen</b>-Arg-Phe-Phe-<b>Pen</b>]-COOH</td><td class="colsep0 rowsep0" align="left">1530 ± 40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d-</span>Cys-Arg-<b>His</b>-Phe-<b>Pen</b>]-COOH</td><td class="colsep0 rowsep0" align="left">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d-</span>Cys-Arg-<b>Tyr</b>-Phe-<b>Pen</b>]-COOH</td><td class="colsep0 rowsep0" align="left">2140 ± 300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d-</span>Cys-Arg-<b>(4-Cl)Phe</b>-Phe-<b>Pen</b>]-COOH</td><td class="colsep0 rowsep0" align="left">70 ± 20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d-</span>Cys-Arg-<b>(4-NO</b><sub><b>2</b></sub><b>)Phe</b>-Phe-<b>Pen</b>]-COOH</td><td class="colsep0 rowsep0" align="left">210 ± 70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d-</span>Cys-Arg-<b>1-Nal</b>-Phe-<b>Pen</b>]-COOH</td><td class="colsep0 rowsep0" align="left">3690 ± 1810</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d-</span>Cys-Arg-<b>2-Nal</b>-Phe-<b>Pen</b>]-COOH</td><td class="colsep0 rowsep0" align="left">22 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d-</span>Cys-Arg-Phe-<b>His-Pen</b>]-COOH</td><td class="colsep0 rowsep0" align="left">6 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d-</span>Cys-Arg-Phe-<b>Tyr-Pen</b>]-COOH</td><td class="colsep0 rowsep0" align="left">360 ± 60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d-</span>Cys-Arg-Phe-<b>(4-Cl)Phe-Pen</b>]-COOH</td><td class="colsep0 rowsep0" align="left">1250 ± 630</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d-</span>Cys-Arg-Phe-<b>(4-NO</b><sub><b>2</b></sub><b>)Phe-Pen</b>]-COOH</td><td class="colsep0 rowsep0" align="left">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d-</span>Cys-Arg-Phe-<b>1-Nal-Pen</b>]-COOH</td><td class="colsep0 rowsep0" align="left">180 ± 40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d-</span>Cys-Arg-Phe-<b>2-Nal-Pen</b>]-COOH</td><td class="colsep0 rowsep0" align="left">1800 ± 560</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d-</span>Cys-Arg-<b>2-Nal-His-Pen</b>]-COOH</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">AMD 3100</td><td class="colsep0 rowsep0" align="left">6 ± 4</td></tr></tbody></table></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Binding Specificity</h3><div class="NLM_p">To demonstrate the specificity of <b>19</b> toward CXCR4 over other chemokine receptors, flow cytometry binding experiments were also conducted on the CXCR3-overexpressing COLO205 human colorectal cancer cell line and on MCF-7 human breast cancer cells which overexpress the CXCR7 receptor. Cells were incubated with <b>19</b>, and then the peptide ability to impair the binding of specific anti-CXCR3 (anti-CXCR3 FITC-antibody, R&D FAB160F clone 49801) and anti-CXCR7 (anti-CXCR7 APC-antibody, R&D FAB4227A clone 11G8) antibodies was evaluated. As shown in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, <b>19</b> was not able to affect the binding of the latter antibodies to their receptor counterpart, indicating that our peptide can bind neither CXCR3 nor CXCR7. These assays therefore demonstrate that similar to its parent peptide <b>3</b>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a><b>19</b> is a selective CXCR4 ligand.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Binding of <b>19</b> to (A) COLO205 colon cancer cells, overexpressing CXCR3, and (B) MCF-7 breast cancer cell line, overexpressing CXCR7. The binding was evaluated through flow cytometry using anti-CXCR3 FITC-antibody and anti-CXCR7 APC-antibody. Data are presented as bar graph showing mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> <sup>125</sup>I-CXCL12 Competition Binding Assay</h3><div class="NLM_p">The enhancement of affinity toward CXCR4 obtained with <b>19</b> was further quantified by investigating the capability of this peptide, in comparison with the lead <b>3</b>, to compete with the radiolabeled tracer <sup>125</sup>I-CXCL12.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Fixed amounts of the <sup>125</sup>I-labeled CXCL12 were incubated with CCRF-CEM cells in the presence of increasing concentrations of <b>3</b> or <b>19</b>. As shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, <b>19</b> can displace <sup>125</sup>I-labeled CXCL12 more efficiently than <b>3</b> (<b>19</b>, IC<sub>50</sub> = 20 ± 2 nM vs <b>3</b>, IC<sub>50</sub> = 338 ± 12 nM), showing a potency similar to other CXCR4 antagonists which are at different stages of development. In particular, the binding affinity of <b>19</b> is comparable to that of <b>1</b>, which is the only CXCR4 antagonist approved for stem cell mobilization.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Competition binding assays of <b>19</b> with <sup>125</sup>I-CXCL12. Experiments were performed on CCRF-CEM cells. Cells were incubated with 60 pM <sup>125</sup>I-CXCL12 as tracer and increasing concentrations (from 10 pM to 10 μM) of either <b>3</b> or <b>19</b> as competitor. The binding curve was fitted to a one-site binding model. Results shown (mean ± SD) are the average of three experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Cell Migration Assay</h3><div class="NLM_p">To functionally characterize the newly developed peptide <b>19</b>, we evaluated its effect on the CXCL12-mediated migration of CCRF-CEM cells in Transwell-based assays, including <b>1</b> as reference compound. These assays revealed that <b>19</b> can inhibit CCRF-CEM migration more efficiently than <b>1</b>, even at low nanomolar concentration (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). Further experiments demonstrated that <b>19</b> can also impair the CXCL12-induced migration of other cancer cell lines such as the PES43 metastatic melanoma cells (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B), the HT29 and HCT116 human colon cancer cells (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C,D), and the A498 and SN12C human renal cancer cells (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>E,F), in a concentration dependent manner, thus showing a comparable range of efficacy with the unique clinically approved CXCR4 antagonist <b>1</b>.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparative CXCL12-dependent cells migration experiments on <b>1</b> and <b>19</b>. Experiments were conducted on the CCRF-CEM (A), PES43 (B), HT29 (C), HCT116 (D), SN12C (E), and A498 (F) cell lines. Migrated cells on the lower surface were fixed, stained with H&E, and counted microscopically. The results are expressed as the migration index relative to migration in the presence of BSA alone. Data are presented as bar graph showing mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> CXCR4 Internalization</h3><div class="NLM_p">Like other GPCR receptors, CXCR4 is rapidly internalized upon ligand binding and accumulates into endosomal vesicles.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Using CHO cells transfected with green fluorescent protein (GFP) tagged CXCR4, we analyzed the effect of the newly developed <b>19</b> in the receptor internalization process in comparison with <b>1</b>. Briefly, CHO-CXCR4-GFP cells were treated with <b>1</b> or <b>19</b>, and the CXCR4 receptor internalization process was studied from 30 min up to 24 h in the presence of the specific ligand CXCL12 (12.5 nM) by confocal microscopy. Upon ligand binding the GFP-CXCR4 receptor (in green, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) clearly accumulates into endosomal vesicles, identifiable as bright green spots in the cytoplasm (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B) as compared to untreated cells (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A); this effect was impaired by <b>19</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C) but not by <b>1</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>D). Thus, <b>19</b>, different from <b>1</b>, is able to efficiently inhibit the CXCR4 internalization process. This effect is detectable from 30 min to 6 h after treatment, while it cannot be determined at 24 h.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. CXCR4 internalization was assessed in CHO-CXCR4-GFP cells in the presence of CXCL12 (12.5 nM), <b>19</b> (10 nM), and <b>1</b> (10 nM): (A) untreated cells; (B) cells treated with CXCL12 (12.5 nM); (C) cells treated with <b>19</b> (10 nM) and then stimulated with CXCL12 (12.5 nM); (D) cells treated with <b>1</b> (10 nM) and then stimulated with CXCL12 (12.5 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Serum Stability</h3><div class="NLM_p">The early metabolic stability of <b>19</b> was assessed by incubating it and its unstable parent peptide <b>2</b> in 90% human serum at 37 °C according to a previously described protocol.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> At several time intervals, aliquots of the mixture reaction were collected, treated with acetonitrile to precipitate the serum proteins, and analyzed by ESI-RP-HPLC. As shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, the reference peptide starts to be significantly degraded already after 15 min, when we could detect around 67% of intact compound and the formation of about 23% and 10% of the corresponding hexapeptide and pentapeptide metabolities, respectively. After 30 min, the reference sequence was fully converted into the corresponding cyclic pentapeptide metabolite H-[Cys-Arg-Phe-Phe-Cys]-COOH. In line with the results of our previous study, <b>19</b> was stable up to 120 min, confirming our observation that the introduction of the acetyl group at the N-terminal region was sufficient to preserve the peptide against human serum proteolytic degradation.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Stability of <b>2</b> and <b>19</b> at different intervals of incubation with 90% human serum. Relative concentrations of peptides were determined by integration of the A230 peaks from analytical HPLC. (B) ESI-MS characterizations of <b>2</b> and <b>19</b> at different intervals of incubation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> NMR Spectroscopy</h3><div class="NLM_p">NMR experiments were performed on the most active compound <b>19</b>. Complete <sup>1</sup>H NMR chemical shift assignments (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01062/suppl_file/jm7b01062_si_001.pdf" class="ext-link">Table S1 in Supporting Information</a>) were performed according to the Wüthrich procedure.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> DQF-COSY,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> TOCSY,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and NOESY<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> experiments, with the support of the XEASY software package,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> were carried out in 200 mM SDS micellar solution. The employment of SDS micelles to investigate the conformational properties is justified on the basis of their interaction with a membrane receptor. For peptides that bind membrane receptors, such as GPCR, the use of membrane mimetic solution is suggested, hypothesizing a membrane-assisted mechanism of interactions between the peptides and their receptors;<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> in fact, micelle solutions have been extensively used for peptide hormones conformational studies.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Many NMR parameters of <b>19</b> indicate a folded structure. In particular, NOE contacts between H<sub>α</sub>-NH<sub><i>i</i>+2</sub> of Arg<sup>1</sup> and <span class="smallcaps smallerCapital">d-</span>Cys<sup>3</sup> and NH-NH<sub><i>i</i>+2</sub> of <span class="smallcaps smallerCapital">d-</span>Cys<sup>3</sup> and Nal<sup>5</sup> and between Arg<sup>4</sup> and His<sup>6</sup> indicated that folded structures span along the entire peptide sequence. The presence of those structures is confirmed by low values of the temperature coefficients of amide protons (|Δδ/Δ<i>T</i>| < 4 ppb/K) of <span class="smallcaps smallerCapital">d-</span>Cys<sup>3</sup>, His<sup>6</sup>, and Pen<sup>7</sup> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01062/suppl_file/jm7b01062_si_001.pdf" class="ext-link">Table S1</a>). Upfield shifts of side chain protons of the Arg<sup>4</sup> and NOE contacts between Arg<sup>4</sup> and 2-Nal<sup>5</sup> and between 2-Nal<sup>5</sup> and His<sup>6</sup> point to a spatial proximity of these couples of side chains. Also Arg<sup>1</sup> and Ala<sup>2</sup> side chains show NOE interactions with 2-Nal<sup>5</sup> naphthyl moiety indicating that the exocyclic side chains are close to the endocyclic pharmacophoric triad formerly consisting of the Arg<sup>4</sup>-Phe<sup>5</sup>-Phe<sup>6</sup> sequence. NMR constraints from SDS micelle solution were used as the input data for a simulated annealing structure calculation (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01062/suppl_file/jm7b01062_si_001.pdf" class="ext-link">Table S2</a>). An ensemble of well-defined structures was obtained (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A). Calculated structures satisfied the NMR-derived constraints (violations smaller than 0.20 Å). The 10 lowest energy structures for <b>19</b> showed a rmsd of 0.12 Å and a well-defined β-turn (type IV) along residues 4–7. Also the side chain positions are well-defined, in fact the all atom rmsd is only 0.64 Å. This structural stability is likely to contribute to the activity enhancement observed for <b>19</b> compared to <b>3</b> that was more flexible in the same experimental conditions.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> A three-dimensional superposition of NMR-derived structures of <b>3</b> and <b>19</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B) shows that both the cycle and the side chains are close in the space (rmsd between the two lowest energy conformers of <b>3</b> and <b>19</b> is only 0.79 Å when all the Cγ atoms are considered).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Stereoimage of the lowest energy conformer of <b>19</b>. Heavy atoms are represented with different colors (carbon, green; nitrogen, blue; oxygen, red; sulfur, yellow). Nonpolar hydrogen atoms are hidden for clarity reasons. (B) Superposition of the NMR lowest energy conformations of <b>19</b> (green) and <b>3</b> (orange)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> on the Cα carbon atoms of residues 3–7.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Molecular Modeling</h3><div class="NLM_p">To elucidate the binding mode of our newly synthesized peptides to CXCR4, molecular modeling studies were performed on the most potent compound of the series <b>19</b>. In analogy with our previous investigations on the lead peptide <b>3</b>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> standard docking algorithms were not able to predict reliable ligand binding poses; therefore, a more advanced computational approach was again employed. Specifically, we carried out extensive molecular dynamics (MD) simulations in explicit solvent and membrane on the <b>19</b>/CXCR4 complex that was obtained through a manual docking procedure (see the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> and the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01062/suppl_file/jm7b01062_si_001.pdf" class="ext-link">Supporting Information</a> for details). According to MD results, the Arg<sup>4</sup>, 2-Nal<sup>5</sup>, and His<sup>6</sup> side chains of <b>19</b> deepen into the transmembrane (TM) bundle of CXCR4 (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A), occupying both the minor (TMS1; between TM1, TM2, TM3, and TM7) and the major pocket (TMS2; between TM3, TM4, TM5, TM6, and TM7)<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> of the ligand binding site. In detail, the Arg<sup>4</sup> guanidinium group establishes a tight salt bridge with the D97<sup>2.63</sup> carboxylate group and a cation−π interaction with W94<sup>2.60</sup>, while the 2-Nal<sup>5</sup> side chain extends into the aromatic cage defined by H113<sup>3.29</sup>, Y116<sup>3.32</sup>, Y121<sup>3.37</sup>, F199<sup>5.38</sup>, H203<sup>5.42</sup>, and Y255<sup>6.51</sup>, forming favorable contacts with the side chains of these residues together with a cation−π with the R188<sup>45.52</sup> guanidinium group. In the neighboring cleft the protonated His<sup>6</sup> imidazole ring establishes a T-shaped stacking interaction with the Y255<sup>6.51</sup> phenol ring and, more interestingly, a salt bridge with the conserved E288<sup>7.39</sup> carboxylate group and a water mediated interaction with D262<sup>6.58</sup>. Aside from the Arg<sup>4</sup>, 2-Nal<sup>5</sup>, and His<sup>6</sup> triad, also the other peptide amino acids are involved in the binding of <b>19</b> to CXCR4. For instance, the Arg<sup>1</sup> side chain, analogous to Arg<sup>4</sup>, makes a salt bridge with the D97<sup>2.63</sup> side chain, but it also contacts D187<sup>45.51</sup> through a water bridge. Moreover, the C-terminal Pen<sup>7</sup> carboxylate group establishes H-bonds with the Y190<sup>45.54</sup> phenolic group and the Q200<sup>5.39</sup> amidic function. Additional contacts are eventually formed by the acetyl cap and the Arg<sup>1</sup> backbone NH with the N37<sup>1.31</sup> and E288<sup>7.39</sup> side chains, respectively. Overall, the binding mode predicted for <b>19</b> is in agreement with its subnanomolar potency and with crystallographic and mutagenesis data indicating residues such W94<sup>2.60</sup>, D97<sup>2.63</sup>, H113<sup>3.29</sup>, and Y116<sup>3.32</sup> in TMS1, H203<sup>5.42</sup>, Y255<sup>6.51</sup>, D262<sup>6.58</sup>, and E288<sup>7.39</sup> in TMS2, and D187<sup>45.51</sup> and R188<sup>45.52</sup> in ECL2 as important for ligand binding to CXCR4.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Likewise, previous computational studies revealed that some of the latter residues are crucial for the binding of potent cyclopeptide CXCR4 antagonists. For instance, the potent cyclic pentapeptides developed by Fujii and co-workers, which feature two positively charged (arginine) and two aromatic residues (Tyr and 2-Nal), were predicted to use D97<sup>2.63</sup> and D187<sup>45.51</sup> as first anchor points for receptor binding and to insert their 2-Nal side chain in the cleft defined by R188<sup>45.52</sup> and H203<sup>5.42</sup>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> similar to <b>19</b>. Docking studies would however suggest that the latter ligands use D171<sup>4.60</sup> as second anchor point,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> different from our peptide that in fact binds D262<sup>6.58</sup> and E288<sup>7.39</sup>. On the other hand, a subnanomolar N-alkylated cyclopeptide analogue developed by Demmer et al. was predicted to interact with the side chains of D97<sup>2.63</sup>, D187<sup>45.51</sup>, and D262<sup>6.58</sup> through its two arginine residues and to form a cation−π with R188<sup>45.52</sup> through the Nal<sup>4</sup> side chain,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> in line with the binding mode predicted for <b>19</b>. It is also interesting to note that the <b>19</b> MD pose is superimposable to that previously described for the lead peptide <b>3</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> although few differences can be found. Particularly, both the Arg<sup>1</sup> side chain and the C-terminal carboxylate group of <b>19</b> directly interact with the target, while in the case of <b>3</b> the same moieties are involved in a tight intramolecular interaction. This could be due to the slight different peptide ring arrangement resulting from the <span class="smallcaps smallerCapital">l-</span>Cys<sup>7</sup>/<span class="smallcaps smallerCapital">l-</span>Pen<sup>7</sup> substitution, which in turn might not allow the Arg<sup>1</sup> side chain of <b>19</b> to fold toward the C-terminus. Furthermore, the introduction of His (<b>19</b>) in place of Phe (<b>3</b>) allows the ligand to form additional tight polar contacts, explaining the remarkable increase in the affinity toward CXCR4 (<b>3</b>, IC<sub>50</sub> = 53 nM; <b>19</b>, IC<sub>50</sub> = 1.5 nM). The MD binding pose of <b>19</b> also allows us to rationalize the structure–activity relationships of all the other compounds presented in this study. Specifically, (i) as already outlined in our previous study,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> the nature and the chirality of the amino acids forming the disulfide bond (cysteine and/or penicillamine) are crucial to properly orient the peptide pharmacophoric groups at the CXCR4 receptor; within this framework, the best results have been achieved with peptides featuring <span class="smallcaps smallerCapital">d-</span>Cys and <span class="smallcaps smallerCapital">l-</span>Pen at the 3 and 7 positions, respectively (compare <b>4</b> vs <b>3</b>, <b>5</b>, and <b>6</b>). (ii) At the 5 position, residues featuring side chains bulkier than Phe can establish additional lipophilic or in the aromatic subpocket of the CXCR4 ligand binding site, although they should satisfy specific steric requisites. Actually, the introduction of residues such as (4-Cl)Phe (<b>9</b>), 1-Nal (<b>11</b>), or 2-Nal (<b>12</b>) produces alternative effects on the peptide target affinity; indeed, the latter amino acids are, respectively, well tolerated, unfavorable, or advantageous for the binding to CXCR4. For the same reasons, the presence, at the 5 position, of amino acids bearing more polar side chains (peptides <b>7</b>, <b>8</b>, and <b>10</b>) is always detrimental for the peptide potency. Finally, (iii) at the 6 position, the replacement of Phe with any aromatic residue (peptides <b>14</b>–<b>18</b>) other than histidine (<b>13</b>) always causes a drop in affinity, mainly for steric reasons.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Binding mode of <b>19</b> (cyan sticks) at the CXCR4 receptor (gray cartoons) obtained through over 300 ns long MD simulations. Receptor amino acids and waters important for peptide binding are shown as sticks. Hydrogen bonds are displayed as dashed yellow lines. Nonpolar hydrogens are omitted for clarity. (B) Superposition between the MD-predicted binding poses of <b>3</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (orange sticks) and <b>19</b> at the CXCR4 receptor (gray cartoons). Both images are shown in stereoview.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87805" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87805" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The overexpression of CXCR4 on the cancer cell membrane, along with the CXCL12 release from secondary organs, cooperates in arranging the environment for metastases nestling.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Hence, during the past decade various CXCR4 antagonists have been in development as potential antimetastatic agents.<a onclick="showRef(event, 'ref10 ref12 ref16 ref30'); return false;" href="javascript:void(0);" class="ref ref10 ref12 ref16 ref30">(10, 12, 16, 30)</a> In this respect, we have recently reported the plasma stable and selective CXCR4 peptide antagonist Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d-</span>Cys-Arg-Phe-Phe-Cys]-COOH (<b>3</b>), which however did not yet exhibit the suitable potency (IC<sub>50</sub> of 53 nM) for in vivo studies. Thus, we here embarked in an extensive lead-optimization campaign of <b>3</b>, which led to the identification of a novel potent CXCR4 antagonist (Ac-Arg-Ala-[<span class="smallcaps smallerCapital">d-</span>Cys-Arg-2-Nal-His-Pen]-COOH, <b>19</b>) endowed with an IC<sub>50</sub> of 1.5 nM. Remarkably, the binding potency of <b>19</b> is comparable to that of plerixafor (<b>1</b>), which is the only clinically approved CXCR4 antagonist.<a onclick="showRef(event, 'ref4 ref30'); return false;" href="javascript:void(0);" class="ref ref4 ref30">(4, 30)</a> We also highlight that the chemical modifications applied did affect neither the selectivity nor the stability in biological fluids of <b>19</b> which indeed cannot interact with the related CXCR7 and unrelated CXCR3 chemokine receptors and remains unaltered up to 2 h in human serum. Moreover, NMR and advanced molecular modeling studies allowed us to define the structural reasons beyond the improved activity observed for <b>19</b> versus the lead peptide <b>3</b>. Finally, functional cell-based assays demonstrated that <b>19</b> was able to prevent both cell migration and receptor internalization, which are validated hallmarks for CXCR4 antagonism, at low nanomolar concentration and more efficiently than <b>1</b>. In light of these data, <b>19</b> possesses all the prerequisites, including high affinity, selectivity, and serum stability, that allow this peptide to move toward preclinical investigations aimed to confirm its efficacy in vivo. Likewise, <b>19</b> might represent the starting point for the development of novel chemical probes for PET or MRI studies in CXCR4 overexpressing cancers with the final aim to improve and fine-tune CXCR4-targeted therapies, in the modern context of personalized medicine.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37046" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37046" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry. Materials</h3><div class="NLM_p last"><i>N</i><sup>α</sup>-Fmoc-protected amino acids, 2-chlorotrityl chloride (2-Cl-TrtCl) resin, Fmoc-Rink amide-Am resin, <i>O</i>-benzotriazole-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate (HBTU), <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), triisopropylsilane (TIS), trifluoroacetic acid (TFA), piperidine, and <i>N</i>-hydroxybenzotriazole (HOBt) were from Iris-Biotech Gmbh (Marktredwitz, Germany). <i>N</i>,<i>N</i>-Dimethylformamide (DMF), dichloromethane (DCM), diethyl ether, <i>N</i>-chlorosuccinimide (NCS), H<sub>2</sub>O, CH<sub>3</sub>CN for HPLC and human serum were reagent grade and were acquired from commercial sources (Sigma-Aldrich, Milano, Italy) and used as received unless otherwise noted. Peptides were purified by preparative HPLC (Shimadzu HPLC system) equipped with a C18-bounded preparative RP-HPLC column (Phenomenex Kinetex 21.2 mm × 150 mm, 5 μm). The purity of all the peptides was ≥95% as confirmed by analytical HPLC (Shimadzu Prominance HPLC system) equipped with a C18-bounded analytical RP-HPLC column (Phenomenex Kinetex, 4.6 mm × 250 mm, 5 μm) using a gradient elution (10–90% acetonitrile in water (0.1% TFA) over 15 min; flow rate = 1.0 mL/min; diode array UV detector). Accurate molecular weights of compounds were confirmed by ESI mass spectrometry using a Q Exactive Orbitrap LC–MS/MS (Thermo Fisher Scientific, Waltham, MA, USA) (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01062/suppl_file/jm7b01062_si_001.pdf" class="ext-link">Supporting Information Table S1</a>).</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Procedure for the Synthesis of Peptides</h3><div class="NLM_p last">2-Cl-TrtCl resin (93.0 mg, 1.60 mmol/g) was swollen in dry DMF (2 mL) over 0.5 h, and a solution of Fmoc-<span class="smallcaps smallerCapital">l</span>-Cys(Trt)-OH (59.0 mg, 0.10 mmol, 0.67 equiv) or Fmoc-<span class="smallcaps smallerCapital">l</span>-Pen(Trt)-OH (62.0 mg, 0.10 mmol, 0.67 equiv) and DIPEA (79 μL, 3 equiv) in DMF (2 mL) was added. The mixture was stirred for 24 h. The residual chloride groups contained in the resin were capped by adding MeOH (200 μL) in DCM (2 mL) in the presence of DIPEA (52 μL, 2 equiv) and stirring for 30 min to avoid eventually parallel synthesis of side products. Fmoc group removal was performed using 20% piperidine in DMF (1 × 5 min and 1 × 25 min). The peptide resin was then washed with DCM (3 × 0.5 min) and DMF (3 × 0.5 min), and positive Kaiser ninhydrin<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and 2,4,6-trinitrobenzenesulfonic acid (TNBS)<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> tests were observed. Fmoc-<span class="smallcaps smallerCapital">l</span>-Phe-OH (155.0 mg, 0.4 mmol, 4 equiv) or Fmoc-<span class="smallcaps smallerCapital">l</span><i>-</i>His(Trt)-OH (248.0 mg, 0.4 mmol, 4 equiv) or Fmoc-<span class="smallcaps smallerCapital">l</span>-Phg-OH (149.4 mg, 0.4 mmol, 4 equiv) or Fmoc- <span class="smallcaps smallerCapital">l</span>-Phe(4-NO<sub>2</sub>)-OH (173.0 mg, 0.4 mmol, 4 equiv) or Fmoc-<span class="smallcaps smallerCapital">l</span>-Phe(4-Cl)-OH (168.8 mg, 0.4 mmol, 4 equiv) or Fmoc-<span class="smallcaps smallerCapital">l</span><i>-</i>1-Nal-OH (175.0 mg, 0.4 mmol, 4 equiv) or Fmoc-<span class="smallcaps smallerCapital">l</span><i>-</i>2-Nal-OH (175.0 mg, 0.4 mmol, 4 equiv), Fmoc-<span class="smallcaps smallerCapital">l</span>-Arg(Pbf)-OH (259. 5 mg, 0.4 mmol, 4 equiv), Fmoc-<span class="smallcaps smallerCapital">l</span>-Cys(Trt)-OH (234.3 mg, 0.4 mmol, 4 equiv) or Fmoc-<span class="smallcaps smallerCapital">d</span>-Pen(Trt)-OH (245.5 mg, 0.4 mmol, 4 equiv), Fmoc-<span class="smallcaps smallerCapital">l</span>-Ala-OH (124.5 mg, 0.4 mmoli, 4 equiv) were sequentially added to the resin bound H-<span class="smallcaps smallerCapital">l</span>-Cys(Trt)/<span class="smallcaps smallerCapital">l</span>-Pen(Trt). Each coupling reaction was achieved using a 4-fold excess of amino acid with HBTU (151. 7 mg, 0.4 mmol, 4 equiv) and HOBt (61.2 mg, 0.4 mmol, 4 equiv) in the presence of DIPEA (140 μL, 0.8 mmol, 8 equiv) in DMF. Fmoc deprotections were accomplished with 20% piperidine in DMF solution (1 × 5 min, 1 × 25 min). Washings with DMF (3 × 0.5 min) and DCM (3 × 0.5 min) were performed through every coupling/deprotection step. Kaiser ninhydrin and TNBS tests were employed for monitoring the progress of peptide synthesis. After removal of the last Fmoc group, the resin bound peptide was treated with Ac<sub>2</sub>O (19 μL, 0.2 mmol, 2 equiv) and DIPEA (70 μL, 0.4 mmol, 2 equiv) in DCM (2 mL) and the mixture was shaken for 1 h. Negative Kaiser ninhydrin and TNBS tests were observed.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Procedure for Peptide Oxidation and Purification</h3><div class="NLM_p last">The peptide was released from the solid support and all the protecting groups were cleaved, treating the resin with TFA/DCM/TIS (80/15/5, v/v/v) (3 mL solvent/0.1 mmol) for 2 h. The resin was then filtered off and the crude linear peptide was recovered by precipitation with chilled ether to give a powder. The crude peptide (0.1 mmol) was dissolved in 45 mL of H<sub>2</sub>O, and a solution of NCS (20 mg, 0.15 mmol, 1.5 equiv) in H<sub>2</sub>O (5 mL) was added. The mixture was mechanically stirred for 30 min at room temperature.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The solution mixture was finally purified by preparative RP-HPLC in 0.1% TFA with an acetonitrile (ACN) gradient (10–70% ACN in H<sub>2</sub>O over 20 min, flow rate of 15 mL/min) on a Phenomenex Kinetex C18 column (21.2 mm × 150 mm, 5 μm). Analytical RP-HPLC was performed in 0.1% TFA with an ACN gradient (10–90% ACN in H<sub>2</sub>O over 20 min, flow rate of 1.0 mL/min) on a Phenomenex Kinetex C18 column (0.46 mm × 150 mm, 5 μm).</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> CXC Receptors Binding Assays</h3><div class="NLM_p last">5 × 10<sup>5</sup> CCRF-CEM cells were preincubated with increasing peptide concentrations (ranging from 10 pM to 10 μM) in the binding buffer (PBS 1× plus 0.2% BSA and 0.1% NaN<sub>3</sub>) for 30 min at 37 °C, 5% CO<sub>2</sub> and then labeled for 30 min using an anti-CXCR4 PE-antibody (FAB170P, clone 12G5, R&D Systems, Minneapolis, MN, USA). To evaluate the selectivity toward CXCR4 against CXCR3 and CXCR7, the experiments were also performed on the CXCR3-overexpressing COLO205 cell line using a specific anti-CXCR3 antibody (BD Pharmingen 560831 clone 1C6/CXCR3) as well as on the CXCR7-overexpressing MCF-7 cell line using a specific anti-CXCR7 antibody (R&D FAB4227A clone 11G8). A FACSCanto II flow cytometer (B.D. Biosciences, CA, USA) and the Diva version 6.1.1 software were used to collect and analyze the data, respectively.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <sup>125</sup>I-CXCL12 Competitive Binding</h3><div class="NLM_p last">CCRF-CEM cells were harvested and suspended in the binding buffer (PBS containing 5 mM MgCl<sub>2</sub>, 1 mM CaCl<sub>2</sub>, 0.25% BSA, pH 7.4) with different ligand (<b>3</b> or <b>19</b>) concentrations, ranging from 10 pM to 10 μM and in the presence of fixed tracer amounts of the <sup>125</sup>I-CXCL12 (PerkinElmer, 2200 Ci/mmol). The amount of bound radioactivity was determined after 1 h at 4 °C using a γ counter and expressed as percent of total counts. IC<sub>50</sub> values were calculated through the GraphPad Prism software (GraphPad Software Inc., CA).</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Migration Assay</h3><div class="NLM_p last">Migration was assayed in 24-well Transwell chambers (Corning Inc., Corning, NY) using inserts with 5 and 8 μm (optimal for lymphocytes and epithelial cells, respectively) pore membranes. Membranes were precoated with collagen (human collagen type I/III) and fibronectin (20 μg/mL each). Cells were placed in the upper chamber (2 × 10<sup>5</sup> cells/well) in culture medium containing 1% BSA (migration media) in the presence of increasing ligand (<b>1</b> or <b>19</b>) concentrations (from 10 nM to 10 μM); 100 ng/mL CXCL12 was added to the lower chamber. After 18 h incubation, cells atop the filter were removed using a cotton wool swab; migration of cells in the alone medium (control) was compared with that observed in media containing CXCL12. The cells were counted in 10 different fields (original 400× magnification). The migration index was defined as the ratio between migrating cells in the experimental group and migrated cells in the control group.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> CXCR4 Internalization Assay</h3><div class="NLM_p last">To create the CHO-CXCR4-GFP cell line, the pEGFP-CXCR4 plasmid was transfected by TurboFectin 8.0 (OriGene) in accordance with the manufacturer’s instructions. CHO-CXCR4-GFP cells were grown on 10 mm coverslips in DMEM containing 10% FBS for 1 day, washed with PBS–0.5% BSA, and equilibrated in DMEM–0.5% BSA. Cells were preincubated with <b>1</b> or <b>19</b> at 10 nM for 45 min at 37 °C. Then, they were then treated with CXCL12 (12.5 nM) and incubated at 37 °C for different time intervals (30 min, 2 h, 6 h, and 24 h), fixed with 4% formaldehyde for 10 min, washed three times in PBS, and inspected with a Zeiss LSM 510 confocal microscope.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Serum Biostability Assay</h3><div class="NLM_p last">Serum stability was evaluated applying a previously described protocol.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Briefly, the reaction solution was prepared by mixing 10 μL of water solution of peptide (1 mM) and 90 μL of human serum (at concentration 0.1 mM, 90% serum) and incubated at 37 °C. Aliquots were collected at different times (0, 15 min, 30 min, 60 min, 90 min, and 120 min), subjected to precipitation by addition of ACN (0.1% TFA) solution, and then centrifuged (12 000 rpm, 15 min, 4 °C). The supernatant obtained was analyzed by HPLC using a linear elution gradient from 10% to 90% ACN (0.1% TFA) in water (0.1% TFA) in 30 min.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> NMR Spectroscopy</h3><div class="NLM_p last">The samples for NMR spectroscopy were prepared by dissolving the appropriate amount of <b>19</b> in 540 μL of <sup>1</sup>H<sub>2</sub>O (pH 5.5), 60 μL of <sup>2</sup>H<sub>2</sub>O to obtain a concentration 2 mM of peptide and 200 mM of SDS-<i>d</i><sub>25</sub>. NMR spectra were recorded on a Varian INOVA 700 MHz spectrometer equipped with a <i>z</i>-gradient 5 mm triple-resonance probe head in a 5 mm tube. The spectra were calibrated relative to TSP (0.00 ppm) as internal standard. 1D and 2D NMR spectra were recorded and processed as previously described.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a><sup>3</sup><i>J</i><sub>HN-Hα</sub> coupling constants were obtained from 1D <sup>1</sup>H NMR and 2D DQF-COSY spectra. The temperature coefficients of the amide proton chemical shifts were calculated from 1D <sup>1</sup>H NMR and 2D TOCSY experiments performed at different temperatures in the range 25–35 °C by means of linear regression. The NOE-based distance restraints were obtained from NOESY spectra collected with a 100 ms mixing time. The NOE cross peaks were integrated with the XEASY program<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and were converted into upper distance bounds using the CALIBA program incorporated into the DYANA program package.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> An error-tolerant target function (tf-type = 3) was used to account for the peptide intrinsic flexibility. From the produced 100 conformations, 10 structures were chosen, whose interproton distances best fitted NOE derived distances, and then refined through successive steps of restrained and unrestrained energy minimization using the Discover algorithm (Accelrys, San Diego, CA) and the consistent valence force field (CVFF).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Molecular graphics images of the ensemble and the overlapped structures of <b>3</b> and <b>19</b> were produced using the UCSF Chimera package.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Molecular Modeling</h3><div class="NLM_p">A manual docking of the <b>19</b> lowest energy conformation in the crystal structure of CXCR4 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OE0">3OE0</a>)<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> was first accomplished according to the procedure described in our previous publication.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The obtained complex was then prepared for submission to MD calculations. In detail, the receptor structure was refined using the protocol described in the same paper.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> For the ligand, every possible protomeric and tautomeric state of the His<sup>6</sup> residue was taken into account; therefore, three distinct <b>19</b>/CXCR4 complexes were set up. Each complex was then embedded in a 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) phospholipids bilayer mimicking the membrane environment. Specifically, a 94 Å × 94 Å (along the <i>x</i> and <i>y</i> axes) pre-equilibrated POPC phospholipid bilayer was first created through the membrane-builder tool of CHARMM-GUI.org (<a href="http://www.charmm-gui.org" class="extLink">http://www.charmm-gui.org</a>). Then, a hole was generated into the bilayer to host the complex, and all lipids in close contact with the receptor (<1 Å distant from any protein atoms) were deleted. Each complex was then solvated according to the TIP3 water model<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> through the solvation module of VMD 1.9.3. Cl<sup>–</sup> counterions were added to each system to ensure neutrality. The ff14SB<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> and lipid14<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Amber force fields were used to parametrize the protein and the peptide, and the lipids, respectively. Missing parameters for the peptide 2-Nal<sup>5</sup> and Pen<sup>7</sup> residues were generated with Antechamber.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Specifically, charges were computed using the restrained electrostatic potential (RESP) fitting procedure.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The ESP was first calculated by means of the Gaussian 09 package<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> using a 6-31G* basis set at the Hartree–Fock level of theory, and then the RESP charges were obtained by a two-stage fitting procedure using Antechamber.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Missing bonds, angles, torsion and improper torsion angle parameters were then generated using the same program. Each complex was then submitted to over 200 ns MD simulations with NAMD 2.10.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> A 10 Å cutoff (switched at 8 Å) was used to calculate atom–pair interactions. The long-range electrostatic interactions were computed by means of the particle mesh Ewald (PME) method using a 1.0 Å grid spacing in periodic boundary conditions. The RATTLE algorithm was applied to constrain bonds involving hydrogen atoms, thus allowing the use of a 2 fs integration time step interval. Each system was minimized and heated up to 300 K while applying harmonic constraints, which were gradually released along the equilibration process. To prevent any distortion in the receptor transmembrane helices, their Cα carbons were constrained for further 10 ns. Production run was then performed in the <i>NPT</i> ensemble at 1 atm and 300 K. At the end of MD calculations, all the trajectories were carefully inspected to evaluate their rate of agreement with the experimental data. The best results were observed for the complex with the ligand His<sup>6</sup> in the protonated form, which was thus selected for further analysis.</div><div class="NLM_p">CXCR4 residues were numbered according to both the wild-type primary sequence and the Ballesteros–Weinstein scheme<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> (as superscript).</div><div class="NLM_p last">All of the pictures were rendered using PyMOL (<a href="http://www.pymol.org" class="extLink">www.pymol.org</a>).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01062">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85355" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85355" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01062" class="ext-link">10.1021/acs.jmedchem.7b01062</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Analytical data for the studied peptides; NMR resonance assignments of <b>19</b>; NOE derived upper limit constraints of <b>19</b>; Cα carbons rmsd of <b>19</b> along the MD production run (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01062/suppl_file/jm7b01062_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Model of <b>19</b> at the CXCR4 binding site (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01062/suppl_file/jm7b01062_si_002.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01062/suppl_file/jm7b01062_si_001.pdf">jm7b01062_si_001.pdf (398.9 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01062/suppl_file/jm7b01062_si_002.pdb">jm7b01062_si_002.pdb (185.34 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB code is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OJT">5OJT</a> for the NMR structure of <b>19</b>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b01062" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefania Scala</span> - <span class="hlFld-Affiliation affiliation">Functional
Genomics Unit, Istituto Nazionale per lo
Studio e la Cura dei Tumori “Fondazione Giovanni Pascale”,
IRCCS, Via M. Semmola 52, 80131 Naples, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e794c99484868b86a78e94938e9392938893928a88958ec98986c98e93"><span class="__cf_email__" data-cfemail="2a590459494b464b6a43595e435e5f5e455e5f4745584304444b04435e">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luciana Marinelli</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, University of Naples “Federico
II”, Via D. Montesano 49, 80131 Naples, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4084-8044" title="Orcid link">http://orcid.org/0000-0002-4084-8044</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a1cdccc0d3c8cfc4cde1d4cfc8cfc08fc8d5"><span class="__cf_email__" data-cfemail="d7bbbab6a5beb9b2bb97a2b9beb9b6f9bea3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Salvatore Di Maro</span> - <span class="hlFld-Affiliation affiliation">DiSTABiF, University of Campania “Luigi Vanvitelli”, Caserta 81100, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesco Saverio Di Leva</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, University of Naples “Federico
II”, Via D. Montesano 49, 80131 Naples, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Maria Trotta</span> - <span class="hlFld-Affiliation affiliation">Functional
Genomics Unit, Istituto Nazionale per lo
Studio e la Cura dei Tumori “Fondazione Giovanni Pascale”,
IRCCS, Via M. Semmola 52, 80131 Naples, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diego Brancaccio</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, University of Naples “Federico
II”, Via D. Montesano 49, 80131 Naples, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luigi Portella</span> - <span class="hlFld-Affiliation affiliation">Functional
Genomics Unit, Istituto Nazionale per lo
Studio e la Cura dei Tumori “Fondazione Giovanni Pascale”,
IRCCS, Via M. Semmola 52, 80131 Naples, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michela Aurilio</span> - <span class="hlFld-Affiliation affiliation">Nuclear
Medicine Unit, Department of Diagnostic Imaging, Radiant and Metabolic
Therapy, Istituto Nazionale per lo Studio
e la Cura dei Tumori “Fondazione Giovanni Pascale”,
IRCCS, Via M. Semmola
52, 80131 Naples, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefano Tomassi</span> - <span class="hlFld-Affiliation affiliation">DiSTABiF, University of Campania “Luigi Vanvitelli”, Caserta 81100, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Messere</span> - <span class="hlFld-Affiliation affiliation">DiSTABiF, University of Campania “Luigi Vanvitelli”, Caserta 81100, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah Sementa</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, University of Naples “Federico
II”, Via D. Montesano 49, 80131 Naples, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Secondo Lastoria</span> - <span class="hlFld-Affiliation affiliation">Nuclear
Medicine Unit, Department of Diagnostic Imaging, Radiant and Metabolic
Therapy, Istituto Nazionale per lo Studio
e la Cura dei Tumori “Fondazione Giovanni Pascale”,
IRCCS, Via M. Semmola
52, 80131 Naples, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alfonso Carotenuto</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, University of Naples “Federico
II”, Via D. Montesano 49, 80131 Naples, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ettore Novellino</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, University of Naples “Federico
II”, Via D. Montesano 49, 80131 Naples, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2181-2142" title="Orcid link">http://orcid.org/0000-0002-2181-2142</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>S.D.M., F.S.D.L., and A.M.T. equally contributed to this work. The manuscript was written through contributions from all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d95e2506-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was funded by Scientific Independence of Young Researchers (SIR) 2014 (Grant RBSI142AMA) to S.D.M, MIUR-PRIN 2015 (Grant FCHJ8E) to L.M., and EuroNanomed (Nano) systems with active targeting to sensitize colorectal cancer stem cells to antitumoral treatment (Target4Cancer) to S.S.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i31" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i31"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i32" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i32"> Abbreviations Used</h2><tr><td class="NLM_term">ACN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">APC</td><td class="NLM_def"><p class="first last">allophycocyanin</p></td></tr><tr><td class="NLM_term">CAF</td><td class="NLM_def"><p class="first last">cancer-associated fibroblast</p></td></tr><tr><td class="NLM_term">CCL</td><td class="NLM_def"><p class="first last">CC chemokine ligand</p></td></tr><tr><td class="NLM_term">CCR</td><td class="NLM_def"><p class="first last">CC chemokine receptor</p></td></tr><tr><td class="NLM_term">CXCL</td><td class="NLM_def"><p class="first last">CC chemokine ligand</p></td></tr><tr><td class="NLM_term">CXCR</td><td class="NLM_def"><p class="first last">CXC chemokine receptor</p></td></tr><tr><td class="NLM_term">CVFF</td><td class="NLM_def"><p class="first last">consistent valence force field</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle’s medium</p></td></tr><tr><td class="NLM_term">DQF</td><td class="NLM_def"><p class="first last">double quantum filter</p></td></tr><tr><td class="NLM_term">ECL</td><td class="NLM_def"><p class="first last">extracellular loop</p></td></tr><tr><td class="NLM_term">ESP</td><td class="NLM_def"><p class="first last">electrostatic potential</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">FITC</td><td class="NLM_def"><p class="first last">fluorescein isothiocyanate</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">GSK3</td><td class="NLM_def"><p class="first last">glycogen synthase kinase 3</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last"><i>O</i>-benzotriazole-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last"><i>N</i>-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">IC</td><td class="NLM_def"><p class="first last">inhibitory concentration</p></td></tr><tr><td class="NLM_term">ICR</td><td class="NLM_def"><p class="first last">immune checkpoint receptor</p></td></tr><tr><td class="NLM_term">MMP2</td><td class="NLM_def"><p class="first last">matrix metalloproteinase 2</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">Nal</td><td class="NLM_def"><p class="first last">naphthylalanine</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">phycoerythrin</p></td></tr><tr><td class="NLM_term">POPC</td><td class="NLM_def"><p class="first last">1-palmitoyl-2-oleoylphosphatidylcholine</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">RESP</td><td class="NLM_def"><p class="first last">restrained electrostatic potential</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">SDF-1α</td><td class="NLM_def"><p class="first last">stromal cell derived factor 1α</p></td></tr><tr><td class="NLM_term">SDS</td><td class="NLM_def"><p class="first last">sodium dodecyl sulfate</p></td></tr><tr><td class="NLM_term">STAT3</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription 3</p></td></tr><tr><td class="NLM_term">TIS</td><td class="NLM_def"><p class="first last">triisopropylsilane</p></td></tr><tr><td class="NLM_term">TIMP-1</td><td class="NLM_def"><p class="first last">TIMP metallopeptidase inhibitor 1</p></td></tr><tr><td class="NLM_term">TNBS</td><td class="NLM_def"><p class="first last">2,4,6-trinitrobenzenesulfonic acid</p></td></tr><tr><td class="NLM_term">TOCSY</td><td class="NLM_def"><p class="first last">total correlation spectroscopy</p></td></tr><tr><td class="NLM_term">VEGF</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20806" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20806" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 54 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kochetkova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McColl, S. R.</span><span> </span><span class="NLM_article-title">Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span><span class="refDoi"> DOI: 10.1038/cdd.2008.190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1038%2Fcdd.2008.190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=19136936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1ygsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=664-673&author=M.+Kochetkovaauthor=S.+Kumarauthor=S.+R.+McColl&title=Chemokine+receptors+CXCR4+and+CCR7+promote+metastasis+by+preventing+anoikis+in+cancer+cells&doi=10.1038%2Fcdd.2008.190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells</span></div><div class="casAuthors">Kochetkova, M.; Kumar, S.; McColl, S. R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">664-673</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chemokine receptors are essential mediators of the metastatic spread in various cancer types; however their precise function in the development of secondary tumors remains poorly understood.  We report here a novel property of the chemokine receptors CXCR4 and CCR7 in inhibiting detachment-induced cell death - anoikis, which is believed to be one of the major blocks in the metastatic spread of various neoplasms.  Activation of these chemokine receptors by their resp. ligands, CXCL12 and CCL21 specifically reduced the sensitivity of metastatic breast cancer cells to anoikis by a distinct mechanism of selective regulation of pro-apoptotic Bmf and anti-apoptotic Bcl-xL proteins.  Consequently, functional CXCR4 and CCR7 increased cell survival in the absence of correct ECM attachment both in vitro and in vivo.  We also demonstrated that preventing chemokine-induced redn. in Bmf levels significantly attenuated breast cancer metastasis in an exptl. mouse model.  These results provide evidence for a previously unknown axis in malignant tumors, which connects chemokine receptors with deregulated apoptosis in the absence of the appropriate cell - ECM interaction and may offer novel targets for therapeutic intervention for the treatment of metastatic breast and potentially other tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDfruw4aUvy7Vg90H21EOLACvtfcHk0lgG-6O931BGnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1ygsbc%253D&md5=2dfe068ea27c8df53b48b1806ac4a0e7</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2008.190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2008.190%26sid%3Dliteratum%253Aachs%26aulast%3DKochetkova%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DMcColl%26aufirst%3DS.%2BR.%26atitle%3DChemokine%2520receptors%2520CXCR4%2520and%2520CCR7%2520promote%2520metastasis%2520by%2520preventing%2520anoikis%2520in%2520cancer%2520cells%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2009%26volume%3D16%26spage%3D664%26epage%3D673%26doi%3D10.1038%2Fcdd.2008.190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mukherjee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span> </span><span class="NLM_article-title">The role of chemokine receptor CXCR4 in breast cancer metastasis</span> <span class="citation_source-journal">Am. J. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=23359227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1Cgtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=46-57&author=D.+Mukherjeeauthor=J.+Zhao&title=The+role+of+chemokine+receptor+CXCR4+in+breast+cancer+metastasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The role of chemokine receptor CXCR4 in breast cancer metastasis</span></div><div class="casAuthors">Mukherjee, Debarati; Zhao, Jihe</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-57</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">A review.  Breast cancer is one of the leading causes of cancer related deaths worldwide.  Breast cancer-related mortality is assocd. with the development of metastatic potential of primary tumor lesions.  The chemokine receptor CXCR4 has been found to be a prognostic marker in various types of cancer, including breast cancer.  Recent advances in the field of cancer biol. has pointed to the crit. role that CXCR4 receptor and its ligand CXCL12 play in the metastasis of various types of cancer, including breast cancer.  Breast tumors preferentially metastasize to the lung, bones and lymph nodes, all of which represent organs that secrete high levels of CXCL12.  CXCL12 acts as a chemoattractant that drives CXCR4-pos. primary tumor cells towards secondary metastatic sites leading to the onset of metastatic lesions.  Since its discovery in 2001, the CXCR4 field has progressed at a very fast rate and further studies have pointed to the role of CXCR4 in dissemination of tumor cells from primary sites, transendothelial migration of tumor cells as well as the trafficking and homing of cancer stem cells.  This review summarizes the information that has been obtained over the years regarding the role of CXCL12-CXCR4 signaling in breast cancer, discusses its potential application to the development of new therapeutic tools for breast cancer control, and elucidates the potential therapeutic challenges which lie ahead and the future directions that this field can take for the improvement of prognosis in breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2GsMPs4WKwLVg90H21EOLACvtfcHk0lgG-6O931BGnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1Cgtb8%253D&md5=8d34d3156f63cfd0f4fa204ec5ef6c20</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26atitle%3DThe%2520role%2520of%2520chemokine%2520receptor%2520CXCR4%2520in%2520breast%2520cancer%2520metastasis%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2013%26volume%3D3%26spage%3D46%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Chatterjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azad, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmagadda, S.</span><span> </span><span class="NLM_article-title">The intricate role of CXCR4 in cancer</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1016/B978-0-12-411638-2.00002-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2FB978-0-12-411638-2.00002-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=25287686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlOjsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=31-82&author=S.+Chatterjeeauthor=B.+B.+Azadauthor=S.+Nimmagadda&title=The+intricate+role+of+CXCR4+in+cancer&doi=10.1016%2FB978-0-12-411638-2.00002-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The intricate role of CXCR4 in cancer</span></div><div class="casAuthors">Chatterjee, Samit; Azad, Babak Behnam; Nimmagadda, Sridhar</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">Emerging Applications of Molecular Imaging to Oncology</span>),
    <span class="NLM_cas:pages">31-82</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Chemokines mediate numerous physiol. and pathol. processes related primarily to cell homing and migration.  The chemokine CXCL12, also known as stromal cell-derived factor-1, binds the G-protein-coupled receptor CXCR4, which, through multiple divergent pathways, leads to chemotaxis, enhanced intracellular calcium, cell adhesion, survival, proliferation, and gene transcription.  CXCR4, initially discovered for its involvement in HIV entry and leukocytes trafficking, is overexpressed in more than 23 human cancers.  Cancer cell CXCR4 overexpression contributes to tumor growth, invasion, angiogenesis, metastasis, relapse, and therapeutic resistance.  CXCR4 antagonism has been shown to disrupt tumor - stromal interactions, sensitize cancer cells to cytotoxic drugs, and reduce tumor growth and metastatic burden.  As such, CXCR4 is a target not only for therapeutic intervention but also for noninvasive monitoring of disease progression and therapeutic guidance.  This review provides a comprehensive overview of the biol. involvement of CXCR4 in human cancers, the current status of CXCR4-based therapeutic approaches, as well as recent advances in noninvasive imaging of CXCR4 expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxrYlLFheE17Vg90H21EOLACvtfcHk0lgG-6O931BGnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlOjsbw%253D&md5=993eb25e051b2bb1bace3e96e57a1545</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-411638-2.00002-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-411638-2.00002-1%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DAzad%26aufirst%3DB.%2BB.%26aulast%3DNimmagadda%26aufirst%3DS.%26atitle%3DThe%2520intricate%2520role%2520of%2520CXCR4%2520in%2520cancer%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2014%26volume%3D124%26spage%3D31%26epage%3D82%26doi%3D10.1016%2FB978-0-12-411638-2.00002-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Peinado, H. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matei, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa-Silva, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Psaila, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromberg, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bissell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccia, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erler, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiratsuka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghajar, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyden, D.</span><span> </span><span class="NLM_article-title">Pre-metastatic niches: organ-specific homes for metastases</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span><span class="refDoi"> DOI: 10.1038/nrc.2017.6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1038%2Fnrc.2017.6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=28303905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt1Ont7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=302-317&author=H.+C.+A.+Peinadoauthor=H.+Zhangauthor=I.+R.+Mateiauthor=B.+Costa-Silvaauthor=A.+Hoshinoauthor=G.+Rodriguesauthor=B.+Psailaauthor=R.+N.+Kaplanauthor=J.+F.+Brombergauthor=Y.+Kangauthor=M.+J.+Bissellauthor=T.+R.+Coxauthor=A.+J.+Giacciaauthor=J.+T.+Erlerauthor=S.+Hiratsukaauthor=C.+M.+Ghajarauthor=D.+Lyden&title=Pre-metastatic+niches%3A+organ-specific+homes+for+metastases&doi=10.1038%2Fnrc.2017.6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pre-metastatic niches: organ-specific homes for metastases</span></div><div class="casAuthors">Peinado, Hector; Zhang, Haiying; Matei, Irina R.; Costa-Silva, Bruno; Hoshino, Ayuko; Rodrigues, Goncalo; Psaila, Bethan; Kaplan, Rosandra N.; Bromberg, Jacqueline F.; Kang, Yibin; Bissell, Mina J.; Cox, Thomas R.; Giaccia, Amato J.; Erler, Janine T.; Hiratsuka, Sachie; Ghajar, Cyrus M.; Lyden, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">302-317</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">It is well established that organs of future metastasis are not passive receivers of circulating tumor cells, but are instead selectively and actively modified by the primary tumor before metastatic spread has even occurred.  Sowing the 'seeds' of metastasis requires the action of tumor-secreted factors and tumor-shed extracellular vesicles that enable the 'soil' at distant metastatic sites to encourage the outgrowth of incoming cancer cells.  In this Review, we summarize the main processes and new mechanisms involved in the formation of the pre-metastatic niche.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotciVXm6vhd7Vg90H21EOLACvtfcHk0lg_aKdMFCfaGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt1Ont7w%253D&md5=1aafdc57c473d50560ceb63f299fb2b8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc.2017.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc.2017.6%26sid%3Dliteratum%253Aachs%26aulast%3DPeinado%26aufirst%3DH.%2BC.%2BA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMatei%26aufirst%3DI.%2BR.%26aulast%3DCosta-Silva%26aufirst%3DB.%26aulast%3DHoshino%26aufirst%3DA.%26aulast%3DRodrigues%26aufirst%3DG.%26aulast%3DPsaila%26aufirst%3DB.%26aulast%3DKaplan%26aufirst%3DR.%2BN.%26aulast%3DBromberg%26aufirst%3DJ.%2BF.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DBissell%26aufirst%3DM.%2BJ.%26aulast%3DCox%26aufirst%3DT.%2BR.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26aulast%3DErler%26aufirst%3DJ.%2BT.%26aulast%3DHiratsuka%26aufirst%3DS.%26aulast%3DGhajar%26aufirst%3DC.%2BM.%26aulast%3DLyden%26aufirst%3DD.%26atitle%3DPre-metastatic%2520niches%253A%2520organ-specific%2520homes%2520for%2520metastases%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2017%26volume%3D17%26spage%3D302%26epage%3D317%26doi%3D10.1038%2Fnrc.2017.6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauwels, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witvrouw, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vreese, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenwirth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peichl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Datema, R.</span><span> </span><span class="NLM_article-title">Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">668</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1128/AAC.38.4.668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1128%2FAAC.38.4.668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=7913308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A280%3ADyaK2czgsVWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1994&pages=668-674&author=E.+De+Clercqauthor=N.+Yamamotoauthor=R.+Pauwelsauthor=J.+Balzariniauthor=M.+Witvrouwauthor=K.+De+Vreeseauthor=Z.+Debyserauthor=B.+Rosenwirthauthor=P.+Peichlauthor=R.+Datema&title=Highly+potent+and+selective+inhibition+of+human+immunodeficiency+virus+by+the+bicyclam+derivative+JM3100&doi=10.1128%2FAAC.38.4.668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100</span></div><div class="casAuthors">De Clercq E; Yamamoto N; Pauwels R; Balzarini J; Witvrouw M; De Vreese K; Debyser Z; Rosenwirth B; Peichl P; Datema R</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial agents and chemotherapy</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">668-74</span>
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">Bicyclams, in which the cyclam (1,4,8,11-tetraazacyclotetradecane) moieties are tethered via an aliphatic bridge (i.e., propylene, as in JM2763) are potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) (E.  De Clercq, N.  Yamamoto, R.  Pauwels, M.  Baba, D.  Schols, H.  Nakashima, J.  Balzarini, Z.  Debyser, B.  A.  Murrer, D.  Schwartz, D.  Thornton, G.  Bridger, S.  Fricker, G.  Henson, M.  Abrams, and D.  Picker, Proc.  Natl.  Acad.  Sci.  USA 89:5286-5290, 1992).  We have now found that the bicyclam JM3100, in which the cyclam moieties are tethered by an aromatic bridge [i.e., phenylenebis(methylene)], inhibits the replication of various HIV-1 and HIV-2 strains in various cell lines at a 50% effective concentration (EC50) of 1 to 10 ng/ml, which is about 100-fold lower than the concentration required for JM2763 to inhibit HIV replication and at least 100,000-fold lower than the cytotoxic concentration (> 500 micrograms/ml).  In primary T4 lymphocytes or primary monocytes, JM3100 proved inhibitory to HIV-1(IIIB) and several clinical HIV-1 isolates at an EC50 of less than 1 ng/ml.  On the basis of time-of-addition experiments, JM3100 appeared to interact with a viral uncoating event, and this was further corroborated by an uncoating assay in which RNase sensitivity of [5-3H]uridine-labeled virions was monitored.  In addition, but possibly mechanistically related, JM3100 blocks formation of infectious particles.  JM3100 was also found to interfere directly with virus-induced syncytium formation, albeit at a higher concentration (1 to 2 microgram/ml) than that required for inhibition of viral replication.  Following subcutaneous injection of 10 mg of JM3100 per kg of body weight to rabbits, anti-HIV activity was detected in serum corresponding to serum drug levels exceeding for at least 6 h by >100-fold the EC(50) required to inhibit HIV replication in vitro.  When combined with either 3'-azido-2',3' -dideoxythymidine or 2',3' -dideoxyinosine, JM3100 achieved a additive inhibition of HIV replication, and when repeatedly subcultivated in the presence of JM3100, the virus remained sensitive to the compound for at least 30 passages (120 days) in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwBIyQ7x-DR8K3uFsUIZtkfW6udTcc2ea1ZREz-39Cqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2czgsVWjtQ%253D%253D&md5=8dc19841c28dcd2ce9277898f69addf1</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1128%2FAAC.38.4.668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.38.4.668%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DPauwels%26aufirst%3DR.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DWitvrouw%26aufirst%3DM.%26aulast%3DDe%2BVreese%26aufirst%3DK.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DRosenwirth%26aufirst%3DB.%26aulast%3DPeichl%26aufirst%3DP.%26aulast%3DDatema%26aufirst%3DR.%26atitle%3DHighly%2520potent%2520and%2520selective%2520inhibition%2520of%2520human%2520immunodeficiency%2520virus%2520by%2520the%2520bicyclam%2520derivative%2520JM3100%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1994%26volume%3D38%26spage%3D668%26epage%3D674%26doi%3D10.1128%2FAAC.38.4.668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Donzella, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Este, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagashima, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddon, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allaway, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakmar, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. P.</span><span> </span><span class="NLM_article-title">AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span><span class="refDoi"> DOI: 10.1038/nm0198-072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1038%2Fnm0198-072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=9427609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaK1cXjt1KjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=72-77&author=G.+A.+Donzellaauthor=D.+Scholsauthor=S.+W.+Linauthor=J.+A.+Esteauthor=K.+A.+Nagashimaauthor=P.+J.+Maddonauthor=G.+P.+Allawayauthor=T.+P.+Sakmarauthor=G.+Hensonauthor=E.+De+Clercqauthor=J.+P.+Moore&title=AMD3100%2C+a+small+molecule+inhibitor+of+HIV-1+entry+via+the+CXCR4+co-receptor&doi=10.1038%2Fnm0198-072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">AMD3100, a small molecule inhibitor of HIV-1 entry via the CXC4 co-receptor</span></div><div class="casAuthors">Donzella, George A.; Schols, Dominique; Lin, Steven W.; Este, Jose A.; Nagashima, Kirsten A.; Maddon, Paul J.; Allaway, Graham P.; Sakmar, Thomas P.; Henson, Geoffrey; De Clercq, Erik; Moore, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-77</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">The bicyclam AMD3100 (formula wt. 830) blocks HIV-1 entry and membrane fusion via the CXCR4 co-receptor, but not via CCR5.  AMD3100 prevents monoclonal antibody 2D7 binding to CCR5.  It also inhibits binding of the CXC-chemokine, SDF-1α, to CXCR4 and subsequent signal transduction, but does not itself cause signaling and has no effect on RANTES signaling via CCR5.  Thus, AMD3100 prevents CXCR4 functioning as both a HIV-1 coreceptor and a CXC-chemokine receptor.  Development of small mol. inhibitors of HIV-1 entry is feasible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8es3KyoNLxLVg90H21EOLACvtfcHk0lg_aKdMFCfaGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjt1KjtA%253D%253D&md5=8a62b8e798d4e6447a361ab9fa2adb2a</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1038%2Fnm0198-072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0198-072%26sid%3Dliteratum%253Aachs%26aulast%3DDonzella%26aufirst%3DG.%2BA.%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DS.%2BW.%26aulast%3DEste%26aufirst%3DJ.%2BA.%26aulast%3DNagashima%26aufirst%3DK.%2BA.%26aulast%3DMaddon%26aufirst%3DP.%2BJ.%26aulast%3DAllaway%26aufirst%3DG.%2BP.%26aulast%3DSakmar%26aufirst%3DT.%2BP.%26aulast%3DHenson%26aufirst%3DG.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26atitle%3DAMD3100%252C%2520a%2520small%2520molecule%2520inhibitor%2520of%2520HIV-1%2520entry%2520via%2520the%2520CXCR4%2520co-receptor%26jtitle%3DNat.%2520Med.%26date%3D1998%26volume%3D4%26spage%3D72%26epage%3D77%26doi%3D10.1038%2Fnm0198-072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">The bicyclam AMD3100 story</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">587</span><span class="refDoi"> DOI: 10.1038/nrd1134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1038%2Fnrd1134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=12815382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks1Oqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=581-587&author=E.+De+Clercq&title=The+bicyclam+AMD3100+story&doi=10.1038%2Fnrd1134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Timeline: The bicyclam AMD3100 story</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">581-587</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery and development of the bicyclam AMD3100 - a chemokine receptor antagonist - has highlighted the therapeutic potential of such compds. in HIV infection, inflammatory diseases, cancer and stem-cell mobilization.  Here, the author describes the development process of AMD3100, which began about 15 yr ago with the isolation of an impurity, and the basis for the clin. application of AMD3100 and its congeners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB-TkHJ79RrbVg90H21EOLACvtfcHk0ljBleK-8ELKVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks1Oqsr8%253D&md5=cf8344ba0e19da8ffaadfe8c9b57200c</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1038%2Fnrd1134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1134%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DThe%2520bicyclam%2520AMD3100%2520story%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D581%26epage%3D587%26doi%3D10.1038%2Fnrd1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Seubert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grünwald, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobuch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelter, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siveke, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonavicius, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heikenwalder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinheckel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleeman, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, K.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knolle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krüger, A.</span><span> </span><span class="NLM_article-title">Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1002/hep.27378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1002%2Fhep.27378" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2015&pages=238-248&author=B.+Seubertauthor=B.+Gr%C3%BCnwaldauthor=J.+Kobuchauthor=H.+Cuiauthor=F.+Schelterauthor=S.+Schatenauthor=J.+T.+Sivekeauthor=N.+H.+Limauthor=H.+Nagaseauthor=N.+Simonaviciusauthor=M.+Heikenwalderauthor=T.+Reinheckelauthor=J.+P.+Sleemanauthor=K.-P.+Janssenauthor=P.+A.+Knolleauthor=A.+Kr%C3%BCger&title=Tissue+inhibitor+of+metalloproteinases+%28TIMP%29-1+creates+a+premetastatic+niche+in+the+liver+through+SDF-1%2FCXCR4-dependent+neutrophil+recruitment+in+mice&doi=10.1002%2Fhep.27378"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fhep.27378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.27378%26sid%3Dliteratum%253Aachs%26aulast%3DSeubert%26aufirst%3DB.%26aulast%3DGr%25C3%25BCnwald%26aufirst%3DB.%26aulast%3DKobuch%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DSchelter%26aufirst%3DF.%26aulast%3DSchaten%26aufirst%3DS.%26aulast%3DSiveke%26aufirst%3DJ.%2BT.%26aulast%3DLim%26aufirst%3DN.%2BH.%26aulast%3DNagase%26aufirst%3DH.%26aulast%3DSimonavicius%26aufirst%3DN.%26aulast%3DHeikenwalder%26aufirst%3DM.%26aulast%3DReinheckel%26aufirst%3DT.%26aulast%3DSleeman%26aufirst%3DJ.%2BP.%26aulast%3DJanssen%26aufirst%3DK.-P.%26aulast%3DKnolle%26aufirst%3DP.%2BA.%26aulast%3DKr%25C3%25BCger%26aufirst%3DA.%26atitle%3DTissue%2520inhibitor%2520of%2520metalloproteinases%2520%2528TIMP%2529-1%2520creates%2520a%2520premetastatic%2520niche%2520in%2520the%2520liver%2520through%2520SDF-1%252FCXCR4-dependent%2520neutrophil%2520recruitment%2520in%2520mice%26jtitle%3DHepatology%26date%3D2015%26volume%3D61%26spage%3D238%26epage%3D248%26doi%3D10.1002%2Fhep.27378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ling, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaeth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hail, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konopleva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreeff, M.</span><span> </span><span class="NLM_article-title">The CXCR4 antagonist AMD3465 regulates oncogenic signaling and invasiveness in Vitro and prevents breast cancer growth and metastasis in vivo</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e58426</span><span class="refDoi"> DOI: 10.1371/journal.pone.0058426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1371%2Fjournal.pone.0058426" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e58426&author=X.+Lingauthor=E.+Spaethauthor=Y.+Chenauthor=Y.+Shiauthor=W.+Zhangauthor=W.+Schoberauthor=N.+Hailauthor=M.+Konoplevaauthor=M.+Andreeff&title=The+CXCR4+antagonist+AMD3465+regulates+oncogenic+signaling+and+invasiveness+in+Vitro+and+prevents+breast+cancer+growth+and+metastasis+in+vivo&doi=10.1371%2Fjournal.pone.0058426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0058426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0058426%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DX.%26aulast%3DSpaeth%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSchober%26aufirst%3DW.%26aulast%3DHail%26aufirst%3DN.%26aulast%3DKonopleva%26aufirst%3DM.%26aulast%3DAndreeff%26aufirst%3DM.%26atitle%3DThe%2520CXCR4%2520antagonist%2520AMD3465%2520regulates%2520oncogenic%2520signaling%2520and%2520invasiveness%2520in%2520Vitro%2520and%2520prevents%2520breast%2520cancer%2520growth%2520and%2520metastasis%2520in%2520vivo%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De58426%26doi%3D10.1371%2Fjournal.pone.0058426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Guo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mok, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span> </span><span class="NLM_article-title">CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">816</span><span class="NLM_x">–</span> <span class="NLM_lpage">826</span><span class="refDoi"> DOI: 10.1038/onc.2015.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1038%2Fonc.2015.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=25961926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC28Xis1Ggsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=816-826&author=F.+Guoauthor=Y.+Wangauthor=J.+Liuauthor=S.+C.+Mokauthor=F.+Xueauthor=W.+Zhang&title=CXCL12%2FCXCR4%3A+a+symbiotic+bridge+linking+cancer+cells+and+their+stromal+neighbors+in+oncogenic+communication+networks&doi=10.1038%2Fonc.2015.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks</span></div><div class="casAuthors">Guo, F.; Wang, Y.; Liu, J.; Mok, S. C.; Xue, F.; Zhang, W.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">816-826</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Increasing evidence indicates that the tumor microenvironment has crit. roles in all aspects of cancer biol., including growth, angiogenesis, metastasis and progression.  Although chemokines and their receptors were originally identified as mediators of inflammatory diseases, it is being increasingly recognized that they serve as crit. communication bridges between tumor cells and stromal cells to create a permissive microenvironment for tumor growth and metastasis.  Thus, an important therapeutic strategy for cancer is to break this communication channel and isolate tumor cells for long-term elimination.  Cytokine CXCL12 (also known as stromal-derived factor 1α) and its receptor CXCR4 represent the most promising actionable targets for this strategy.  Both are overexpressed in various cancer types, and this aberrant expression strongly promotes proliferation, migration and invasion through multiple signal pathways.  Several mols. that target CXCL12 or CXCR4 have been developed to interfere with tumor growth and metastasis.  In this article, we review our current understanding of the CXCL12/CXCR4 axis in cancer tumorigenesis and progression and discuss its therapeutic implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv-bVfKbELB7Vg90H21EOLACvtfcHk0ljBleK-8ELKVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xis1Ggsro%253D&md5=72a644a161ef658f930d9adb9474df97</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.139%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMok%26aufirst%3DS.%2BC.%26aulast%3DXue%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DCXCL12%252FCXCR4%253A%2520a%2520symbiotic%2520bridge%2520linking%2520cancer%2520cells%2520and%2520their%2520stromal%2520neighbors%2520in%2520oncogenic%2520communication%2520networks%26jtitle%3DOncogene%26date%3D2016%26volume%3D35%26spage%3D816%26epage%3D826%26doi%3D10.1038%2Fonc.2015.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Scala, S.</span><span> </span><span class="NLM_article-title">Molecular pathways: targeting the CXCR4-CXCL12 axis–untapped potential in the tumor microenvironment</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4278</span><span class="NLM_x">–</span> <span class="NLM_lpage">4285</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-0914</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1158%2F1078-0432.CCR-14-0914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=26199389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1antL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=4278-4285&author=S.+Scala&title=Molecular+pathways%3A+targeting+the+CXCR4-CXCL12+axis%E2%80%93untapped+potential+in+the+tumor+microenvironment&doi=10.1158%2F1078-0432.CCR-14-0914"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Pathways: Targeting the CXCR4-CXCL12 Axis-Untapped Potential in the Tumor Microenvironment</span></div><div class="casAuthors">Scala, Stefania</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4278-4285</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Evidence suggests that the CXC-chemokine receptor-4 pathway plays a role in cancer cell homing and metastasis, and thus represents a potential target for cancer therapy.  The homeostatic microenvironment chemokine CXCL12 binds the CXCR4 and CXCR7 receptors, activating divergent signals on multiple pathways, such as ERK1/2, p38, SAPK/JNK, AKT, mTOR, and the Bruton tyrosine kinase (BTK).  An activating mutation in CXCR4 is responsible for a rare disease, WHIM syndrome (warts, hypogammaglobulinemia, infections, and myelokathexis), and dominant CXCR4 mutations have also been reported in Waldenstrom macroglobulinemia.  The CXCR4-CXCL12 axis regulates the hematopoietic stem cell niche-a property that has led to the approval of the CXCR4 antagonist plerixafor (AMD3100) for mobilization of hematopoietic precursors.  In preclin. models, plerixafor has shown antimetastatic potential in vivo, offering proof of concept.  Other antagonists are in preclin. and clin. development.  Recent evidence demonstrates that inhibiting CXCR4 signaling restores sensitivity to CTLA-4 and PD-1 checkpoint inhibitors, creating a new line for investigation.  Targeting the CXCR4-CXCL12 axis thus offers the possibility of affecting CXCR4-expressing primary tumor cells, modulating the immune response, or synergizing with other targeted anticancer therapies.  Clin Cancer Res; 21(19); 4278-85. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7gM36xQ_iW7Vg90H21EOLACvtfcHk0liBf9XrjB2Dxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1antL3K&md5=6ba33ca92d647c046bdb5a0f7cbd6ac0</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-0914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-0914%26sid%3Dliteratum%253Aachs%26aulast%3DScala%26aufirst%3DS.%26atitle%3DMolecular%2520pathways%253A%2520targeting%2520the%2520CXCR4-CXCL12%2520axis%25E2%2580%2593untapped%2520potential%2520in%2520the%2520tumor%2520microenvironment%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D4278%26epage%3D4285%26doi%3D10.1158%2F1078-0432.CCR-14-0914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mahoney, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennert, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, G. J.</span><span> </span><span class="NLM_article-title">Combination cancer immunotherapy and new immunomodulatory targets</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span><span class="refDoi"> DOI: 10.1038/nrd4591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1038%2Fnrd4591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=26228759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KiurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=561-84&author=M.+K.+Mahoneyauthor=D.+P.+Rennertauthor=G.+J.+Freeman&title=Combination+cancer+immunotherapy+and+new+immunomodulatory+targets&doi=10.1038%2Fnrd4591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Combination cancer immunotherapy and new immunomodulatory targets</span></div><div class="casAuthors">Mahoney, Kathleen M.; Rennert, Paul D.; Freeman, Gordon J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">561-584</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Targeting immune checkpoints such as programmed cell death protein 1 (PD1), programmed cell death 1 ligand 1 (PDL1) and cytotoxic T lymphocyte antigen 4 (CTLA4) has achieved noteworthy benefit in multiple cancers by blocking immunoinhibitory signals and enabling patients to produce an effective antitumor response.  Inhibitors of CTLA4, PD1 or PDL1 administered as single agents have resulted in durable tumor regression in some patients, and combinations of PD1 and CTLA4 inhibitors may enhance antitumor benefit.  Numerous addnl. immunomodulatory pathways as well as inhibitory factors expressed or secreted by myeloid and stromal cells in the tumor microenvironment are potential targets for synergizing with immune checkpoint blockade.  Given the breadth of potential targets in the immune system, crit. questions to address include which combinations should move forward in development and which patients will benefit from these treatments.  This Review discusses the leading drug targets that are expressed on tumor cells and in the tumor microenvironment that allow enhancement of the antitumor immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwi7ChUpfjArVg90H21EOLACvtfcHk0liBf9XrjB2Dxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KiurrJ&md5=b0b598b2a7c62794b4f03c4cea196a97</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1038%2Fnrd4591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4591%26sid%3Dliteratum%253Aachs%26aulast%3DMahoney%26aufirst%3DM.%2BK.%26aulast%3DRennert%26aufirst%3DD.%2BP.%26aulast%3DFreeman%26aufirst%3DG.%2BJ.%26atitle%3DCombination%2520cancer%2520immunotherapy%2520and%2520new%2520immunomodulatory%2520targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D561%26epage%3D84%26doi%3D10.1038%2Fnrd4591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Xing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, J.</span><span> </span><span class="NLM_article-title">Metabolic reprogramming of the tumour microenvironment</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">3892</span><span class="NLM_x">–</span> <span class="NLM_lpage">3898</span><span class="refDoi"> DOI: 10.1111/febs.13402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1111%2Ffebs.13402" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2015&pages=3892-3898&author=Y.+Xingauthor=S.+Zhaoauthor=B.+P.+Zhouauthor=J.+Mi&title=Metabolic+reprogramming+of+the+tumour+microenvironment&doi=10.1111%2Ffebs.13402"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13402%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DB.%2BP.%26aulast%3DMi%26aufirst%3DJ.%26atitle%3DMetabolic%2520reprogramming%2520of%2520the%2520tumour%2520microenvironment%26jtitle%3DFEBS%2520J.%26date%3D2015%26volume%3D282%26spage%3D3892%26epage%3D3898%26doi%3D10.1111%2Ffebs.13402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Braun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qorraj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büttner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saul, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aigner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackensen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jitschin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mougiakakos, D.</span><span> </span><span class="NLM_article-title">CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1788</span><span class="NLM_x">–</span> <span class="NLM_lpage">1792</span><span class="refDoi"> DOI: 10.1038/leu.2016.58</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1038%2Fleu.2016.58" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=1788-1792&author=M.+Braunauthor=M.+Qorrajauthor=M.+B%C3%BCttnerauthor=F.+A.+Kleinauthor=D.+Saulauthor=M.+Aignerauthor=W.+Huberauthor=A.+Mackensenauthor=R.+Jitschinauthor=D.+Mougiakakos&title=CXCL12+promotes+glycolytic+reprogramming+in+acute+myeloid+leukemia+cells+via+the+CXCR4%2FmTOR+axis&doi=10.1038%2Fleu.2016.58"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fleu.2016.58&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2016.58%26sid%3Dliteratum%253Aachs%26aulast%3DBraun%26aufirst%3DM.%26aulast%3DQorraj%26aufirst%3DM.%26aulast%3DB%25C3%25BCttner%26aufirst%3DM.%26aulast%3DKlein%26aufirst%3DF.%2BA.%26aulast%3DSaul%26aufirst%3DD.%26aulast%3DAigner%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DMackensen%26aufirst%3DA.%26aulast%3DJitschin%26aufirst%3DR.%26aulast%3DMougiakakos%26aufirst%3DD.%26atitle%3DCXCL12%2520promotes%2520glycolytic%2520reprogramming%2520in%2520acute%2520myeloid%2520leukemia%2520cells%2520via%2520the%2520CXCR4%252FmTOR%2520axis%26jtitle%3DLeukemia%26date%3D2016%26volume%3D30%26spage%3D1788%26epage%3D1792%26doi%3D10.1038%2Fleu.2016.58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Karpova, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spohn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chudziak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiercinska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevalier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembowsky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonig, H.</span><span> </span><span class="NLM_article-title">The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than plerixafor</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2322</span><span class="NLM_x">–</span> <span class="NLM_lpage">2331</span><span class="refDoi"> DOI: 10.1038/leu.2013.266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1038%2Fleu.2013.266" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=2322-2331&author=D.+Karpovaauthor=K.+Dauberauthor=G.+Spohnauthor=D.+Chudziakauthor=E.+Wiercinskaauthor=M.+Schulzauthor=A.+R.+Pettitauthor=J.+P.+Levesqueauthor=B.+Romagnoliauthor=K.+Patelauthor=E.+Chevalierauthor=K.+Dembowskyauthor=H.+Bonig&title=The+novel+CXCR4+antagonist+POL5551+mobilizes+hematopoietic+stem+and+progenitor+cells+with+greater+efficiency+than+plerixafor&doi=10.1038%2Fleu.2013.266"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1038%2Fleu.2013.266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2013.266%26sid%3Dliteratum%253Aachs%26aulast%3DKarpova%26aufirst%3DD.%26aulast%3DDauber%26aufirst%3DK.%26aulast%3DSpohn%26aufirst%3DG.%26aulast%3DChudziak%26aufirst%3DD.%26aulast%3DWiercinska%26aufirst%3DE.%26aulast%3DSchulz%26aufirst%3DM.%26aulast%3DPettit%26aufirst%3DA.%2BR.%26aulast%3DLevesque%26aufirst%3DJ.%2BP.%26aulast%3DRomagnoli%26aufirst%3DB.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DChevalier%26aufirst%3DE.%26aulast%3DDembowsky%26aufirst%3DK.%26aulast%3DBonig%26aufirst%3DH.%26atitle%3DThe%2520novel%2520CXCR4%2520antagonist%2520POL5551%2520mobilizes%2520hematopoietic%2520stem%2520and%2520progenitor%2520cells%2520with%2520greater%2520efficiency%2520than%2520plerixafor%26jtitle%3DLeukemia%26date%3D2013%26volume%3D27%26spage%3D2322%26epage%3D2331%26doi%3D10.1038%2Fleu.2013.266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sison, E. A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magoon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annesley, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuffin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span> </span><span class="NLM_article-title">POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">30902</span><span class="NLM_x">–</span> <span class="NLM_lpage">30918</span><span class="refDoi"> DOI: 10.18632/oncotarget.5094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.18632%2Foncotarget.5094" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=30902-30918&author=E.+A.+R.+Sisonauthor=D.+Magoonauthor=L.+Liauthor=C.+E.+Annesleyauthor=B.+Romagnoliauthor=G.+J.+Douglasauthor=G.+Tuffinauthor=J.+Zimmermannauthor=P.+Brown&title=POL5551%2C+a+novel+and+potent+CXCR4+antagonist%2C+enhances+sensitivity+to+chemotherapy+in+pediatric+ALL&doi=10.18632%2Foncotarget.5094"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.5094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.5094%26sid%3Dliteratum%253Aachs%26aulast%3DSison%26aufirst%3DE.%2BA.%2BR.%26aulast%3DMagoon%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DAnnesley%26aufirst%3DC.%2BE.%26aulast%3DRomagnoli%26aufirst%3DB.%26aulast%3DDouglas%26aufirst%3DG.%2BJ.%26aulast%3DTuffin%26aufirst%3DG.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DP.%26atitle%3DPOL5551%252C%2520a%2520novel%2520and%2520potent%2520CXCR4%2520antagonist%252C%2520enhances%2520sensitivity%2520to%2520chemotherapy%2520in%2520pediatric%2520ALL%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D30902%26epage%3D30918%26doi%3D10.18632%2Foncotarget.5094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Tamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arakaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanbara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omagari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibuka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">882</span><span class="refDoi"> DOI: 10.1006/bbrc.1998.9871</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1006%2Fbbrc.1998.9871" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=9918823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaK1MXjs1Gntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1998&pages=877-882&author=H.+Tamamuraauthor=Y.+Xuauthor=T.+Hattoriauthor=X.+Zhangauthor=R.+Arakakiauthor=K.+Kanbaraauthor=A.+Omagariauthor=A.+Otakaauthor=T.+Ibukaauthor=N.+Yamamotoauthor=H.+Nakashimaauthor=N.+Fujii&title=A+low-molecular-weight+inhibitor+against+the+chemokine+receptor+CXCR4%3A+a+strong+anti-HIV+peptide+T140&doi=10.1006%2Fbbrc.1998.9871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140</span></div><div class="casAuthors">Tamamura, Hirokazu; Xu, Younong; Hattori, Toshio; Zhang, Xiaoyan; Arakaki, Rieko; Kanbara, Kenji; Omagari, Akane; Otaka, Akira; Ibuka, Toshiro; Yamamoto, Naoki; Nakashima, Hideki; Fujii, Nobutaka</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">877-882</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">T22 ([Tyr5,12, Lys7]-polyphemusin II) is an 18-residue peptide amide, which has strong anti-HIV activity.  T22 inhibits the T cell line-tropic (T-tropic) HIV-1 infection through its specific binding to a chemokine receptor CXCR4, which serves as a coreceptor for the entry of T-tropic HIV-1 strains.  Herein, we report our finding of novel 14-residue CXCR4 inhibitors, T134 and T140, on the basis of the T22 structure.  In the assays we examd., T140 showed the highest inhibitory activity against HIV-1 entry and the strongest inhibitory effect on the binding of an anti-CXCR4 monoclonal antibody (12G5) to CXCR4 among all the CXCR4 inhibitors that have been reported up to now.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEj0riEXDmLbVg90H21EOLACvtfcHk0lhIn1fIK8RRBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs1Gntg%253D%253D&md5=e35371993e05ac4d4bba3a47a97a4633</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1998.9871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1998.9871%26sid%3Dliteratum%253Aachs%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DArakaki%26aufirst%3DR.%26aulast%3DKanbara%26aufirst%3DK.%26aulast%3DOmagari%26aufirst%3DA.%26aulast%3DOtaka%26aufirst%3DA.%26aulast%3DIbuka%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DA%2520low-molecular-weight%2520inhibitor%2520against%2520the%2520chemokine%2520receptor%2520CXCR4%253A%2520a%2520strong%2520anti-HIV%2520peptide%2520T140%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1998%26volume%3D253%26spage%3D877%26epage%3D882%26doi%3D10.1006%2Fbbrc.1998.9871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Tamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramatsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">550</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span><span class="refDoi"> DOI: 10.1016/S0014-5793(03)00824-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2FS0014-5793%2803%2900824-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=12935890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVKntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=550&publication_year=2003&pages=79-83&author=H.+Tamamuraauthor=A.+Horiauthor=N.+Kanzakiauthor=K.+Hiramatsuauthor=M.+Mizumotoauthor=H.+Nakashimaauthor=N.+Yamamotoauthor=A.+Otakaauthor=N.+Fujii&title=T140+analogs+as+CXCR4+antagonists+identified+as+anti-metastatic+agents+in+the+treatment+of+breast+cancer&doi=10.1016%2FS0014-5793%2803%2900824-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer</span></div><div class="casAuthors">Tamamura, Hirokazu; Hori, Akira; Kanzaki, Naoyuki; Hiramatsu, Kenichi; Mizumoto, Makiko; Nakashima, Hideki; Yamamoto, Naoki; Otaka, Akira; Fujii, Nobutaka</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">550</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">79-83</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A chemokine receptor, CXCR4, and its endogenous ligand, stromal cell-derived factor-1 (SDF-1), have been recognized to be involved in the metastasis of several types of cancers.  T140 analogs are peptidic CXCR4 antagonists composed of 14 amino acid residues that were previously developed as anti-HIV agents having inhibitory activity against HIV-entry through its co-receptor, CXCR4.  Herein, we report that these compds. effectively inhibited SDF-1-induced migration of human breast cancer cells (MDA-MB-231), human leukemia T cells (Sup-T1) and human umbilical vein endothelial cells at concns. of 10-100 nM in vitro.  Furthermore, slow release administration by s.c. injection using an Alzet osmotic pump of a potent and bio-stable T140 analog, 4F-benzoyl-TN14003, gave a partial, but statistically significant (P≤0.05 (t-test)) redn. in pulmonary metastasis of MDA-MB-231 in SCID mice, even though no attempt was made to inhibit other important targets such as CCR7.  These results suggest that T140 analogs have potential use for cancer therapy, and that small mol. CXCR4 antagonists could potentially replace neutralizing antibodies as anti-metastatic agents for breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk7c7EwYgSAbVg90H21EOLACvtfcHk0lhIn1fIK8RRBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVKntr0%253D&md5=a82059ca8a491623b48cb722819238ab</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2803%2900824-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252803%252900824-X%26sid%3Dliteratum%253Aachs%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DHori%26aufirst%3DA.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DHiramatsu%26aufirst%3DK.%26aulast%3DMizumoto%26aufirst%3DM.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DOtaka%26aufirst%3DA.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DT140%2520analogs%2520as%2520CXCR4%2520antagonists%2520identified%2520as%2520anti-metastatic%2520agents%2520in%2520the%2520treatment%2520of%2520breast%2520cancer%26jtitle%3DFEBS%2520Lett.%26date%3D2003%26volume%3D550%26spage%3D79%26epage%3D83%26doi%3D10.1016%2FS0014-5793%2803%2900824-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kobayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">Structure-activity relationship study of a CXC chemokine receptor type 4 antagonist, FC131, using a series of alkene dipeptide isosteres</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2746</span><span class="NLM_x">–</span> <span class="NLM_lpage">2757</span><span class="refDoi"> DOI: 10.1021/jm2016914</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2016914" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2746-2757&author=K.+Kobayashiauthor=S.+Oishiauthor=R.+Hayashiauthor=K.+Tomitaauthor=T.+Kuboauthor=N.+Tanaharaauthor=H.+Ohnoauthor=Y.+Yoshikawaauthor=T.+Furuyaauthor=M.+Hoshinoauthor=N.+Fujii&title=Structure-activity+relationship+study+of+a+CXC+chemokine+receptor+type+4+antagonist%2C+FC131%2C+using+a+series+of+alkene+dipeptide+isosteres&doi=10.1021%2Fjm2016914"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm2016914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2016914%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DHayashi%26aufirst%3DR.%26aulast%3DTomita%26aufirst%3DK.%26aulast%3DKubo%26aufirst%3DT.%26aulast%3DTanahara%26aufirst%3DN.%26aulast%3DOhno%26aufirst%3DH.%26aulast%3DYoshikawa%26aufirst%3DY.%26aulast%3DFuruya%26aufirst%3DT.%26aulast%3DHoshino%26aufirst%3DM.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520a%2520CXC%2520chemokine%2520receptor%2520type%25204%2520antagonist%252C%2520FC131%252C%2520using%2520a%2520series%2520of%2520alkene%2520dipeptide%2520isosteres%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2746%26epage%3D2757%26doi%3D10.1021%2Fjm2016914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Mungalpara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, Ø.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eksteen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Våbenø, J.</span><span> </span><span class="NLM_article-title">Rational design of conformationally constrained cyclopentapeptide antagonists for C-X-C chemokine receptor 4 (CXCR4)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10287</span><span class="NLM_x">–</span> <span class="NLM_lpage">10291</span><span class="refDoi"> DOI: 10.1021/jm300926y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300926y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10287-10291&author=J.+Mungalparaauthor=S.+Thieleauthor=%C3%98.+Eriksenauthor=J.+Eksteenauthor=M.+M.+Rosenkildeauthor=J.+V%C3%A5ben%C3%B8&title=Rational+design+of+conformationally+constrained+cyclopentapeptide+antagonists+for+C-X-C+chemokine+receptor+4+%28CXCR4%29&doi=10.1021%2Fjm300926y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm300926y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300926y%26sid%3Dliteratum%253Aachs%26aulast%3DMungalpara%26aufirst%3DJ.%26aulast%3DThiele%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3D%25C3%2598.%26aulast%3DEksteen%26aufirst%3DJ.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26atitle%3DRational%2520design%2520of%2520conformationally%2520constrained%2520cyclopentapeptide%2520antagonists%2520for%2520C-X-C%2520chemokine%2520receptor%25204%2520%2528CXCR4%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10287%26epage%3D10291%26doi%3D10.1021%2Fjm300926y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Demmer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dijkgraaf, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span> </span><span class="NLM_article-title">Design, synthesis, and functionalization of dimeric peptides targeting chemokine receptor CXCR4</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7648</span><span class="NLM_x">–</span> <span class="NLM_lpage">7662</span><span class="refDoi"> DOI: 10.1021/jm2009716</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2009716" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7648-7662&author=O.+Demmerauthor=I.+Dijkgraafauthor=U.+Schumacherauthor=L.+Marinelliauthor=S.+Cosconatiauthor=E.+Gourniauthor=H.+J.+Westerauthor=H.+Kessler&title=Design%2C+synthesis%2C+and+functionalization+of+dimeric+peptides+targeting+chemokine+receptor+CXCR4&doi=10.1021%2Fjm2009716"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1021%2Fjm2009716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2009716%26sid%3Dliteratum%253Aachs%26aulast%3DDemmer%26aufirst%3DO.%26aulast%3DDijkgraaf%26aufirst%3DI.%26aulast%3DSchumacher%26aufirst%3DU.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DGourni%26aufirst%3DE.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DKessler%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520functionalization%2520of%2520dimeric%2520peptides%2520targeting%2520chemokine%2520receptor%2520CXCR4%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7648%26epage%3D7662%26doi%3D10.1021%2Fjm2009716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Demmer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagn, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schottelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brack-Werner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span> </span><span class="NLM_article-title">A conformationally frozen peptoid boosts CXCR4 affinity and anti-HIV activity</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">8110</span><span class="NLM_x">–</span> <span class="NLM_lpage">8113</span><span class="refDoi"> DOI: 10.1002/anie.201202090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1002%2Fanie.201202090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVSrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=8110-8113&author=O.+Demmerauthor=A.+O.+Frankauthor=F.+Hagnauthor=M.+Schotteliusauthor=L.+Marinelliauthor=S.+Cosconatiauthor=R.+Brack-Wernerauthor=S.+Krembauthor=H.+J.+Westerauthor=H.+Kessler&title=A+conformationally+frozen+peptoid+boosts+CXCR4+affinity+and+anti-HIV+activity&doi=10.1002%2Fanie.201202090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">A conformationally frozen peptoid boosts CXCR4 affinity and anti-HIV activity</span></div><div class="casAuthors">Demmer, Oliver; Frank, Andreas O.; Hagn, Franz; Schottelius, Margret; Marinelli, Luciana; Cosconati, Sandro; Brack-Werner, Ruth; Kremb, Stephan; Wester, Hans-Juergen; Kessler, Horst</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">8110-8113, S8110/1-S8110/27</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We succeeded in restricting the conformation of a known CXCR4 ligand into a single active conformation by using a peptoid motif.  In combination with structure-activity relationship studies the binding affinity was optimized to be 400 to 1500-fold higher than compds. currently under clin. development, such as KRH-1636 or AMD3100.  AMD3100 is approved by the FDA for treatment of non-Hodgkin lymphoma and multiple myeloma.  Together with the advantages of modified cyclic peptides as drugs (e.g. biocompatible metab., high stability against enzymic degrdn., selectivity profile) this mol. has the potential to be a promising candidate for future medical applications in CXCR4 related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbf7rrhGn4zbVg90H21EOLACvtfcHk0lhMTmU2ECz1Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVSrtLk%253D&md5=c4dfb9d7271aa2cd85c36c5605a1a511</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1002%2Fanie.201202090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201202090%26sid%3Dliteratum%253Aachs%26aulast%3DDemmer%26aufirst%3DO.%26aulast%3DFrank%26aufirst%3DA.%2BO.%26aulast%3DHagn%26aufirst%3DF.%26aulast%3DSchottelius%26aufirst%3DM.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DBrack-Werner%26aufirst%3DR.%26aulast%3DKremb%26aufirst%3DS.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DKessler%26aufirst%3DH.%26atitle%3DA%2520conformationally%2520frozen%2520peptoid%2520boosts%2520CXCR4%2520affinity%2520and%2520anti-HIV%2520activity%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D8110%26epage%3D8113%26doi%3D10.1002%2Fanie.201202090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Peng, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kays, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gough, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uhlik, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamek-Gliszczynski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijsman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Credille, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L. Z.</span><span> </span><span class="NLM_article-title">Identification of LY2510924, a novel cyclic peptide CXCR4 antagonist that exhibits antitumor activities in solid tumor and breast cancer metastatic models</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">480</span><span class="NLM_x">–</span> <span class="NLM_lpage">490</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0850</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1158%2F1535-7163.MCT-14-0850" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=25504752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitlOjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=480-490&author=S.+B.+Pengauthor=X.+Zhangauthor=D.+Paulauthor=L.+M.+Kaysauthor=W.+Goughauthor=J.+Stewartauthor=M.+T.+Uhlikauthor=Q.+Chenauthor=Y.+H.+Huiauthor=M.+J.+Zamek-Gliszczynskiauthor=J.+A.+Wijsmanauthor=K.+M.+Credilleauthor=L.+Z.+Yan&title=Identification+of+LY2510924%2C+a+novel+cyclic+peptide+CXCR4+antagonist+that+exhibits+antitumor+activities+in+solid+tumor+and+breast+cancer+metastatic+models&doi=10.1158%2F1535-7163.MCT-14-0850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of LY2510924, a Novel Cyclic Peptide CXCR4 Antagonist That Exhibits Antitumor Activities in Solid Tumor and Breast Cancer Metastatic Models</span></div><div class="casAuthors">Peng, Sheng-Bin; Zhang, Xiaoyi; Paul, Donald; Kays, Lisa M.; Gough, Wendy; Stewart, Julie; Uhlik, Mark T.; Chen, Qi; Hui, Yu-Hua; Zamek-Gliszczynski, Maciej J.; Wijsman, John A.; Credille, Kelly M.; Yan, Liang Zeng</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">480-490</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Emerging evidence demonstrates that stromal cell-derived factor 1 (SDF-1) and CXCR4, a chemokine and chemokine receptor pair, play important roles in tumorigenesis.  In this report, we describe a small cyclic peptide, LY2510924, which is a potent and selective CXCR4 antagonist currently in phase II clin. studies for cancer.  LY2510924 specifically blocked SDF-1 binding to CXCR4 with IC50 value of 0.079 nmol/L, and inhibited SDF-1-induced GTP binding with Kb value of 0.38 nmol/L.  In human lymphoma U937 cells expressing endogenous CXCR4, LY2510924 inhibited SDF-1-induced cell migration with IC50 value of 0.26 nmol/L and inhibited SDF-1/CXCR4-mediated intracellular signaling.  LY2510924 exhibited a concn.-dependent inhibition of SDF-1-stimulated phospho-ERK and phospho-Akt in tumor cells.  Biochem. and cellular analyses revealed that LY2510924 had no apparent agonist activity.  Pharmacokinetic analyses suggested that LY2510924 had acceptable in vivo stability and a pharmacokinetic profile similar to a typical small-mol. inhibitor in preclin. species.  LY2510924 showed dose-dependent inhibition of tumor growth in human xenograft models developed with non-Hodgkin lymphoma, renal cell carcinoma, lung, and colon cancer cells that express functional CXCR4.  In MDA-MB-231, a breast cancer metastatic model, LY2510924 inhibited tumor metastasis by blocking migration/homing process of tumor cells to the lung and by inhibiting cell proliferation after tumor cell homing.  Collectively, the preclin. data support further investigation of LY2510924 in clin. studies for cancer.  Mol Cancer Ther; 14(2); 480-90. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeA_Qz6C59GLVg90H21EOLACvtfcHk0lhMTmU2ECz1Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitlOjtrw%253D&md5=bb0e6b2bbd36e8c2c10ae5edd8b1755d</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0850%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DS.%2BB.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DPaul%26aufirst%3DD.%26aulast%3DKays%26aufirst%3DL.%2BM.%26aulast%3DGough%26aufirst%3DW.%26aulast%3DStewart%26aufirst%3DJ.%26aulast%3DUhlik%26aufirst%3DM.%2BT.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DHui%26aufirst%3DY.%2BH.%26aulast%3DZamek-Gliszczynski%26aufirst%3DM.%2BJ.%26aulast%3DWijsman%26aufirst%3DJ.%2BA.%26aulast%3DCredille%26aufirst%3DK.%2BM.%26aulast%3DYan%26aufirst%3DL.%2BZ.%26atitle%3DIdentification%2520of%2520LY2510924%252C%2520a%2520novel%2520cyclic%2520peptide%2520CXCR4%2520antagonist%2520that%2520exhibits%2520antitumor%2520activities%2520in%2520solid%2520tumor%2520and%2520breast%2520cancer%2520metastatic%2520models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D480%26epage%3D490%26doi%3D10.1158%2F1535-7163.MCT-14-0850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hainsworth, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mace, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamid, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stille, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polzer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, E. R.</span><span> </span><span class="NLM_article-title">A Randomized, open-label phase 2 study of the CXCR4 inhibitor LY2510924 in combination with sunitinib versus sunitinib alone in patients with metastatic renal cell carcinoma (RCC)</span> <span class="citation_source-journal">Target Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">653</span><span class="refDoi"> DOI: 10.1007/s11523-016-0434-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1007%2Fs11523-016-0434-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=27154357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A280%3ADC%252BC28bntFantA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=643-653&author=J.+D.+Hainsworthauthor=J.+A.+Reevesauthor=J.+R.+Maceauthor=E.+J.+Craneauthor=O.+Hamidauthor=J.+R.+Stilleauthor=A.+Flyntauthor=S.+Robersonauthor=J.+Polzerauthor=E.+R.+Arrowsmith&title=A+Randomized%2C+open-label+phase+2+study+of+the+CXCR4+inhibitor+LY2510924+in+combination+with+sunitinib+versus+sunitinib+alone+in+patients+with+metastatic+renal+cell+carcinoma+%28RCC%29&doi=10.1007%2Fs11523-016-0434-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC)</span></div><div class="casAuthors">Hainsworth John D; Reeves James A; Mace Joseph R; Crane Edward J; Hamid Oday; Stille John R; Roberson Stephanie; Polzer John; Flynt Amy; Arrowsmith Edward R</div><div class="citationInfo"><span class="NLM_cas:title">Targeted oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">643-653</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The chemokine (C-X-C Motif) receptor 4 (CXCR4) and its ligand, stromal-cell derived factor-1 (SDF-1), are frequently overexpressed in a variety of solid tumors, and are believed to play important roles in the regulation of organ-specific metastasis, tumor growth, invasion, and survival.  In this randomized Phase 2 trial, we evaluated the safety and efficacy of LY2510924 (LY), a peptide antagonist of CXCR4, combined with sunitinib (SUN) in the first-line treatment of advanced renal cell carcinoma (RCC).  PATIENTS AND METHODS:  Eligible patients were randomized (2:1) to receive LY (20 mg SC daily) + SUN (50 mg PO daily for 4 weeks followed by 2 weeks off) or SUN alone.  Response was assessed after two cycles; patients continued treatment until tumor progression or intolerable toxicity.  The study was powered to detect a 47 % increase in median progression-free survival (PFS).  RESULTS:  One hundred eight patients were randomized and treated (LY + SUN, 72; SUN, 36); median duration of treatment of five cycles.  Observed median PFS was 8.1 months with LY + SUN and 12.3 months with SUN; Bayesian time-to-event HR 1.23; 95 % credible interval: 0.74, 1.96.  LY was well tolerated; the toxicity profile was typical of SUN.  No efficacy differences were seen between treatments groups when subsets with high versus low levels of CXCR4 tumor expression were compared.  CONCLUSIONS:  The addition of LY to SUN in the first-line treatment of metastatic RCC was well tolerated, but did not improve the PFS or overall survival (OS) vs.  SUN alone.  CXCR4 remains an unproven therapeutic target for the treatment of RCC.  CLINICAL TRIAL:  GOV IDENTIFIER:  NCT01391130.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTP19WHsYgumJggzHGM8X5CfW6udTcc2ebHCCmyNT68KLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bntFantA%253D%253D&md5=5a1f149efdfa191afe88beb5b6f4f92c</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1007%2Fs11523-016-0434-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11523-016-0434-9%26sid%3Dliteratum%253Aachs%26aulast%3DHainsworth%26aufirst%3DJ.%2BD.%26aulast%3DReeves%26aufirst%3DJ.%2BA.%26aulast%3DMace%26aufirst%3DJ.%2BR.%26aulast%3DCrane%26aufirst%3DE.%2BJ.%26aulast%3DHamid%26aufirst%3DO.%26aulast%3DStille%26aufirst%3DJ.%2BR.%26aulast%3DFlynt%26aufirst%3DA.%26aulast%3DRoberson%26aufirst%3DS.%26aulast%3DPolzer%26aufirst%3DJ.%26aulast%3DArrowsmith%26aufirst%3DE.%2BR.%26atitle%3DA%2520Randomized%252C%2520open-label%2520phase%25202%2520study%2520of%2520the%2520CXCR4%2520inhibitor%2520LY2510924%2520in%2520combination%2520with%2520sunitinib%2520versus%2520sunitinib%2520alone%2520in%2520patients%2520with%2520metastatic%2520renal%2520cell%2520carcinoma%2520%2528RCC%2529%26jtitle%3DTarget%2520Oncol.%26date%3D2016%26volume%3D11%26spage%3D643%26epage%3D653%26doi%3D10.1007%2Fs11523-016-0434-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Salgia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stille, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleod, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamid, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polzer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spigel, D. R.</span><span> </span><span class="NLM_article-title">A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer</span> <span class="citation_source-journal">Lung Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1016/j.lungcan.2016.12.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2Fj.lungcan.2016.12.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=28236984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A280%3ADC%252BC1czgsFGrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2017&pages=7-13&author=R.+Salgiaauthor=J.+R.+Stilleauthor=R.+W.+Weaverauthor=M.+McCleodauthor=O.+Hamidauthor=J.+Polzerauthor=S.+Robersonauthor=A.+Flyntauthor=D.+R.+Spigel&title=A+randomized+phase+II+study+of+LY2510924+and+carboplatin%2Fetoposide+versus+carboplatin%2Fetoposide+in+extensive-disease+small+cell+lung+cancer&doi=10.1016%2Fj.lungcan.2016.12.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer</span></div><div class="casAuthors">Salgia Ravi; Stille John R; Hamid Oday; Polzer John; Roberson Stephanie; Weaver R Waide; McCleod Michael; Flynt Amy; Spigel David R</div><div class="citationInfo"><span class="NLM_cas:title">Lung cancer (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  This multicenter, open-label, randomized phase II study evaluated the efficacy and safety of LY2510924 (LY) added to first-line standard of care (SOC) chemotherapy for extensive-disease small cell lung cancer (ED-SCLC) and explored the predictive value of C-X-C motif receptor 4 (CXCR4) tumor response.  MATERIALS AND METHODS:  Patients with treatment-naive ED-SCLC were randomized (1:1) to receive up to six 21-day cycles of carboplatin/etoposide alone (SOC) or in combination with 20mg LY2510924 administered subcutaneously on days 1-7 of each cycle (LY+SOC).  The primary efficacy endpoint was progression-free survival (PFS).  Secondary endpoints were overall survival (OS), overall response rate (ORR), and safety.  Response relative to CXCR4 expression on baseline tumor was an exploratory endpoint.  RESULTS:  Of 94 patients randomized, 90 received treatment (LY+SOC, n=47; SOC, n=43).  Median PFS (95% confidence interval [CI]) was 5.88 (4.83, 6.24) months for LY+SOC versus 5.85 (4.63, 5.51) months for SOC (hazard ratio [95% CI], 1.01 [0.62, 1.63]; p=0.9806).  Median OS (95% CI) was 9.72 (6.64, 11.70) months for LY+SOC versus 11.14 (8.25, 13.44) months for SOC.  ORR was 74.5% for LY+SOC versus 81% for SOC.  Safety results between arms were similar, although the following adverse events were more frequent on the LY+SOC arm: anemia (61.7% vs 46.5%), neutropenia (61.7% vs 53.5%), leukopenia (27.7% vs 9.3%), vomiting (27.7% vs 16.3%), and pneumonia (10.6% vs 2.3%).  In patients whose baseline CXCR4 expression was above the optimal cutoff (H-score 210), the hazard ratio (95% CI) was 1.27 (0.51, 3.15).  CONCLUSION:  LY2510924 did not improve efficacy but had an acceptable toxicity profile when added to SOC for ED-SCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQM8R0bCaEq4u_Q9URG6Dx8fW6udTcc2ebHCCmyNT68KLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czgsFGrsA%253D%253D&md5=42ad7f380503dd698528c74a33120341</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1016%2Fj.lungcan.2016.12.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lungcan.2016.12.020%26sid%3Dliteratum%253Aachs%26aulast%3DSalgia%26aufirst%3DR.%26aulast%3DStille%26aufirst%3DJ.%2BR.%26aulast%3DWeaver%26aufirst%3DR.%2BW.%26aulast%3DMcCleod%26aufirst%3DM.%26aulast%3DHamid%26aufirst%3DO.%26aulast%3DPolzer%26aufirst%3DJ.%26aulast%3DRoberson%26aufirst%3DS.%26aulast%3DFlynt%26aufirst%3DA.%26aulast%3DSpigel%26aufirst%3DD.%2BR.%26atitle%3DA%2520randomized%2520phase%2520II%2520study%2520of%2520LY2510924%2520and%2520carboplatin%252Fetoposide%2520versus%2520carboplatin%252Fetoposide%2520in%2520extensive-disease%2520small%2520cell%2520lung%2520cancer%26jtitle%3DLung%2520Cancer%26date%3D2017%26volume%3D105%26spage%3D7%26epage%3D13%26doi%3D10.1016%2Fj.lungcan.2016.12.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ros-Blanco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esté, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clotet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruíz-Ávila, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixidó, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seoane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrell, J. I.</span><span> </span><span class="NLM_article-title">Noncyclam tetraamines inhibit CXC chemokine receptor type 4 and target glioma-initiating cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7560</span><span class="NLM_x">–</span> <span class="NLM_lpage">7570</span><span class="refDoi"> DOI: 10.1021/jm300862u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300862u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7560-7570&author=L.+Ros-Blancoauthor=J.+Anidoauthor=R.+Bosserauthor=J.+Est%C3%A9author=B.+Clotetauthor=A.+Kosoyauthor=L.+Ru%C3%ADz-%C3%81vilaauthor=J.+Teixid%C3%B3author=J.+Seoaneauthor=J.+I.+Borrell&title=Noncyclam+tetraamines+inhibit+CXC+chemokine+receptor+type+4+and+target+glioma-initiating+cells&doi=10.1021%2Fjm300862u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fjm300862u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300862u%26sid%3Dliteratum%253Aachs%26aulast%3DRos-Blanco%26aufirst%3DL.%26aulast%3DAnido%26aufirst%3DJ.%26aulast%3DBosser%26aufirst%3DR.%26aulast%3DEst%25C3%25A9%26aufirst%3DJ.%26aulast%3DClotet%26aufirst%3DB.%26aulast%3DKosoy%26aufirst%3DA.%26aulast%3DRu%25C3%25ADz-%25C3%2581vila%26aufirst%3DL.%26aulast%3DTeixid%25C3%25B3%26aufirst%3DJ.%26aulast%3DSeoane%26aufirst%3DJ.%26aulast%3DBorrell%26aufirst%3DJ.%2BI.%26atitle%3DNoncyclam%2520tetraamines%2520inhibit%2520CXC%2520chemokine%2520receptor%2520type%25204%2520and%2520target%2520glioma-initiating%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7560%26epage%3D7570%26doi%3D10.1021%2Fjm300862u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Truax, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaraz, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saindane, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruddanti, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natchus, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. L.</span><span> </span><span class="NLM_article-title">Discovery of tetrahydroisoquinoline-based CXCR4 antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span><span class="refDoi"> DOI: 10.1021/ml400183q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400183q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSisL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1025-1030&author=V.+M.+Truaxauthor=H.+Zhaoauthor=B.+M.+Katzmanauthor=A.+R.+Prosserauthor=A.+A.+Alcarazauthor=M.+T.+Saindaneauthor=R.+B.+Howardauthor=D.+Culverauthor=R.+F.+Arrendaleauthor=P.+R.+Gruddantiauthor=T.+J.+Eversauthor=M.+G.+Natchusauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=J.+L.+Wilson&title=Discovery+of+tetrahydroisoquinoline-based+CXCR4+antagonists&doi=10.1021%2Fml400183q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists</span></div><div class="casAuthors">Truax, Valarie M.; Zhao, Huanyu; Katzman, Brooke M.; Prosser, Anthony R.; Alcaraz, Ana A.; Saindane, Manohar T.; Howard, Randy B.; Culver, Deborah; Arrendale, Richard F.; Gruddanti, Prahbakar R.; Evers, Taylor J.; Natchus, Michael G.; Snyder, James P.; Liotta, Dennis C.; Wilson, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1025-1030</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A de novo hit-to-lead effort involving the redesign of benzimidazole-contg. antagonists of the CXCR4 receptor resulted in the discovery of a novel series of 1,2,3,4-tetrahydroisoquinoline (TIQ) analogs.  In general, this series of compds. show good potencies (3-650 nM) in assays involving CXCR4 function, including both inhibition of attachment of X4 HIV-1IIIB virus in MAGI-CCR5/CXCR4 cells and inhibition of calcium release in Chem-1 cells.  Series profiling permitted the identification of TIQ-(R)-stereoisomer I as a potent and selective CXCR4 antagonist lead candidate with a promising in vitro profile.  The drug-like properties of I were detd. in ADME in vitro studies, revealing low metabolic liability potential.  Further in vivo evaluations included pharmacokinetic expts. in rats and mice, where I was shown to have oral bioavailability (F = 63%) and resulted in the mobilization of white blood cells (WBCs) in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEHgfxHZaoI7Vg90H21EOLACvtfcHk0ljMSQy9lnIHog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSisL3O&md5=aaea8e1f85d3898d1c33b20c0fca64c9</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fml400183q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400183q%26sid%3Dliteratum%253Aachs%26aulast%3DTruax%26aufirst%3DV.%2BM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DKatzman%26aufirst%3DB.%2BM.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DAlcaraz%26aufirst%3DA.%2BA.%26aulast%3DSaindane%26aufirst%3DM.%2BT.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DGruddanti%26aufirst%3DP.%2BR.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DJ.%2BL.%26atitle%3DDiscovery%2520of%2520tetrahydroisoquinoline-based%2520CXCR4%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1025%26epage%3D1030%26doi%3D10.1021%2Fml400183q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zachariassen, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlshøj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haug, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Våbenø, J.</span><span> </span><span class="NLM_article-title">Probing the molecular interactions between CXC chemokine receptor 4 (CXCR4) and an arginine-based tripeptidomimetic antagonist (KRH-1636)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8141</span><span class="NLM_x">–</span> <span class="NLM_lpage">8153</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00987</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00987" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8141-8153&author=Z.+G.+Zachariassenauthor=S.+Karlsh%C3%B8jauthor=B.+E.+Haugauthor=M.+M.+Rosenkildeauthor=J.+V%C3%A5ben%C3%B8&title=Probing+the+molecular+interactions+between+CXC+chemokine+receptor+4+%28CXCR4%29+and+an+arginine-based+tripeptidomimetic+antagonist+%28KRH-1636%29&doi=10.1021%2Facs.jmedchem.5b00987"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00987%26sid%3Dliteratum%253Aachs%26aulast%3DZachariassen%26aufirst%3DZ.%2BG.%26aulast%3DKarlsh%25C3%25B8j%26aufirst%3DS.%26aulast%3DHaug%26aufirst%3DB.%2BE.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26atitle%3DProbing%2520the%2520molecular%2520interactions%2520between%2520CXC%2520chemokine%2520receptor%25204%2520%2528CXCR4%2529%2520and%2520an%2520arginine-based%2520tripeptidomimetic%2520antagonist%2520%2528KRH-1636%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8141%26epage%3D8153%26doi%3D10.1021%2Facs.jmedchem.5b00987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Demmer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span> </span><span class="NLM_article-title">PET imaging of CXCR4 receptors in cancer by a new optimized ligand</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1789</span><span class="NLM_x">–</span> <span class="NLM_lpage">1791</span><span class="refDoi"> DOI: 10.1002/cmdc.201100320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1002%2Fcmdc.201100320" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1789-1791&author=O.+Demmerauthor=E.+Gourniauthor=U.+Schumacherauthor=H.+Kesslerauthor=H.+J.+Wester&title=PET+imaging+of+CXCR4+receptors+in+cancer+by+a+new+optimized+ligand&doi=10.1002%2Fcmdc.201100320"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100320%26sid%3Dliteratum%253Aachs%26aulast%3DDemmer%26aufirst%3DO.%26aulast%3DGourni%26aufirst%3DE.%26aulast%3DSchumacher%26aufirst%3DU.%26aulast%3DKessler%26aufirst%3DH.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26atitle%3DPET%2520imaging%2520of%2520CXCR4%2520receptors%2520in%2520cancer%2520by%2520a%2520new%2520optimized%2520ligand%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1789%26epage%3D1791%26doi%3D10.1002%2Fcmdc.201100320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Philipp-Abbrederis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knop, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schottelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luckerath, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietschmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habringer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerngross, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirbel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwamborn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steidle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenwald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kropf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peschel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einsele, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaiger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Götze, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, U.</span><span> </span><span class="NLM_article-title">In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">487</span><span class="refDoi"> DOI: 10.15252/emmm.201404698</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.15252%2Femmm.201404698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=25736399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVKjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=477-487&author=K.+Philipp-Abbrederisauthor=K.+Herrmannauthor=S.+Knopauthor=M.+Schotteliusauthor=M.+Eiberauthor=K.+Luckerathauthor=E.+Pietschmannauthor=S.+Habringerauthor=C.+Gerngrossauthor=K.+Frankeauthor=M.+Rudeliusauthor=A.+Schirbelauthor=C.+Lapaauthor=K.+Schwambornauthor=S.+Steidleauthor=E.+Hartmannauthor=A.+Rosenwaldauthor=S.+Kropfauthor=A.+J.+Beerauthor=C.+Peschelauthor=H.+Einseleauthor=A.+K.+Buckauthor=M.+Schwaigerauthor=K.+G%C3%B6tzeauthor=H.+J.+Westerauthor=U.+Keller&title=In+vivo+molecular+imaging+of+chemokine+receptor+CXCR4+expression+in+patients+with+advanced+multiple+myeloma&doi=10.15252%2Femmm.201404698"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma</span></div><div class="casAuthors">Philipp-Abbrederis, Kathrin; Herrmann, Ken; Knop, Stefan; Schottelius, Margret; Eiber, Matthias; Lueckerath, Katharina; Pietschmann, Elke; Habringer, Stefan; Gerngross, Carlos; Franke, Katharina; Rudelius, Martina; Schirbel, Andreas; Lapa, Constantin; Schwamborn, Kristina; Steidle, Sabine; Hartmann, Elena; Rosenwald, Andreas; Kropf, Saskia; Beer, Ambros J.; Peschel, Christian; Einsele, Hermann; Buck, Andreas K.; Schwaiger, Markus; Goetze, Katharina; Wester, Hans-Juergen; Keller, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">477-487</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">CXCR4 is a G-protein-coupled receptor that mediates recruitment of blood cells toward its ligand SDF-1.  In cancer, high CXCR4 expression is frequently assocd. with tumor dissemination and poor prognosis.  We evaluated the novel CXCR4 probe [68Ga]Pentixafor for in vivo mapping of CXCR4 expression d. in mice xenografted with human CXCR4-pos. MM cell lines and patients with advanced MM by means of positron emission tomog. (PET).  [68Ga]Pentixafor PET provided images with excellent specificity and contrast.  In 10 of 14 patients with advanced MM [68Ga]Pentixafor PET/CT scans revealed MM manifestations, whereas only nine of 14 std. [18F]fluorodeoxyglucose PET/CT scans were rated visually pos.  Assessment of blood counts and std. CD34+ flow cytometry did not reveal significant blood count changes assocd. with tracer application.  Based on these highly encouraging data on clin. PET imaging of CXCR4 expression in a cohort of MM patients, we conclude that [68Ga]Pentixafor PET opens a broad field for clin. investigations on CXCR4 expression and for CXCR4-directed therapeutic approaches in MM and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGUzSAHxUizbVg90H21EOLACvtfcHk0liStQYou5pxcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVKjs7g%253D&md5=77153cc7b917938fdba483d857a2c302</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.15252%2Femmm.201404698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201404698%26sid%3Dliteratum%253Aachs%26aulast%3DPhilipp-Abbrederis%26aufirst%3DK.%26aulast%3DHerrmann%26aufirst%3DK.%26aulast%3DKnop%26aufirst%3DS.%26aulast%3DSchottelius%26aufirst%3DM.%26aulast%3DEiber%26aufirst%3DM.%26aulast%3DLuckerath%26aufirst%3DK.%26aulast%3DPietschmann%26aufirst%3DE.%26aulast%3DHabringer%26aufirst%3DS.%26aulast%3DGerngross%26aufirst%3DC.%26aulast%3DFranke%26aufirst%3DK.%26aulast%3DRudelius%26aufirst%3DM.%26aulast%3DSchirbel%26aufirst%3DA.%26aulast%3DLapa%26aufirst%3DC.%26aulast%3DSchwamborn%26aufirst%3DK.%26aulast%3DSteidle%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DE.%26aulast%3DRosenwald%26aufirst%3DA.%26aulast%3DKropf%26aufirst%3DS.%26aulast%3DBeer%26aufirst%3DA.%2BJ.%26aulast%3DPeschel%26aufirst%3DC.%26aulast%3DEinsele%26aufirst%3DH.%26aulast%3DBuck%26aufirst%3DA.%2BK.%26aulast%3DSchwaiger%26aufirst%3DM.%26aulast%3DG%25C3%25B6tze%26aufirst%3DK.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DKeller%26aufirst%3DU.%26atitle%3DIn%2520vivo%2520molecular%2520imaging%2520of%2520chemokine%2520receptor%2520CXCR4%2520expression%2520in%2520patients%2520with%2520advanced%2520multiple%2520myeloma%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D477%26epage%3D487%26doi%3D10.15252%2Femmm.201404698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lesniak, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikorska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shallal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azad, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisok, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullambhatla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmagadda, S.</span><span> </span><span class="NLM_article-title">Structural characterization and in vivo evaluation of β-hairpin peptidomimetics as specific CXCR4 imaging agents</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">953</span><span class="refDoi"> DOI: 10.1021/mp500799q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp500799q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovFGgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=941-953&author=W.+G.+Lesniakauthor=E.+Sikorskaauthor=H.+Shallalauthor=B.+B.+Azadauthor=A.+Lisokauthor=M.+Pullambhatlaauthor=M.+G.+Pomperauthor=S.+Nimmagadda&title=Structural+characterization+and+in+vivo+evaluation+of+%CE%B2-hairpin+peptidomimetics+as+specific+CXCR4+imaging+agents&doi=10.1021%2Fmp500799q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18cR"><div class="casContent"><span class="casTitleNuber">18c</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Characterization and in Vivo Evaluation of β-Hairpin Peptidomimetics as Specific CXCR4 Imaging Agents</span></div><div class="casAuthors">Lesniak, Wojciech G.; Sikorska, Emilia; Shallal, Hassan; Behnam Azad, Babak; Lisok, Ala; Pullambhatla, Mrudula; Pomper, Martin G.; Nimmagadda, Sridhar</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">941-953</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The CXCR4 chemokine receptor is integral to several biol. functions and plays a pivotal role in the pathophysiol. of many diseases.  As such, CXCR4 is an enticing target for the development of imaging and therapeutic agents.  Here we report the evaluation of the POL3026 peptidomimetic template for the development of imaging agents that target CXCR4.  Structural and conformational analyses of POL3026 and two of its conjugates, DOTA (POL-D) and PEG12-DOTA (POL-PD), by CD, two-dimensional NMR spectroscopy and mol. dynamics calcns. are reported.  In silico observations were exptl. verified with in vitro affinity assays and rationalized using crystal structure-based mol. modeling studies. [111In]-labeled DOTA conjugates were assessed in vivo for target specificity in CXCR4 expressing s.c. U87 tumors (U87-stb-CXCR4) through single photon emission computed tomog. (SPECT/CT) imaging and biodistribution studies.  In silico and in vitro studies show that POL3026 and its conjugates demonstrate similar interactions with different micelles that mimic cellular membrane and that the ε-NH2 of lysine7 is crit. to maintain high affinity to CXCR4.  Modification of this group with DOTA or PEG12-DOTA led to the decrease of IC50 value from 0.087 nM for POL3026 to 0.47 nM and 1.42 nM for POL-D and POL-PD, resp.  In spite of the decreased affinity toward CXCR4, [111In]POL-D and [111In]POL-PD demonstrated high and significant uptake in U87-stb-CXCR4 tumors compared to the control U87 tumors at 90 min and 24 h post injection.  Uptake in U87-stb-CXCR4 tumors could be blocked by unlabeled POL3026, indicating specificity of the agents in vivo.  These results suggest POL3026 as a promising template to develop new imaging agents that target CXCR4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWiehnfy4gbrVg90H21EOLACvtfcHk0liStQYou5pxcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovFGgsg%253D%253D&md5=4cbba0fdc42813fdd1e46eb9c16d8586</span></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1021%2Fmp500799q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp500799q%26sid%3Dliteratum%253Aachs%26aulast%3DLesniak%26aufirst%3DW.%2BG.%26aulast%3DSikorska%26aufirst%3DE.%26aulast%3DShallal%26aufirst%3DH.%26aulast%3DAzad%26aufirst%3DB.%2BB.%26aulast%3DLisok%26aufirst%3DA.%26aulast%3DPullambhatla%26aufirst%3DM.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26aulast%3DNimmagadda%26aufirst%3DS.%26atitle%3DStructural%2520characterization%2520and%2520in%2520vivo%2520evaluation%2520of%2520%25CE%25B2-hairpin%2520peptidomimetics%2520as%2520specific%2520CXCR4%2520imaging%2520agents%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2015%26volume%3D12%26spage%3D941%26epage%3D953%26doi%3D10.1021%2Fmp500799q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Detering, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sultan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luehmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehdashti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooley, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPersio, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span> </span><span class="NLM_article-title">Gold nanoclusters doped with <sup>64</sup>Cu for CXCR4 positron emission tomography imaging of breast cancer and metastasis</span> <span class="citation_source-journal">ACS Nano</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">5959</span><span class="NLM_x">–</span> <span class="NLM_lpage">5970</span><span class="refDoi"> DOI: 10.1021/acsnano.6b01326</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsnano.6b01326" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsF2qsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=5959-5970&author=Y.+Zhaoauthor=L.+Deteringauthor=D.+Sultanauthor=M.+L.+Cooperauthor=M.+Youauthor=S.+Choauthor=S.+L.+Meierauthor=H.+Luehmannauthor=G.+Sunauthor=M.+Rettigauthor=F.+Dehdashtiauthor=K.+L.+Wooleyauthor=J.+F.+DiPersioauthor=Y.+Liu&title=Gold+nanoclusters+doped+with+64Cu+for+CXCR4+positron+emission+tomography+imaging+of+breast+cancer+and+metastasis&doi=10.1021%2Facsnano.6b01326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18dR"><div class="casContent"><span class="casTitleNuber">18d</span><div class="casTitle"><span class="NLM_cas:atitle">Gold Nanoclusters Doped with 64Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis</span></div><div class="casAuthors">Zhao, Yongfeng; Detering, Lisa; Sultan, Deborah; Cooper, Matthew L.; You, Meng; Cho, Sangho; Meier, Stephanie L.; Luehmann, Hannah; Sun, Guorong; Rettig, Michael; Dehdashti, Farrokh; Wooley, Karen L.; DiPersio, John F.; Liu, Yongjian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Nano</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">5959-5970</span>CODEN:
                <span class="NLM_cas:coden">ANCAC3</span>;
        ISSN:<span class="NLM_cas:issn">1936-0851</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As an emerging class of nanomaterial, nanoclusters hold great potential for biomedical applications due to their unique sizes and related properties.  Herein, we prepd. a 64Cu doped gold nanocluster (64CuAuNC, hydrodynamic size: 4.2 ± 0.5 nm) functionalized with AMD3100 (or Plerixafor) for targeted positron emission tomog. (PET) imaging of CXCR4, an up-regulated receptor on primary tumor and lung metastasis in a mouse 4T1 orthotopic breast cancer model.  The prepn. of targeted 64CuAuNCs-AMD3100 (4.5 ± 0.4 nm) was done via one-step reaction with controlled conjugation of AMD3100 and specific activity, as well as improved colloid stability.  In vivo pharmacokinetic evaluation showed favorable organ distribution and significant renal and fecal clearance within 48 h post injection.  The expression of CXCR4 in tumors and metastasis was characterized by immunohistochem., Western blot, and reverse transcription polymerase chain reaction anal.  PET imaging with 64CuAuNCs-AMD3100 demonstrated sensitive and accurate detection of CXCR4 in engineered tumors expressing various levels of the receptor, while competitive receptor blocking studies confirmed targeting specificity of the nanoclusters.  In contrast to nontargeted 64CuAuNCs and 64Cu-AMD3100 alone, the targeted 64CuAuNCs-AMD3100 detected up-regulated CXCR4 in early stage tumors and premetastatic niche of lung earlier and with greater sensitivity.  Taken together, we believe that 64CuAuNCs-AMD3100 could serve as a useful platform for early and accurate detection of breast cancer and metastasis providing an essential tool to guide the treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV0U5LOre2p7Vg90H21EOLACvtfcHk0lh0ELMVKYWwfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsF2qsrg%253D&md5=a7342f8d349c997bc13541bd2a161fd4</span></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=10.1021%2Facsnano.6b01326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsnano.6b01326%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DDetering%26aufirst%3DL.%26aulast%3DSultan%26aufirst%3DD.%26aulast%3DCooper%26aufirst%3DM.%2BL.%26aulast%3DYou%26aufirst%3DM.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DMeier%26aufirst%3DS.%2BL.%26aulast%3DLuehmann%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DG.%26aulast%3DRettig%26aufirst%3DM.%26aulast%3DDehdashti%26aufirst%3DF.%26aulast%3DWooley%26aufirst%3DK.%2BL.%26aulast%3DDiPersio%26aufirst%3DJ.%2BF.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DGold%2520nanoclusters%2520doped%2520with%252064Cu%2520for%2520CXCR4%2520positron%2520emission%2520tomography%2520imaging%2520of%2520breast%2520cancer%2520and%2520metastasis%26jtitle%3DACS%2520Nano%26date%3D2016%26volume%3D10%26spage%3D5959%26epage%3D5970%26doi%3D10.1021%2Facsnano.6b01326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Vag, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerngross, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herhaus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philipp-Abbrederis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graner, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ettl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaiger, M.</span><span> </span><span class="NLM_article-title">First experience with chemokine receptor CXCR4-targeted PET imaging of patients with solid cancers</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span><span class="refDoi"> DOI: 10.2967/jnumed.115.161034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.2967%2Fjnumed.115.161034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=26769866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslaktLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=741-746&author=T.+Vagauthor=C.+Gerngrossauthor=P.+Herhausauthor=M.+Eiberauthor=K.+Philipp-Abbrederisauthor=F.+P.+Granerauthor=J.+Ettlauthor=U.+Kellerauthor=H.+J.+Westerauthor=M.+Schwaiger&title=First+experience+with+chemokine+receptor+CXCR4-targeted+PET+imaging+of+patients+with+solid+cancers&doi=10.2967%2Fjnumed.115.161034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18eR"><div class="casContent"><span class="casTitleNuber">18e</span><div class="casTitle"><span class="NLM_cas:atitle">First experience with chemokine receptor CXCR4-Targeted PET imaging of patients with solid cancers</span></div><div class="casAuthors">Vag, Tibor; Gerngross, Carlos; Herhaus, Peter; Eiber, Matthias; Philipp-Abbrederis, Kathrin; Graner, Frank-Philipp; Ettl, Johannes; Keller, Ulrich; Wester, Hans-Juergen; Schwaiger, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">741-746</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">1535-5667</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">CXCR4 is a chemokine receptor that is overexpressed in various human cancers and is involved in tumor metastasis.  The aim of this proof-of-concept study was to evaluate a novel CXCR4-targeted PET probe in patients with solid cancers with reported in vitro evidence of CXCR4 overexpression and to est. its potential diagnostic value.  Twenty-one patients with histol. proven pancreatic cancer, laryngeal cancer, non-small cell lung cancer, prostate cancer, melanoma, breast cancer, hepatocellular carcinoma, glioblastoma, sarcoma, or cancer of unknown primary underwent PET imaging using the novel CXCR4 nuclear probe 68Ga-pentixafor.  The SUVmax of the liver, spleen, and bone marrow was measured to det. physiol. tracer distribution.  For evaluation of tracer accumulation in solid cancers, SUVmax and tumor-to-background (T/B) ratios were detd. in a total of 43 malignant lesions, including 8 primary tumors, 3 locally recurrent tumors, and 32 metastases.  When available, the SUVmax of malignant lesions was compared with the corresponding SUVmax measured in routine 18F-FDG PET.  Moderate tracer accumulation was detectable in the liver, bone marrow, and spleen, with a mean SUVmax of 3.1, 3.7, and 5.6, resp.  By visual interpretation criteria, 9 of 11 primary and locally recurrent tumors were detectable, exhibiting a mean SUVmax of 4.7 (range, 2.1-10.9) and a mean T/B ratio of 2.9.  Twenty of 32 evaluated metastases were visually detectable (mean SUVmax, 4.5 [range, 3.2-13.8]; mean T/B ratio, 2.8).  The highest signal was detected in a patient with non-small cell lung cancer (SUVmax, 10.9; T/B ratio, 8.4) and a patient with cancer of unknown primary (SUVmax, 13.8; T/B ratio, 8.1).  Compared with 18F-FDG PET, which was addnl. performed in 10 patients, 68Ga-pentixafor PET had a lower SUVmax in all measured malignant lesions.  On the basis of these first observations in a small and heterogeneous patient cohort, the in vitro CXCR4 expression profile of solid cancers and metastases described in the previous literature does not seem to sufficiently depict the in vivo distribution revealed by CXCR4-targeted PET.  Moreover, the detectability of solid cancers seems to be generally lower for 68Ga-pentixafor than for 18F-FDG PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEliS1Eh7bzbVg90H21EOLACvtfcHk0lh0ELMVKYWwfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslaktLjO&md5=d370182cec2b5399292806fdecf247b0</span></div><a href="/servlet/linkout?suffix=cit18e&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.161034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.161034%26sid%3Dliteratum%253Aachs%26aulast%3DVag%26aufirst%3DT.%26aulast%3DGerngross%26aufirst%3DC.%26aulast%3DHerhaus%26aufirst%3DP.%26aulast%3DEiber%26aufirst%3DM.%26aulast%3DPhilipp-Abbrederis%26aufirst%3DK.%26aulast%3DGraner%26aufirst%3DF.%2BP.%26aulast%3DEttl%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DU.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DSchwaiger%26aufirst%3DM.%26atitle%3DFirst%2520experience%2520with%2520chemokine%2520receptor%2520CXCR4-targeted%2520PET%2520imaging%2520of%2520patients%2520with%2520solid%2520cancers%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D741%26epage%3D746%26doi%3D10.2967%2Fjnumed.115.161034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Weiss, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiesewetter, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobus, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szajek, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farber, J. M.</span><span> </span><span class="NLM_article-title">Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of <sup>64</sup>Cu-AMD3100</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span><span class="refDoi"> DOI: 10.1007/s11307-010-0466-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1007%2Fs11307-010-0466-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=21347799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A280%3ADC%252BC387kt1Cnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=106-114&author=I.+D.+Weissauthor=O.+Jacobsonauthor=D.+O.+Kiesewetterauthor=J.+P.+Jacobusauthor=L.+P.+Szajekauthor=X.+Chenauthor=J.+M.+Farber&title=Positron+emission+tomography+imaging+of+tumors+expressing+the+human+chemokine+receptor+CXCR4+in+mice+with+the+use+of+64Cu-AMD3100&doi=10.1007%2Fs11307-010-0466-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100</span></div><div class="casAuthors">Weiss Ido D; Jacobson Orit; Kiesewetter Dale O; Jacobus John P; Szajek Lawrence P; Chen Xiaoyuan; Farber Joshua M</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">106-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Expression of CXCR4 in cancers has been correlated with poor prognosis and increased metastasis.  Quantifying CXCR4 expression non-invasively might aid in prognostication and monitoring therapy.  We evaluated a radiolabeled antagonist of CXCR4, 64Cu-AMD3100, as a positron-emitting imaging agent.  PROCEDURES:  CXCR4-transfected or non-transfected cell lines were injected into mice to form xenografts.  Accumulation of 64Cu-AMD3100 in tumors was analyzed by small-animal PET and biodistribution assays.  RESULTS:  64Cu-AMD3100 accumulated in CXCR4-expressing, but not CXCR4-negative, tumors.  For CXCR4-expressing tumors, tumor-to-blood and tumor-to-muscle ratios were 23-41 and 50-59, respectively, depending on tumor type.  Excess of unlabeled Cu-AMD3100 or AMD3100 significantly reduced 64Cu-AMD3100 accumulation in CXCR4-expressing tumors.  Human-absorbed dose calculations predicted a dose limit of 444 MBq.  CONCLUSIONS:  CXCR4 can be imaged in tumors using 64Cu-AMD3100.  Dosimetry studies suggest that imaging in humans is feasible.  We conclude that 64Cu-AMD3100 should be investigated as a potential agent for imaging and quantifying CXCR4 in tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRjq4f6HCGJACEJCPKhJPuqfW6udTcc2ebmItyJcqyjPbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387kt1Cnuw%253D%253D&md5=240796270cdcd082e5af983322f7b69d</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1007%2Fs11307-010-0466-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-010-0466-y%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DI.%2BD.%26aulast%3DJacobson%26aufirst%3DO.%26aulast%3DKiesewetter%26aufirst%3DD.%2BO.%26aulast%3DJacobus%26aufirst%3DJ.%2BP.%26aulast%3DSzajek%26aufirst%3DL.%2BP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DFarber%26aufirst%3DJ.%2BM.%26atitle%3DPositron%2520emission%2520tomography%2520imaging%2520of%2520tumors%2520expressing%2520the%2520human%2520chemokine%2520receptor%2520CXCR4%2520in%2520mice%2520with%2520the%2520use%2520of%252064Cu-AMD3100%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2012%26volume%3D14%26spage%3D106%26epage%3D114%26doi%3D10.1007%2Fs11307-010-0466-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Woodard, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Silva, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnam Azad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisok, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullambhatla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesniak, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmagadda, S.</span><span> </span><span class="NLM_article-title">Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4)</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2014.04.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2Fj.nucmedbio.2014.04.081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=25038987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A280%3ADC%252BC2cbktlyluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=552-561&author=L.+E.+Woodardauthor=R.+A.+De+Silvaauthor=B.+Behnam+Azadauthor=A.+Lisokauthor=M.+Pullambhatlaauthor=W.+G.+Lesniakauthor=R.+C.+Measeauthor=M.+G.+Pomperauthor=S.+Nimmagadda&title=Bridged+cyclams+as+imaging+agents+for+chemokine+receptor+4+%28CXCR4%29&doi=10.1016%2Fj.nucmedbio.2014.04.081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4)</span></div><div class="casAuthors">Woodard Lauren E; De Silva Ravindra A; Behnam Azad Babak; Lisok Ala; Pullambhatla Mrudula; G Lesniak Wojciech; Mease Ronnie C; Pomper Martin G; Nimmagadda Sridhar</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear medicine and biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">552-61</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Over-expression of chemokine receptor 4 (CXCR4) is present in a majority of cancers, has been linked to an aggressive phenotype, and may indicate the metastatic potential of primary tumor.  Several CXCR4 targeted therapeutics are in clinical trials and the development of the corresponding imaging agents is an area of active interest.  Previously, (64)Cu-labeled imaging agents for CXCR4 have provided clear images of CXCR4-bearing tissues in relevant experimental models but demonstrated fast washout from tissues harboring receptor.  Addition of stabilizing bridges is known to provide more robust chelator-Cu(II) complexes.  In addition, bridged cyclam-based CXCR4 binding agents demonstrated increased receptor residence times relative to existing agents.  Based on that knowledge we synthesized several bridged cyclam analogs of AMD3465, a monocyclam-based CXCR4 imaging agent, to increase the retention time of the tracer bound to the receptor to allow for protracted imaging and improved target-to-non-target ratios.  Specific accumulation of two radiolabeled, cross-bridged analogs ([(64)Cu] RAD1-24 and [(64)Cu]RAD1-52) was observed in U87-stb-CXCR4 tumors in both PET/CT imaging and biodistribution studies.  At 90min post-injection of radiotracer, tumor-to-muscle and tumor-to-blood ratios reached 106.05±17.19 and 28.08±4.78, respectively, for cross-bridged pyrimidine analog [(64)Cu]RAD1-52.  Receptor blockade performed in vivo denoted target binding specificity.  The biodistribution and PET/CT imaging studies with the radiolabeled bridged cyclams demonstrated longer tumor retention and comparable uptake to [(64)Cu]AMD3465, though [(64)Cu]AMD3465 demonstrated superior overall pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIknGsHNfccmgRQsDqrjW_fW6udTcc2eboNKf2OAfEsrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbktlyluw%253D%253D&md5=f469a9508f3287402107f4785df86a12</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2014.04.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2014.04.081%26sid%3Dliteratum%253Aachs%26aulast%3DWoodard%26aufirst%3DL.%2BE.%26aulast%3DDe%2BSilva%26aufirst%3DR.%2BA.%26aulast%3DBehnam%2BAzad%26aufirst%3DB.%26aulast%3DLisok%26aufirst%3DA.%26aulast%3DPullambhatla%26aufirst%3DM.%26aulast%3DLesniak%26aufirst%3DW.%2BG.%26aulast%3DMease%26aufirst%3DR.%2BC.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26aulast%3DNimmagadda%26aufirst%3DS.%26atitle%3DBridged%2520cyclams%2520as%2520imaging%2520agents%2520for%2520chemokine%2520receptor%25204%2520%2528CXCR4%2529%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2014%26volume%3D41%26spage%3D552%26epage%3D561%26doi%3D10.1016%2Fj.nucmedbio.2014.04.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Oltmanns, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zitzmann-Kolbe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauder-Wuest, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haberkorn, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhut, M.</span><span> </span><span class="NLM_article-title">Zn(II)-bis(cyclen) complexes and the imaging of apoptosis/necrosis</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2611</span><span class="NLM_x">–</span> <span class="NLM_lpage">2624</span><span class="refDoi"> DOI: 10.1021/bc200457b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc200457b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyhtbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=2611-2624&author=D.+Oltmannsauthor=S.+Zitzmann-Kolbeauthor=A.+Muellerauthor=U.+Bauder-Wuestauthor=M.+Schaeferauthor=M.+Ederauthor=U.+Haberkornauthor=M.+Eisenhut&title=Zn%28II%29-bis%28cyclen%29+complexes+and+the+imaging+of+apoptosis%2Fnecrosis&doi=10.1021%2Fbc200457b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Zn(II)-bis(cyclen) Complexes and the Imaging of Apoptosis/Necrosis</span></div><div class="casAuthors">Oltmanns, Dorte; Zitzmann-Kolbe, Sabine; Mueller, Andre; Bauder-Wuest, Ulrike; Schaefer, Martin; Eder, Matthias; Haberkorn, Uwe; Eisenhut, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2611-2624</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In vivo cell-death imaging is still a challenging issue.  Until now, only 99mTc-labeled HYNIC-rh-annexin A5 has been extensively studied in clin. trials.  In the ongoing search for an alternative imaging agent, we synthesized a series of fluorescent zinc-cyclen complexes as annexin A5 mimics and studied structural variations on the uptake behavior of cells undergoing apoptosis/necrosis.  The no. of cyclen chelators was varied and the spacer sepg. cyclen from the central scaffold was modified.  Five zinc-cyclen complexes were labeled with fluorescein for flow cytometric studies and one was labeled with 18F for in vivo applications.  Jurkat cells were treated with staurosporine to induce apoptosis/necrosis, incubated with the fluorescein-labeled zinc complexes and analyzed them by flow cytometry.  Fluorescent annexin A5 and propidium iodide were applied as ref. dyes.  Flow cytometry revealed greater accumulation of zinc-cyclen complexes in staurosporine treated cells.  The uptake was contingent on the presence of zinc and the fluorescence intensity was dependent on the no. of zinc-cyclen groups.  Confocal laser scanning microscopy showed the {bis[Zn(cyclen)]}4+ complex distributed throughout the cytosol different to annexin A5.  Owing to the structural similarity of the bis-cyclen ligands with CXCR4 binding bis-cyclam derivs. the zinc-cyclen complex uptake was challenged with the meta deriv. of AMD3100.  Lack of uptake depletion in staurosporine treated cells ruled out measurable CXCR4 interaction.  PET imaging using the 18F labeled zinc-cyclen complex revealed significantly higher uptake in an irradiated Dunning R3327-AT1 prostate tumor as compared to the contralateral control tumor.  PET imaging of a HelaMatu tumor model addnl. showed an increased uptake after taxol treatment.  It could be demonstrated that the fluorescent zinc-cyclen complexes offer potential as new agents for flow cytometry and microscopic imaging of cell death.  In addn., the 18F labeled analog holds promise for in vivo applications providing informations about cell death after radiation therapy and cytostatic drug treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1BYC9UE0FArVg90H21EOLACvtfcHk0liMa5eyuZSh0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyhtbjN&md5=dc2c5ced06bee67d7b4e7a42311cbced</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fbc200457b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc200457b%26sid%3Dliteratum%253Aachs%26aulast%3DOltmanns%26aufirst%3DD.%26aulast%3DZitzmann-Kolbe%26aufirst%3DS.%26aulast%3DMueller%26aufirst%3DA.%26aulast%3DBauder-Wuest%26aufirst%3DU.%26aulast%3DSchaefer%26aufirst%3DM.%26aulast%3DEder%26aufirst%3DM.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DEisenhut%26aufirst%3DM.%26atitle%3DZn%2528II%2529-bis%2528cyclen%2529%2520complexes%2520and%2520the%2520imaging%2520of%2520apoptosis%252Fnecrosis%26jtitle%3DBioconjugate%2520Chem.%26date%3D2011%26volume%3D22%26spage%3D2611%26epage%3D2624%26doi%3D10.1021%2Fbc200457b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hartimath, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Waarde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierckx, R. A. J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, E. F. J.</span><span> </span><span class="NLM_article-title">Evaluation of <i>N</i>-[<sup>11</sup>C]methyl-AMD3465 as a PET tracer for imaging of CXCR4 receptor expression in a C6 glioma tumor model</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3810</span><span class="NLM_x">–</span> <span class="NLM_lpage">3817</span><span class="refDoi"> DOI: 10.1021/mp500398r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp500398r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1KmsbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=3810-3817&author=S.+V.+Hartimathauthor=A.+van+Waardeauthor=R.+A.+J.+O.+Dierckxauthor=E.+F.+J.+de+Vries&title=Evaluation+of+N-%5B11C%5Dmethyl-AMD3465+as+a+PET+tracer+for+imaging+of+CXCR4+receptor+expression+in+a+C6+glioma+tumor+model&doi=10.1021%2Fmp500398r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of N-[11C]Methyl-AMD3465 as a PET Tracer for Imaging of CXCR4 Receptor Expression in a C6 Glioma Tumor Model</span></div><div class="casAuthors">Hartimath, S. V.; van Waarde, A.; Dierckx, R. A. J. O.; de Vries, E. F. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3810-3817</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The chemokine receptor CXCR4 and its ligand CXCL12 play an important role in tumor progression and metastasis.  CXCR4 receptors are expressed by many cancer types and provide a potential target for treatment.  Noninvasive detection of CXCR4 may aid diagnosis and improve therapy selection.  It has been demonstrated in preclin. studies that positron emission tomog. (PET) with a radiolabeled small mol. could enable noninvasive monitoring of CXCR4 expression.  Here, we prepd. N-[11C]methyl-AMD3465 as a new PET tracer for CXCR4.  N-[11C]Methyl-AMD3465 was readily prepd. by N-methylation with [11C]CH3OTf.  The tracer was obtained in a 60 ± 2% yield (decay cor.), the purity of the tracer was >99%, and specific activity was 47 ± 14 GBq/μmol.  Tracer stability was tested in vitro using liver microsomes and rat plasma; excellent stability was obsd.  The tracer was evaluated in rat C6 glioma and human PC-3 cell lines.  In vitro cellular uptake of N-[11C]methyl-AMD3465 was receptor mediated.  The effect of transition metal ions (Cu2+, Ni2+, and Zn2+) on cellular binding was examd. in C6 cells, and the presence of these ions increased the cellular binding of the tracer 9-, 7-, and 3-fold, resp.  Ex vivo biodistribution and PET imaging of N-[11C]methyl-AMD3465 were performed in rats with C6 tumor xenografts.  Both PET and biodistribution studies demonstrated specific accumulation of the tracer in the tumor (SUV 0.6 ± 0.2) and other CXCR4 expressing organs, such as lymph node (1.5 ± 0.2), liver (8.9 ± 1.0), bone marrow (1.0 ± 0.3), and spleen (1.0 ± 0.1).  Tumor uptake was significantly reduced (66%, p < 0.01) after pretreatment with Plerixafor (AMD3100).  Biodistribution data indicates a tumor-to-muscle ratio of 7.85 and tumor-to-plasma ratio of 1.14, at 60 min after tracer injection.  Our data demonstrated that N-[11C]methyl-AMD3465 is capable of detecting physiol. CXCR4 expression in tumors and other CXCR4 expressing tissues.  These results warrant further evaluation of N-[11C]methyl-AMD3465 as a potential PET tracer for CXCR4 receptor imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwklF80Iku0LVg90H21EOLACvtfcHk0liMa5eyuZSh0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1KmsbnP&md5=404eb68dafccaacb4114bea718860029</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fmp500398r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp500398r%26sid%3Dliteratum%253Aachs%26aulast%3DHartimath%26aufirst%3DS.%2BV.%26aulast%3Dvan%2BWaarde%26aufirst%3DA.%26aulast%3DDierckx%26aufirst%3DR.%2BA.%2BJ.%2BO.%26aulast%3Dde%2BVries%26aufirst%3DE.%2BF.%2BJ.%26atitle%3DEvaluation%2520of%2520N-%255B11C%255Dmethyl-AMD3465%2520as%2520a%2520PET%2520tracer%2520for%2520imaging%2520of%2520CXCR4%2520receptor%2520expression%2520in%2520a%2520C6%2520glioma%2520tumor%2520model%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2014%26volume%3D11%26spage%3D3810%26epage%3D3817%26doi%3D10.1021%2Fmp500398r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schottelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philipp-Abbrederis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simecek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerngross, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaiger, M.</span><span> </span><span class="NLM_article-title">Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging</span> <span class="citation_source-journal">Theranostics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span><span class="refDoi"> DOI: 10.7150/thno.11251</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.7150%2Fthno.11251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=25825601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksFeis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=618-630&author=H.+J.+Westerauthor=U.+Kellerauthor=M.+Schotteliusauthor=A.+Beerauthor=K.+Philipp-Abbrederisauthor=F.+Hoffmannauthor=J.+Simecekauthor=C.+Gerngrossauthor=M.+Lassmannauthor=K.+Herrmannauthor=N.+Pellegataauthor=M.+Rudeliusauthor=H.+Kesslerauthor=M.+Schwaiger&title=Disclosing+the+CXCR4+expression+in+lymphoproliferative+diseases+by+targeted+molecular+imaging&doi=10.7150%2Fthno.11251"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging</span></div><div class="casAuthors">Wester, Hans Juergen; Keller, Ulrich; Schottelius, Margret; Beer, Ambros; Philipp-Abbrederis, Kathrin; Hoffmann, Frauke; Simecek, Jakub; Gerngross, Carlos; Lassmann, Michael; Herrmann, Ken; Pellegata, Natalia; Rudelius, Martina; Kessler, Horst; Schwaiger, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">618-630</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Chemokine ligand-receptor interactions play a pivotal role in cell attraction and cellular trafficking, both in normal tissue homeostasis and in disease.  In cancer, chemokine receptor-4 (CXCR4) expression is an adverse prognostic factor.  Early clin. studies suggest that targeting CXCR4 with suitable high-affinity antagonists might be a novel means for therapy.  In addn. to the preclin. evaluation of [68Ga]Pentixafor in mice bearing human lymphoma xenografts as an exemplary CXCR4-expressing tumor entity, we report on the first clin. applications of [68Ga]Pentixafor-Positron Emission Tomog. as a powerful method for CXCR4 imaging in cancer patients.  [68Ga]Pentixafor binds with high affinity and selectivity to human CXCR4 and exhibits a favorable dosimetry. [68Ga]Pentixafor-PET provides images with excellent specificity and contrast.  This non-invasive imaging technol. for quant. assessment of CXCR4 expression allows to further elucidate the role of CXCR4/CXCL12 ligand interaction in the pathogenesis and treatment of cancer, cardiovascular diseases and autoimmune and inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIStJF7qe9T7Vg90H21EOLACvtfcHk0lglb79FKdkxFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksFeis78%253D&md5=f71460418fb4564414bdbc1f098a4aa7</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.7150%2Fthno.11251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.11251%26sid%3Dliteratum%253Aachs%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DKeller%26aufirst%3DU.%26aulast%3DSchottelius%26aufirst%3DM.%26aulast%3DBeer%26aufirst%3DA.%26aulast%3DPhilipp-Abbrederis%26aufirst%3DK.%26aulast%3DHoffmann%26aufirst%3DF.%26aulast%3DSimecek%26aufirst%3DJ.%26aulast%3DGerngross%26aufirst%3DC.%26aulast%3DLassmann%26aufirst%3DM.%26aulast%3DHerrmann%26aufirst%3DK.%26aulast%3DPellegata%26aufirst%3DN.%26aulast%3DRudelius%26aufirst%3DM.%26aulast%3DKessler%26aufirst%3DH.%26aulast%3DSchwaiger%26aufirst%3DM.%26atitle%3DDisclosing%2520the%2520CXCR4%2520expression%2520in%2520lymphoproliferative%2520diseases%2520by%2520targeted%2520molecular%2520imaging%26jtitle%3DTheranostics%26date%3D2015%26volume%3D5%26spage%3D618%26epage%3D630%26doi%3D10.7150%2Fthno.11251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lapa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lückerath, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoene, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirbel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samnick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelzer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kropf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, K.</span><span> </span><span class="NLM_article-title">[<sup>68</sup>Ga]pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer-initial experience</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">9288</span><span class="NLM_x">–</span> <span class="NLM_lpage">9295</span><span class="refDoi"> DOI: 10.18632/oncotarget.7063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.18632%2Foncotarget.7063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=9288-9295&author=C.+Lapaauthor=K.+L%C3%BCckerathauthor=M.+Rudeliusauthor=J.+S.+Schmidauthor=A.+Schoeneauthor=A.+Schirbelauthor=S.+Samnickauthor=T.+Pelzerauthor=A.+K.+Buckauthor=S.+Kropfauthor=H.+J.+Westerauthor=K.+Herrmann&title=%5B68Ga%5Dpentixafor-PET%2FCT+for+imaging+of+chemokine+receptor+4+expression+in+small+cell+lung+cancer-initial+experience&doi=10.18632%2Foncotarget.7063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7063%26sid%3Dliteratum%253Aachs%26aulast%3DLapa%26aufirst%3DC.%26aulast%3DL%25C3%25BCckerath%26aufirst%3DK.%26aulast%3DRudelius%26aufirst%3DM.%26aulast%3DSchmid%26aufirst%3DJ.%2BS.%26aulast%3DSchoene%26aufirst%3DA.%26aulast%3DSchirbel%26aufirst%3DA.%26aulast%3DSamnick%26aufirst%3DS.%26aulast%3DPelzer%26aufirst%3DT.%26aulast%3DBuck%26aufirst%3DA.%2BK.%26aulast%3DKropf%26aufirst%3DS.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DHerrmann%26aufirst%3DK.%26atitle%3D%255B68Ga%255Dpentixafor-PET%252FCT%2520for%2520imaging%2520of%2520chemokine%2520receptor%25204%2520expression%2520in%2520small%2520cell%2520lung%2520cancer-initial%2520experience%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D9288%26epage%3D9295%26doi%3D10.18632%2Foncotarget.7063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lapa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lückerath, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinlein, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monoranu, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linsenmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kropf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernestus, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löhr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, K.</span><span> </span><span class="NLM_article-title"><sup>68</sup>Ga-pentixafor-PET/CT for imaging of chemokine receptor 4 expression in glioblastoma</span> <span class="citation_source-journal">Theranostics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span><span class="refDoi"> DOI: 10.7150/thno.13986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.7150%2Fthno.13986" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=428-434&author=C.+Lapaauthor=K.+L%C3%BCckerathauthor=I.+Kleinleinauthor=C.+M.+Monoranuauthor=T.+Linsenmannauthor=A.+F.+Kesslerauthor=M.+Rudeliusauthor=S.+Kropfauthor=A.+K.+Buckauthor=R.+I.+Ernestusauthor=H.+J.+Westerauthor=M.+L%C3%B6hrauthor=K.+Herrmann&title=68Ga-pentixafor-PET%2FCT+for+imaging+of+chemokine+receptor+4+expression+in+glioblastoma&doi=10.7150%2Fthno.13986"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.7150%2Fthno.13986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.13986%26sid%3Dliteratum%253Aachs%26aulast%3DLapa%26aufirst%3DC.%26aulast%3DL%25C3%25BCckerath%26aufirst%3DK.%26aulast%3DKleinlein%26aufirst%3DI.%26aulast%3DMonoranu%26aufirst%3DC.%2BM.%26aulast%3DLinsenmann%26aufirst%3DT.%26aulast%3DKessler%26aufirst%3DA.%2BF.%26aulast%3DRudelius%26aufirst%3DM.%26aulast%3DKropf%26aufirst%3DS.%26aulast%3DBuck%26aufirst%3DA.%2BK.%26aulast%3DErnestus%26aufirst%3DR.%2BI.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DL%25C3%25B6hr%26aufirst%3DM.%26aulast%3DHerrmann%26aufirst%3DK.%26atitle%3D68Ga-pentixafor-PET%252FCT%2520for%2520imaging%2520of%2520chemokine%2520receptor%25204%2520expression%2520in%2520glioblastoma%26jtitle%3DTheranostics%26date%3D2016%26volume%3D6%26spage%3D428%26epage%3D434%26doi%3D10.7150%2Fthno.13986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Poschenrieder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schottelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaiger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of [<sup>68</sup>Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo—a comparison to [<sup>68</sup>Ga]pentixafor</span> <span class="citation_source-journal">EJNMMI Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="refDoi"> DOI: 10.1186/s13550-016-0227-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1186%2Fs13550-016-0227-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=27655427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A280%3ADC%252BC2svkt1Glsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=70&author=A.+Poschenriederauthor=M.+Schotteliusauthor=M.+Schwaigerauthor=H.+J.+Wester&title=Preclinical+evaluation+of+%5B68Ga%5DNOTA-pentixafor+for+PET+imaging+of+CXCR4+expression+in+vivo%E2%80%94a+comparison+to+%5B68Ga%5Dpentixafor&doi=10.1186%2Fs13550-016-0227-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22dR"><div class="casContent"><span class="casTitleNuber">22d</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo - a comparison to [(68)Ga]pentixafor</span></div><div class="casAuthors">Poschenrieder Andreas; Schottelius Margret; Wester Hans-Jurgen; Schwaiger Markus</div><div class="citationInfo"><span class="NLM_cas:title">EJNMMI research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70</span>
        ISSN:<span class="NLM_cas:issn">2191-219X</span>.
    </div><div class="casAbstract">BACKGROUND:  Due to its overexpression in a variety of tumor types, the chemokine receptor 4 (CXCR4) represents a highly relevant diagnostic and therapeutic target in nuclear oncology.  Recently, [(68)Ga]pentixafor has emerged as an excellent imaging agent for positron emission tomography (PET) of CXCR4 expression in vivo.  In this study, the corresponding [(68)Ga]-1,4,7-triazacyclononane-triacetic acid (NOTA) analog was preclinically evaluated and compared to the 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) parent compound [(68)Ga]pentixafor.  METHODS:  NOTA-pentixafor was synthesized by combining solid and solution-phase peptide synthesis.  The CXCR4 receptor affinities of [(68)Ga]pentixafor and [(68)Ga]NOTA-pentixafor were determined in competitive binding assays using the leukemic CXCR4-expressing Jurkat T-cell line and [(125)I]FC131 as the radioligand.  Internalization and cell efflux assays were performed using CXCR4-transfected Chem-1 cells.  Small-animal PET and biodistribution studies were carried out using Daudi-tumor bearing SCID mice.  RESULTS:  [(68)Ga]NOTA-pentixafor showed a 1.4-fold improved affinity towards CXCR4 (IC50).  However, internalization efficiency into CXCR4(+)-Chem-1 cells was substantially decreased compared to [(68)Ga]pentixafor.  Accordingly, small-animal PET imaging and biodistribution studies revealed a 9.5-fold decreased uptake of [(68)Ga]NOTA-pentixafor in Daudi lymphoma xenografts (1.7 ± 0.4 % vs 16.2 ± 3.8 % ID/g at 90 min p.i.) and higher levels of non-specific accumulation, primarily in the excretory organs such as the liver, intestines, and kidneys (2.3 ± 0.9 % vs 2.0 ± 0.3 % ID/g, 1.9 ± 0.8 % vs 0.7 ± 0.2 % ID/g, and 2.7 ± 1.1 % vs 1.7 ± 0.9 % ID/g, respectively).  CONCLUSIONS:  Despite enhanced CXCR4-affinity in vitro, the [(68)Ga]NOTA-analog of pentixafor showed reduced CXCR4 targeting efficiency in vivo.  In combination with enhanced background accumulation, this resulted in significantly inferior PET imaging contrast, and thus, [(68)Ga]NOTA-pentixafor offers no advantages over [(68)Ga]pentixafor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCTVJR05pgY4IRAdBLKY41fW6udTcc2eYFRBbu6YBe4bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svkt1Glsw%253D%253D&md5=426a0659c82874778a53f996688bda02</span></div><a href="/servlet/linkout?suffix=cit22d&amp;dbid=16384&amp;doi=10.1186%2Fs13550-016-0227-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13550-016-0227-2%26sid%3Dliteratum%253Aachs%26aulast%3DPoschenrieder%26aufirst%3DA.%26aulast%3DSchottelius%26aufirst%3DM.%26aulast%3DSchwaiger%26aufirst%3DM.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26atitle%3DPreclinical%2520evaluation%2520of%2520%255B68Ga%255DNOTA-pentixafor%2520for%2520PET%2520imaging%2520of%2520CXCR4%2520expression%2520in%2520vivo%25E2%2580%2594a%2520comparison%2520to%2520%255B68Ga%255Dpentixafor%26jtitle%3DEJNMMI%2520Res.%26date%3D2016%26volume%3D6%26spage%3D70%26doi%3D10.1186%2Fs13550-016-0227-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Portella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Luca, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Alterio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ierano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napolitano, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polimeno, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monfregola, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbieri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luciano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciarmiello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amodeo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scala, S.</span><span> </span><span class="NLM_article-title">Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e74548</span><span class="refDoi"> DOI: 10.1371/journal.pone.0074548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1371%2Fjournal.pone.0074548" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e74548&author=L.+Portellaauthor=R.+Vitaleauthor=S.+De+Lucaauthor=C.+D%E2%80%99Alterioauthor=C.+Ieranoauthor=N.+Napolitanoauthor=A.+Riccioauthor=M.+N.+Polimenoauthor=L.+Monfregolaauthor=A.+Barbieriauthor=A.+Lucianoauthor=A.+Ciarmielloauthor=C.+Arraauthor=G.+Castelloauthor=P.+Amodeoauthor=S.+Scala&title=Preclinical+development+of+a+novel+class+of+CXCR4+antagonist+impairing+solid+tumors+growth+and+metastases&doi=10.1371%2Fjournal.pone.0074548"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0074548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0074548%26sid%3Dliteratum%253Aachs%26aulast%3DPortella%26aufirst%3DL.%26aulast%3DVitale%26aufirst%3DR.%26aulast%3DDe%2BLuca%26aufirst%3DS.%26aulast%3DD%25E2%2580%2599Alterio%26aufirst%3DC.%26aulast%3DIerano%26aufirst%3DC.%26aulast%3DNapolitano%26aufirst%3DN.%26aulast%3DRiccio%26aufirst%3DA.%26aulast%3DPolimeno%26aufirst%3DM.%2BN.%26aulast%3DMonfregola%26aufirst%3DL.%26aulast%3DBarbieri%26aufirst%3DA.%26aulast%3DLuciano%26aufirst%3DA.%26aulast%3DCiarmiello%26aufirst%3DA.%26aulast%3DArra%26aufirst%3DC.%26aulast%3DCastello%26aufirst%3DG.%26aulast%3DAmodeo%26aufirst%3DP.%26aulast%3DScala%26aufirst%3DS.%26atitle%3DPreclinical%2520development%2520of%2520a%2520novel%2520class%2520of%2520CXCR4%2520antagonist%2520impairing%2520solid%2520tumors%2520growth%2520and%2520metastases%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De74548%26doi%3D10.1371%2Fjournal.pone.0074548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Di Maro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotta, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancaccio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Leva, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Pietra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ieranò, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napolitano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Alterio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siciliano, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sementa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomassi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotenuto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span> </span><span class="NLM_article-title">Exploring the N-terminal region of C-X-C motif chemokine 12 (CXCL12): Identification of plasma-stable cyclic peptides as novel, potent C-X-C chemokine receptor type 4 (CXCR4) antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">8369</span><span class="NLM_x">–</span> <span class="NLM_lpage">8380</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00695</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00695" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVagu7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8369-8380&author=S.+Di+Maroauthor=A.+M.+Trottaauthor=D.+Brancaccioauthor=F.+S.+Di+Levaauthor=V.+La+Pietraauthor=C.+Ieran%C3%B2author=M.+Napolitanoauthor=L.+Portellaauthor=C.+D%E2%80%99Alterioauthor=R.+A.+Sicilianoauthor=D.+Sementaauthor=S.+Tomassiauthor=A.+Carotenutoauthor=E.+Novellinoauthor=S.+Scalaauthor=L.+Marinelli&title=Exploring+the+N-terminal+region+of+C-X-C+motif+chemokine+12+%28CXCL12%29%3A+Identification+of+plasma-stable+cyclic+peptides+as+novel%2C+potent+C-X-C+chemokine+receptor+type+4+%28CXCR4%29+antagonists&doi=10.1021%2Facs.jmedchem.6b00695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists</span></div><div class="casAuthors">Di Maro, Salvatore; Trotta, Anna Maria; Brancaccio, Diego; Di Leva, Francesco Saverio; La Pietra, Valeria; Ierano, Caterina; Napolitano, Maria; Portella, Luigi; D'Alterio, Crescenzo; Siciliano, Rosa Anna; Sementa, Deborah; Tomassi, Stefano; Carotenuto, Alfonso; Novellino, Ettore; Scala, Stefania; Marinelli, Luciana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8369-8380</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors previously reported the discovery of a CXCL12-mimetic cyclic peptide (H-Arg-Ala-[Cys-Arg-Phe-Phe-Cys]-COOH (compd. 2))as selective CXCR4 antagonist showing promising in vitro and in vivo anticancer activity.  However, further development of this peptide was hampered by its degrdn. in biol. fluids as well as by its low micromolar affinity for the receptor.  Herein, extensive chem. modifications led to the development of a new analog (Ac-Arg-Ala-[DCys-Arg-Phe-Phe-Cys] -COOH (compd. 10)) with enhanced potency, specificity and plasma stability.  A combined approach of Ala-amino acid scan, NMR and mol. modeling unraveled the reasons behind the improved binding properties of (10) vs. (2).  Biol. investigations on leukemia (CEM) and colon (HT29 and HCT116) cancer cell lines showed that (10) is able to impair CXCL12-mediated cell migration, ERK-phosphorylation and CXCR4 internalization.  These outcomes might pave the way for the future preclin. development of (10) in CXCR4 overexpressing leukemia and colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpneAY14o5mFrVg90H21EOLACvtfcHk0lhvt7TSX6MYYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVagu7rN&md5=4dfb5d8ce770469fd7612f1aef2050c2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00695%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMaro%26aufirst%3DS.%26aulast%3DTrotta%26aufirst%3DA.%2BM.%26aulast%3DBrancaccio%26aufirst%3DD.%26aulast%3DDi%2BLeva%26aufirst%3DF.%2BS.%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DIeran%25C3%25B2%26aufirst%3DC.%26aulast%3DNapolitano%26aufirst%3DM.%26aulast%3DPortella%26aufirst%3DL.%26aulast%3DD%25E2%2580%2599Alterio%26aufirst%3DC.%26aulast%3DSiciliano%26aufirst%3DR.%2BA.%26aulast%3DSementa%26aufirst%3DD.%26aulast%3DTomassi%26aufirst%3DS.%26aulast%3DCarotenuto%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DScala%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26atitle%3DExploring%2520the%2520N-terminal%2520region%2520of%2520C-X-C%2520motif%2520chemokine%252012%2520%2528CXCL12%2529%253A%2520Identification%2520of%2520plasma-stable%2520cyclic%2520peptides%2520as%2520novel%252C%2520potent%2520C-X-C%2520chemokine%2520receptor%2520type%25204%2520%2528CXCR4%2529%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8369%26epage%3D8380%26doi%3D10.1021%2Facs.jmedchem.6b00695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Barlos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatzi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavropoulos, G.</span><span> </span><span class="NLM_article-title">2-Chlorotrityl chloride resin. Studies on anchoring of Fmoc-amino acids and peptide cleavage</span> <span class="citation_source-journal">Int. J. Pept. Protein Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span><span class="refDoi"> DOI: 10.1111/j.1399-3011.1991.tb00769.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1111%2Fj.1399-3011.1991.tb00769.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1917309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaK3MXltFGjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1991&pages=513-520&author=K.+Barlosauthor=O.+Chatziauthor=D.+Gatosauthor=G.+Stavropoulos&title=2-Chlorotrityl+chloride+resin.+Studies+on+anchoring+of+Fmoc-amino+acids+and+peptide+cleavage&doi=10.1111%2Fj.1399-3011.1991.tb00769.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">2-Chlorotrityl chloride resin.  Studies on anchoring of Fmoc-aminio acids and peptide cleavage</span></div><div class="casAuthors">Barlos, Kleomenis; Chatzi, Olga; Gatos, Dimitrios; Stavropoulos, George</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Peptide & Protein Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">513-20</span>CODEN:
                <span class="NLM_cas:coden">IJPPC3</span>;
        ISSN:<span class="NLM_cas:issn">0367-8377</span>.
    </div><div class="casAbstract">The esterification of 2-chlorotrityl chloride resin with 9-fluorenylmethoxycarbonyl (Fmoc) amino acids in the presence of EtN(CHMe2)2 is studied under various conditions.  High esterification yields are obtained using 0.6 equiv. Fmoc-amino acid/mmol resin in CH2Cl2 or ClCH2CH2Cl in 25 min at room temp.  The reaction proceeds without byproduct formation even in the case of Fmoc-Asn-OH and Fmoc-Gln-OH.  The quant. and easy cleavage of amino acids and peptides from 2-chlorotrityl resin using AcOH/CF3CH2OH/CH2Cl2 mixts. is accomplished within 15-60 min at room temp. while tert-Bu type protecting groups remain unaffected.  Under these exceptionally mild conditions, 2-chlorotrityl cations generated during the cleavage of amino acids and peptides from resin do not attack the nucleophilic side chains of tryptophan, methionine, and tyrosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ5Em66XBXF7Vg90H21EOLACvtfcHk0lhvt7TSX6MYYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXltFGjur4%253D&md5=2ac32b2f179e3b9e2a4977b6d7fa0aaa</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-3011.1991.tb00769.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-3011.1991.tb00769.x%26sid%3Dliteratum%253Aachs%26aulast%3DBarlos%26aufirst%3DK.%26aulast%3DChatzi%26aufirst%3DO.%26aulast%3DGatos%26aufirst%3DD.%26aulast%3DStavropoulos%26aufirst%3DG.%26atitle%3D2-Chlorotrityl%2520chloride%2520resin.%2520Studies%2520on%2520anchoring%2520of%2520Fmoc-amino%2520acids%2520and%2520peptide%2520cleavage%26jtitle%3DInt.%2520J.%2520Pept.%2520Protein%2520Res.%26date%3D1991%26volume%3D37%26spage%3D513%26epage%3D520%26doi%3D10.1111%2Fj.1399-3011.1991.tb00769.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Postma, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albericio, F.</span><span> </span><span class="NLM_article-title"><i>N</i>-Chlorosuccinimide, an efficient peptide disulfide bond-forming reagent in aqueous solution</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">14277</span><span class="NLM_x">–</span> <span class="NLM_lpage">14280</span><span class="refDoi"> DOI: 10.1039/c3ra43149e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1039%2Fc3ra43149e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1WitLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=14277-14280&author=T.+M.+Postmaauthor=F.+Albericio&title=N-Chlorosuccinimide%2C+an+efficient+peptide+disulfide+bond-forming+reagent+in+aqueous+solution&doi=10.1039%2Fc3ra43149e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">N-chlorosuccinimide, an efficient peptide disulfide bond-forming reagent in aqueous solution</span></div><div class="casAuthors">Postma, Tobias M.; Albericio, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">14277-14280</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel method has been developed for the efficient formation of peptide disulfide bonds under aq. conditions using N-chlorosuccinimide.  Complete disulfide bond formation is achieved in 15 min with solvent mixts. contg. water and acetonitrile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVpZCDqeEa37Vg90H21EOLACvtfcHk0lhvt7TSX6MYYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1WitLrI&md5=e7ee93d35b7e49782adaab43d1e23e19</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1039%2Fc3ra43149e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ra43149e%26sid%3Dliteratum%253Aachs%26aulast%3DPostma%26aufirst%3DT.%2BM.%26aulast%3DAlbericio%26aufirst%3DF.%26atitle%3DN-Chlorosuccinimide%252C%2520an%2520efficient%2520peptide%2520disulfide%2520bond-forming%2520reagent%2520in%2520aqueous%2520solution%26jtitle%3DRSC%2520Adv.%26date%3D2013%26volume%3D3%26spage%3D14277%26epage%3D14280%26doi%3D10.1039%2Fc3ra43149e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Postma, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albericio, F.</span><span> </span><span class="NLM_article-title"><i>N</i>-Chlorosuccinimide, an efficient reagent for on-resin disulfide formation in solid-phase peptide synthesis</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span><span class="refDoi"> DOI: 10.1021/ol303428d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol303428d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1ensw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=616-619&author=T.+M.+Postmaauthor=F.+Albericio&title=N-Chlorosuccinimide%2C+an+efficient+reagent+for+on-resin+disulfide+formation+in+solid-phase+peptide+synthesis&doi=10.1021%2Fol303428d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">N-Chlorosuccinimide, an Efficient Reagent for On-Resin Disulfide Formation in Solid-Phase Peptide Synthesis</span></div><div class="casAuthors">Postma, Tobias M.; Albericio, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">616-619</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Chlorosuccinimide is described as a widely applicable on-resin disulfide-forming reagent.  Disulfide bond formation was completed within 15 min in DMF.  This strategy was successfully used in the synthesis of oxytocin and a regioselective synthesis of an α-conotoxin.  Moreover, disulfide formation with N-chlorosuccinimide was found to be compatible with oxidn.-prone methionine and tryptophan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVYKBVLrDPILVg90H21EOLACvtfcHk0lgbVqwaM7Gojg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1ensw%253D%253D&md5=1f7ded0192c4800d166a5ae309c00f94</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1021%2Fol303428d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol303428d%26sid%3Dliteratum%253Aachs%26aulast%3DPostma%26aufirst%3DT.%2BM.%26aulast%3DAlbericio%26aufirst%3DF.%26atitle%3DN-Chlorosuccinimide%252C%2520an%2520efficient%2520reagent%2520for%2520on-resin%2520disulfide%2520formation%2520in%2520solid-phase%2520peptide%2520synthesis%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D616%26epage%3D619%26doi%3D10.1021%2Fol303428d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Thiele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mungalpara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Våbenø, J.</span><span> </span><span class="NLM_article-title">Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">5313</span><span class="NLM_x">–</span> <span class="NLM_lpage">5329</span><span class="refDoi"> DOI: 10.1111/bph.12842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1111%2Fbph.12842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=25039237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVamt7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=5313-5329&author=S.+Thieleauthor=J.+Mungalparaauthor=A.+Steenauthor=M.+M.+Rosenkildeauthor=J.+V%C3%A5ben%C3%B8&title=Determination+of+the+binding+mode+for+the+cyclopentapeptide+CXCR4+antagonist+FC131+using+a+dual+approach+of+ligand+modifications+and+receptor+mutagenesis&doi=10.1111%2Fbph.12842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis</span></div><div class="casAuthors">Thiele, S.; Mungalpara, J.; Steen, A.; Rosenkilde, M. M.; Vabeno, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5313-5329</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The cyclopentapeptide FC131 (cyclo(-L-Arg1-L-Arg2-L-2-Nal3-Gly4-D-Tyr5-)) is an antagonist at the CXC chemokine receptor CXCR4, which plays a role in human immunodeficiency virus infection, cancer and stem cell recruitment.  Binding modes for FC131 in CXCR4 have previously been suggested based on mol. docking guided by structure-activity relationship (SAR) data; however, none of these have been verified by in vitro expts.  Exptl. Approach : Heterologous 125I-12G5-competition binding and functional assays (inhibition of CXCL12-mediated activation) of FC131 and three analogs were performed on wild-type CXCR4 and 25 receptor mutants.  Computational modeling was used to rationalize the exptl. data.  Key Results : The Arg2 and 2-Nal3 side chains of FC131 interact with residues in TM-3 (His113, Asp171) and TM-5 (hydrophobic pocket) resp.  Arg1 forms charge-charge interactions with Asp187 in ECL-2, while D-Tyr5 points to the extracellular side of CXCR4.  Furthermore, the backbone of FC131 interacts with the chemokine receptor-conserved Glu288 via two water mols.  Intriguingly, Tyr116 and Glu288 form a H-bond in CXCR4 crystal structures and mutation of either residue to Ala abolishes CXCR4 activity.  Conclusions and Implications : Ligand modification, receptor mutagenesis and computational modeling approaches were used to identify the binding mode of FC131 in CXCR4, which was in agreement with binding modes suggested from previous SAR studies.  Furthermore, insights into the mechanism for CXCR4 activation by CXCL12 were gained.  The combined findings will facilitate future design of novel CXCR4 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTJVv4tLiRYrVg90H21EOLACvtfcHk0lgbVqwaM7Gojg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVamt7nE&md5=de979e35933c1b6566e6b4b43034e875</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Fbph.12842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12842%26sid%3Dliteratum%253Aachs%26aulast%3DThiele%26aufirst%3DS.%26aulast%3DMungalpara%26aufirst%3DJ.%26aulast%3DSteen%26aufirst%3DA.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26atitle%3DDetermination%2520of%2520the%2520binding%2520mode%2520for%2520the%2520cyclopentapeptide%2520CXCR4%2520antagonist%2520FC131%2520using%2520a%2520dual%2520approach%2520of%2520ligand%2520modifications%2520and%2520receptor%2520mutagenesis%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D5313%26epage%3D5329%26doi%3D10.1111%2Fbph.12842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Grieco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotenuto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiglia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zampelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patacchini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggi, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovero, P.</span><span> </span><span class="NLM_article-title">A new, potent urotensin II receptor peptide agonist containing a Pen residue at the disulphide bridge</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4391</span><span class="NLM_x">–</span> <span class="NLM_lpage">4394</span><span class="refDoi"> DOI: 10.1021/jm025549i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm025549i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4391-4394&author=P.+Griecoauthor=A.+Carotenutoauthor=P.+Campigliaauthor=E.+Zampelliauthor=R.+Patacchiniauthor=C.+A.+Maggiauthor=E.+Novellinoauthor=P.+Rovero&title=A+new%2C+potent+urotensin+II+receptor+peptide+agonist+containing+a+Pen+residue+at+the+disulphide+bridge&doi=10.1021%2Fjm025549i"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm025549i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm025549i%26sid%3Dliteratum%253Aachs%26aulast%3DGrieco%26aufirst%3DP.%26aulast%3DCarotenuto%26aufirst%3DA.%26aulast%3DCampiglia%26aufirst%3DP.%26aulast%3DZampelli%26aufirst%3DE.%26aulast%3DPatacchini%26aufirst%3DR.%26aulast%3DMaggi%26aufirst%3DC.%2BA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DRovero%26aufirst%3DP.%26atitle%3DA%2520new%252C%2520potent%2520urotensin%2520II%2520receptor%2520peptide%2520agonist%2520containing%2520a%2520Pen%2520residue%2520at%2520the%2520disulphide%2520bridge%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4391%26epage%3D4394%26doi%3D10.1021%2Fjm025549i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Fricker, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anastassov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darkes, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grujic, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idzan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrecque, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosi, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santucci, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, R. S. Y.</span><span> </span><span class="NLM_article-title">Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">588</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span><span class="refDoi"> DOI: 10.1016/j.bcp.2006.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2Fj.bcp.2006.05.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=588-596&author=S.+P.+Frickerauthor=V.+Anastassovauthor=J.+Coxauthor=M.+C.+Darkesauthor=O.+Grujicauthor=S.+R.+Idzanauthor=J.+Labrecqueauthor=G.+Lauauthor=R.+M.+Mosiauthor=K.+L.+Nelsonauthor=L.+Qinauthor=Z.+Santucciauthor=R.+S.+Y.+Wong&title=Characterization+of+the+molecular+pharmacology+of+AMD3100%3A+a+specific+antagonist+of+the+G-protein+coupled+chemokine+receptor%2C+CXCR4&doi=10.1016%2Fj.bcp.2006.05.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2006.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2006.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DFricker%26aufirst%3DS.%2BP.%26aulast%3DAnastassov%26aufirst%3DV.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DDarkes%26aufirst%3DM.%2BC.%26aulast%3DGrujic%26aufirst%3DO.%26aulast%3DIdzan%26aufirst%3DS.%2BR.%26aulast%3DLabrecque%26aufirst%3DJ.%26aulast%3DLau%26aufirst%3DG.%26aulast%3DMosi%26aufirst%3DR.%2BM.%26aulast%3DNelson%26aufirst%3DK.%2BL.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DSantucci%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DR.%2BS.%2BY.%26atitle%3DCharacterization%2520of%2520the%2520molecular%2520pharmacology%2520of%2520AMD3100%253A%2520a%2520specific%2520antagonist%2520of%2520the%2520G-protein%2520coupled%2520chemokine%2520receptor%252C%2520CXCR4%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D72%26spage%3D588%26epage%3D596%26doi%3D10.1016%2Fj.bcp.2006.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">DiPersio, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micallef, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolwell, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maziarz, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nademanee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span> </span><span class="NLM_article-title">Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin’s lymphoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4767</span><span class="NLM_x">–</span> <span class="NLM_lpage">4773</span><span class="refDoi"> DOI: 10.1200/JCO.2008.20.7209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1200%2FJCO.2008.20.7209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=19720922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGgtbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=4767-4773&author=J.+F.+DiPersioauthor=I.+N.+Micallefauthor=P.+J.+Stiffauthor=B.+J.+Bolwellauthor=R.+T.+Maziarzauthor=E.+Jacobsenauthor=A.+Nademaneeauthor=J.+McCartyauthor=G.+Bridgerauthor=G.+Calandra&title=Phase+III+prospective+randomized+double-blind+placebo-controlled+trial+of+plerixafor+plus+granulocyte+colony-stimulating+factor+compared+with+placebo+plus+granulocyte+colony-stimulating+factor+for+autologous+stem-cell+mobilization+and+transplantation+for+patients+with+non-Hodgkin%E2%80%99s+lymphoma&doi=10.1200%2FJCO.2008.20.7209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma</span></div><div class="casAuthors">DiPersio, John F.; Micallef, Ivana N.; Stiff, Patrick J.; Bolwell, Brian J.; Maziarz, Richard T.; Jacobsen, Eric; Nademanee, Auayporn; McCarty, John; Bridger, Gary; Calandra, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">4767-4773</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: This study evaluates the safety and efficacy of plerixafor (AMD3100), a CXCR4 antagonist, in mobilizing hematopoietic stem cells for autologous stem-cell transplantation in non-Hodgkin's lymphoma (NHL) patients.  Patients and Methods: This is a phase III, multicenter, randomized (1:1), double-blind, placebo-controlled study.  Patients with non-Hodgkin's lymphoma requiring an autologous hematopoietic stem-cell transplantation in first or second complete or partial remission were eligible.  Patients received granulocyte colony-stimulating factor (G-CSF; 10 μg/kg) s.c. daily for up to 8 days.  Beginning on evening of day 4 and continuing daily for up to 4 days, patients received either plerixafor (240 μg/kg) or placebo s.c.  Starting on day 5, patients began daily apheresis for up to 4 days or until ≥ 5 × 106 CD34+ cells/kg were collected.  The primary end point was the percentage of patients who collected ≥ 5 × 106 CD34+ cells/kg in 4 or fewer apheresis days.  Results: This report presents all data for all patients (n = 298) through 12 mo follow-up.  Eighty-nine (59%) of 150 patients in the plerixafor group and 29 (20%) of 148 patients in the placebo group met the primary end point (P < .001).  One hundred thirty-five patients (90%) in plerixafor group and 82 patients (55%) in placebo group underwent transplantation after initial mobilization.  Median time to engraftment was similar in both groups.  The most common plerixafor-assocd. adverse events were GI disorders and injection site reactions.  Conclusion: Plerixafor and G-CSF were well tolerated and resulted in a significantly higher proportion of patients with non-Hodgkin's lymphoma achieving the optimal CD34+ cell target for transplantation in fewer apheresis days, compared with G-CSF alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYjfnL3AIfbbVg90H21EOLACvtfcHk0lhaByYa6RC9Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGgtbbI&md5=b2e30e8f1372875267ca61af49ee96cd</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1200%2FJCO.2008.20.7209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2008.20.7209%26sid%3Dliteratum%253Aachs%26aulast%3DDiPersio%26aufirst%3DJ.%2BF.%26aulast%3DMicallef%26aufirst%3DI.%2BN.%26aulast%3DStiff%26aufirst%3DP.%2BJ.%26aulast%3DBolwell%26aufirst%3DB.%2BJ.%26aulast%3DMaziarz%26aufirst%3DR.%2BT.%26aulast%3DJacobsen%26aufirst%3DE.%26aulast%3DNademanee%26aufirst%3DA.%26aulast%3DMcCarty%26aufirst%3DJ.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DCalandra%26aufirst%3DG.%26atitle%3DPhase%2520III%2520prospective%2520randomized%2520double-blind%2520placebo-controlled%2520trial%2520of%2520plerixafor%2520plus%2520granulocyte%2520colony-stimulating%2520factor%2520compared%2520with%2520placebo%2520plus%2520granulocyte%2520colony-stimulating%2520factor%2520for%2520autologous%2520stem-cell%2520mobilization%2520and%2520transplantation%2520for%2520patients%2520with%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2009%26volume%3D27%26spage%3D4767%26epage%3D4773%26doi%3D10.1200%2FJCO.2008.20.7209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Haribabu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sozzani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peiper, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horuk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyderman, R.</span><span> </span><span class="NLM_article-title">Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">28726</span><span class="NLM_x">–</span> <span class="NLM_lpage">28731</span><span class="refDoi"> DOI: 10.1074/jbc.272.45.28726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1074%2Fjbc.272.45.28726" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=28726-28731&author=B.+Haribabuauthor=R.+M.+Richardsonauthor=I.+Fisherauthor=S.+Sozzaniauthor=S.+C.+Peiperauthor=R.+Horukauthor=H.+Aliauthor=R.+Snyderman&title=Regulation+of+human+chemokine+receptors+CXCR4.+Role+of+phosphorylation+in+desensitization+and+internalization&doi=10.1074%2Fjbc.272.45.28726"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.45.28726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.45.28726%26sid%3Dliteratum%253Aachs%26aulast%3DHaribabu%26aufirst%3DB.%26aulast%3DRichardson%26aufirst%3DR.%2BM.%26aulast%3DFisher%26aufirst%3DI.%26aulast%3DSozzani%26aufirst%3DS.%26aulast%3DPeiper%26aufirst%3DS.%2BC.%26aulast%3DHoruk%26aufirst%3DR.%26aulast%3DAli%26aufirst%3DH.%26aulast%3DSnyderman%26aufirst%3DR.%26atitle%3DRegulation%2520of%2520human%2520chemokine%2520receptors%2520CXCR4.%2520Role%2520of%2520phosphorylation%2520in%2520desensitization%2520and%2520internalization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D28726%26epage%3D28731%26doi%3D10.1074%2Fjbc.272.45.28726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Mercurio, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomassi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaglione, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambery, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiuso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messere, A.</span><span> </span><span class="NLM_article-title">Switchable protecting strategy for solid phase synthesis of DNA and RNA interacting nucleopeptides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">11612</span><span class="NLM_x">–</span> <span class="NLM_lpage">11625</span><span class="refDoi"> DOI: 10.1021/acs.joc.6b01829</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.6b01829" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslGhtLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2016&pages=11612-11625&author=M.+E.+Mercurioauthor=S.+Tomassiauthor=M.+Gaglioneauthor=R.+Russoauthor=A.+Chamberyauthor=S.+Lamaauthor=P.+Stiusoauthor=S.+Cosconatiauthor=E.+Novellinoauthor=S.+Di+Maroauthor=A.+Messere&title=Switchable+protecting+strategy+for+solid+phase+synthesis+of+DNA+and+RNA+interacting+nucleopeptides&doi=10.1021%2Facs.joc.6b01829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Switchable protecting strategy for solid phase synthesis of DNA and RNA interacting nucleopeptides</span></div><div class="casAuthors">Mercurio, Maria Emilia; Tomassi, Stefano; Gaglione, Maria; Russo, Rosita; Chambery, Angela; Lama, Stefania; Stiuso, Paola; Cosconati, Sandro; Novellino, Ettore; Di Maro, Salvatore; Messere, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">11612-11625</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nucleopeptides are promising nucleic acid mimetics in which the peptide backbone bears nucleobases.  They can recognize DNA and RNA targets modulating their biol. functions.  To date, the lack of an effective strategy for the synthesis of nucleopeptides prevents their evaluation for biol. and biomedical applications.  Herein, we describe an unprecedented approach that enables the synthesis of cationic both homo and heterosequence nucleopeptides wholly on solid support with high yield and purity.  Spectroscopic studies indicate advantageous properties of the nucleopeptides in terms of binding, thermodn. stability and sequence specific recognition.  Biostability assay and laser scanning confocal microscopy analyses reveal that the nucleopeptides feature acceptable serum stability and ability to cross the cell membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLBpPY2vI5T7Vg90H21EOLACvtfcHk0lhaByYa6RC9Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslGhtLvI&md5=0c184314f5da557b6fe6769b9f64940a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.6b01829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.6b01829%26sid%3Dliteratum%253Aachs%26aulast%3DMercurio%26aufirst%3DM.%2BE.%26aulast%3DTomassi%26aufirst%3DS.%26aulast%3DGaglione%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DChambery%26aufirst%3DA.%26aulast%3DLama%26aufirst%3DS.%26aulast%3DStiuso%26aufirst%3DP.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DDi%2BMaro%26aufirst%3DS.%26aulast%3DMessere%26aufirst%3DA.%26atitle%3DSwitchable%2520protecting%2520strategy%2520for%2520solid%2520phase%2520synthesis%2520of%2520DNA%2520and%2520RNA%2520interacting%2520nucleopeptides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2016%26volume%3D81%26spage%3D11612%26epage%3D11625%26doi%3D10.1021%2Facs.joc.6b01829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Wüthrich, K.</span> <span class="citation_source-book">NMR of Proteins and Nucleic Acids</span>; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1986</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1051%2Fepn%2F19861701011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&author=K.+W%C3%BCthrich&title=NMR+of+Proteins+and+Nucleic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1051%2Fepn%2F19861701011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1051%252Fepn%252F19861701011%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25BCthrich%26aufirst%3DK.%26btitle%3DNMR%2520of%2520Proteins%2520and%2520Nucleic%2520Acids%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D1986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Piantini, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorensen, O. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, R. R.</span><span> </span><span class="NLM_article-title">Multiple quantum filters for elucidating NMR coupling network</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">6800</span><span class="NLM_x">–</span> <span class="NLM_lpage">6801</span><span class="refDoi"> DOI: 10.1021/ja00388a062</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00388a062" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1982&pages=6800-6801&author=U.+Piantiniauthor=O.+W.+Sorensenauthor=R.+R.+Ernst&title=Multiple+quantum+filters+for+elucidating+NMR+coupling+network&doi=10.1021%2Fja00388a062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1021%2Fja00388a062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00388a062%26sid%3Dliteratum%253Aachs%26aulast%3DPiantini%26aufirst%3DU.%26aulast%3DSorensen%26aufirst%3DO.%2BW.%26aulast%3DErnst%26aufirst%3DR.%2BR.%26atitle%3DMultiple%2520quantum%2520filters%2520for%2520elucidating%2520NMR%2520coupling%2520network%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1982%26volume%3D104%26spage%3D6800%26epage%3D6801%26doi%3D10.1021%2Fja00388a062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Marion, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wüthrich, K.</span><span> </span><span class="NLM_article-title">Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of <sup>1</sup>H-<sup>1</sup>H spin-spin coupling constants in proteins</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span><span class="refDoi"> DOI: 10.1016/0006-291X(83)91093-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2F0006-291X%2883%2991093-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=6307308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaL3sXltVWkurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1983&pages=967-974&author=D.+Marionauthor=K.+W%C3%BCthrich&title=Application+of+phase+sensitive+two-dimensional+correlated+spectroscopy+%28COSY%29+for+measurements+of+1H-1H+spin-spin+coupling+constants+in+proteins&doi=10.1016%2F0006-291X%2883%2991093-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34bR"><div class="casContent"><span class="casTitleNuber">34b</span><div class="casTitle"><span class="NLM_cas:atitle">Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of proton-proton spin-spin coupling constants in proteins</span></div><div class="casAuthors">Marion, D.; Wuethrich, K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">967-74</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Two-dimensional correlated spectroscopy (COSY) is used for measurements of proton-proton spin-spin coupling consts. in protein 1H NMR spectra.  High digital resoln. along the frequency axis ω2 is achieved by placing the carrier frequency in the center of the spectrum, by using quadrature detection in both dimensions, and presenting the spectrum in the phase-sensitive mode.  Compared to other techniques for studies of spin-spin coupling consts., COSY provides greatly improved spectral resoln.  This is illustrated by expts. with H2O solns. of the small globular protein BUSI IIA (bull seminal inhibitor IIA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb5Hc_b_NcfrVg90H21EOLACvtfcHk0lj8OvLkadUkEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXltVWkurY%253D&md5=0153273e1faf9425d8c6641d1451ed7c</span></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2883%2991093-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252883%252991093-8%26sid%3Dliteratum%253Aachs%26aulast%3DMarion%26aufirst%3DD.%26aulast%3DW%25C3%25BCthrich%26aufirst%3DK.%26atitle%3DApplication%2520of%2520phase%2520sensitive%2520two-dimensional%2520correlated%2520spectroscopy%2520%2528COSY%2529%2520for%2520measurements%2520of%25201H-1H%2520spin-spin%2520coupling%2520constants%2520in%2520proteins%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1983%26volume%3D113%26spage%3D967%26epage%3D974%26doi%3D10.1016%2F0006-291X%2883%2991093-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Braunschweiler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, R. R.</span><span> </span><span class="NLM_article-title">Coherence transfer by isotropic mixing: application to proton correlation spectroscopy</span> <span class="citation_source-journal">J. Magn. Reson.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span><span class="refDoi"> DOI: 10.1016/0022-2364(83)90226-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2F0022-2364%2883%2990226-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaL3sXks1eju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1983&pages=521-528&author=L.+Braunschweilerauthor=R.+R.+Ernst&title=Coherence+transfer+by+isotropic+mixing%3A+application+to+proton+correlation+spectroscopy&doi=10.1016%2F0022-2364%2883%2990226-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Coherence transfer by isotropic mixing:  application to proton correlation spectroscopy</span></div><div class="casAuthors">Braunschweiler, L.; Ernst, R. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Magnetic Resonance (1969-1992)</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">521-8</span>CODEN:
                <span class="NLM_cas:coden">JOMRA4</span>;
        ISSN:<span class="NLM_cas:issn">0022-2364</span>.
    </div><div class="casAbstract">A new mechanism of coherence transfer is proposed which is useful for 2-dimensional correlation spectroscopy in liqs.  Cross-peaks are generated between all members of a coupled spin network leading to 4 most complete correlation diagram.  The scheme produces net coherence transfer and can be arranged to create pure absorption mode spectra with peaks of pos. intensity.  A new type of 2-dimensional correlation NMR expt. is illustrated.  After a prepn. pulse the spin system is allowed to evolve freely under the (assumed) weak coupling Hamiltonian in terms of single spin modes.  For the mixing process the Hamiltonian is modified to a form which is dominated by the full isotropic coupling terms.  The coherence of the spins is periodically exchanged during the mixing time and is obsd. during the detection period again under the unperturbed Hamiltonian.  Illustrative examples of 2-dimensional correlated spectra with and without relayed peaks are shown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo25_GwCJe3XrVg90H21EOLACvtfcHk0lj8OvLkadUkEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXks1eju7c%253D&md5=693eaaee37b0224796b7d9e3403759c6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2F0022-2364%2883%2990226-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-2364%252883%252990226-3%26sid%3Dliteratum%253Aachs%26aulast%3DBraunschweiler%26aufirst%3DL.%26aulast%3DErnst%26aufirst%3DR.%2BR.%26atitle%3DCoherence%2520transfer%2520by%2520isotropic%2520mixing%253A%2520application%2520to%2520proton%2520correlation%2520spectroscopy%26jtitle%3DJ.%2520Magn.%2520Reson.%26date%3D1983%26volume%3D53%26spage%3D521%26epage%3D528%26doi%3D10.1016%2F0022-2364%2883%2990226-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Jeener, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, R. R.</span><span> </span><span class="NLM_article-title">Investigation of exchange processes by two-dimensional NMR spectroscopy</span> <span class="citation_source-journal">J. Chem. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">4546</span><span class="NLM_x">–</span> <span class="NLM_lpage">4553</span><span class="refDoi"> DOI: 10.1063/1.438208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1063%2F1.438208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaL3cXkvFOqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1979&pages=4546-4553&author=J.+Jeenerauthor=B.+H.+Meierauthor=P.+Bachmannauthor=R.+R.+Ernst&title=Investigation+of+exchange+processes+by+two-dimensional+NMR+spectroscopy&doi=10.1063%2F1.438208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of exchange processes by two-dimensional NMR spectroscopy</span></div><div class="casAuthors">Jeener, J.; Meier, B. H.; Bachmann, P.; Ernst, R. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4546-53</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">A new general technique for the investigation of exchange processes in mol. systems is proposed and demonstrated.  Applications comprise the study of chem. exchange, of magnetization transfer by inter- and intramol. relaxation in liqs., and the spin diffusion and cross-relaxation processes in solids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC2mejjZuTKbVg90H21EOLACvtfcHk0lj8OvLkadUkEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXkvFOqtw%253D%253D&md5=014ee72eb4b37485dbaec604ede8d3b3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1063%2F1.438208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.438208%26sid%3Dliteratum%253Aachs%26aulast%3DJeener%26aufirst%3DJ.%26aulast%3DMeier%26aufirst%3DB.%2BH.%26aulast%3DBachmann%26aufirst%3DP.%26aulast%3DErnst%26aufirst%3DR.%2BR.%26atitle%3DInvestigation%2520of%2520exchange%2520processes%2520by%2520two-dimensional%2520NMR%2520spectroscopy%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1979%26volume%3D71%26spage%3D4546%26epage%3D4553%26doi%3D10.1063%2F1.438208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Bartels, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billeter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guentert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wüthrich, K.</span><span> </span><span class="NLM_article-title">The program XEASY for computer-supported NMR spectral analysis of biological macromolecules</span> <span class="citation_source-journal">J. Biomol. NMR</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><span class="refDoi"> DOI: 10.1007/BF00417486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1007%2FBF00417486" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=1-10&author=C.+Bartelsauthor=T.+Xiaauthor=M.+Billeterauthor=P.+Guentertauthor=K.+W%C3%BCthrich&title=The+program+XEASY+for+computer-supported+NMR+spectral+analysis+of+biological+macromolecules&doi=10.1007%2FBF00417486"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2FBF00417486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00417486%26sid%3Dliteratum%253Aachs%26aulast%3DBartels%26aufirst%3DC.%26aulast%3DXia%26aufirst%3DT.%26aulast%3DBilleter%26aufirst%3DM.%26aulast%3DGuentert%26aufirst%3DP.%26aulast%3DW%25C3%25BCthrich%26aufirst%3DK.%26atitle%3DThe%2520program%2520XEASY%2520for%2520computer-supported%2520NMR%2520spectral%2520analysis%2520of%2520biological%2520macromolecules%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D1995%26volume%3D6%26spage%3D1%26epage%3D10%26doi%3D10.1007%2FBF00417486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Sargent, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwyzer, R.</span><span> </span><span class="NLM_article-title">Membrane lipid phase as catalyst for peptide-receptor interactions</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">5774</span><span class="NLM_x">–</span> <span class="NLM_lpage">5778</span><span class="refDoi"> DOI: 10.1073/pnas.83.16.5774</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1073%2Fpnas.83.16.5774" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=5774-5778&author=D.+F.+Sargentauthor=R.+Schwyzer&title=Membrane+lipid+phase+as+catalyst+for+peptide-receptor+interactions&doi=10.1073%2Fpnas.83.16.5774"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1073%2Fpnas.83.16.5774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.83.16.5774%26sid%3Dliteratum%253Aachs%26aulast%3DSargent%26aufirst%3DD.%2BF.%26aulast%3DSchwyzer%26aufirst%3DR.%26atitle%3DMembrane%2520lipid%2520phase%2520as%2520catalyst%2520for%2520peptide-receptor%2520interactions%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1986%26volume%3D83%26spage%3D5774%26epage%3D5778%26doi%3D10.1073%2Fpnas.83.16.5774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Grieco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancaccio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotenuto, A.</span><span> </span><span class="NLM_article-title">Conformational study on cyclic melanocortin ligands and new insight into their binding mode at the MC4 receptor</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3721</span><span class="NLM_x">–</span> <span class="NLM_lpage">3733</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.05.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2Fj.ejmech.2011.05.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=3721-3733&author=P.+Griecoauthor=D.+Brancaccioauthor=E.+Novellinoauthor=V.+J.+Hrubyauthor=A.+Carotenuto&title=Conformational+study+on+cyclic+melanocortin+ligands+and+new+insight+into+their+binding+mode+at+the+MC4+receptor&doi=10.1016%2Fj.ejmech.2011.05.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.05.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.05.038%26sid%3Dliteratum%253Aachs%26aulast%3DGrieco%26aufirst%3DP.%26aulast%3DBrancaccio%26aufirst%3DD.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26aulast%3DCarotenuto%26aufirst%3DA.%26atitle%3DConformational%2520study%2520on%2520cyclic%2520melanocortin%2520ligands%2520and%2520new%2520insight%2520into%2520their%2520binding%2520mode%2520at%2520the%2520MC4%2520receptor%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D3721%26epage%3D3733%26doi%3D10.1016%2Fj.ejmech.2011.05.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit39b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mollica, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotenuto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limatola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costante, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinnen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieretti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsodi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samavati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zador, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benyhe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Novel cyclic biphalin analogue with improved antinociceptive properties</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1032</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span><span class="refDoi"> DOI: 10.1021/ml500241n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500241n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1032-1036&author=A.+Mollicaauthor=A.+Carotenutoauthor=E.+Novellinoauthor=A.+Limatolaauthor=R.+Costanteauthor=F.+Pinnenauthor=A.+Stefanucciauthor=S.+Pierettiauthor=A.+Borsodiauthor=R.+Samavatiauthor=F.+Zadorauthor=S.+Benyheauthor=P.+Davisauthor=F.+Porrecaauthor=V.+J.+Hruby&title=Novel+cyclic+biphalin+analogue+with+improved+antinociceptive+properties&doi=10.1021%2Fml500241n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Cyclic Biphalin Analogue with Improved Antinociceptive Properties</span></div><div class="casAuthors">Mollica, Adriano; Carotenuto, Alfonso; Novellino, Ettore; Limatola, Antonio; Costante, Roberto; Pinnen, Francesco; Stefanucci, Azzurra; Pieretti, Stefano; Borsodi, Anna; Samavati, Reza; Zador, Ferenc; Benyhe, Sandor; Davis, Peg; Porreca, Frank; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1032-1036</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two novel opioid analogs have been designed by substituting the native D-Ala residues in position 2,2' of biphalin with two residues of D-penicillamine or L-penicillamine and by forming a disulfide bond between the thiol groups.  The so-obtained compd. 9 contg. D-penicillamines showed excellent μ/δ mixed receptor affinities (K i δ = 5.2 nM; K i μ = 1.9 nM), together with an efficacious capacity to trigger the second messenger and a very good in vivo antinociceptive activity, whereas product 10 was scarcely active.  An explanation of the two different pharmacol. behaviors of products 9 and 10 was found by studying their conformational properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomcpAB9Zk-1bVg90H21EOLACvtfcHk0ljecX2EPFW8lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtbnJ&md5=5bb0b213b04bddfed5f835c4cf307f5b</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1021%2Fml500241n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500241n%26sid%3Dliteratum%253Aachs%26aulast%3DMollica%26aufirst%3DA.%26aulast%3DCarotenuto%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DLimatola%26aufirst%3DA.%26aulast%3DCostante%26aufirst%3DR.%26aulast%3DPinnen%26aufirst%3DF.%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DBorsodi%26aufirst%3DA.%26aulast%3DSamavati%26aufirst%3DR.%26aulast%3DZador%26aufirst%3DF.%26aulast%3DBenyhe%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DNovel%2520cyclic%2520biphalin%2520analogue%2520with%2520improved%2520antinociceptive%2520properties%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1032%26epage%3D1036%26doi%3D10.1021%2Fml500241n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Arimont, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Graaf, C.</span><span> </span><span class="NLM_article-title">Structural analysis of chemokine receptor–ligand interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">4735</span><span class="NLM_x">–</span> <span class="NLM_lpage">4779</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01309</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01309" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1Sjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4735-4779&author=M.+Arimontauthor=S.+L.+Sunauthor=R.+Leursauthor=M.+Smitauthor=I.+J.+P.+de+Eschauthor=C.+de+Graaf&title=Structural+analysis+of+chemokine+receptor%E2%80%93ligand+interactions&doi=10.1021%2Facs.jmedchem.6b01309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Analysis of Chemokine Receptor-Ligand Interactions</span></div><div class="casAuthors">Arimont, Marta; Sun, Shan-Liang; Leurs, Rob; Smit, Martine; de Esch, Iwan J. P.; de Graaf, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4735-4779</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review focuses on the construction and application of structural chemokine receptor models for the elucidation of mol. determinants of chemokine receptor modulation and the structure-based discovery and design of chemokine receptor ligands.  A comparative anal. of ligand binding pockets in chemokine receptors is presented, including a detailed description of the CXCR4, CCR2, CCR5, CCR9 and US28 X-ray structures, and their implication for modeling mol. interactions of chemokine receptors with small-mol. ligands, peptide ligands, and large antibodies and chemokines.  These studies demonstrate how the integration of new structural information of chemokine receptors with extensive structure-activity relationship and site-directed mutagenesis data facilitates the prediction of the structure of chemokine receptor-ligand complexes that have not been crystd.  Finally a review of structure-based ligand discovery and design studies based on chemokine receptor crystal structures and homol. models illustrates the possibilities and challenges to find novel ligands for chemokine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQjIDUCY7fubVg90H21EOLACvtfcHk0ljecX2EPFW8lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1Sjs78%253D&md5=7a4e23ff0f003157e4416ad0caf7517d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01309%26sid%3Dliteratum%253Aachs%26aulast%3DArimont%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.%2BL.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DSmit%26aufirst%3DM.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26atitle%3DStructural%2520analysis%2520of%2520chemokine%2520receptor%25E2%2580%2593ligand%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4735%26epage%3D4779%26doi%3D10.1021%2Facs.jmedchem.6b01309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Kaiser, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colescott, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossinger, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, P. I.</span><span> </span><span class="NLM_article-title">Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span><span class="refDoi"> DOI: 10.1016/0003-2697(70)90146-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2F0003-2697%2870%2990146-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=5443684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaE3cXhtVWjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1970&pages=595-598&author=E.+Kaiserauthor=R.+L.+Colescottauthor=C.+D.+Bossingerauthor=P.+I.+Cook&title=Color+test+for+detection+of+free+terminal+amino+groups+in+the+solid-phase+synthesis+of+peptides&doi=10.1016%2F0003-2697%2870%2990146-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides</span></div><div class="casAuthors">Kaiser, Emil; Colescott, R. L.; Bossinger, C. D.; Cook, P. I.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">595-8</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">A rapid color test is described for detecting ≥5 micromoles free terminal amino group/g in the reaction mixt. from solid-phase peptide synthesis according to R. B. Merrifield (1968).  After washing the solid phase with CH2Cl2, a 10-20 mg sample of the resin peptide is treated with 2-3 drops each of the following reagents: 500 mg ninhydrin/10 ml EtOH; 80 g PhOH/ 20 ml EtOH; and 20 ml 0.001M KCN dild. to 100 ml with pyridine.  The mixt. is heated 2-5 min at 100°.  The development of an intense blue color on the beads and in the soln. (except that terminal proline or terminal β-benzyl aspartate gave a brown or red-brown color) is a pos. result.  In the absence of untreated terminal amino groups, the beads remained white and the soln. yellow (neg. result).  The formation of pale blue beads and a light green soln. was a slightly pos. result.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE5EMxGtKGTrVg90H21EOLACvtfcHk0lgXuzdO0IQWgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXhtVWjur0%253D&md5=c6caf0b6e42136c56e24a1df93a63f3f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2870%2990146-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252870%252990146-6%26sid%3Dliteratum%253Aachs%26aulast%3DKaiser%26aufirst%3DE.%26aulast%3DColescott%26aufirst%3DR.%2BL.%26aulast%3DBossinger%26aufirst%3DC.%2BD.%26aulast%3DCook%26aufirst%3DP.%2BI.%26atitle%3DColor%2520test%2520for%2520detection%2520of%2520free%2520terminal%2520amino%2520groups%2520in%2520the%2520solid-phase%2520synthesis%2520of%2520peptides%26jtitle%3DAnal.%2520Biochem.%26date%3D1970%26volume%3D34%26spage%3D595%26epage%3D598%26doi%3D10.1016%2F0003-2697%2870%2990146-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Hancock, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battersby, J. E.</span><span> </span><span class="NLM_article-title">A new micro-test for the detection of incomplete coupling reactions in solid-phase peptide synthesis using 2,4,6-trinitrobenzenesulphonic acid</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span><span class="refDoi"> DOI: 10.1016/0003-2697(76)90034-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2F0003-2697%2876%2990034-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1976&pages=260-264&author=W.+S.+Hancockauthor=J.+E.+Battersby&title=A+new+micro-test+for+the+detection+of+incomplete+coupling+reactions+in+solid-phase+peptide+synthesis+using+2%2C4%2C6-trinitrobenzenesulphonic+acid&doi=10.1016%2F0003-2697%2876%2990034-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2876%2990034-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252876%252990034-8%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DW.%2BS.%26aulast%3DBattersby%26aufirst%3DJ.%2BE.%26atitle%3DA%2520new%2520micro-test%2520for%2520the%2520detection%2520of%2520incomplete%2520coupling%2520reactions%2520in%2520solid-phase%2520peptide%2520synthesis%2520using%25202%252C4%252C6-trinitrobenzenesulphonic%2520acid%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D71%26spage%3D260%26epage%3D264%26doi%3D10.1016%2F0003-2697%2876%2990034-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Güntert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mumenthaler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wüthrich, K.</span><span> </span><span class="NLM_article-title">Torsion angle dynamics for NMR structure calculation with the new program DYANA</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span><span class="refDoi"> DOI: 10.1006/jmbi.1997.1284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1006%2Fjmbi.1997.1284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=9367762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaK2sXmvFymtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1997&pages=283-298&author=P.+G%C3%BCntertauthor=C.+Mumenthalerauthor=K.+W%C3%BCthrich&title=Torsion+angle+dynamics+for+NMR+structure+calculation+with+the+new+program+DYANA&doi=10.1006%2Fjmbi.1997.1284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Torsion angle dynamics for NMR structure calculation with the new program DYANA</span></div><div class="casAuthors">Guntert, P.; Mumenthaler, C.; Wuthrich, K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">283-298</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">The new program DYANA (DYnamics Algorithm for Nmr Applications) for efficient calcn. of three-dimensional protein and nucleic acid structures from distance constraints and torsion angle constraints collected by NMR expts. performs simulated annealing by mol. dynamics in torsion angle space and uses a fast recursive algorithm to integrate the equations of motions.  Torsion angle dynamics can be more efficient than mol. dynamics in Cartesian coordinate space because of the reduced no. of degrees of freedom and the concomitant absence of high-frequency bond and angle vibrations, which allows for the use of longer time-steps and/or higher temps. in the structure calcn.  It also represents a significant advance over the variable target function method in torsion angle space with the REDAC strategy used by the predecessor program DIANA.  DYANA computation times per accepted conformer in the "bundle" used to represent the NMR structure compare favorably with those of other presently available structure calcn. algorithms, and are of the order of 160 s for a protein of 165 amino acid residues when using a DEC Alpha 8400 5/300 computer.  Test calcns. starting from conformers with random torsion angle values further showed that DYANA is capable of efficient calcn. of high-quality protein structures with up to 400 amino acid residues, and of nucleic acid structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSScNysHFGa7Vg90H21EOLACvtfcHk0lgXuzdO0IQWgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvFymtbw%253D&md5=403b201ea5726641fc0aea34969de69a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1997.1284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1997.1284%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25BCntert%26aufirst%3DP.%26aulast%3DMumenthaler%26aufirst%3DC.%26aulast%3DW%25C3%25BCthrich%26aufirst%3DK.%26atitle%3DTorsion%2520angle%2520dynamics%2520for%2520NMR%2520structure%2520calculation%2520with%2520the%2520new%2520program%2520DYANA%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D273%26spage%3D283%26epage%3D298%26doi%3D10.1006%2Fjmbi.1997.1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Maple, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinur, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagler, A. T.</span><span> </span><span class="NLM_article-title">Derivation of force fields for molecular mechanics and dynamics from ab initio energy surface</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">5350</span><span class="NLM_x">–</span> <span class="NLM_lpage">5353</span><span class="refDoi"> DOI: 10.1073/pnas.85.15.5350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1073%2Fpnas.85.15.5350" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1988&pages=5350-5353&author=J.+Mapleauthor=U.+Dinurauthor=A.+T.+Hagler&title=Derivation+of+force+fields+for+molecular+mechanics+and+dynamics+from+ab+initio+energy+surface&doi=10.1073%2Fpnas.85.15.5350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1073%2Fpnas.85.15.5350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.85.15.5350%26sid%3Dliteratum%253Aachs%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DDinur%26aufirst%3DU.%26aulast%3DHagler%26aufirst%3DA.%2BT.%26atitle%3DDerivation%2520of%2520force%2520fields%2520for%2520molecular%2520mechanics%2520and%2520dynamics%2520from%2520ab%2520initio%2520energy%2520surface%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1988%26volume%3D85%26spage%3D5350%26epage%3D5353%26doi%3D10.1073%2Fpnas.85.15.5350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Pettersen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couch, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenblatt, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrin, T. E.</span><span> </span><span class="NLM_article-title">UCSF Chimera - A visualization system for exploratory research and analysis</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span><span class="refDoi"> DOI: 10.1002/jcc.20084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1002%2Fjcc.20084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=15264254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1605-1612&author=E.+F.+Pettersenauthor=T.+D.+Goddardauthor=C.+C.+Huangauthor=G.+S.+Couchauthor=D.+M.+Greenblattauthor=E.+C.+Mengauthor=T.+E.+Ferrin&title=UCSF+Chimera+-+A+visualization+system+for+exploratory+research+and+analysis&doi=10.1002%2Fjcc.20084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">UCSF Chimera-A visualization system for exploratory research and analysis</span></div><div class="casAuthors">Pettersen, Eric F.; Goddard, Thomas D.; Huang, Conrad C.; Couch, Gregory S.; Greenblatt, Daniel M.; Meng, Elaine C.; Ferrin, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1605-1612</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The design, implementation, and capabilities of an extensible visualization system, UCSF Chimera, are discussed.  Chimera is segmented into a core that provides basic services and visualization, and extensions that provide most higher level functionality.  This architecture ensures that the extension mechanism satisfies the demands of outside developers who wish to incorporate new features.  Two unusual extensions are presented: Multiscale, which adds the ability to visualize large-scale mol. assemblies such as viral coats, and Collab., which allows researchers to share a Chimera session interactively despite being at sep. locales.  Other extensions include Multalign Viewer, for showing multiple sequence alignments and assocd. structures; ViewDock, for screening docked ligand orientations; Movie, for replaying mol. dynamics trajectories; and Vol. Viewer, for display and anal. of volumetric data.  A discussion of the usage of Chimera in real-world situations is given, along with anticipated future directions.  Chimera includes full user documentation, is free to academic and nonprofit users, and is available for Microsoft Windows, Linux, Apple Mac OS X, SGI IRIX, and HP Tru64 Unix from http://www.cgl.ucsf.edu/chimera/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmD4M5S0cPbVg90H21EOLACvtfcHk0lgXuzdO0IQWgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D&md5=944b175f440c1ff323705987cf937ee7</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20084%26sid%3Dliteratum%253Aachs%26aulast%3DPettersen%26aufirst%3DE.%2BF.%26aulast%3DGoddard%26aufirst%3DT.%2BD.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DCouch%26aufirst%3DG.%2BS.%26aulast%3DGreenblatt%26aufirst%3DD.%2BM.%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DFerrin%26aufirst%3DT.%2BE.%26atitle%3DUCSF%2520Chimera%2520-%2520A%2520visualization%2520system%2520for%2520exploratory%2520research%2520and%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1605%26epage%3D1612%26doi%3D10.1002%2Fjcc.20084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, E. Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mol, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenalti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handel, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structures of the CXCR4 chemokine receptor in complex with small molecule and cyclic peptide antagonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">1066</span><span class="NLM_x">–</span> <span class="NLM_lpage">1071</span><span class="refDoi"> DOI: 10.1126/science.1194396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1126%2Fscience.1194396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=20929726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1066-1071&author=B.+Wuauthor=E.+Y.+T.+Chienauthor=C.+D.+Molauthor=G.+Fenaltiauthor=W.+Liuauthor=V.+Katritchauthor=R.+Abagyanauthor=A.+Broounauthor=P.+Wellsauthor=F.+C.+Biauthor=D.+J.+Hamelauthor=P.+Kuhnauthor=T.+M.+Handelauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structures+of+the+CXCR4+chemokine+receptor+in+complex+with+small+molecule+and+cyclic+peptide+antagonists&doi=10.1126%2Fscience.1194396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists</span></div><div class="casAuthors">Wu, Beili; Chien, Ellen Y. T.; Mol, Clifford D.; Fenalti, Gustavo; Liu, Wei; Katritch, Vsevolod; Abagyan, Ruben; Brooun, Alexei; Wells, Peter; Bi, F. Christopher; Hamel, Damon J.; Kuhn, Peter; Handel, Tracy M.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6007</span>),
    <span class="NLM_cas:pages">1066-1071</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chemokine receptors are crit. regulators of cell migration in the context of immune surveillance, inflammation, and development.  The G protein-coupled chemokine receptor CXCR4 is specifically implicated in cancer metastasis and HIV-1 infection.  Here we report five independent crystal structures of CXCR4 bound to an antagonist small mol. IT1t and a cyclic peptide CVX15 at 2.5 to 3.2 angstrom resoln.  All structures reveal a consistent homodimer with an interface including helixes V and VI that may be involved in regulating signaling.  The location and shape of the ligand-binding sites differ from other G protein-coupled receptors and are closer to the extracellular surface.  These structures provide new clues about the interactions between CXCR4 and its natural ligand CXCL12, and with the HIV-1 glycoprotein gp120.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeofqcIJsBzLVg90H21EOLACvtfcHk0lguNhZ63DuSQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahurnM&md5=2d39cc2cff4adce72e63f427e568e35d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1126%2Fscience.1194396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1194396%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DB.%26aulast%3DChien%26aufirst%3DE.%2BY.%2BT.%26aulast%3DMol%26aufirst%3DC.%2BD.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DWells%26aufirst%3DP.%26aulast%3DBi%26aufirst%3DF.%2BC.%26aulast%3DHamel%26aufirst%3DD.%2BJ.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DHandel%26aufirst%3DT.%2BM.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructures%2520of%2520the%2520CXCR4%2520chemokine%2520receptor%2520in%2520complex%2520with%2520small%2520molecule%2520and%2520cyclic%2520peptide%2520antagonists%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1066%26epage%3D1071%26doi%3D10.1126%2Fscience.1194396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirado-Rives, J.</span><span> </span><span class="NLM_article-title">Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">11225</span><span class="NLM_x">–</span> <span class="NLM_lpage">11236</span><span class="refDoi"> DOI: 10.1021/ja9621760</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9621760" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaK28XmtlOitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=11225-11236&author=W.+L.+Jorgensenauthor=D.+S.+Maxwellauthor=J.+Tirado-Rives&title=Development+and+testing+of+the+OPLS+all-atom+force+field+on+conformational+energetics+and+properties+of+organic+liquids&doi=10.1021%2Fja9621760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids</span></div><div class="casAuthors">Jorgensen, William L.; Maxwell, David S.; Tirado-Rives, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">11225-11236</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and testing of the OPLS all-atom force field for org. mols. and peptides are described.  Parameters for both torsional and nonbonded energetics have been derived, while the bond stretching and angle bending parameters have been adopted mostly from the AMBER all-atom force field.  The torsional parameters were detd. by fitting to rotational energy profiles obtained from ab initio MO calcns. at the RHF/6-31G*//RHF/6-31G* level for more than 50 org. mols. and ions.  The quality of the fits was high with av. errors for conformational energies of less than 0.2 kcal/mol.  The force-field results for mol. structures are also demonstrated to closely match the ab initio predictions.  The nonbonded parameters were developed in conjunction with Monte Carlo statistical mechanics simulations by computing thermodn. and structural properties for 34 pure org. liqs. including alkanes, alkenes, alcs., ethers, acetals, thiols, sulfides, disulfides, aldehydes, ketones, and amides.  Av. errors in comparison with exptl. data are 2% for heats of vaporization and densities.  The Monte Carlo simulations included sampling all internal and intermol. degrees of freedom.  It is found that such non-polar and monofunctional systems do not show significant condensed-phase effects on internal energies in going from the gas phase to the pure liqs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhGotSev_b1LVg90H21EOLACvtfcHk0lguNhZ63DuSQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtlOitrs%253D&md5=fef2924a69421881390282aa309ae91b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fja9621760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9621760%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DMaxwell%26aufirst%3DD.%2BS.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520the%2520OPLS%2520all-atom%2520force%2520field%2520on%2520conformational%2520energetics%2520and%2520properties%2520of%2520organic%2520liquids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D11225%26epage%3D11236%26doi%3D10.1021%2Fja9621760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Maier, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasavajhala, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickstrom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmerling, C.</span><span> </span><span class="NLM_article-title">ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3696</span><span class="NLM_x">–</span> <span class="NLM_lpage">3713</span><span class="refDoi"> DOI: 10.1021/acs.jctc.5b00255</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00255" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFequ7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=3696-3713&author=J.+A.+Maierauthor=C.+Martinezauthor=K.+Kasavajhalaauthor=L.+Wickstromauthor=K.+E.+Hauserauthor=C.+Simmerling&title=ff14SB%3A+improving+the+accuracy+of+protein+side+chain+and+backbone+parameters+from+ff99SB&doi=10.1021%2Facs.jctc.5b00255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB</span></div><div class="casAuthors">Maier, James A.; Martinez, Carmenza; Kasavajhala, Koushik; Wickstrom, Lauren; Hauser, Kevin E.; Simmerling, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3696-3713</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. mechanics is powerful for its speed in atomistic simulations, but an accurate force field is required.  The Amber ff99SB force field improved protein secondary structure balance and dynamics from earlier force fields like ff99, but weaknesses in side chain rotamer and backbone secondary structure preferences have been identified.  Here, we performed a complete refit of all amino acid side chain dihedral parameters, which had been carried over from ff94.  The training set of conformations included multidimensional dihedral scans designed to improve transferability of the parameters.  Improvement in all amino acids was obtained as compared to ff99SB.  Parameters were also generated for alternate protonation states of ionizable side chains.  Av. errors in relative energies of pairs of conformations were under 1.0 kcal/mol as compared to QM, reduced 35% from ff99SB.  We also took the opportunity to make empirical adjustments to the protein backbone dihedral parameters as compared to ff99SB.  Multiple small adjustments of φ and ψ parameters were tested against NMR scalar coupling data and secondary structure content for short peptides.  The best results were obtained from a phys. motivated adjustment to the φ rotational profile that compensates for lack of ff99SB QM training data in the β-ppII transition region.  Together, these backbone and side chain modifications (hereafter called ff14SB) not only better reproduced their benchmarks, but also improved secondary structure content in small peptides and reprodn. of NMR χ1 scalar coupling measurements for proteins in soln.  We also discuss the Amber ff12SB parameter set, a preliminary version of ff14SB that includes most of its improvements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgntnN9ES97rVg90H21EOLACvtfcHk0lguNhZ63DuSQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFequ7rN&md5=7b803577b3b6912cc6750cfbd356596e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00255%26sid%3Dliteratum%253Aachs%26aulast%3DMaier%26aufirst%3DJ.%2BA.%26aulast%3DMartinez%26aufirst%3DC.%26aulast%3DKasavajhala%26aufirst%3DK.%26aulast%3DWickstrom%26aufirst%3DL.%26aulast%3DHauser%26aufirst%3DK.%2BE.%26aulast%3DSimmerling%26aufirst%3DC.%26atitle%3Dff14SB%253A%2520improving%2520the%2520accuracy%2520of%2520protein%2520side%2520chain%2520and%2520backbone%2520parameters%2520from%2520ff99SB%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2015%26volume%3D11%26spage%3D3696%26epage%3D3713%26doi%3D10.1021%2Facs.jctc.5b00255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Dickson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madej, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skjevik, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teigen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, R. C.</span><span> </span><span class="NLM_article-title">Lipid14: the amber lipid force field</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">865</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span><span class="refDoi"> DOI: 10.1021/ct4010307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct4010307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Wgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=865-879&author=C.+J.+Dicksonauthor=B.+D.+Madejauthor=A.+A.+Skjevikauthor=R.+M.+Betzauthor=K.+Teigenauthor=I.+R.+Gouldauthor=R.+C.+Walker&title=Lipid14%3A+the+amber+lipid+force+field&doi=10.1021%2Fct4010307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid14: The Amber Lipid Force Field</span></div><div class="casAuthors">Dickson, Callum J.; Madej, Benjamin D.; Skjevik, Age A.; Betz, Robin M.; Teigen, Knut; Gould, Ian R.; Walker, Ross C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">865-879</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The AMBER lipid force field has been updated to create Lipid14, allowing tensionless simulation of a no. of lipid types with the AMBER MD package.  The modular nature of this force field allows numerous combinations of head and tail groups to create different lipid types, enabling the easy insertion of new lipid species.  The Lennard-Jones and torsion parameters of both the head and tail groups have been revised and updated partial charges calcd.  The force field has been validated by simulating bilayers of six different lipid types for a total of 0.5 μs each without applying a surface tension; with favorable comparison to expt. for properties such as area per lipid, vol. per lipid, bilayer thickness, NMR order parameters, scattering data, and lipid lateral diffusion.  As the derivation of this force field is consistent with the AMBER development philosophy, Lipid14 is compatible with the AMBER protein, nucleic acid, carbohydrate, and small mol. force fields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo60Ks38bQOe7Vg90H21EOLACvtfcHk0ljR0WQ31hYsew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Wgt70%253D&md5=6efe3346bab426a93016d10418b6957a</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fct4010307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct4010307%26sid%3Dliteratum%253Aachs%26aulast%3DDickson%26aufirst%3DC.%2BJ.%26aulast%3DMadej%26aufirst%3DB.%2BD.%26aulast%3DSkjevik%26aufirst%3DA.%2BA.%26aulast%3DBetz%26aufirst%3DR.%2BM.%26aulast%3DTeigen%26aufirst%3DK.%26aulast%3DGould%26aufirst%3DI.%2BR.%26aulast%3DWalker%26aufirst%3DR.%2BC.%26atitle%3DLipid14%253A%2520the%2520amber%2520lipid%2520force%2520field%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2014%26volume%3D10%26spage%3D865%26epage%3D879%26doi%3D10.1021%2Fct4010307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, D. A.</span><span> </span><span class="NLM_article-title">Automatic atom type and bond type perception in molecular mechanical calculations</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span><span class="refDoi"> DOI: 10.1016/j.jmgm.2005.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2Fj.jmgm.2005.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=16458552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1Gis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=247-260&author=J.+Wangauthor=W.+Wangauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Automatic+atom+type+and+bond+type+perception+in+molecular+mechanical+calculations&doi=10.1016%2Fj.jmgm.2005.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Automatic atom type and bond type perception in molecular mechanical calculations</span></div><div class="casAuthors">Wang, Junmei; Wang, Wei; Kollman, Peter A.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-260</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">In mol. mechanics (MM) studies, atom types and/or bond types of mols. are needed to det. prior to energy calcns.  The authors present here an automatic algorithm of perceiving atom types that are defined in a description table, and an automatic algorithm of assigning bond types just based on at. connectivity.  The algorithms have been implemented in a new module of the AMBER packages.  This auxiliary module, antechamber (roughly meaning "before AMBER"), can be applied to generate necessary inputs of leap-the AMBER program to generate topologies for minimization, mol. dynamics, etc., for most org. mols.  The algorithms behind the manipulations may be useful for other mol. mech. packages as well as applications that need to designate atom types and bond types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqizj6F18nBYbVg90H21EOLACvtfcHk0ljR0WQ31hYsew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1Gis7g%253D&md5=8031a21d2784d5dea12e70868522aa61</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2005.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmgm.2005.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DAutomatic%2520atom%2520type%2520and%2520bond%2520type%2520perception%2520in%2520molecular%2520mechanical%2520calculations%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2006%26volume%3D25%26spage%3D247%26epage%3D260%26doi%3D10.1016%2Fj.jmgm.2005.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieplak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornell, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model</span> <span class="citation_source-journal">J. Phys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">10269</span><span class="NLM_x">–</span> <span class="NLM_lpage">10280</span><span class="refDoi"> DOI: 10.1021/j100142a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/j100142a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaK3sXlvVyqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1993&pages=10269-10280&author=C.+I.+Baylyauthor=P.+Cieplakauthor=W.+Cornellauthor=P.+A.+Kollman&title=A+well-behaved+electrostatic+potential+based+method+using+charge+restraints+for+deriving+atomic+charges%3A+the+RESP+model&doi=10.1021%2Fj100142a004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model</span></div><div class="casAuthors">Bayly, Christopher I.; Cieplak, Piotr; Cornell, Wendy; Kollman, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">10269-80</span>CODEN:
                <span class="NLM_cas:coden">JPCHAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-3654</span>.
    </div><div class="casAbstract">The authors present a new approach to generating electrostatic potential (ESP) derived charges for mols.  The major strength of electrostatic potential derived charges is that they optimally reproduce the intermol. interaction properties of mols. with a simple two-body additive potential, provided, of course, that a suitably accurate level of quantum mech. calcn. is used to derive the ESP around the mol.  Previously, the major weaknesses of these charges have been that they were not easily transferably between common functional groups in related mols., they have often been conformationally dependent, and the large charges that frequently occur can be problematic for simulating intramol. interactions.  Introducing restraints in the form of a penalty function into the fitting process considerably reduces the above problems, with only a minor decrease in the quality of the fit to the quantum mech. ESP.  Several other refinements in addn. to the restrained electrostatic potential (RESP) fit yield a general and algorithmic charge fitting procedure for generating atom-centered point charges.  This approach can thus be recommended for general use in mol. mechanics, mol. dynamics, and free energy calcns. for any org. or bioorg. system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRAz3o6S1gOrVg90H21EOLACvtfcHk0ljR0WQ31hYsew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlvVyqsLs%253D&md5=e65c6a556ffc174df4f327687912a0bd</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fj100142a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fj100142a004%26sid%3Dliteratum%253Aachs%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DCieplak%26aufirst%3DP.%26aulast%3DCornell%26aufirst%3DW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DA%2520well-behaved%2520electrostatic%2520potential%2520based%2520method%2520using%2520charge%2520restraints%2520for%2520deriving%2520atomic%2520charges%253A%2520the%2520RESP%2520model%26jtitle%3DJ.%2520Phys.%2520Chem.%26date%3D1993%26volume%3D97%26spage%3D10269%26epage%3D10280%26doi%3D10.1021%2Fj100142a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, J. A.,  Jr.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, N. J.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas, Ö.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J.</span>Gaussian 09, revision <span class="NLM_edition">D.01</span>; <span class="NLM_publisher-name">Gaussian, Inc.</span>: <span class="NLM_publisher-loc">Wallingford, CT</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+J.+Frisch&author=G.+W.+Trucks&author=H.+B.+Schlegel&author=G.+E.+Scuseria&author=M.+A.+Robb&author=J.+R.+Cheeseman&author=G.+Scalmani&author=V.+Barone&author=B.+Mennucci&author=G.+A.+Petersson&author=H.+Nakatsuji&author=M.+Caricato&author=X.+Li&author=H.+P.+Hratchian&author=A.+F.+Izmaylov&author=J.+Bloino&author=G.+Zheng&author=J.+L.+Sonnenberg&author=M.+Hada&author=M.+Ehara&author=K.+Toyota&author=R.+Fukuda&author=J.+Hasegawa&author=M.+Ishida&author=T.+Nakajima&author=Y.+Honda&author=O.+Kitao&author=H.+Nakai&author=T.+Vreven&author=J.+A.+Montgomery&author=J.+E.+Peralta&author=F.+Ogliaro&author=M.+Bearpark&author=J.+J.+Heyd&author=E.+Brothers&author=K.+N.+Kudin&author=V.+N.+Staroverov&author=R.+Kobayashi&author=J.+Normand&author=K.+Raghavachari&author=A.+Rendell&author=J.+C.+Burant&author=S.+S.+Iyengar&author=J.+Tomasi&author=M.+Cossi&author=N.+Rega&author=N.+J.+Millam&author=M.+Klene&author=J.+E.+Knox&author=J.+B.+Cross&author=V.+Bakken&author=C.+Adamo&author=J.+Jaramillo&author=R.+Gomperts&author=R.+E.+Stratmann&author=O.+Yazyev&author=A.+J.+Austin&author=R.+Cammi&author=C.+Pomelli&author=J.+W.+Ochterski&author=R.+L.+Martin&author=K.+Morokuma&author=V.+G.+Zakrzewski&author=G.+A.+Voth&author=P.+Salvador&author=J.+J.+Dannenberg&author=S.+Dapprich&author=A.+D.+Daniels&author=%C3%96.+Farkas&author=J.+B.+Foresman&author=J.+V.+Ortiz&author=J.+Cioslowski&author=D.+J.+Fox&title=Gaussian+09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DM.%2BJ.%26jtitle%3DGaussian%252009%26pub%3DGaussian%252C%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Phillips, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gumbart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajkhorshid, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chipot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skeel, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kale, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulten, K.</span><span> </span><span class="NLM_article-title">Scalable molecular dynamics with NAMD</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1781</span><span class="NLM_x">–</span> <span class="NLM_lpage">1802</span><span class="refDoi"> DOI: 10.1002/jcc.20289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1002%2Fjcc.20289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=16222654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=1781-1802&author=J.+C.+Phillipsauthor=R.+Braunauthor=W.+Wangauthor=J.+Gumbartauthor=E.+Tajkhorshidauthor=E.+Villaauthor=C.+Chipotauthor=R.+D.+Skeelauthor=L.+Kaleauthor=K.+Schulten&title=Scalable+molecular+dynamics+with+NAMD&doi=10.1002%2Fjcc.20289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Scalable molecular dynamics with NAMD</span></div><div class="casAuthors">Phillips, James C.; Braun, Rosemary; Wang, Wei; Gumbart, James; Tajkhorshid, Emad; Villa, Elizabeth; Chipot, Christophe; Skeel, Robert D.; Kale, Laxmikant; Schulten, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1781-1802</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">NAMD is a parallel mol. dynamics code designed for high-performance simulation of large biomol. systems.  NAMD scales to hundreds of processors on high-end parallel platforms, as well as tens of processors on low-cost commodity clusters, and also runs on individual desktop and laptop computers.  NAMD works with AMBER and CHARMM potential functions, parameters, and file formats.  This article, directed to novices as well as experts, first introduces concepts and methods used in the NAMD program, describing the classical mol. dynamics force field, equations of motion, and integration methods along with the efficient electrostatics evaluation algorithms employed and temp. and pressure controls used.  Features for steering the simulation across barriers and for calcg. both alchem. and conformational free energy differences are presented.  The motivations for and a roadmap to the internal design of NAMD, implemented in C++ and based on Charm++ parallel objects, are outlined.  The factors affecting the serial and parallel performance of a simulation are discussed.  Finally, typical NAMD use is illustrated with representative applications to a small, a medium, and a large biomol. system, highlighting particular features of NAMD, for example, the Tcl scripting language.  The article also provides a list of the key features of NAMD and discusses the benefits of combining NAMD with the mol. graphics/sequence anal. software VMD and the grid computing/collab. software BioCoRE.  NAMD is distributed free of charge with source code at www.ks.uiuc.edu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7fq_yG00T1rVg90H21EOLACvtfcHk0linKKkHcDgeJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbJ&md5=189051128443b547f4300a1b8fb0e034</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20289%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DJ.%2BC.%26aulast%3DBraun%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DGumbart%26aufirst%3DJ.%26aulast%3DTajkhorshid%26aufirst%3DE.%26aulast%3DVilla%26aufirst%3DE.%26aulast%3DChipot%26aufirst%3DC.%26aulast%3DSkeel%26aufirst%3DR.%2BD.%26aulast%3DKale%26aufirst%3DL.%26aulast%3DSchulten%26aufirst%3DK.%26atitle%3DScalable%2520molecular%2520dynamics%2520with%2520NAMD%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2005%26volume%3D26%26spage%3D1781%26epage%3D1802%26doi%3D10.1002%2Fjcc.20289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Ballesteros, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span> </span><span class="NLM_article-title">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span> <span class="citation_source-journal">Methods Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span><span class="refDoi"> DOI: 10.1016/S1043-9471(05)80049-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2FS1043-9471%2805%2980049-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=366-428&author=J.+A.+Ballesterosauthor=H.+Weinstein&title=Integrated+methods+for+the+construction+of+three-dimensional+models+and+computational+probing+of+structure-function+relations+in+G+protein-coupled+receptors&doi=10.1016%2FS1043-9471%2805%2980049-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span></div><div class="casAuthors">Ballesteros, Juan A.; Weinstein, Harel</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Neurosciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">366-428</span>CODEN:
                <span class="NLM_cas:coden">MENEE5</span>;
        ISSN:<span class="NLM_cas:issn">1043-9471</span>.
    </div><div class="casAbstract">A review, with 135 refs., on approaches that can be used to resolve the apparent ambiguities that burden the pharmacol. testing of G protein-coupled receptor (GPCR) models, based on the integration of structural information about the receptor, about mutants, and about the changes induced by ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfENoRspqa7LVg90H21EOLACvtfcHk0linKKkHcDgeJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D&md5=d3f99e9d07cea245a770f3f099bc8cc7</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS1043-9471%2805%2980049-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-9471%252805%252980049-7%26sid%3Dliteratum%253Aachs%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26aulast%3DWeinstein%26aufirst%3DH.%26atitle%3DIntegrated%2520methods%2520for%2520the%2520construction%2520of%2520three-dimensional%2520models%2520and%2520computational%2520probing%2520of%2520structure-function%2520relations%2520in%2520G%2520protein-coupled%2520receptors%26jtitle%3DMethods%2520Neurosci.%26date%3D1995%26volume%3D25%26spage%3D366%26epage%3D428%26doi%3D10.1016%2FS1043-9471%2805%2980049-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5'],'ref6':['cit6a','cit6b'],'ref7':['cit7a','cit7b'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15a','cit15b'],'ref16':['cit16a','cit16b','cit16c'],'ref17':['cit17a','cit17b','cit17c'],'ref18':['cit18a','cit18b','cit18c','cit18d','cit18e'],'ref19':['cit19a','cit19b'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b','cit22c','cit22d'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34a','cit34b'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39a','cit39b'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Anna Maria Trotta, Michela Aurilio, Crescenzo D’Alterio, Caterina Ieranò, Daria Di Martino, Antonio Barbieri, Antonio Luciano, Paolo Gaballo, Sara Santagata, Luigi Portella, Stefano Tomassi, Luciana Marinelli, Deborah Sementa, Ettore Novellino, Secondo Lastoria, Stefania Scala, Margret Schottelius, <span class="NLM_string-name hlFld-ContribAuthor">Salvatore Di Maro</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 3449-3461. <a href="https://doi.org/10.1021/acs.jmedchem.1c00066" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00066%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BPeptide-Based%252BPET%252BProbe%252Bfor%252BNon-invasive%252BImaging%252Bof%252BC-X-C%252BChemokine%252BReceptor%252BType%252B4%252B%252528CXCR4%252529%252Bin%252BTumors%26aulast%3DTrotta%26aufirst%3DAnna%2BMaria%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D14012021%26date%3D04032021%26volume%3D64%26issue%3D6%26spage%3D3449%26epage%3D3461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yu Fu, Xiaodong Li, Hongda Chen, Zhenxin Wang, Wensheng Yang, <span class="NLM_string-name hlFld-ContribAuthor">Huimao Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">CXC Chemokine Receptor 4 Antagonist Functionalized Renal Clearable Manganese-Doped Iron Oxide Nanoparticles for Active-Tumor-Targeting Magnetic Resonance Imaging-Guided Bio-Photothermal Therapy. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Bio Materials</span><span> <strong>2019,</strong> <em>2 </em>
                                    (8)
                                     , 3613-3621. <a href="https://doi.org/10.1021/acsabm.9b00475" title="DOI URL">https://doi.org/10.1021/acsabm.9b00475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsabm.9b00475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsabm.9b00475%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Bio%2520Materials%26atitle%3DCXC%252BChemokine%252BReceptor%252B4%252BAntagonist%252BFunctionalized%252BRenal%252BClearable%252BManganese-Doped%252BIron%252BOxide%252BNanoparticles%252Bfor%252BActive-Tumor-Targeting%252BMagnetic%252BResonance%252BImaging-Guided%252BBio-Photothermal%252BTherapy%26aulast%3DFu%26aufirst%3DYu%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D01062019%26date%3D12072019%26date%3D24072019%26date%3D12072019%26volume%3D2%26issue%3D8%26spage%3D3613%26epage%3D3621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Diego Brancaccio, Donatella Diana, Salvatore Di Maro, Francesco Saverio Di Leva, Stefano Tomassi, Roberto Fattorusso, Luigi Russo, Stefania Scala, Anna Maria Trotta, Luigi Portella, Ettore Novellino, Luciana Marinelli, <span class="NLM_string-name hlFld-ContribAuthor">Alfonso Carotenuto</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)–Ligand Interactions on Living Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (7)
                                     , 2910-2923. <a href="https://doi.org/10.1021/acs.jmedchem.7b01830" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01830</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01830%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLigand-Based%252BNMR%252BStudy%252Bof%252BC-X-C%252BChemokine%252BReceptor%252BType%252B4%252B%252528CXCR4%252529%2525E2%252580%252593Ligand%252BInteractions%252Bon%252BLiving%252BCancer%252BCells%26aulast%3DBrancaccio%26aufirst%3DDiego%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D13122017%26date%3D19032018%26date%3D09032018%26volume%3D61%26issue%3D7%26spage%3D2910%26epage%3D2923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jen-Shin  Song</span>, <span class="hlFld-ContribAuthor ">Chih-Chun  Chang</span>, <span class="hlFld-ContribAuthor ">Chien-Huang  Wu</span>, <span class="hlFld-ContribAuthor ">Trinh Kieu  Dinh</span>, <span class="hlFld-ContribAuthor ">Jiing-Jyh  Jan</span>, <span class="hlFld-ContribAuthor ">Kuan-Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Ming-Chen  Chou</span>, <span class="hlFld-ContribAuthor ">Ting-Yun  Shiue</span>, <span class="hlFld-ContribAuthor ">Kai-Chia  Yeh</span>, <span class="hlFld-ContribAuthor ">Yi-Yu  Ke</span>, <span class="hlFld-ContribAuthor ">Teng-Kuang  Yeh</span>, <span class="hlFld-ContribAuthor ">Yen-Nhi Ngoc  Ta</span>, <span class="hlFld-ContribAuthor ">Chia-Jui  Lee</span>, <span class="hlFld-ContribAuthor ">Jing-Kai  Huang</span>, <span class="hlFld-ContribAuthor ">Yun-Chieh  Sung</span>, <span class="hlFld-ContribAuthor ">Kak-Shan  Shia</span>, <span class="hlFld-ContribAuthor ">Yunching  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2021,</strong> <em>118 </em>
                                    (13)
                                     , e2015433118. <a href="https://doi.org/10.1073/pnas.2015433118" title="DOI URL">https://doi.org/10.1073/pnas.2015433118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.2015433118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.2015433118%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DA%252Bhighly%252Bselective%252Band%252Bpotent%252BCXCR4%252Bantagonist%252Bfor%252Bhepatocellular%252Bcarcinoma%252Btreatment%26aulast%3DSong%26aufirst%3DJen-Shin%26date%3D2021%26date%3D2021%26volume%3D118%26issue%3D13%26spage%3De2015433118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberto G. S.  Berlinck</span>, <span class="hlFld-ContribAuthor ">Darlon I.  Bernardi</span>, <span class="hlFld-ContribAuthor ">Taicia  Fill</span>, <span class="hlFld-ContribAuthor ">Alessandra A. G.  Fernandes</span>, <span class="hlFld-ContribAuthor ">Igor D.  Jurberg</span>. </span><span class="cited-content_cbyCitation_article-title">The chemistry and biology of guanidine secondary metabolites. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Reports</span><span> <strong>2021,</strong> <em>66 </em><a href="https://doi.org/10.1039/D0NP00051E" title="DOI URL">https://doi.org/10.1039/D0NP00051E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NP00051E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NP00051E%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Reports%26atitle%3DThe%252Bchemistry%252Band%252Bbiology%252Bof%252Bguanidine%252Bsecondary%252Bmetabolites%26aulast%3DBerlinck%26aufirst%3DRoberto%2BG.%2BS.%26date%3D2021%26date%3D2021%26volume%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefano  Tomassi</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Trotta</span>, <span class="hlFld-ContribAuthor ">Caterina  Ieranò</span>, <span class="hlFld-ContribAuthor ">Francesco  Merlino</span>, <span class="hlFld-ContribAuthor ">Anna  Messere</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Rea</span>, <span class="hlFld-ContribAuthor ">Federica  Santoro</span>, <span class="hlFld-ContribAuthor ">Diego  Brancaccio</span>, <span class="hlFld-ContribAuthor ">Alfonso  Carotenuto</span>, <span class="hlFld-ContribAuthor ">Vincenzo Maria  D'Amore</span>, <span class="hlFld-ContribAuthor ">Francesco Saverio  Di Leva</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Sandro  Cosconati</span>, <span class="hlFld-ContribAuthor ">Luciana  Marinelli</span>, <span class="hlFld-ContribAuthor ">Stefania  Scala</span>, <span class="hlFld-ContribAuthor ">Salvatore  Di Maro</span>. </span><span class="cited-content_cbyCitation_article-title">Disulfide Bond Replacement with 1,4‐ and 1,5‐Disubstituted [1,2,3]‐Triazole on C‐X‐C Chemokine Receptor Type 4 (CXCR4) Peptide Ligands: Small Changes that Make Big Differences. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (44)
                                     , 10113-10125. <a href="https://doi.org/10.1002/chem.202002468" title="DOI URL">https://doi.org/10.1002/chem.202002468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202002468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202002468%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DDisulfide%252BBond%252BReplacement%252Bwith%252B1%25252C4%2525E2%252580%252590%252Band%252B1%25252C5%2525E2%252580%252590Disubstituted%252B%25255B1%25252C2%25252C3%25255D%2525E2%252580%252590Triazole%252Bon%252BC%2525E2%252580%252590X%2525E2%252580%252590C%252BChemokine%252BReceptor%252BType%252B4%252B%252528CXCR4%252529%252BPeptide%252BLigands%25253A%252BSmall%252BChanges%252Bthat%252BMake%252BBig%252BDifferences%26aulast%3DTomassi%26aufirst%3DStefano%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D44%26spage%3D10113%26epage%3D10125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Crescenzo  D’Alterio</span>, <span class="hlFld-ContribAuthor ">Stefania  Scala</span>, <span class="hlFld-ContribAuthor ">Gabriella  Sozzi</span>, <span class="hlFld-ContribAuthor ">Luca  Roz</span>, <span class="hlFld-ContribAuthor ">Giulia  Bertolini</span>. </span><span class="cited-content_cbyCitation_article-title">Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cancer Biology</span><span> <strong>2020,</strong> <em>60 </em>, 351-361. <a href="https://doi.org/10.1016/j.semcancer.2019.08.019" title="DOI URL">https://doi.org/10.1016/j.semcancer.2019.08.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcancer.2019.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcancer.2019.08.019%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cancer%2520Biology%26atitle%3DParadoxical%252Beffects%252Bof%252Bchemotherapy%252Bon%252Btumor%252Brelapse%252Band%252Bmetastasis%252Bpromotion%26aulast%3DD%25E2%2580%2599Alterio%26aufirst%3DCrescenzo%26date%3D2020%26volume%3D60%26spage%3D351%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Wu</span>, <span class="hlFld-ContribAuthor ">Wenyan  Yu</span>, <span class="hlFld-ContribAuthor ">Chuansheng  Yao</span>, <span class="hlFld-ContribAuthor ">Zhongxing  Liang</span>, <span class="hlFld-ContribAuthor ">Younghyoun  Yoon</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Xie</span>, <span class="hlFld-ContribAuthor ">Hyunsuk  Shim</span>, <span class="hlFld-ContribAuthor ">Renren  Bai</span>. </span><span class="cited-content_cbyCitation_article-title">Amide-sulfamide modulators as effective anti-tumor metastatic agents targeting CXCR4/CXCL12 axis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111823. <a href="https://doi.org/10.1016/j.ejmech.2019.111823" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111823</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111823%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAmide-sulfamide%252Bmodulators%252Bas%252Beffective%252Banti-tumor%252Bmetastatic%252Bagents%252Btargeting%252BCXCR4%25252FCXCL12%252Baxis%26aulast%3DWu%26aufirst%3DRui%26date%3D2020%26volume%3D185%26spage%3D111823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Arimont</span>, <span class="hlFld-ContribAuthor ">Carsten  Hoffmann</span>, <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>, <span class="hlFld-ContribAuthor ">Rob  Leurs</span>. </span><span class="cited-content_cbyCitation_article-title">Chemokine Receptor Crystal Structures: What Can Be Learned from Them?. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2019,</strong> <em>96 </em>
                                    (6)
                                     , 765-777. <a href="https://doi.org/10.1124/mol.119.117168" title="DOI URL">https://doi.org/10.1124/mol.119.117168</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.119.117168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.119.117168%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DChemokine%252BReceptor%252BCrystal%252BStructures%25253A%252BWhat%252BCan%252BBe%252BLearned%252Bfrom%252BThem%25253F%26aulast%3DArimont%26aufirst%3DMarta%26date%3D2019%26date%3D2019%26volume%3D96%26issue%3D6%26spage%3D765%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Crescenzo  D’Alterio</span>, <span class="hlFld-ContribAuthor ">Maria  Buoncervello</span>, <span class="hlFld-ContribAuthor ">Caterina  Ieranò</span>, <span class="hlFld-ContribAuthor ">Maria  Napolitano</span>, <span class="hlFld-ContribAuthor ">Luigi  Portella</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Rea</span>, <span class="hlFld-ContribAuthor ">Antonio  Barbieri</span>, <span class="hlFld-ContribAuthor ">Antonio  Luciano</span>, <span class="hlFld-ContribAuthor ">Giosuè  Scognamiglio</span>, <span class="hlFld-ContribAuthor ">Fabiana  Tatangelo</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Anniciello</span>, <span class="hlFld-ContribAuthor ">Mario  Monaco</span>, <span class="hlFld-ContribAuthor ">Ernesta  Cavalcanti</span>, <span class="hlFld-ContribAuthor ">Piera  Maiolino</span>, <span class="hlFld-ContribAuthor ">Giulia  Romagnoli</span>, <span class="hlFld-ContribAuthor ">Claudio  Arra</span>, <span class="hlFld-ContribAuthor ">Gerardo  Botti</span>, <span class="hlFld-ContribAuthor ">Lucia  Gabriele</span>, <span class="hlFld-ContribAuthor ">Stefania  Scala</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2019,</strong> <em>38 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-019-1420-8" title="DOI URL">https://doi.org/10.1186/s13046-019-1420-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-019-1420-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-019-1420-8%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DTargeting%252BCXCR4%252Bpotentiates%252Banti-PD-1%252Befficacy%252Bmodifying%252Bthe%252Btumor%252Bmicroenvironment%252Band%252Binhibiting%252Bneoplastic%252BPD-1%26aulast%3DD%25E2%2580%2599Alterio%26aufirst%3DCrescenzo%26date%3D2019%26date%3D2019%26volume%3D38%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malte  Kircher</span>, <span class="hlFld-ContribAuthor ">Peter  Herhaus</span>, <span class="hlFld-ContribAuthor ">Margret  Schottelius</span>, <span class="hlFld-ContribAuthor ">Andreas K.  Buck</span>, <span class="hlFld-ContribAuthor ">Rudolf A.  Werner</span>, <span class="hlFld-ContribAuthor ">Hans-Jürgen  Wester</span>, <span class="hlFld-ContribAuthor ">Ulrich  Keller</span>, <span class="hlFld-ContribAuthor ">Constantin  Lapa</span>. </span><span class="cited-content_cbyCitation_article-title">CXCR4-directed theranostics in oncology and inflammation. </span><span class="cited-content_cbyCitation_journal-name">Annals of Nuclear Medicine</span><span> <strong>2018,</strong> <em>32 </em>
                                    (8)
                                     , 503-511. <a href="https://doi.org/10.1007/s12149-018-1290-8" title="DOI URL">https://doi.org/10.1007/s12149-018-1290-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12149-018-1290-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12149-018-1290-8%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520Nuclear%2520Medicine%26atitle%3DCXCR4-directed%252Btheranostics%252Bin%252Boncology%252Band%252Binflammation%26aulast%3DKircher%26aufirst%3DMalte%26date%3D2018%26date%3D2018%26volume%3D32%26issue%3D8%26spage%3D503%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Chemical Structures of <b>1</b> (plerixafor) and <b>3</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Binding of <b>19</b> to (A) COLO205 colon cancer cells, overexpressing CXCR3, and (B) MCF-7 breast cancer cell line, overexpressing CXCR7. The binding was evaluated through flow cytometry using anti-CXCR3 FITC-antibody and anti-CXCR7 APC-antibody. Data are presented as bar graph showing mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Competition binding assays of <b>19</b> with <sup>125</sup>I-CXCL12. Experiments were performed on CCRF-CEM cells. Cells were incubated with 60 pM <sup>125</sup>I-CXCL12 as tracer and increasing concentrations (from 10 pM to 10 μM) of either <b>3</b> or <b>19</b> as competitor. The binding curve was fitted to a one-site binding model. Results shown (mean ± SD) are the average of three experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparative CXCL12-dependent cells migration experiments on <b>1</b> and <b>19</b>. Experiments were conducted on the CCRF-CEM (A), PES43 (B), HT29 (C), HCT116 (D), SN12C (E), and A498 (F) cell lines. Migrated cells on the lower surface were fixed, stained with H&E, and counted microscopically. The results are expressed as the migration index relative to migration in the presence of BSA alone. Data are presented as bar graph showing mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. CXCR4 internalization was assessed in CHO-CXCR4-GFP cells in the presence of CXCL12 (12.5 nM), <b>19</b> (10 nM), and <b>1</b> (10 nM): (A) untreated cells; (B) cells treated with CXCL12 (12.5 nM); (C) cells treated with <b>19</b> (10 nM) and then stimulated with CXCL12 (12.5 nM); (D) cells treated with <b>1</b> (10 nM) and then stimulated with CXCL12 (12.5 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Stability of <b>2</b> and <b>19</b> at different intervals of incubation with 90% human serum. Relative concentrations of peptides were determined by integration of the A230 peaks from analytical HPLC. (B) ESI-MS characterizations of <b>2</b> and <b>19</b> at different intervals of incubation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Stereoimage of the lowest energy conformer of <b>19</b>. Heavy atoms are represented with different colors (carbon, green; nitrogen, blue; oxygen, red; sulfur, yellow). Nonpolar hydrogen atoms are hidden for clarity reasons. (B) Superposition of the NMR lowest energy conformations of <b>19</b> (green) and <b>3</b> (orange)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> on the Cα carbon atoms of residues 3–7.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/medium/jm-2017-01062y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Binding mode of <b>19</b> (cyan sticks) at the CXCR4 receptor (gray cartoons) obtained through over 300 ns long MD simulations. Receptor amino acids and waters important for peptide binding are shown as sticks. Hydrogen bonds are displayed as dashed yellow lines. Nonpolar hydrogens are omitted for clarity. (B) Superposition between the MD-predicted binding poses of <b>3</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (orange sticks) and <b>19</b> at the CXCR4 receptor (gray cartoons). Both images are shown in stereoview.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01062/20171215/images/large/jm-2017-01062y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01062&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24871" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24871" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 54 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kochetkova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McColl, S. R.</span><span> </span><span class="NLM_article-title">Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span><span class="refDoi"> DOI: 10.1038/cdd.2008.190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1038%2Fcdd.2008.190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=19136936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1ygsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=664-673&author=M.+Kochetkovaauthor=S.+Kumarauthor=S.+R.+McColl&title=Chemokine+receptors+CXCR4+and+CCR7+promote+metastasis+by+preventing+anoikis+in+cancer+cells&doi=10.1038%2Fcdd.2008.190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells</span></div><div class="casAuthors">Kochetkova, M.; Kumar, S.; McColl, S. R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">664-673</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chemokine receptors are essential mediators of the metastatic spread in various cancer types; however their precise function in the development of secondary tumors remains poorly understood.  We report here a novel property of the chemokine receptors CXCR4 and CCR7 in inhibiting detachment-induced cell death - anoikis, which is believed to be one of the major blocks in the metastatic spread of various neoplasms.  Activation of these chemokine receptors by their resp. ligands, CXCL12 and CCL21 specifically reduced the sensitivity of metastatic breast cancer cells to anoikis by a distinct mechanism of selective regulation of pro-apoptotic Bmf and anti-apoptotic Bcl-xL proteins.  Consequently, functional CXCR4 and CCR7 increased cell survival in the absence of correct ECM attachment both in vitro and in vivo.  We also demonstrated that preventing chemokine-induced redn. in Bmf levels significantly attenuated breast cancer metastasis in an exptl. mouse model.  These results provide evidence for a previously unknown axis in malignant tumors, which connects chemokine receptors with deregulated apoptosis in the absence of the appropriate cell - ECM interaction and may offer novel targets for therapeutic intervention for the treatment of metastatic breast and potentially other tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDfruw4aUvy7Vg90H21EOLACvtfcHk0lgjfgAPY-AK3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1ygsbc%253D&md5=2dfe068ea27c8df53b48b1806ac4a0e7</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2008.190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2008.190%26sid%3Dliteratum%253Aachs%26aulast%3DKochetkova%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DMcColl%26aufirst%3DS.%2BR.%26atitle%3DChemokine%2520receptors%2520CXCR4%2520and%2520CCR7%2520promote%2520metastasis%2520by%2520preventing%2520anoikis%2520in%2520cancer%2520cells%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2009%26volume%3D16%26spage%3D664%26epage%3D673%26doi%3D10.1038%2Fcdd.2008.190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mukherjee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span> </span><span class="NLM_article-title">The role of chemokine receptor CXCR4 in breast cancer metastasis</span> <span class="citation_source-journal">Am. J. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=23359227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1Cgtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=46-57&author=D.+Mukherjeeauthor=J.+Zhao&title=The+role+of+chemokine+receptor+CXCR4+in+breast+cancer+metastasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The role of chemokine receptor CXCR4 in breast cancer metastasis</span></div><div class="casAuthors">Mukherjee, Debarati; Zhao, Jihe</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-57</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">A review.  Breast cancer is one of the leading causes of cancer related deaths worldwide.  Breast cancer-related mortality is assocd. with the development of metastatic potential of primary tumor lesions.  The chemokine receptor CXCR4 has been found to be a prognostic marker in various types of cancer, including breast cancer.  Recent advances in the field of cancer biol. has pointed to the crit. role that CXCR4 receptor and its ligand CXCL12 play in the metastasis of various types of cancer, including breast cancer.  Breast tumors preferentially metastasize to the lung, bones and lymph nodes, all of which represent organs that secrete high levels of CXCL12.  CXCL12 acts as a chemoattractant that drives CXCR4-pos. primary tumor cells towards secondary metastatic sites leading to the onset of metastatic lesions.  Since its discovery in 2001, the CXCR4 field has progressed at a very fast rate and further studies have pointed to the role of CXCR4 in dissemination of tumor cells from primary sites, transendothelial migration of tumor cells as well as the trafficking and homing of cancer stem cells.  This review summarizes the information that has been obtained over the years regarding the role of CXCL12-CXCR4 signaling in breast cancer, discusses its potential application to the development of new therapeutic tools for breast cancer control, and elucidates the potential therapeutic challenges which lie ahead and the future directions that this field can take for the improvement of prognosis in breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2GsMPs4WKwLVg90H21EOLACvtfcHk0lgjfgAPY-AK3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1Cgtb8%253D&md5=8d34d3156f63cfd0f4fa204ec5ef6c20</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26atitle%3DThe%2520role%2520of%2520chemokine%2520receptor%2520CXCR4%2520in%2520breast%2520cancer%2520metastasis%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2013%26volume%3D3%26spage%3D46%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Chatterjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azad, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmagadda, S.</span><span> </span><span class="NLM_article-title">The intricate role of CXCR4 in cancer</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1016/B978-0-12-411638-2.00002-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2FB978-0-12-411638-2.00002-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=25287686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlOjsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=31-82&author=S.+Chatterjeeauthor=B.+B.+Azadauthor=S.+Nimmagadda&title=The+intricate+role+of+CXCR4+in+cancer&doi=10.1016%2FB978-0-12-411638-2.00002-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The intricate role of CXCR4 in cancer</span></div><div class="casAuthors">Chatterjee, Samit; Azad, Babak Behnam; Nimmagadda, Sridhar</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">Emerging Applications of Molecular Imaging to Oncology</span>),
    <span class="NLM_cas:pages">31-82</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Chemokines mediate numerous physiol. and pathol. processes related primarily to cell homing and migration.  The chemokine CXCL12, also known as stromal cell-derived factor-1, binds the G-protein-coupled receptor CXCR4, which, through multiple divergent pathways, leads to chemotaxis, enhanced intracellular calcium, cell adhesion, survival, proliferation, and gene transcription.  CXCR4, initially discovered for its involvement in HIV entry and leukocytes trafficking, is overexpressed in more than 23 human cancers.  Cancer cell CXCR4 overexpression contributes to tumor growth, invasion, angiogenesis, metastasis, relapse, and therapeutic resistance.  CXCR4 antagonism has been shown to disrupt tumor - stromal interactions, sensitize cancer cells to cytotoxic drugs, and reduce tumor growth and metastatic burden.  As such, CXCR4 is a target not only for therapeutic intervention but also for noninvasive monitoring of disease progression and therapeutic guidance.  This review provides a comprehensive overview of the biol. involvement of CXCR4 in human cancers, the current status of CXCR4-based therapeutic approaches, as well as recent advances in noninvasive imaging of CXCR4 expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxrYlLFheE17Vg90H21EOLACvtfcHk0lgjfgAPY-AK3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlOjsbw%253D&md5=993eb25e051b2bb1bace3e96e57a1545</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-411638-2.00002-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-411638-2.00002-1%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DAzad%26aufirst%3DB.%2BB.%26aulast%3DNimmagadda%26aufirst%3DS.%26atitle%3DThe%2520intricate%2520role%2520of%2520CXCR4%2520in%2520cancer%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2014%26volume%3D124%26spage%3D31%26epage%3D82%26doi%3D10.1016%2FB978-0-12-411638-2.00002-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Peinado, H. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matei, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa-Silva, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Psaila, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromberg, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bissell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccia, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erler, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiratsuka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghajar, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyden, D.</span><span> </span><span class="NLM_article-title">Pre-metastatic niches: organ-specific homes for metastases</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span><span class="refDoi"> DOI: 10.1038/nrc.2017.6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1038%2Fnrc.2017.6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=28303905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt1Ont7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=302-317&author=H.+C.+A.+Peinadoauthor=H.+Zhangauthor=I.+R.+Mateiauthor=B.+Costa-Silvaauthor=A.+Hoshinoauthor=G.+Rodriguesauthor=B.+Psailaauthor=R.+N.+Kaplanauthor=J.+F.+Brombergauthor=Y.+Kangauthor=M.+J.+Bissellauthor=T.+R.+Coxauthor=A.+J.+Giacciaauthor=J.+T.+Erlerauthor=S.+Hiratsukaauthor=C.+M.+Ghajarauthor=D.+Lyden&title=Pre-metastatic+niches%3A+organ-specific+homes+for+metastases&doi=10.1038%2Fnrc.2017.6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pre-metastatic niches: organ-specific homes for metastases</span></div><div class="casAuthors">Peinado, Hector; Zhang, Haiying; Matei, Irina R.; Costa-Silva, Bruno; Hoshino, Ayuko; Rodrigues, Goncalo; Psaila, Bethan; Kaplan, Rosandra N.; Bromberg, Jacqueline F.; Kang, Yibin; Bissell, Mina J.; Cox, Thomas R.; Giaccia, Amato J.; Erler, Janine T.; Hiratsuka, Sachie; Ghajar, Cyrus M.; Lyden, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">302-317</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">It is well established that organs of future metastasis are not passive receivers of circulating tumor cells, but are instead selectively and actively modified by the primary tumor before metastatic spread has even occurred.  Sowing the 'seeds' of metastasis requires the action of tumor-secreted factors and tumor-shed extracellular vesicles that enable the 'soil' at distant metastatic sites to encourage the outgrowth of incoming cancer cells.  In this Review, we summarize the main processes and new mechanisms involved in the formation of the pre-metastatic niche.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotciVXm6vhd7Vg90H21EOLACvtfcHk0ljDy33o0yERAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt1Ont7w%253D&md5=1aafdc57c473d50560ceb63f299fb2b8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc.2017.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc.2017.6%26sid%3Dliteratum%253Aachs%26aulast%3DPeinado%26aufirst%3DH.%2BC.%2BA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMatei%26aufirst%3DI.%2BR.%26aulast%3DCosta-Silva%26aufirst%3DB.%26aulast%3DHoshino%26aufirst%3DA.%26aulast%3DRodrigues%26aufirst%3DG.%26aulast%3DPsaila%26aufirst%3DB.%26aulast%3DKaplan%26aufirst%3DR.%2BN.%26aulast%3DBromberg%26aufirst%3DJ.%2BF.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DBissell%26aufirst%3DM.%2BJ.%26aulast%3DCox%26aufirst%3DT.%2BR.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26aulast%3DErler%26aufirst%3DJ.%2BT.%26aulast%3DHiratsuka%26aufirst%3DS.%26aulast%3DGhajar%26aufirst%3DC.%2BM.%26aulast%3DLyden%26aufirst%3DD.%26atitle%3DPre-metastatic%2520niches%253A%2520organ-specific%2520homes%2520for%2520metastases%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2017%26volume%3D17%26spage%3D302%26epage%3D317%26doi%3D10.1038%2Fnrc.2017.6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauwels, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witvrouw, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vreese, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenwirth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peichl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Datema, R.</span><span> </span><span class="NLM_article-title">Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">668</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1128/AAC.38.4.668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1128%2FAAC.38.4.668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=7913308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A280%3ADyaK2czgsVWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1994&pages=668-674&author=E.+De+Clercqauthor=N.+Yamamotoauthor=R.+Pauwelsauthor=J.+Balzariniauthor=M.+Witvrouwauthor=K.+De+Vreeseauthor=Z.+Debyserauthor=B.+Rosenwirthauthor=P.+Peichlauthor=R.+Datema&title=Highly+potent+and+selective+inhibition+of+human+immunodeficiency+virus+by+the+bicyclam+derivative+JM3100&doi=10.1128%2FAAC.38.4.668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100</span></div><div class="casAuthors">De Clercq E; Yamamoto N; Pauwels R; Balzarini J; Witvrouw M; De Vreese K; Debyser Z; Rosenwirth B; Peichl P; Datema R</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial agents and chemotherapy</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">668-74</span>
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">Bicyclams, in which the cyclam (1,4,8,11-tetraazacyclotetradecane) moieties are tethered via an aliphatic bridge (i.e., propylene, as in JM2763) are potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) (E.  De Clercq, N.  Yamamoto, R.  Pauwels, M.  Baba, D.  Schols, H.  Nakashima, J.  Balzarini, Z.  Debyser, B.  A.  Murrer, D.  Schwartz, D.  Thornton, G.  Bridger, S.  Fricker, G.  Henson, M.  Abrams, and D.  Picker, Proc.  Natl.  Acad.  Sci.  USA 89:5286-5290, 1992).  We have now found that the bicyclam JM3100, in which the cyclam moieties are tethered by an aromatic bridge [i.e., phenylenebis(methylene)], inhibits the replication of various HIV-1 and HIV-2 strains in various cell lines at a 50% effective concentration (EC50) of 1 to 10 ng/ml, which is about 100-fold lower than the concentration required for JM2763 to inhibit HIV replication and at least 100,000-fold lower than the cytotoxic concentration (> 500 micrograms/ml).  In primary T4 lymphocytes or primary monocytes, JM3100 proved inhibitory to HIV-1(IIIB) and several clinical HIV-1 isolates at an EC50 of less than 1 ng/ml.  On the basis of time-of-addition experiments, JM3100 appeared to interact with a viral uncoating event, and this was further corroborated by an uncoating assay in which RNase sensitivity of [5-3H]uridine-labeled virions was monitored.  In addition, but possibly mechanistically related, JM3100 blocks formation of infectious particles.  JM3100 was also found to interfere directly with virus-induced syncytium formation, albeit at a higher concentration (1 to 2 microgram/ml) than that required for inhibition of viral replication.  Following subcutaneous injection of 10 mg of JM3100 per kg of body weight to rabbits, anti-HIV activity was detected in serum corresponding to serum drug levels exceeding for at least 6 h by >100-fold the EC(50) required to inhibit HIV replication in vitro.  When combined with either 3'-azido-2',3' -dideoxythymidine or 2',3' -dideoxyinosine, JM3100 achieved a additive inhibition of HIV replication, and when repeatedly subcultivated in the presence of JM3100, the virus remained sensitive to the compound for at least 30 passages (120 days) in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwBIyQ7x-DR8K3uFsUIZtkfW6udTcc2eZFLRf5kkfQs7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2czgsVWjtQ%253D%253D&md5=8dc19841c28dcd2ce9277898f69addf1</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1128%2FAAC.38.4.668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.38.4.668%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DPauwels%26aufirst%3DR.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DWitvrouw%26aufirst%3DM.%26aulast%3DDe%2BVreese%26aufirst%3DK.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DRosenwirth%26aufirst%3DB.%26aulast%3DPeichl%26aufirst%3DP.%26aulast%3DDatema%26aufirst%3DR.%26atitle%3DHighly%2520potent%2520and%2520selective%2520inhibition%2520of%2520human%2520immunodeficiency%2520virus%2520by%2520the%2520bicyclam%2520derivative%2520JM3100%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1994%26volume%3D38%26spage%3D668%26epage%3D674%26doi%3D10.1128%2FAAC.38.4.668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Donzella, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Este, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagashima, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddon, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allaway, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakmar, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. P.</span><span> </span><span class="NLM_article-title">AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span><span class="refDoi"> DOI: 10.1038/nm0198-072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1038%2Fnm0198-072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=9427609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaK1cXjt1KjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=72-77&author=G.+A.+Donzellaauthor=D.+Scholsauthor=S.+W.+Linauthor=J.+A.+Esteauthor=K.+A.+Nagashimaauthor=P.+J.+Maddonauthor=G.+P.+Allawayauthor=T.+P.+Sakmarauthor=G.+Hensonauthor=E.+De+Clercqauthor=J.+P.+Moore&title=AMD3100%2C+a+small+molecule+inhibitor+of+HIV-1+entry+via+the+CXCR4+co-receptor&doi=10.1038%2Fnm0198-072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">AMD3100, a small molecule inhibitor of HIV-1 entry via the CXC4 co-receptor</span></div><div class="casAuthors">Donzella, George A.; Schols, Dominique; Lin, Steven W.; Este, Jose A.; Nagashima, Kirsten A.; Maddon, Paul J.; Allaway, Graham P.; Sakmar, Thomas P.; Henson, Geoffrey; De Clercq, Erik; Moore, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-77</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">The bicyclam AMD3100 (formula wt. 830) blocks HIV-1 entry and membrane fusion via the CXCR4 co-receptor, but not via CCR5.  AMD3100 prevents monoclonal antibody 2D7 binding to CCR5.  It also inhibits binding of the CXC-chemokine, SDF-1α, to CXCR4 and subsequent signal transduction, but does not itself cause signaling and has no effect on RANTES signaling via CCR5.  Thus, AMD3100 prevents CXCR4 functioning as both a HIV-1 coreceptor and a CXC-chemokine receptor.  Development of small mol. inhibitors of HIV-1 entry is feasible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8es3KyoNLxLVg90H21EOLACvtfcHk0lgHb2JlAY2rqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjt1KjtA%253D%253D&md5=8a62b8e798d4e6447a361ab9fa2adb2a</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1038%2Fnm0198-072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0198-072%26sid%3Dliteratum%253Aachs%26aulast%3DDonzella%26aufirst%3DG.%2BA.%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DS.%2BW.%26aulast%3DEste%26aufirst%3DJ.%2BA.%26aulast%3DNagashima%26aufirst%3DK.%2BA.%26aulast%3DMaddon%26aufirst%3DP.%2BJ.%26aulast%3DAllaway%26aufirst%3DG.%2BP.%26aulast%3DSakmar%26aufirst%3DT.%2BP.%26aulast%3DHenson%26aufirst%3DG.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26atitle%3DAMD3100%252C%2520a%2520small%2520molecule%2520inhibitor%2520of%2520HIV-1%2520entry%2520via%2520the%2520CXCR4%2520co-receptor%26jtitle%3DNat.%2520Med.%26date%3D1998%26volume%3D4%26spage%3D72%26epage%3D77%26doi%3D10.1038%2Fnm0198-072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">The bicyclam AMD3100 story</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">587</span><span class="refDoi"> DOI: 10.1038/nrd1134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1038%2Fnrd1134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=12815382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks1Oqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=581-587&author=E.+De+Clercq&title=The+bicyclam+AMD3100+story&doi=10.1038%2Fnrd1134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Timeline: The bicyclam AMD3100 story</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">581-587</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery and development of the bicyclam AMD3100 - a chemokine receptor antagonist - has highlighted the therapeutic potential of such compds. in HIV infection, inflammatory diseases, cancer and stem-cell mobilization.  Here, the author describes the development process of AMD3100, which began about 15 yr ago with the isolation of an impurity, and the basis for the clin. application of AMD3100 and its congeners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB-TkHJ79RrbVg90H21EOLACvtfcHk0licp9G_hW7MFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks1Oqsr8%253D&md5=cf8344ba0e19da8ffaadfe8c9b57200c</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1038%2Fnrd1134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1134%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DThe%2520bicyclam%2520AMD3100%2520story%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D581%26epage%3D587%26doi%3D10.1038%2Fnrd1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Seubert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grünwald, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobuch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelter, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siveke, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonavicius, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heikenwalder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinheckel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleeman, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, K.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knolle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krüger, A.</span><span> </span><span class="NLM_article-title">Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1002/hep.27378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1002%2Fhep.27378" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2015&pages=238-248&author=B.+Seubertauthor=B.+Gr%C3%BCnwaldauthor=J.+Kobuchauthor=H.+Cuiauthor=F.+Schelterauthor=S.+Schatenauthor=J.+T.+Sivekeauthor=N.+H.+Limauthor=H.+Nagaseauthor=N.+Simonaviciusauthor=M.+Heikenwalderauthor=T.+Reinheckelauthor=J.+P.+Sleemanauthor=K.-P.+Janssenauthor=P.+A.+Knolleauthor=A.+Kr%C3%BCger&title=Tissue+inhibitor+of+metalloproteinases+%28TIMP%29-1+creates+a+premetastatic+niche+in+the+liver+through+SDF-1%2FCXCR4-dependent+neutrophil+recruitment+in+mice&doi=10.1002%2Fhep.27378"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fhep.27378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.27378%26sid%3Dliteratum%253Aachs%26aulast%3DSeubert%26aufirst%3DB.%26aulast%3DGr%25C3%25BCnwald%26aufirst%3DB.%26aulast%3DKobuch%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DSchelter%26aufirst%3DF.%26aulast%3DSchaten%26aufirst%3DS.%26aulast%3DSiveke%26aufirst%3DJ.%2BT.%26aulast%3DLim%26aufirst%3DN.%2BH.%26aulast%3DNagase%26aufirst%3DH.%26aulast%3DSimonavicius%26aufirst%3DN.%26aulast%3DHeikenwalder%26aufirst%3DM.%26aulast%3DReinheckel%26aufirst%3DT.%26aulast%3DSleeman%26aufirst%3DJ.%2BP.%26aulast%3DJanssen%26aufirst%3DK.-P.%26aulast%3DKnolle%26aufirst%3DP.%2BA.%26aulast%3DKr%25C3%25BCger%26aufirst%3DA.%26atitle%3DTissue%2520inhibitor%2520of%2520metalloproteinases%2520%2528TIMP%2529-1%2520creates%2520a%2520premetastatic%2520niche%2520in%2520the%2520liver%2520through%2520SDF-1%252FCXCR4-dependent%2520neutrophil%2520recruitment%2520in%2520mice%26jtitle%3DHepatology%26date%3D2015%26volume%3D61%26spage%3D238%26epage%3D248%26doi%3D10.1002%2Fhep.27378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ling, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaeth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hail, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konopleva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreeff, M.</span><span> </span><span class="NLM_article-title">The CXCR4 antagonist AMD3465 regulates oncogenic signaling and invasiveness in Vitro and prevents breast cancer growth and metastasis in vivo</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e58426</span><span class="refDoi"> DOI: 10.1371/journal.pone.0058426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1371%2Fjournal.pone.0058426" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e58426&author=X.+Lingauthor=E.+Spaethauthor=Y.+Chenauthor=Y.+Shiauthor=W.+Zhangauthor=W.+Schoberauthor=N.+Hailauthor=M.+Konoplevaauthor=M.+Andreeff&title=The+CXCR4+antagonist+AMD3465+regulates+oncogenic+signaling+and+invasiveness+in+Vitro+and+prevents+breast+cancer+growth+and+metastasis+in+vivo&doi=10.1371%2Fjournal.pone.0058426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0058426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0058426%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DX.%26aulast%3DSpaeth%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSchober%26aufirst%3DW.%26aulast%3DHail%26aufirst%3DN.%26aulast%3DKonopleva%26aufirst%3DM.%26aulast%3DAndreeff%26aufirst%3DM.%26atitle%3DThe%2520CXCR4%2520antagonist%2520AMD3465%2520regulates%2520oncogenic%2520signaling%2520and%2520invasiveness%2520in%2520Vitro%2520and%2520prevents%2520breast%2520cancer%2520growth%2520and%2520metastasis%2520in%2520vivo%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De58426%26doi%3D10.1371%2Fjournal.pone.0058426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Guo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mok, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span> </span><span class="NLM_article-title">CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">816</span><span class="NLM_x">–</span> <span class="NLM_lpage">826</span><span class="refDoi"> DOI: 10.1038/onc.2015.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1038%2Fonc.2015.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=25961926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC28Xis1Ggsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=816-826&author=F.+Guoauthor=Y.+Wangauthor=J.+Liuauthor=S.+C.+Mokauthor=F.+Xueauthor=W.+Zhang&title=CXCL12%2FCXCR4%3A+a+symbiotic+bridge+linking+cancer+cells+and+their+stromal+neighbors+in+oncogenic+communication+networks&doi=10.1038%2Fonc.2015.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks</span></div><div class="casAuthors">Guo, F.; Wang, Y.; Liu, J.; Mok, S. C.; Xue, F.; Zhang, W.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">816-826</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Increasing evidence indicates that the tumor microenvironment has crit. roles in all aspects of cancer biol., including growth, angiogenesis, metastasis and progression.  Although chemokines and their receptors were originally identified as mediators of inflammatory diseases, it is being increasingly recognized that they serve as crit. communication bridges between tumor cells and stromal cells to create a permissive microenvironment for tumor growth and metastasis.  Thus, an important therapeutic strategy for cancer is to break this communication channel and isolate tumor cells for long-term elimination.  Cytokine CXCL12 (also known as stromal-derived factor 1α) and its receptor CXCR4 represent the most promising actionable targets for this strategy.  Both are overexpressed in various cancer types, and this aberrant expression strongly promotes proliferation, migration and invasion through multiple signal pathways.  Several mols. that target CXCL12 or CXCR4 have been developed to interfere with tumor growth and metastasis.  In this article, we review our current understanding of the CXCL12/CXCR4 axis in cancer tumorigenesis and progression and discuss its therapeutic implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv-bVfKbELB7Vg90H21EOLACvtfcHk0licp9G_hW7MFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xis1Ggsro%253D&md5=72a644a161ef658f930d9adb9474df97</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.139%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMok%26aufirst%3DS.%2BC.%26aulast%3DXue%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DCXCL12%252FCXCR4%253A%2520a%2520symbiotic%2520bridge%2520linking%2520cancer%2520cells%2520and%2520their%2520stromal%2520neighbors%2520in%2520oncogenic%2520communication%2520networks%26jtitle%3DOncogene%26date%3D2016%26volume%3D35%26spage%3D816%26epage%3D826%26doi%3D10.1038%2Fonc.2015.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Scala, S.</span><span> </span><span class="NLM_article-title">Molecular pathways: targeting the CXCR4-CXCL12 axis–untapped potential in the tumor microenvironment</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4278</span><span class="NLM_x">–</span> <span class="NLM_lpage">4285</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-0914</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1158%2F1078-0432.CCR-14-0914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=26199389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1antL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=4278-4285&author=S.+Scala&title=Molecular+pathways%3A+targeting+the+CXCR4-CXCL12+axis%E2%80%93untapped+potential+in+the+tumor+microenvironment&doi=10.1158%2F1078-0432.CCR-14-0914"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Pathways: Targeting the CXCR4-CXCL12 Axis-Untapped Potential in the Tumor Microenvironment</span></div><div class="casAuthors">Scala, Stefania</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4278-4285</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Evidence suggests that the CXC-chemokine receptor-4 pathway plays a role in cancer cell homing and metastasis, and thus represents a potential target for cancer therapy.  The homeostatic microenvironment chemokine CXCL12 binds the CXCR4 and CXCR7 receptors, activating divergent signals on multiple pathways, such as ERK1/2, p38, SAPK/JNK, AKT, mTOR, and the Bruton tyrosine kinase (BTK).  An activating mutation in CXCR4 is responsible for a rare disease, WHIM syndrome (warts, hypogammaglobulinemia, infections, and myelokathexis), and dominant CXCR4 mutations have also been reported in Waldenstrom macroglobulinemia.  The CXCR4-CXCL12 axis regulates the hematopoietic stem cell niche-a property that has led to the approval of the CXCR4 antagonist plerixafor (AMD3100) for mobilization of hematopoietic precursors.  In preclin. models, plerixafor has shown antimetastatic potential in vivo, offering proof of concept.  Other antagonists are in preclin. and clin. development.  Recent evidence demonstrates that inhibiting CXCR4 signaling restores sensitivity to CTLA-4 and PD-1 checkpoint inhibitors, creating a new line for investigation.  Targeting the CXCR4-CXCL12 axis thus offers the possibility of affecting CXCR4-expressing primary tumor cells, modulating the immune response, or synergizing with other targeted anticancer therapies.  Clin Cancer Res; 21(19); 4278-85. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7gM36xQ_iW7Vg90H21EOLACvtfcHk0lioSp7WHa_e7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1antL3K&md5=6ba33ca92d647c046bdb5a0f7cbd6ac0</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-0914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-0914%26sid%3Dliteratum%253Aachs%26aulast%3DScala%26aufirst%3DS.%26atitle%3DMolecular%2520pathways%253A%2520targeting%2520the%2520CXCR4-CXCL12%2520axis%25E2%2580%2593untapped%2520potential%2520in%2520the%2520tumor%2520microenvironment%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D4278%26epage%3D4285%26doi%3D10.1158%2F1078-0432.CCR-14-0914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mahoney, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennert, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, G. J.</span><span> </span><span class="NLM_article-title">Combination cancer immunotherapy and new immunomodulatory targets</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span><span class="refDoi"> DOI: 10.1038/nrd4591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1038%2Fnrd4591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=26228759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KiurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=561-84&author=M.+K.+Mahoneyauthor=D.+P.+Rennertauthor=G.+J.+Freeman&title=Combination+cancer+immunotherapy+and+new+immunomodulatory+targets&doi=10.1038%2Fnrd4591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Combination cancer immunotherapy and new immunomodulatory targets</span></div><div class="casAuthors">Mahoney, Kathleen M.; Rennert, Paul D.; Freeman, Gordon J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">561-584</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Targeting immune checkpoints such as programmed cell death protein 1 (PD1), programmed cell death 1 ligand 1 (PDL1) and cytotoxic T lymphocyte antigen 4 (CTLA4) has achieved noteworthy benefit in multiple cancers by blocking immunoinhibitory signals and enabling patients to produce an effective antitumor response.  Inhibitors of CTLA4, PD1 or PDL1 administered as single agents have resulted in durable tumor regression in some patients, and combinations of PD1 and CTLA4 inhibitors may enhance antitumor benefit.  Numerous addnl. immunomodulatory pathways as well as inhibitory factors expressed or secreted by myeloid and stromal cells in the tumor microenvironment are potential targets for synergizing with immune checkpoint blockade.  Given the breadth of potential targets in the immune system, crit. questions to address include which combinations should move forward in development and which patients will benefit from these treatments.  This Review discusses the leading drug targets that are expressed on tumor cells and in the tumor microenvironment that allow enhancement of the antitumor immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwi7ChUpfjArVg90H21EOLACvtfcHk0lioSp7WHa_e7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KiurrJ&md5=b0b598b2a7c62794b4f03c4cea196a97</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1038%2Fnrd4591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4591%26sid%3Dliteratum%253Aachs%26aulast%3DMahoney%26aufirst%3DM.%2BK.%26aulast%3DRennert%26aufirst%3DD.%2BP.%26aulast%3DFreeman%26aufirst%3DG.%2BJ.%26atitle%3DCombination%2520cancer%2520immunotherapy%2520and%2520new%2520immunomodulatory%2520targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D561%26epage%3D84%26doi%3D10.1038%2Fnrd4591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Xing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, J.</span><span> </span><span class="NLM_article-title">Metabolic reprogramming of the tumour microenvironment</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">3892</span><span class="NLM_x">–</span> <span class="NLM_lpage">3898</span><span class="refDoi"> DOI: 10.1111/febs.13402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1111%2Ffebs.13402" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2015&pages=3892-3898&author=Y.+Xingauthor=S.+Zhaoauthor=B.+P.+Zhouauthor=J.+Mi&title=Metabolic+reprogramming+of+the+tumour+microenvironment&doi=10.1111%2Ffebs.13402"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13402%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DB.%2BP.%26aulast%3DMi%26aufirst%3DJ.%26atitle%3DMetabolic%2520reprogramming%2520of%2520the%2520tumour%2520microenvironment%26jtitle%3DFEBS%2520J.%26date%3D2015%26volume%3D282%26spage%3D3892%26epage%3D3898%26doi%3D10.1111%2Ffebs.13402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Braun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qorraj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büttner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saul, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aigner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackensen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jitschin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mougiakakos, D.</span><span> </span><span class="NLM_article-title">CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1788</span><span class="NLM_x">–</span> <span class="NLM_lpage">1792</span><span class="refDoi"> DOI: 10.1038/leu.2016.58</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1038%2Fleu.2016.58" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=1788-1792&author=M.+Braunauthor=M.+Qorrajauthor=M.+B%C3%BCttnerauthor=F.+A.+Kleinauthor=D.+Saulauthor=M.+Aignerauthor=W.+Huberauthor=A.+Mackensenauthor=R.+Jitschinauthor=D.+Mougiakakos&title=CXCL12+promotes+glycolytic+reprogramming+in+acute+myeloid+leukemia+cells+via+the+CXCR4%2FmTOR+axis&doi=10.1038%2Fleu.2016.58"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fleu.2016.58&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2016.58%26sid%3Dliteratum%253Aachs%26aulast%3DBraun%26aufirst%3DM.%26aulast%3DQorraj%26aufirst%3DM.%26aulast%3DB%25C3%25BCttner%26aufirst%3DM.%26aulast%3DKlein%26aufirst%3DF.%2BA.%26aulast%3DSaul%26aufirst%3DD.%26aulast%3DAigner%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DMackensen%26aufirst%3DA.%26aulast%3DJitschin%26aufirst%3DR.%26aulast%3DMougiakakos%26aufirst%3DD.%26atitle%3DCXCL12%2520promotes%2520glycolytic%2520reprogramming%2520in%2520acute%2520myeloid%2520leukemia%2520cells%2520via%2520the%2520CXCR4%252FmTOR%2520axis%26jtitle%3DLeukemia%26date%3D2016%26volume%3D30%26spage%3D1788%26epage%3D1792%26doi%3D10.1038%2Fleu.2016.58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Karpova, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spohn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chudziak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiercinska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevalier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembowsky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonig, H.</span><span> </span><span class="NLM_article-title">The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than plerixafor</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2322</span><span class="NLM_x">–</span> <span class="NLM_lpage">2331</span><span class="refDoi"> DOI: 10.1038/leu.2013.266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1038%2Fleu.2013.266" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=2322-2331&author=D.+Karpovaauthor=K.+Dauberauthor=G.+Spohnauthor=D.+Chudziakauthor=E.+Wiercinskaauthor=M.+Schulzauthor=A.+R.+Pettitauthor=J.+P.+Levesqueauthor=B.+Romagnoliauthor=K.+Patelauthor=E.+Chevalierauthor=K.+Dembowskyauthor=H.+Bonig&title=The+novel+CXCR4+antagonist+POL5551+mobilizes+hematopoietic+stem+and+progenitor+cells+with+greater+efficiency+than+plerixafor&doi=10.1038%2Fleu.2013.266"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1038%2Fleu.2013.266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2013.266%26sid%3Dliteratum%253Aachs%26aulast%3DKarpova%26aufirst%3DD.%26aulast%3DDauber%26aufirst%3DK.%26aulast%3DSpohn%26aufirst%3DG.%26aulast%3DChudziak%26aufirst%3DD.%26aulast%3DWiercinska%26aufirst%3DE.%26aulast%3DSchulz%26aufirst%3DM.%26aulast%3DPettit%26aufirst%3DA.%2BR.%26aulast%3DLevesque%26aufirst%3DJ.%2BP.%26aulast%3DRomagnoli%26aufirst%3DB.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DChevalier%26aufirst%3DE.%26aulast%3DDembowsky%26aufirst%3DK.%26aulast%3DBonig%26aufirst%3DH.%26atitle%3DThe%2520novel%2520CXCR4%2520antagonist%2520POL5551%2520mobilizes%2520hematopoietic%2520stem%2520and%2520progenitor%2520cells%2520with%2520greater%2520efficiency%2520than%2520plerixafor%26jtitle%3DLeukemia%26date%3D2013%26volume%3D27%26spage%3D2322%26epage%3D2331%26doi%3D10.1038%2Fleu.2013.266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sison, E. A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magoon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annesley, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuffin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P.</span><span> </span><span class="NLM_article-title">POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">30902</span><span class="NLM_x">–</span> <span class="NLM_lpage">30918</span><span class="refDoi"> DOI: 10.18632/oncotarget.5094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.18632%2Foncotarget.5094" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=30902-30918&author=E.+A.+R.+Sisonauthor=D.+Magoonauthor=L.+Liauthor=C.+E.+Annesleyauthor=B.+Romagnoliauthor=G.+J.+Douglasauthor=G.+Tuffinauthor=J.+Zimmermannauthor=P.+Brown&title=POL5551%2C+a+novel+and+potent+CXCR4+antagonist%2C+enhances+sensitivity+to+chemotherapy+in+pediatric+ALL&doi=10.18632%2Foncotarget.5094"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.5094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.5094%26sid%3Dliteratum%253Aachs%26aulast%3DSison%26aufirst%3DE.%2BA.%2BR.%26aulast%3DMagoon%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DAnnesley%26aufirst%3DC.%2BE.%26aulast%3DRomagnoli%26aufirst%3DB.%26aulast%3DDouglas%26aufirst%3DG.%2BJ.%26aulast%3DTuffin%26aufirst%3DG.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DP.%26atitle%3DPOL5551%252C%2520a%2520novel%2520and%2520potent%2520CXCR4%2520antagonist%252C%2520enhances%2520sensitivity%2520to%2520chemotherapy%2520in%2520pediatric%2520ALL%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D30902%26epage%3D30918%26doi%3D10.18632%2Foncotarget.5094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Tamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arakaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanbara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omagari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibuka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">882</span><span class="refDoi"> DOI: 10.1006/bbrc.1998.9871</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1006%2Fbbrc.1998.9871" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=9918823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaK1MXjs1Gntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1998&pages=877-882&author=H.+Tamamuraauthor=Y.+Xuauthor=T.+Hattoriauthor=X.+Zhangauthor=R.+Arakakiauthor=K.+Kanbaraauthor=A.+Omagariauthor=A.+Otakaauthor=T.+Ibukaauthor=N.+Yamamotoauthor=H.+Nakashimaauthor=N.+Fujii&title=A+low-molecular-weight+inhibitor+against+the+chemokine+receptor+CXCR4%3A+a+strong+anti-HIV+peptide+T140&doi=10.1006%2Fbbrc.1998.9871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140</span></div><div class="casAuthors">Tamamura, Hirokazu; Xu, Younong; Hattori, Toshio; Zhang, Xiaoyan; Arakaki, Rieko; Kanbara, Kenji; Omagari, Akane; Otaka, Akira; Ibuka, Toshiro; Yamamoto, Naoki; Nakashima, Hideki; Fujii, Nobutaka</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">877-882</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">T22 ([Tyr5,12, Lys7]-polyphemusin II) is an 18-residue peptide amide, which has strong anti-HIV activity.  T22 inhibits the T cell line-tropic (T-tropic) HIV-1 infection through its specific binding to a chemokine receptor CXCR4, which serves as a coreceptor for the entry of T-tropic HIV-1 strains.  Herein, we report our finding of novel 14-residue CXCR4 inhibitors, T134 and T140, on the basis of the T22 structure.  In the assays we examd., T140 showed the highest inhibitory activity against HIV-1 entry and the strongest inhibitory effect on the binding of an anti-CXCR4 monoclonal antibody (12G5) to CXCR4 among all the CXCR4 inhibitors that have been reported up to now.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEj0riEXDmLbVg90H21EOLACvtfcHk0lj9zFg-DulezA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs1Gntg%253D%253D&md5=e35371993e05ac4d4bba3a47a97a4633</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1998.9871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1998.9871%26sid%3Dliteratum%253Aachs%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DArakaki%26aufirst%3DR.%26aulast%3DKanbara%26aufirst%3DK.%26aulast%3DOmagari%26aufirst%3DA.%26aulast%3DOtaka%26aufirst%3DA.%26aulast%3DIbuka%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DA%2520low-molecular-weight%2520inhibitor%2520against%2520the%2520chemokine%2520receptor%2520CXCR4%253A%2520a%2520strong%2520anti-HIV%2520peptide%2520T140%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1998%26volume%3D253%26spage%3D877%26epage%3D882%26doi%3D10.1006%2Fbbrc.1998.9871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Tamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramatsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">550</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span><span class="refDoi"> DOI: 10.1016/S0014-5793(03)00824-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2FS0014-5793%2803%2900824-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=12935890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVKntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=550&publication_year=2003&pages=79-83&author=H.+Tamamuraauthor=A.+Horiauthor=N.+Kanzakiauthor=K.+Hiramatsuauthor=M.+Mizumotoauthor=H.+Nakashimaauthor=N.+Yamamotoauthor=A.+Otakaauthor=N.+Fujii&title=T140+analogs+as+CXCR4+antagonists+identified+as+anti-metastatic+agents+in+the+treatment+of+breast+cancer&doi=10.1016%2FS0014-5793%2803%2900824-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer</span></div><div class="casAuthors">Tamamura, Hirokazu; Hori, Akira; Kanzaki, Naoyuki; Hiramatsu, Kenichi; Mizumoto, Makiko; Nakashima, Hideki; Yamamoto, Naoki; Otaka, Akira; Fujii, Nobutaka</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">550</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">79-83</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A chemokine receptor, CXCR4, and its endogenous ligand, stromal cell-derived factor-1 (SDF-1), have been recognized to be involved in the metastasis of several types of cancers.  T140 analogs are peptidic CXCR4 antagonists composed of 14 amino acid residues that were previously developed as anti-HIV agents having inhibitory activity against HIV-entry through its co-receptor, CXCR4.  Herein, we report that these compds. effectively inhibited SDF-1-induced migration of human breast cancer cells (MDA-MB-231), human leukemia T cells (Sup-T1) and human umbilical vein endothelial cells at concns. of 10-100 nM in vitro.  Furthermore, slow release administration by s.c. injection using an Alzet osmotic pump of a potent and bio-stable T140 analog, 4F-benzoyl-TN14003, gave a partial, but statistically significant (P≤0.05 (t-test)) redn. in pulmonary metastasis of MDA-MB-231 in SCID mice, even though no attempt was made to inhibit other important targets such as CCR7.  These results suggest that T140 analogs have potential use for cancer therapy, and that small mol. CXCR4 antagonists could potentially replace neutralizing antibodies as anti-metastatic agents for breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk7c7EwYgSAbVg90H21EOLACvtfcHk0lj9zFg-DulezA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVKntr0%253D&md5=a82059ca8a491623b48cb722819238ab</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2803%2900824-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252803%252900824-X%26sid%3Dliteratum%253Aachs%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DHori%26aufirst%3DA.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DHiramatsu%26aufirst%3DK.%26aulast%3DMizumoto%26aufirst%3DM.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DOtaka%26aufirst%3DA.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DT140%2520analogs%2520as%2520CXCR4%2520antagonists%2520identified%2520as%2520anti-metastatic%2520agents%2520in%2520the%2520treatment%2520of%2520breast%2520cancer%26jtitle%3DFEBS%2520Lett.%26date%3D2003%26volume%3D550%26spage%3D79%26epage%3D83%26doi%3D10.1016%2FS0014-5793%2803%2900824-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kobayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">Structure-activity relationship study of a CXC chemokine receptor type 4 antagonist, FC131, using a series of alkene dipeptide isosteres</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2746</span><span class="NLM_x">–</span> <span class="NLM_lpage">2757</span><span class="refDoi"> DOI: 10.1021/jm2016914</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2016914" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2746-2757&author=K.+Kobayashiauthor=S.+Oishiauthor=R.+Hayashiauthor=K.+Tomitaauthor=T.+Kuboauthor=N.+Tanaharaauthor=H.+Ohnoauthor=Y.+Yoshikawaauthor=T.+Furuyaauthor=M.+Hoshinoauthor=N.+Fujii&title=Structure-activity+relationship+study+of+a+CXC+chemokine+receptor+type+4+antagonist%2C+FC131%2C+using+a+series+of+alkene+dipeptide+isosteres&doi=10.1021%2Fjm2016914"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm2016914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2016914%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DHayashi%26aufirst%3DR.%26aulast%3DTomita%26aufirst%3DK.%26aulast%3DKubo%26aufirst%3DT.%26aulast%3DTanahara%26aufirst%3DN.%26aulast%3DOhno%26aufirst%3DH.%26aulast%3DYoshikawa%26aufirst%3DY.%26aulast%3DFuruya%26aufirst%3DT.%26aulast%3DHoshino%26aufirst%3DM.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520a%2520CXC%2520chemokine%2520receptor%2520type%25204%2520antagonist%252C%2520FC131%252C%2520using%2520a%2520series%2520of%2520alkene%2520dipeptide%2520isosteres%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2746%26epage%3D2757%26doi%3D10.1021%2Fjm2016914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Mungalpara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, Ø.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eksteen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Våbenø, J.</span><span> </span><span class="NLM_article-title">Rational design of conformationally constrained cyclopentapeptide antagonists for C-X-C chemokine receptor 4 (CXCR4)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10287</span><span class="NLM_x">–</span> <span class="NLM_lpage">10291</span><span class="refDoi"> DOI: 10.1021/jm300926y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300926y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10287-10291&author=J.+Mungalparaauthor=S.+Thieleauthor=%C3%98.+Eriksenauthor=J.+Eksteenauthor=M.+M.+Rosenkildeauthor=J.+V%C3%A5ben%C3%B8&title=Rational+design+of+conformationally+constrained+cyclopentapeptide+antagonists+for+C-X-C+chemokine+receptor+4+%28CXCR4%29&doi=10.1021%2Fjm300926y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm300926y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300926y%26sid%3Dliteratum%253Aachs%26aulast%3DMungalpara%26aufirst%3DJ.%26aulast%3DThiele%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3D%25C3%2598.%26aulast%3DEksteen%26aufirst%3DJ.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26atitle%3DRational%2520design%2520of%2520conformationally%2520constrained%2520cyclopentapeptide%2520antagonists%2520for%2520C-X-C%2520chemokine%2520receptor%25204%2520%2528CXCR4%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10287%26epage%3D10291%26doi%3D10.1021%2Fjm300926y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Demmer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dijkgraaf, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span> </span><span class="NLM_article-title">Design, synthesis, and functionalization of dimeric peptides targeting chemokine receptor CXCR4</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7648</span><span class="NLM_x">–</span> <span class="NLM_lpage">7662</span><span class="refDoi"> DOI: 10.1021/jm2009716</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2009716" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7648-7662&author=O.+Demmerauthor=I.+Dijkgraafauthor=U.+Schumacherauthor=L.+Marinelliauthor=S.+Cosconatiauthor=E.+Gourniauthor=H.+J.+Westerauthor=H.+Kessler&title=Design%2C+synthesis%2C+and+functionalization+of+dimeric+peptides+targeting+chemokine+receptor+CXCR4&doi=10.1021%2Fjm2009716"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1021%2Fjm2009716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2009716%26sid%3Dliteratum%253Aachs%26aulast%3DDemmer%26aufirst%3DO.%26aulast%3DDijkgraaf%26aufirst%3DI.%26aulast%3DSchumacher%26aufirst%3DU.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DGourni%26aufirst%3DE.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DKessler%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520functionalization%2520of%2520dimeric%2520peptides%2520targeting%2520chemokine%2520receptor%2520CXCR4%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7648%26epage%3D7662%26doi%3D10.1021%2Fjm2009716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Demmer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagn, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schottelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brack-Werner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span> </span><span class="NLM_article-title">A conformationally frozen peptoid boosts CXCR4 affinity and anti-HIV activity</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">8110</span><span class="NLM_x">–</span> <span class="NLM_lpage">8113</span><span class="refDoi"> DOI: 10.1002/anie.201202090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1002%2Fanie.201202090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVSrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=8110-8113&author=O.+Demmerauthor=A.+O.+Frankauthor=F.+Hagnauthor=M.+Schotteliusauthor=L.+Marinelliauthor=S.+Cosconatiauthor=R.+Brack-Wernerauthor=S.+Krembauthor=H.+J.+Westerauthor=H.+Kessler&title=A+conformationally+frozen+peptoid+boosts+CXCR4+affinity+and+anti-HIV+activity&doi=10.1002%2Fanie.201202090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">A conformationally frozen peptoid boosts CXCR4 affinity and anti-HIV activity</span></div><div class="casAuthors">Demmer, Oliver; Frank, Andreas O.; Hagn, Franz; Schottelius, Margret; Marinelli, Luciana; Cosconati, Sandro; Brack-Werner, Ruth; Kremb, Stephan; Wester, Hans-Juergen; Kessler, Horst</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">8110-8113, S8110/1-S8110/27</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We succeeded in restricting the conformation of a known CXCR4 ligand into a single active conformation by using a peptoid motif.  In combination with structure-activity relationship studies the binding affinity was optimized to be 400 to 1500-fold higher than compds. currently under clin. development, such as KRH-1636 or AMD3100.  AMD3100 is approved by the FDA for treatment of non-Hodgkin lymphoma and multiple myeloma.  Together with the advantages of modified cyclic peptides as drugs (e.g. biocompatible metab., high stability against enzymic degrdn., selectivity profile) this mol. has the potential to be a promising candidate for future medical applications in CXCR4 related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbf7rrhGn4zbVg90H21EOLACvtfcHk0liq7gr6Jex67Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVSrtLk%253D&md5=c4dfb9d7271aa2cd85c36c5605a1a511</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1002%2Fanie.201202090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201202090%26sid%3Dliteratum%253Aachs%26aulast%3DDemmer%26aufirst%3DO.%26aulast%3DFrank%26aufirst%3DA.%2BO.%26aulast%3DHagn%26aufirst%3DF.%26aulast%3DSchottelius%26aufirst%3DM.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DBrack-Werner%26aufirst%3DR.%26aulast%3DKremb%26aufirst%3DS.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DKessler%26aufirst%3DH.%26atitle%3DA%2520conformationally%2520frozen%2520peptoid%2520boosts%2520CXCR4%2520affinity%2520and%2520anti-HIV%2520activity%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D8110%26epage%3D8113%26doi%3D10.1002%2Fanie.201202090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Peng, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kays, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gough, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uhlik, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamek-Gliszczynski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijsman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Credille, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L. Z.</span><span> </span><span class="NLM_article-title">Identification of LY2510924, a novel cyclic peptide CXCR4 antagonist that exhibits antitumor activities in solid tumor and breast cancer metastatic models</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">480</span><span class="NLM_x">–</span> <span class="NLM_lpage">490</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0850</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1158%2F1535-7163.MCT-14-0850" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=25504752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitlOjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=480-490&author=S.+B.+Pengauthor=X.+Zhangauthor=D.+Paulauthor=L.+M.+Kaysauthor=W.+Goughauthor=J.+Stewartauthor=M.+T.+Uhlikauthor=Q.+Chenauthor=Y.+H.+Huiauthor=M.+J.+Zamek-Gliszczynskiauthor=J.+A.+Wijsmanauthor=K.+M.+Credilleauthor=L.+Z.+Yan&title=Identification+of+LY2510924%2C+a+novel+cyclic+peptide+CXCR4+antagonist+that+exhibits+antitumor+activities+in+solid+tumor+and+breast+cancer+metastatic+models&doi=10.1158%2F1535-7163.MCT-14-0850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of LY2510924, a Novel Cyclic Peptide CXCR4 Antagonist That Exhibits Antitumor Activities in Solid Tumor and Breast Cancer Metastatic Models</span></div><div class="casAuthors">Peng, Sheng-Bin; Zhang, Xiaoyi; Paul, Donald; Kays, Lisa M.; Gough, Wendy; Stewart, Julie; Uhlik, Mark T.; Chen, Qi; Hui, Yu-Hua; Zamek-Gliszczynski, Maciej J.; Wijsman, John A.; Credille, Kelly M.; Yan, Liang Zeng</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">480-490</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Emerging evidence demonstrates that stromal cell-derived factor 1 (SDF-1) and CXCR4, a chemokine and chemokine receptor pair, play important roles in tumorigenesis.  In this report, we describe a small cyclic peptide, LY2510924, which is a potent and selective CXCR4 antagonist currently in phase II clin. studies for cancer.  LY2510924 specifically blocked SDF-1 binding to CXCR4 with IC50 value of 0.079 nmol/L, and inhibited SDF-1-induced GTP binding with Kb value of 0.38 nmol/L.  In human lymphoma U937 cells expressing endogenous CXCR4, LY2510924 inhibited SDF-1-induced cell migration with IC50 value of 0.26 nmol/L and inhibited SDF-1/CXCR4-mediated intracellular signaling.  LY2510924 exhibited a concn.-dependent inhibition of SDF-1-stimulated phospho-ERK and phospho-Akt in tumor cells.  Biochem. and cellular analyses revealed that LY2510924 had no apparent agonist activity.  Pharmacokinetic analyses suggested that LY2510924 had acceptable in vivo stability and a pharmacokinetic profile similar to a typical small-mol. inhibitor in preclin. species.  LY2510924 showed dose-dependent inhibition of tumor growth in human xenograft models developed with non-Hodgkin lymphoma, renal cell carcinoma, lung, and colon cancer cells that express functional CXCR4.  In MDA-MB-231, a breast cancer metastatic model, LY2510924 inhibited tumor metastasis by blocking migration/homing process of tumor cells to the lung and by inhibiting cell proliferation after tumor cell homing.  Collectively, the preclin. data support further investigation of LY2510924 in clin. studies for cancer.  Mol Cancer Ther; 14(2); 480-90. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeA_Qz6C59GLVg90H21EOLACvtfcHk0liq7gr6Jex67Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitlOjtrw%253D&md5=bb0e6b2bbd36e8c2c10ae5edd8b1755d</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0850%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DS.%2BB.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DPaul%26aufirst%3DD.%26aulast%3DKays%26aufirst%3DL.%2BM.%26aulast%3DGough%26aufirst%3DW.%26aulast%3DStewart%26aufirst%3DJ.%26aulast%3DUhlik%26aufirst%3DM.%2BT.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DHui%26aufirst%3DY.%2BH.%26aulast%3DZamek-Gliszczynski%26aufirst%3DM.%2BJ.%26aulast%3DWijsman%26aufirst%3DJ.%2BA.%26aulast%3DCredille%26aufirst%3DK.%2BM.%26aulast%3DYan%26aufirst%3DL.%2BZ.%26atitle%3DIdentification%2520of%2520LY2510924%252C%2520a%2520novel%2520cyclic%2520peptide%2520CXCR4%2520antagonist%2520that%2520exhibits%2520antitumor%2520activities%2520in%2520solid%2520tumor%2520and%2520breast%2520cancer%2520metastatic%2520models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D480%26epage%3D490%26doi%3D10.1158%2F1535-7163.MCT-14-0850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hainsworth, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mace, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamid, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stille, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polzer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, E. R.</span><span> </span><span class="NLM_article-title">A Randomized, open-label phase 2 study of the CXCR4 inhibitor LY2510924 in combination with sunitinib versus sunitinib alone in patients with metastatic renal cell carcinoma (RCC)</span> <span class="citation_source-journal">Target Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">653</span><span class="refDoi"> DOI: 10.1007/s11523-016-0434-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1007%2Fs11523-016-0434-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=27154357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A280%3ADC%252BC28bntFantA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=643-653&author=J.+D.+Hainsworthauthor=J.+A.+Reevesauthor=J.+R.+Maceauthor=E.+J.+Craneauthor=O.+Hamidauthor=J.+R.+Stilleauthor=A.+Flyntauthor=S.+Robersonauthor=J.+Polzerauthor=E.+R.+Arrowsmith&title=A+Randomized%2C+open-label+phase+2+study+of+the+CXCR4+inhibitor+LY2510924+in+combination+with+sunitinib+versus+sunitinib+alone+in+patients+with+metastatic+renal+cell+carcinoma+%28RCC%29&doi=10.1007%2Fs11523-016-0434-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC)</span></div><div class="casAuthors">Hainsworth John D; Reeves James A; Mace Joseph R; Crane Edward J; Hamid Oday; Stille John R; Roberson Stephanie; Polzer John; Flynt Amy; Arrowsmith Edward R</div><div class="citationInfo"><span class="NLM_cas:title">Targeted oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">643-653</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The chemokine (C-X-C Motif) receptor 4 (CXCR4) and its ligand, stromal-cell derived factor-1 (SDF-1), are frequently overexpressed in a variety of solid tumors, and are believed to play important roles in the regulation of organ-specific metastasis, tumor growth, invasion, and survival.  In this randomized Phase 2 trial, we evaluated the safety and efficacy of LY2510924 (LY), a peptide antagonist of CXCR4, combined with sunitinib (SUN) in the first-line treatment of advanced renal cell carcinoma (RCC).  PATIENTS AND METHODS:  Eligible patients were randomized (2:1) to receive LY (20 mg SC daily) + SUN (50 mg PO daily for 4 weeks followed by 2 weeks off) or SUN alone.  Response was assessed after two cycles; patients continued treatment until tumor progression or intolerable toxicity.  The study was powered to detect a 47 % increase in median progression-free survival (PFS).  RESULTS:  One hundred eight patients were randomized and treated (LY + SUN, 72; SUN, 36); median duration of treatment of five cycles.  Observed median PFS was 8.1 months with LY + SUN and 12.3 months with SUN; Bayesian time-to-event HR 1.23; 95 % credible interval: 0.74, 1.96.  LY was well tolerated; the toxicity profile was typical of SUN.  No efficacy differences were seen between treatments groups when subsets with high versus low levels of CXCR4 tumor expression were compared.  CONCLUSIONS:  The addition of LY to SUN in the first-line treatment of metastatic RCC was well tolerated, but did not improve the PFS or overall survival (OS) vs.  SUN alone.  CXCR4 remains an unproven therapeutic target for the treatment of RCC.  CLINICAL TRIAL:  GOV IDENTIFIER:  NCT01391130.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTP19WHsYgumJggzHGM8X5CfW6udTcc2eaVB1NaeVRt77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bntFantA%253D%253D&md5=5a1f149efdfa191afe88beb5b6f4f92c</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1007%2Fs11523-016-0434-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11523-016-0434-9%26sid%3Dliteratum%253Aachs%26aulast%3DHainsworth%26aufirst%3DJ.%2BD.%26aulast%3DReeves%26aufirst%3DJ.%2BA.%26aulast%3DMace%26aufirst%3DJ.%2BR.%26aulast%3DCrane%26aufirst%3DE.%2BJ.%26aulast%3DHamid%26aufirst%3DO.%26aulast%3DStille%26aufirst%3DJ.%2BR.%26aulast%3DFlynt%26aufirst%3DA.%26aulast%3DRoberson%26aufirst%3DS.%26aulast%3DPolzer%26aufirst%3DJ.%26aulast%3DArrowsmith%26aufirst%3DE.%2BR.%26atitle%3DA%2520Randomized%252C%2520open-label%2520phase%25202%2520study%2520of%2520the%2520CXCR4%2520inhibitor%2520LY2510924%2520in%2520combination%2520with%2520sunitinib%2520versus%2520sunitinib%2520alone%2520in%2520patients%2520with%2520metastatic%2520renal%2520cell%2520carcinoma%2520%2528RCC%2529%26jtitle%3DTarget%2520Oncol.%26date%3D2016%26volume%3D11%26spage%3D643%26epage%3D653%26doi%3D10.1007%2Fs11523-016-0434-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Salgia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stille, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleod, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamid, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polzer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spigel, D. R.</span><span> </span><span class="NLM_article-title">A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer</span> <span class="citation_source-journal">Lung Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1016/j.lungcan.2016.12.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2Fj.lungcan.2016.12.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=28236984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A280%3ADC%252BC1czgsFGrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2017&pages=7-13&author=R.+Salgiaauthor=J.+R.+Stilleauthor=R.+W.+Weaverauthor=M.+McCleodauthor=O.+Hamidauthor=J.+Polzerauthor=S.+Robersonauthor=A.+Flyntauthor=D.+R.+Spigel&title=A+randomized+phase+II+study+of+LY2510924+and+carboplatin%2Fetoposide+versus+carboplatin%2Fetoposide+in+extensive-disease+small+cell+lung+cancer&doi=10.1016%2Fj.lungcan.2016.12.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer</span></div><div class="casAuthors">Salgia Ravi; Stille John R; Hamid Oday; Polzer John; Roberson Stephanie; Weaver R Waide; McCleod Michael; Flynt Amy; Spigel David R</div><div class="citationInfo"><span class="NLM_cas:title">Lung cancer (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  This multicenter, open-label, randomized phase II study evaluated the efficacy and safety of LY2510924 (LY) added to first-line standard of care (SOC) chemotherapy for extensive-disease small cell lung cancer (ED-SCLC) and explored the predictive value of C-X-C motif receptor 4 (CXCR4) tumor response.  MATERIALS AND METHODS:  Patients with treatment-naive ED-SCLC were randomized (1:1) to receive up to six 21-day cycles of carboplatin/etoposide alone (SOC) or in combination with 20mg LY2510924 administered subcutaneously on days 1-7 of each cycle (LY+SOC).  The primary efficacy endpoint was progression-free survival (PFS).  Secondary endpoints were overall survival (OS), overall response rate (ORR), and safety.  Response relative to CXCR4 expression on baseline tumor was an exploratory endpoint.  RESULTS:  Of 94 patients randomized, 90 received treatment (LY+SOC, n=47; SOC, n=43).  Median PFS (95% confidence interval [CI]) was 5.88 (4.83, 6.24) months for LY+SOC versus 5.85 (4.63, 5.51) months for SOC (hazard ratio [95% CI], 1.01 [0.62, 1.63]; p=0.9806).  Median OS (95% CI) was 9.72 (6.64, 11.70) months for LY+SOC versus 11.14 (8.25, 13.44) months for SOC.  ORR was 74.5% for LY+SOC versus 81% for SOC.  Safety results between arms were similar, although the following adverse events were more frequent on the LY+SOC arm: anemia (61.7% vs 46.5%), neutropenia (61.7% vs 53.5%), leukopenia (27.7% vs 9.3%), vomiting (27.7% vs 16.3%), and pneumonia (10.6% vs 2.3%).  In patients whose baseline CXCR4 expression was above the optimal cutoff (H-score 210), the hazard ratio (95% CI) was 1.27 (0.51, 3.15).  CONCLUSION:  LY2510924 did not improve efficacy but had an acceptable toxicity profile when added to SOC for ED-SCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQM8R0bCaEq4u_Q9URG6Dx8fW6udTcc2eaVB1NaeVRt77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czgsFGrsA%253D%253D&md5=42ad7f380503dd698528c74a33120341</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1016%2Fj.lungcan.2016.12.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lungcan.2016.12.020%26sid%3Dliteratum%253Aachs%26aulast%3DSalgia%26aufirst%3DR.%26aulast%3DStille%26aufirst%3DJ.%2BR.%26aulast%3DWeaver%26aufirst%3DR.%2BW.%26aulast%3DMcCleod%26aufirst%3DM.%26aulast%3DHamid%26aufirst%3DO.%26aulast%3DPolzer%26aufirst%3DJ.%26aulast%3DRoberson%26aufirst%3DS.%26aulast%3DFlynt%26aufirst%3DA.%26aulast%3DSpigel%26aufirst%3DD.%2BR.%26atitle%3DA%2520randomized%2520phase%2520II%2520study%2520of%2520LY2510924%2520and%2520carboplatin%252Fetoposide%2520versus%2520carboplatin%252Fetoposide%2520in%2520extensive-disease%2520small%2520cell%2520lung%2520cancer%26jtitle%3DLung%2520Cancer%26date%3D2017%26volume%3D105%26spage%3D7%26epage%3D13%26doi%3D10.1016%2Fj.lungcan.2016.12.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ros-Blanco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esté, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clotet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruíz-Ávila, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixidó, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seoane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrell, J. I.</span><span> </span><span class="NLM_article-title">Noncyclam tetraamines inhibit CXC chemokine receptor type 4 and target glioma-initiating cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7560</span><span class="NLM_x">–</span> <span class="NLM_lpage">7570</span><span class="refDoi"> DOI: 10.1021/jm300862u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300862u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7560-7570&author=L.+Ros-Blancoauthor=J.+Anidoauthor=R.+Bosserauthor=J.+Est%C3%A9author=B.+Clotetauthor=A.+Kosoyauthor=L.+Ru%C3%ADz-%C3%81vilaauthor=J.+Teixid%C3%B3author=J.+Seoaneauthor=J.+I.+Borrell&title=Noncyclam+tetraamines+inhibit+CXC+chemokine+receptor+type+4+and+target+glioma-initiating+cells&doi=10.1021%2Fjm300862u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fjm300862u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300862u%26sid%3Dliteratum%253Aachs%26aulast%3DRos-Blanco%26aufirst%3DL.%26aulast%3DAnido%26aufirst%3DJ.%26aulast%3DBosser%26aufirst%3DR.%26aulast%3DEst%25C3%25A9%26aufirst%3DJ.%26aulast%3DClotet%26aufirst%3DB.%26aulast%3DKosoy%26aufirst%3DA.%26aulast%3DRu%25C3%25ADz-%25C3%2581vila%26aufirst%3DL.%26aulast%3DTeixid%25C3%25B3%26aufirst%3DJ.%26aulast%3DSeoane%26aufirst%3DJ.%26aulast%3DBorrell%26aufirst%3DJ.%2BI.%26atitle%3DNoncyclam%2520tetraamines%2520inhibit%2520CXC%2520chemokine%2520receptor%2520type%25204%2520and%2520target%2520glioma-initiating%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7560%26epage%3D7570%26doi%3D10.1021%2Fjm300862u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Truax, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaraz, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saindane, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruddanti, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natchus, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. L.</span><span> </span><span class="NLM_article-title">Discovery of tetrahydroisoquinoline-based CXCR4 antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span><span class="refDoi"> DOI: 10.1021/ml400183q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400183q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSisL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1025-1030&author=V.+M.+Truaxauthor=H.+Zhaoauthor=B.+M.+Katzmanauthor=A.+R.+Prosserauthor=A.+A.+Alcarazauthor=M.+T.+Saindaneauthor=R.+B.+Howardauthor=D.+Culverauthor=R.+F.+Arrendaleauthor=P.+R.+Gruddantiauthor=T.+J.+Eversauthor=M.+G.+Natchusauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=J.+L.+Wilson&title=Discovery+of+tetrahydroisoquinoline-based+CXCR4+antagonists&doi=10.1021%2Fml400183q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists</span></div><div class="casAuthors">Truax, Valarie M.; Zhao, Huanyu; Katzman, Brooke M.; Prosser, Anthony R.; Alcaraz, Ana A.; Saindane, Manohar T.; Howard, Randy B.; Culver, Deborah; Arrendale, Richard F.; Gruddanti, Prahbakar R.; Evers, Taylor J.; Natchus, Michael G.; Snyder, James P.; Liotta, Dennis C.; Wilson, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1025-1030</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A de novo hit-to-lead effort involving the redesign of benzimidazole-contg. antagonists of the CXCR4 receptor resulted in the discovery of a novel series of 1,2,3,4-tetrahydroisoquinoline (TIQ) analogs.  In general, this series of compds. show good potencies (3-650 nM) in assays involving CXCR4 function, including both inhibition of attachment of X4 HIV-1IIIB virus in MAGI-CCR5/CXCR4 cells and inhibition of calcium release in Chem-1 cells.  Series profiling permitted the identification of TIQ-(R)-stereoisomer I as a potent and selective CXCR4 antagonist lead candidate with a promising in vitro profile.  The drug-like properties of I were detd. in ADME in vitro studies, revealing low metabolic liability potential.  Further in vivo evaluations included pharmacokinetic expts. in rats and mice, where I was shown to have oral bioavailability (F = 63%) and resulted in the mobilization of white blood cells (WBCs) in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEHgfxHZaoI7Vg90H21EOLACvtfcHk0lg51BoDrgwqXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSisL3O&md5=aaea8e1f85d3898d1c33b20c0fca64c9</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fml400183q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400183q%26sid%3Dliteratum%253Aachs%26aulast%3DTruax%26aufirst%3DV.%2BM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DKatzman%26aufirst%3DB.%2BM.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DAlcaraz%26aufirst%3DA.%2BA.%26aulast%3DSaindane%26aufirst%3DM.%2BT.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DGruddanti%26aufirst%3DP.%2BR.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DJ.%2BL.%26atitle%3DDiscovery%2520of%2520tetrahydroisoquinoline-based%2520CXCR4%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1025%26epage%3D1030%26doi%3D10.1021%2Fml400183q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zachariassen, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlshøj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haug, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Våbenø, J.</span><span> </span><span class="NLM_article-title">Probing the molecular interactions between CXC chemokine receptor 4 (CXCR4) and an arginine-based tripeptidomimetic antagonist (KRH-1636)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8141</span><span class="NLM_x">–</span> <span class="NLM_lpage">8153</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00987</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00987" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8141-8153&author=Z.+G.+Zachariassenauthor=S.+Karlsh%C3%B8jauthor=B.+E.+Haugauthor=M.+M.+Rosenkildeauthor=J.+V%C3%A5ben%C3%B8&title=Probing+the+molecular+interactions+between+CXC+chemokine+receptor+4+%28CXCR4%29+and+an+arginine-based+tripeptidomimetic+antagonist+%28KRH-1636%29&doi=10.1021%2Facs.jmedchem.5b00987"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00987%26sid%3Dliteratum%253Aachs%26aulast%3DZachariassen%26aufirst%3DZ.%2BG.%26aulast%3DKarlsh%25C3%25B8j%26aufirst%3DS.%26aulast%3DHaug%26aufirst%3DB.%2BE.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26atitle%3DProbing%2520the%2520molecular%2520interactions%2520between%2520CXC%2520chemokine%2520receptor%25204%2520%2528CXCR4%2529%2520and%2520an%2520arginine-based%2520tripeptidomimetic%2520antagonist%2520%2528KRH-1636%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8141%26epage%3D8153%26doi%3D10.1021%2Facs.jmedchem.5b00987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Demmer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span> </span><span class="NLM_article-title">PET imaging of CXCR4 receptors in cancer by a new optimized ligand</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1789</span><span class="NLM_x">–</span> <span class="NLM_lpage">1791</span><span class="refDoi"> DOI: 10.1002/cmdc.201100320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1002%2Fcmdc.201100320" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1789-1791&author=O.+Demmerauthor=E.+Gourniauthor=U.+Schumacherauthor=H.+Kesslerauthor=H.+J.+Wester&title=PET+imaging+of+CXCR4+receptors+in+cancer+by+a+new+optimized+ligand&doi=10.1002%2Fcmdc.201100320"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100320%26sid%3Dliteratum%253Aachs%26aulast%3DDemmer%26aufirst%3DO.%26aulast%3DGourni%26aufirst%3DE.%26aulast%3DSchumacher%26aufirst%3DU.%26aulast%3DKessler%26aufirst%3DH.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26atitle%3DPET%2520imaging%2520of%2520CXCR4%2520receptors%2520in%2520cancer%2520by%2520a%2520new%2520optimized%2520ligand%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1789%26epage%3D1791%26doi%3D10.1002%2Fcmdc.201100320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Philipp-Abbrederis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knop, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schottelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luckerath, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietschmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habringer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerngross, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirbel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwamborn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steidle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenwald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kropf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peschel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einsele, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaiger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Götze, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, U.</span><span> </span><span class="NLM_article-title">In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">487</span><span class="refDoi"> DOI: 10.15252/emmm.201404698</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.15252%2Femmm.201404698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=25736399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVKjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=477-487&author=K.+Philipp-Abbrederisauthor=K.+Herrmannauthor=S.+Knopauthor=M.+Schotteliusauthor=M.+Eiberauthor=K.+Luckerathauthor=E.+Pietschmannauthor=S.+Habringerauthor=C.+Gerngrossauthor=K.+Frankeauthor=M.+Rudeliusauthor=A.+Schirbelauthor=C.+Lapaauthor=K.+Schwambornauthor=S.+Steidleauthor=E.+Hartmannauthor=A.+Rosenwaldauthor=S.+Kropfauthor=A.+J.+Beerauthor=C.+Peschelauthor=H.+Einseleauthor=A.+K.+Buckauthor=M.+Schwaigerauthor=K.+G%C3%B6tzeauthor=H.+J.+Westerauthor=U.+Keller&title=In+vivo+molecular+imaging+of+chemokine+receptor+CXCR4+expression+in+patients+with+advanced+multiple+myeloma&doi=10.15252%2Femmm.201404698"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma</span></div><div class="casAuthors">Philipp-Abbrederis, Kathrin; Herrmann, Ken; Knop, Stefan; Schottelius, Margret; Eiber, Matthias; Lueckerath, Katharina; Pietschmann, Elke; Habringer, Stefan; Gerngross, Carlos; Franke, Katharina; Rudelius, Martina; Schirbel, Andreas; Lapa, Constantin; Schwamborn, Kristina; Steidle, Sabine; Hartmann, Elena; Rosenwald, Andreas; Kropf, Saskia; Beer, Ambros J.; Peschel, Christian; Einsele, Hermann; Buck, Andreas K.; Schwaiger, Markus; Goetze, Katharina; Wester, Hans-Juergen; Keller, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">477-487</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">CXCR4 is a G-protein-coupled receptor that mediates recruitment of blood cells toward its ligand SDF-1.  In cancer, high CXCR4 expression is frequently assocd. with tumor dissemination and poor prognosis.  We evaluated the novel CXCR4 probe [68Ga]Pentixafor for in vivo mapping of CXCR4 expression d. in mice xenografted with human CXCR4-pos. MM cell lines and patients with advanced MM by means of positron emission tomog. (PET).  [68Ga]Pentixafor PET provided images with excellent specificity and contrast.  In 10 of 14 patients with advanced MM [68Ga]Pentixafor PET/CT scans revealed MM manifestations, whereas only nine of 14 std. [18F]fluorodeoxyglucose PET/CT scans were rated visually pos.  Assessment of blood counts and std. CD34+ flow cytometry did not reveal significant blood count changes assocd. with tracer application.  Based on these highly encouraging data on clin. PET imaging of CXCR4 expression in a cohort of MM patients, we conclude that [68Ga]Pentixafor PET opens a broad field for clin. investigations on CXCR4 expression and for CXCR4-directed therapeutic approaches in MM and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGUzSAHxUizbVg90H21EOLACvtfcHk0lg51BoDrgwqXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVKjs7g%253D&md5=77153cc7b917938fdba483d857a2c302</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.15252%2Femmm.201404698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201404698%26sid%3Dliteratum%253Aachs%26aulast%3DPhilipp-Abbrederis%26aufirst%3DK.%26aulast%3DHerrmann%26aufirst%3DK.%26aulast%3DKnop%26aufirst%3DS.%26aulast%3DSchottelius%26aufirst%3DM.%26aulast%3DEiber%26aufirst%3DM.%26aulast%3DLuckerath%26aufirst%3DK.%26aulast%3DPietschmann%26aufirst%3DE.%26aulast%3DHabringer%26aufirst%3DS.%26aulast%3DGerngross%26aufirst%3DC.%26aulast%3DFranke%26aufirst%3DK.%26aulast%3DRudelius%26aufirst%3DM.%26aulast%3DSchirbel%26aufirst%3DA.%26aulast%3DLapa%26aufirst%3DC.%26aulast%3DSchwamborn%26aufirst%3DK.%26aulast%3DSteidle%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DE.%26aulast%3DRosenwald%26aufirst%3DA.%26aulast%3DKropf%26aufirst%3DS.%26aulast%3DBeer%26aufirst%3DA.%2BJ.%26aulast%3DPeschel%26aufirst%3DC.%26aulast%3DEinsele%26aufirst%3DH.%26aulast%3DBuck%26aufirst%3DA.%2BK.%26aulast%3DSchwaiger%26aufirst%3DM.%26aulast%3DG%25C3%25B6tze%26aufirst%3DK.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DKeller%26aufirst%3DU.%26atitle%3DIn%2520vivo%2520molecular%2520imaging%2520of%2520chemokine%2520receptor%2520CXCR4%2520expression%2520in%2520patients%2520with%2520advanced%2520multiple%2520myeloma%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D477%26epage%3D487%26doi%3D10.15252%2Femmm.201404698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lesniak, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikorska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shallal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azad, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisok, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullambhatla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmagadda, S.</span><span> </span><span class="NLM_article-title">Structural characterization and in vivo evaluation of β-hairpin peptidomimetics as specific CXCR4 imaging agents</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">953</span><span class="refDoi"> DOI: 10.1021/mp500799q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp500799q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovFGgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=941-953&author=W.+G.+Lesniakauthor=E.+Sikorskaauthor=H.+Shallalauthor=B.+B.+Azadauthor=A.+Lisokauthor=M.+Pullambhatlaauthor=M.+G.+Pomperauthor=S.+Nimmagadda&title=Structural+characterization+and+in+vivo+evaluation+of+%CE%B2-hairpin+peptidomimetics+as+specific+CXCR4+imaging+agents&doi=10.1021%2Fmp500799q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18cR"><div class="casContent"><span class="casTitleNuber">18c</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Characterization and in Vivo Evaluation of β-Hairpin Peptidomimetics as Specific CXCR4 Imaging Agents</span></div><div class="casAuthors">Lesniak, Wojciech G.; Sikorska, Emilia; Shallal, Hassan; Behnam Azad, Babak; Lisok, Ala; Pullambhatla, Mrudula; Pomper, Martin G.; Nimmagadda, Sridhar</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">941-953</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The CXCR4 chemokine receptor is integral to several biol. functions and plays a pivotal role in the pathophysiol. of many diseases.  As such, CXCR4 is an enticing target for the development of imaging and therapeutic agents.  Here we report the evaluation of the POL3026 peptidomimetic template for the development of imaging agents that target CXCR4.  Structural and conformational analyses of POL3026 and two of its conjugates, DOTA (POL-D) and PEG12-DOTA (POL-PD), by CD, two-dimensional NMR spectroscopy and mol. dynamics calcns. are reported.  In silico observations were exptl. verified with in vitro affinity assays and rationalized using crystal structure-based mol. modeling studies. [111In]-labeled DOTA conjugates were assessed in vivo for target specificity in CXCR4 expressing s.c. U87 tumors (U87-stb-CXCR4) through single photon emission computed tomog. (SPECT/CT) imaging and biodistribution studies.  In silico and in vitro studies show that POL3026 and its conjugates demonstrate similar interactions with different micelles that mimic cellular membrane and that the ε-NH2 of lysine7 is crit. to maintain high affinity to CXCR4.  Modification of this group with DOTA or PEG12-DOTA led to the decrease of IC50 value from 0.087 nM for POL3026 to 0.47 nM and 1.42 nM for POL-D and POL-PD, resp.  In spite of the decreased affinity toward CXCR4, [111In]POL-D and [111In]POL-PD demonstrated high and significant uptake in U87-stb-CXCR4 tumors compared to the control U87 tumors at 90 min and 24 h post injection.  Uptake in U87-stb-CXCR4 tumors could be blocked by unlabeled POL3026, indicating specificity of the agents in vivo.  These results suggest POL3026 as a promising template to develop new imaging agents that target CXCR4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWiehnfy4gbrVg90H21EOLACvtfcHk0lioFsapWRnflw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovFGgsg%253D%253D&md5=4cbba0fdc42813fdd1e46eb9c16d8586</span></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1021%2Fmp500799q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp500799q%26sid%3Dliteratum%253Aachs%26aulast%3DLesniak%26aufirst%3DW.%2BG.%26aulast%3DSikorska%26aufirst%3DE.%26aulast%3DShallal%26aufirst%3DH.%26aulast%3DAzad%26aufirst%3DB.%2BB.%26aulast%3DLisok%26aufirst%3DA.%26aulast%3DPullambhatla%26aufirst%3DM.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26aulast%3DNimmagadda%26aufirst%3DS.%26atitle%3DStructural%2520characterization%2520and%2520in%2520vivo%2520evaluation%2520of%2520%25CE%25B2-hairpin%2520peptidomimetics%2520as%2520specific%2520CXCR4%2520imaging%2520agents%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2015%26volume%3D12%26spage%3D941%26epage%3D953%26doi%3D10.1021%2Fmp500799q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Detering, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sultan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luehmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehdashti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooley, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPersio, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span> </span><span class="NLM_article-title">Gold nanoclusters doped with <sup>64</sup>Cu for CXCR4 positron emission tomography imaging of breast cancer and metastasis</span> <span class="citation_source-journal">ACS Nano</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">5959</span><span class="NLM_x">–</span> <span class="NLM_lpage">5970</span><span class="refDoi"> DOI: 10.1021/acsnano.6b01326</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsnano.6b01326" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsF2qsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=5959-5970&author=Y.+Zhaoauthor=L.+Deteringauthor=D.+Sultanauthor=M.+L.+Cooperauthor=M.+Youauthor=S.+Choauthor=S.+L.+Meierauthor=H.+Luehmannauthor=G.+Sunauthor=M.+Rettigauthor=F.+Dehdashtiauthor=K.+L.+Wooleyauthor=J.+F.+DiPersioauthor=Y.+Liu&title=Gold+nanoclusters+doped+with+64Cu+for+CXCR4+positron+emission+tomography+imaging+of+breast+cancer+and+metastasis&doi=10.1021%2Facsnano.6b01326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18dR"><div class="casContent"><span class="casTitleNuber">18d</span><div class="casTitle"><span class="NLM_cas:atitle">Gold Nanoclusters Doped with 64Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis</span></div><div class="casAuthors">Zhao, Yongfeng; Detering, Lisa; Sultan, Deborah; Cooper, Matthew L.; You, Meng; Cho, Sangho; Meier, Stephanie L.; Luehmann, Hannah; Sun, Guorong; Rettig, Michael; Dehdashti, Farrokh; Wooley, Karen L.; DiPersio, John F.; Liu, Yongjian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Nano</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">5959-5970</span>CODEN:
                <span class="NLM_cas:coden">ANCAC3</span>;
        ISSN:<span class="NLM_cas:issn">1936-0851</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As an emerging class of nanomaterial, nanoclusters hold great potential for biomedical applications due to their unique sizes and related properties.  Herein, we prepd. a 64Cu doped gold nanocluster (64CuAuNC, hydrodynamic size: 4.2 ± 0.5 nm) functionalized with AMD3100 (or Plerixafor) for targeted positron emission tomog. (PET) imaging of CXCR4, an up-regulated receptor on primary tumor and lung metastasis in a mouse 4T1 orthotopic breast cancer model.  The prepn. of targeted 64CuAuNCs-AMD3100 (4.5 ± 0.4 nm) was done via one-step reaction with controlled conjugation of AMD3100 and specific activity, as well as improved colloid stability.  In vivo pharmacokinetic evaluation showed favorable organ distribution and significant renal and fecal clearance within 48 h post injection.  The expression of CXCR4 in tumors and metastasis was characterized by immunohistochem., Western blot, and reverse transcription polymerase chain reaction anal.  PET imaging with 64CuAuNCs-AMD3100 demonstrated sensitive and accurate detection of CXCR4 in engineered tumors expressing various levels of the receptor, while competitive receptor blocking studies confirmed targeting specificity of the nanoclusters.  In contrast to nontargeted 64CuAuNCs and 64Cu-AMD3100 alone, the targeted 64CuAuNCs-AMD3100 detected up-regulated CXCR4 in early stage tumors and premetastatic niche of lung earlier and with greater sensitivity.  Taken together, we believe that 64CuAuNCs-AMD3100 could serve as a useful platform for early and accurate detection of breast cancer and metastasis providing an essential tool to guide the treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV0U5LOre2p7Vg90H21EOLACvtfcHk0lioFsapWRnflw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsF2qsrg%253D&md5=a7342f8d349c997bc13541bd2a161fd4</span></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=10.1021%2Facsnano.6b01326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsnano.6b01326%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DDetering%26aufirst%3DL.%26aulast%3DSultan%26aufirst%3DD.%26aulast%3DCooper%26aufirst%3DM.%2BL.%26aulast%3DYou%26aufirst%3DM.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DMeier%26aufirst%3DS.%2BL.%26aulast%3DLuehmann%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DG.%26aulast%3DRettig%26aufirst%3DM.%26aulast%3DDehdashti%26aufirst%3DF.%26aulast%3DWooley%26aufirst%3DK.%2BL.%26aulast%3DDiPersio%26aufirst%3DJ.%2BF.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DGold%2520nanoclusters%2520doped%2520with%252064Cu%2520for%2520CXCR4%2520positron%2520emission%2520tomography%2520imaging%2520of%2520breast%2520cancer%2520and%2520metastasis%26jtitle%3DACS%2520Nano%26date%3D2016%26volume%3D10%26spage%3D5959%26epage%3D5970%26doi%3D10.1021%2Facsnano.6b01326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Vag, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerngross, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herhaus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philipp-Abbrederis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graner, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ettl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaiger, M.</span><span> </span><span class="NLM_article-title">First experience with chemokine receptor CXCR4-targeted PET imaging of patients with solid cancers</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span><span class="refDoi"> DOI: 10.2967/jnumed.115.161034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.2967%2Fjnumed.115.161034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=26769866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslaktLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=741-746&author=T.+Vagauthor=C.+Gerngrossauthor=P.+Herhausauthor=M.+Eiberauthor=K.+Philipp-Abbrederisauthor=F.+P.+Granerauthor=J.+Ettlauthor=U.+Kellerauthor=H.+J.+Westerauthor=M.+Schwaiger&title=First+experience+with+chemokine+receptor+CXCR4-targeted+PET+imaging+of+patients+with+solid+cancers&doi=10.2967%2Fjnumed.115.161034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18eR"><div class="casContent"><span class="casTitleNuber">18e</span><div class="casTitle"><span class="NLM_cas:atitle">First experience with chemokine receptor CXCR4-Targeted PET imaging of patients with solid cancers</span></div><div class="casAuthors">Vag, Tibor; Gerngross, Carlos; Herhaus, Peter; Eiber, Matthias; Philipp-Abbrederis, Kathrin; Graner, Frank-Philipp; Ettl, Johannes; Keller, Ulrich; Wester, Hans-Juergen; Schwaiger, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">741-746</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">1535-5667</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">CXCR4 is a chemokine receptor that is overexpressed in various human cancers and is involved in tumor metastasis.  The aim of this proof-of-concept study was to evaluate a novel CXCR4-targeted PET probe in patients with solid cancers with reported in vitro evidence of CXCR4 overexpression and to est. its potential diagnostic value.  Twenty-one patients with histol. proven pancreatic cancer, laryngeal cancer, non-small cell lung cancer, prostate cancer, melanoma, breast cancer, hepatocellular carcinoma, glioblastoma, sarcoma, or cancer of unknown primary underwent PET imaging using the novel CXCR4 nuclear probe 68Ga-pentixafor.  The SUVmax of the liver, spleen, and bone marrow was measured to det. physiol. tracer distribution.  For evaluation of tracer accumulation in solid cancers, SUVmax and tumor-to-background (T/B) ratios were detd. in a total of 43 malignant lesions, including 8 primary tumors, 3 locally recurrent tumors, and 32 metastases.  When available, the SUVmax of malignant lesions was compared with the corresponding SUVmax measured in routine 18F-FDG PET.  Moderate tracer accumulation was detectable in the liver, bone marrow, and spleen, with a mean SUVmax of 3.1, 3.7, and 5.6, resp.  By visual interpretation criteria, 9 of 11 primary and locally recurrent tumors were detectable, exhibiting a mean SUVmax of 4.7 (range, 2.1-10.9) and a mean T/B ratio of 2.9.  Twenty of 32 evaluated metastases were visually detectable (mean SUVmax, 4.5 [range, 3.2-13.8]; mean T/B ratio, 2.8).  The highest signal was detected in a patient with non-small cell lung cancer (SUVmax, 10.9; T/B ratio, 8.4) and a patient with cancer of unknown primary (SUVmax, 13.8; T/B ratio, 8.1).  Compared with 18F-FDG PET, which was addnl. performed in 10 patients, 68Ga-pentixafor PET had a lower SUVmax in all measured malignant lesions.  On the basis of these first observations in a small and heterogeneous patient cohort, the in vitro CXCR4 expression profile of solid cancers and metastases described in the previous literature does not seem to sufficiently depict the in vivo distribution revealed by CXCR4-targeted PET.  Moreover, the detectability of solid cancers seems to be generally lower for 68Ga-pentixafor than for 18F-FDG PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEliS1Eh7bzbVg90H21EOLACvtfcHk0lioFsapWRnflw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslaktLjO&md5=d370182cec2b5399292806fdecf247b0</span></div><a href="/servlet/linkout?suffix=cit18e&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.161034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.161034%26sid%3Dliteratum%253Aachs%26aulast%3DVag%26aufirst%3DT.%26aulast%3DGerngross%26aufirst%3DC.%26aulast%3DHerhaus%26aufirst%3DP.%26aulast%3DEiber%26aufirst%3DM.%26aulast%3DPhilipp-Abbrederis%26aufirst%3DK.%26aulast%3DGraner%26aufirst%3DF.%2BP.%26aulast%3DEttl%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DU.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DSchwaiger%26aufirst%3DM.%26atitle%3DFirst%2520experience%2520with%2520chemokine%2520receptor%2520CXCR4-targeted%2520PET%2520imaging%2520of%2520patients%2520with%2520solid%2520cancers%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D741%26epage%3D746%26doi%3D10.2967%2Fjnumed.115.161034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Weiss, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiesewetter, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobus, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szajek, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farber, J. M.</span><span> </span><span class="NLM_article-title">Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of <sup>64</sup>Cu-AMD3100</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span><span class="refDoi"> DOI: 10.1007/s11307-010-0466-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1007%2Fs11307-010-0466-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=21347799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A280%3ADC%252BC387kt1Cnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=106-114&author=I.+D.+Weissauthor=O.+Jacobsonauthor=D.+O.+Kiesewetterauthor=J.+P.+Jacobusauthor=L.+P.+Szajekauthor=X.+Chenauthor=J.+M.+Farber&title=Positron+emission+tomography+imaging+of+tumors+expressing+the+human+chemokine+receptor+CXCR4+in+mice+with+the+use+of+64Cu-AMD3100&doi=10.1007%2Fs11307-010-0466-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100</span></div><div class="casAuthors">Weiss Ido D; Jacobson Orit; Kiesewetter Dale O; Jacobus John P; Szajek Lawrence P; Chen Xiaoyuan; Farber Joshua M</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">106-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Expression of CXCR4 in cancers has been correlated with poor prognosis and increased metastasis.  Quantifying CXCR4 expression non-invasively might aid in prognostication and monitoring therapy.  We evaluated a radiolabeled antagonist of CXCR4, 64Cu-AMD3100, as a positron-emitting imaging agent.  PROCEDURES:  CXCR4-transfected or non-transfected cell lines were injected into mice to form xenografts.  Accumulation of 64Cu-AMD3100 in tumors was analyzed by small-animal PET and biodistribution assays.  RESULTS:  64Cu-AMD3100 accumulated in CXCR4-expressing, but not CXCR4-negative, tumors.  For CXCR4-expressing tumors, tumor-to-blood and tumor-to-muscle ratios were 23-41 and 50-59, respectively, depending on tumor type.  Excess of unlabeled Cu-AMD3100 or AMD3100 significantly reduced 64Cu-AMD3100 accumulation in CXCR4-expressing tumors.  Human-absorbed dose calculations predicted a dose limit of 444 MBq.  CONCLUSIONS:  CXCR4 can be imaged in tumors using 64Cu-AMD3100.  Dosimetry studies suggest that imaging in humans is feasible.  We conclude that 64Cu-AMD3100 should be investigated as a potential agent for imaging and quantifying CXCR4 in tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRjq4f6HCGJACEJCPKhJPuqfW6udTcc2ebd172wlM63sLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387kt1Cnuw%253D%253D&md5=240796270cdcd082e5af983322f7b69d</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1007%2Fs11307-010-0466-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-010-0466-y%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DI.%2BD.%26aulast%3DJacobson%26aufirst%3DO.%26aulast%3DKiesewetter%26aufirst%3DD.%2BO.%26aulast%3DJacobus%26aufirst%3DJ.%2BP.%26aulast%3DSzajek%26aufirst%3DL.%2BP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DFarber%26aufirst%3DJ.%2BM.%26atitle%3DPositron%2520emission%2520tomography%2520imaging%2520of%2520tumors%2520expressing%2520the%2520human%2520chemokine%2520receptor%2520CXCR4%2520in%2520mice%2520with%2520the%2520use%2520of%252064Cu-AMD3100%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2012%26volume%3D14%26spage%3D106%26epage%3D114%26doi%3D10.1007%2Fs11307-010-0466-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Woodard, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Silva, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnam Azad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisok, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullambhatla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesniak, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmagadda, S.</span><span> </span><span class="NLM_article-title">Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4)</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2014.04.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2Fj.nucmedbio.2014.04.081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=25038987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A280%3ADC%252BC2cbktlyluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=552-561&author=L.+E.+Woodardauthor=R.+A.+De+Silvaauthor=B.+Behnam+Azadauthor=A.+Lisokauthor=M.+Pullambhatlaauthor=W.+G.+Lesniakauthor=R.+C.+Measeauthor=M.+G.+Pomperauthor=S.+Nimmagadda&title=Bridged+cyclams+as+imaging+agents+for+chemokine+receptor+4+%28CXCR4%29&doi=10.1016%2Fj.nucmedbio.2014.04.081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4)</span></div><div class="casAuthors">Woodard Lauren E; De Silva Ravindra A; Behnam Azad Babak; Lisok Ala; Pullambhatla Mrudula; G Lesniak Wojciech; Mease Ronnie C; Pomper Martin G; Nimmagadda Sridhar</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear medicine and biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">552-61</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Over-expression of chemokine receptor 4 (CXCR4) is present in a majority of cancers, has been linked to an aggressive phenotype, and may indicate the metastatic potential of primary tumor.  Several CXCR4 targeted therapeutics are in clinical trials and the development of the corresponding imaging agents is an area of active interest.  Previously, (64)Cu-labeled imaging agents for CXCR4 have provided clear images of CXCR4-bearing tissues in relevant experimental models but demonstrated fast washout from tissues harboring receptor.  Addition of stabilizing bridges is known to provide more robust chelator-Cu(II) complexes.  In addition, bridged cyclam-based CXCR4 binding agents demonstrated increased receptor residence times relative to existing agents.  Based on that knowledge we synthesized several bridged cyclam analogs of AMD3465, a monocyclam-based CXCR4 imaging agent, to increase the retention time of the tracer bound to the receptor to allow for protracted imaging and improved target-to-non-target ratios.  Specific accumulation of two radiolabeled, cross-bridged analogs ([(64)Cu] RAD1-24 and [(64)Cu]RAD1-52) was observed in U87-stb-CXCR4 tumors in both PET/CT imaging and biodistribution studies.  At 90min post-injection of radiotracer, tumor-to-muscle and tumor-to-blood ratios reached 106.05±17.19 and 28.08±4.78, respectively, for cross-bridged pyrimidine analog [(64)Cu]RAD1-52.  Receptor blockade performed in vivo denoted target binding specificity.  The biodistribution and PET/CT imaging studies with the radiolabeled bridged cyclams demonstrated longer tumor retention and comparable uptake to [(64)Cu]AMD3465, though [(64)Cu]AMD3465 demonstrated superior overall pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIknGsHNfccmgRQsDqrjW_fW6udTcc2ebd172wlM63sLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbktlyluw%253D%253D&md5=f469a9508f3287402107f4785df86a12</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2014.04.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2014.04.081%26sid%3Dliteratum%253Aachs%26aulast%3DWoodard%26aufirst%3DL.%2BE.%26aulast%3DDe%2BSilva%26aufirst%3DR.%2BA.%26aulast%3DBehnam%2BAzad%26aufirst%3DB.%26aulast%3DLisok%26aufirst%3DA.%26aulast%3DPullambhatla%26aufirst%3DM.%26aulast%3DLesniak%26aufirst%3DW.%2BG.%26aulast%3DMease%26aufirst%3DR.%2BC.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26aulast%3DNimmagadda%26aufirst%3DS.%26atitle%3DBridged%2520cyclams%2520as%2520imaging%2520agents%2520for%2520chemokine%2520receptor%25204%2520%2528CXCR4%2529%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2014%26volume%3D41%26spage%3D552%26epage%3D561%26doi%3D10.1016%2Fj.nucmedbio.2014.04.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Oltmanns, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zitzmann-Kolbe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauder-Wuest, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haberkorn, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhut, M.</span><span> </span><span class="NLM_article-title">Zn(II)-bis(cyclen) complexes and the imaging of apoptosis/necrosis</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2611</span><span class="NLM_x">–</span> <span class="NLM_lpage">2624</span><span class="refDoi"> DOI: 10.1021/bc200457b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc200457b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyhtbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=2611-2624&author=D.+Oltmannsauthor=S.+Zitzmann-Kolbeauthor=A.+Muellerauthor=U.+Bauder-Wuestauthor=M.+Schaeferauthor=M.+Ederauthor=U.+Haberkornauthor=M.+Eisenhut&title=Zn%28II%29-bis%28cyclen%29+complexes+and+the+imaging+of+apoptosis%2Fnecrosis&doi=10.1021%2Fbc200457b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Zn(II)-bis(cyclen) Complexes and the Imaging of Apoptosis/Necrosis</span></div><div class="casAuthors">Oltmanns, Dorte; Zitzmann-Kolbe, Sabine; Mueller, Andre; Bauder-Wuest, Ulrike; Schaefer, Martin; Eder, Matthias; Haberkorn, Uwe; Eisenhut, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2611-2624</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In vivo cell-death imaging is still a challenging issue.  Until now, only 99mTc-labeled HYNIC-rh-annexin A5 has been extensively studied in clin. trials.  In the ongoing search for an alternative imaging agent, we synthesized a series of fluorescent zinc-cyclen complexes as annexin A5 mimics and studied structural variations on the uptake behavior of cells undergoing apoptosis/necrosis.  The no. of cyclen chelators was varied and the spacer sepg. cyclen from the central scaffold was modified.  Five zinc-cyclen complexes were labeled with fluorescein for flow cytometric studies and one was labeled with 18F for in vivo applications.  Jurkat cells were treated with staurosporine to induce apoptosis/necrosis, incubated with the fluorescein-labeled zinc complexes and analyzed them by flow cytometry.  Fluorescent annexin A5 and propidium iodide were applied as ref. dyes.  Flow cytometry revealed greater accumulation of zinc-cyclen complexes in staurosporine treated cells.  The uptake was contingent on the presence of zinc and the fluorescence intensity was dependent on the no. of zinc-cyclen groups.  Confocal laser scanning microscopy showed the {bis[Zn(cyclen)]}4+ complex distributed throughout the cytosol different to annexin A5.  Owing to the structural similarity of the bis-cyclen ligands with CXCR4 binding bis-cyclam derivs. the zinc-cyclen complex uptake was challenged with the meta deriv. of AMD3100.  Lack of uptake depletion in staurosporine treated cells ruled out measurable CXCR4 interaction.  PET imaging using the 18F labeled zinc-cyclen complex revealed significantly higher uptake in an irradiated Dunning R3327-AT1 prostate tumor as compared to the contralateral control tumor.  PET imaging of a HelaMatu tumor model addnl. showed an increased uptake after taxol treatment.  It could be demonstrated that the fluorescent zinc-cyclen complexes offer potential as new agents for flow cytometry and microscopic imaging of cell death.  In addn., the 18F labeled analog holds promise for in vivo applications providing informations about cell death after radiation therapy and cytostatic drug treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1BYC9UE0FArVg90H21EOLACvtfcHk0liigPP1wOc1dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyhtbjN&md5=dc2c5ced06bee67d7b4e7a42311cbced</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fbc200457b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc200457b%26sid%3Dliteratum%253Aachs%26aulast%3DOltmanns%26aufirst%3DD.%26aulast%3DZitzmann-Kolbe%26aufirst%3DS.%26aulast%3DMueller%26aufirst%3DA.%26aulast%3DBauder-Wuest%26aufirst%3DU.%26aulast%3DSchaefer%26aufirst%3DM.%26aulast%3DEder%26aufirst%3DM.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DEisenhut%26aufirst%3DM.%26atitle%3DZn%2528II%2529-bis%2528cyclen%2529%2520complexes%2520and%2520the%2520imaging%2520of%2520apoptosis%252Fnecrosis%26jtitle%3DBioconjugate%2520Chem.%26date%3D2011%26volume%3D22%26spage%3D2611%26epage%3D2624%26doi%3D10.1021%2Fbc200457b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hartimath, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Waarde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierckx, R. A. J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, E. F. J.</span><span> </span><span class="NLM_article-title">Evaluation of <i>N</i>-[<sup>11</sup>C]methyl-AMD3465 as a PET tracer for imaging of CXCR4 receptor expression in a C6 glioma tumor model</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3810</span><span class="NLM_x">–</span> <span class="NLM_lpage">3817</span><span class="refDoi"> DOI: 10.1021/mp500398r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp500398r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1KmsbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=3810-3817&author=S.+V.+Hartimathauthor=A.+van+Waardeauthor=R.+A.+J.+O.+Dierckxauthor=E.+F.+J.+de+Vries&title=Evaluation+of+N-%5B11C%5Dmethyl-AMD3465+as+a+PET+tracer+for+imaging+of+CXCR4+receptor+expression+in+a+C6+glioma+tumor+model&doi=10.1021%2Fmp500398r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of N-[11C]Methyl-AMD3465 as a PET Tracer for Imaging of CXCR4 Receptor Expression in a C6 Glioma Tumor Model</span></div><div class="casAuthors">Hartimath, S. V.; van Waarde, A.; Dierckx, R. A. J. O.; de Vries, E. F. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3810-3817</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The chemokine receptor CXCR4 and its ligand CXCL12 play an important role in tumor progression and metastasis.  CXCR4 receptors are expressed by many cancer types and provide a potential target for treatment.  Noninvasive detection of CXCR4 may aid diagnosis and improve therapy selection.  It has been demonstrated in preclin. studies that positron emission tomog. (PET) with a radiolabeled small mol. could enable noninvasive monitoring of CXCR4 expression.  Here, we prepd. N-[11C]methyl-AMD3465 as a new PET tracer for CXCR4.  N-[11C]Methyl-AMD3465 was readily prepd. by N-methylation with [11C]CH3OTf.  The tracer was obtained in a 60 ± 2% yield (decay cor.), the purity of the tracer was >99%, and specific activity was 47 ± 14 GBq/μmol.  Tracer stability was tested in vitro using liver microsomes and rat plasma; excellent stability was obsd.  The tracer was evaluated in rat C6 glioma and human PC-3 cell lines.  In vitro cellular uptake of N-[11C]methyl-AMD3465 was receptor mediated.  The effect of transition metal ions (Cu2+, Ni2+, and Zn2+) on cellular binding was examd. in C6 cells, and the presence of these ions increased the cellular binding of the tracer 9-, 7-, and 3-fold, resp.  Ex vivo biodistribution and PET imaging of N-[11C]methyl-AMD3465 were performed in rats with C6 tumor xenografts.  Both PET and biodistribution studies demonstrated specific accumulation of the tracer in the tumor (SUV 0.6 ± 0.2) and other CXCR4 expressing organs, such as lymph node (1.5 ± 0.2), liver (8.9 ± 1.0), bone marrow (1.0 ± 0.3), and spleen (1.0 ± 0.1).  Tumor uptake was significantly reduced (66%, p < 0.01) after pretreatment with Plerixafor (AMD3100).  Biodistribution data indicates a tumor-to-muscle ratio of 7.85 and tumor-to-plasma ratio of 1.14, at 60 min after tracer injection.  Our data demonstrated that N-[11C]methyl-AMD3465 is capable of detecting physiol. CXCR4 expression in tumors and other CXCR4 expressing tissues.  These results warrant further evaluation of N-[11C]methyl-AMD3465 as a potential PET tracer for CXCR4 receptor imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwklF80Iku0LVg90H21EOLACvtfcHk0lhSmS3wgGpkig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1KmsbnP&md5=404eb68dafccaacb4114bea718860029</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fmp500398r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp500398r%26sid%3Dliteratum%253Aachs%26aulast%3DHartimath%26aufirst%3DS.%2BV.%26aulast%3Dvan%2BWaarde%26aufirst%3DA.%26aulast%3DDierckx%26aufirst%3DR.%2BA.%2BJ.%2BO.%26aulast%3Dde%2BVries%26aufirst%3DE.%2BF.%2BJ.%26atitle%3DEvaluation%2520of%2520N-%255B11C%255Dmethyl-AMD3465%2520as%2520a%2520PET%2520tracer%2520for%2520imaging%2520of%2520CXCR4%2520receptor%2520expression%2520in%2520a%2520C6%2520glioma%2520tumor%2520model%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2014%26volume%3D11%26spage%3D3810%26epage%3D3817%26doi%3D10.1021%2Fmp500398r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schottelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philipp-Abbrederis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simecek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerngross, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaiger, M.</span><span> </span><span class="NLM_article-title">Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging</span> <span class="citation_source-journal">Theranostics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span><span class="refDoi"> DOI: 10.7150/thno.11251</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.7150%2Fthno.11251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=25825601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksFeis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=618-630&author=H.+J.+Westerauthor=U.+Kellerauthor=M.+Schotteliusauthor=A.+Beerauthor=K.+Philipp-Abbrederisauthor=F.+Hoffmannauthor=J.+Simecekauthor=C.+Gerngrossauthor=M.+Lassmannauthor=K.+Herrmannauthor=N.+Pellegataauthor=M.+Rudeliusauthor=H.+Kesslerauthor=M.+Schwaiger&title=Disclosing+the+CXCR4+expression+in+lymphoproliferative+diseases+by+targeted+molecular+imaging&doi=10.7150%2Fthno.11251"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging</span></div><div class="casAuthors">Wester, Hans Juergen; Keller, Ulrich; Schottelius, Margret; Beer, Ambros; Philipp-Abbrederis, Kathrin; Hoffmann, Frauke; Simecek, Jakub; Gerngross, Carlos; Lassmann, Michael; Herrmann, Ken; Pellegata, Natalia; Rudelius, Martina; Kessler, Horst; Schwaiger, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">618-630</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Chemokine ligand-receptor interactions play a pivotal role in cell attraction and cellular trafficking, both in normal tissue homeostasis and in disease.  In cancer, chemokine receptor-4 (CXCR4) expression is an adverse prognostic factor.  Early clin. studies suggest that targeting CXCR4 with suitable high-affinity antagonists might be a novel means for therapy.  In addn. to the preclin. evaluation of [68Ga]Pentixafor in mice bearing human lymphoma xenografts as an exemplary CXCR4-expressing tumor entity, we report on the first clin. applications of [68Ga]Pentixafor-Positron Emission Tomog. as a powerful method for CXCR4 imaging in cancer patients.  [68Ga]Pentixafor binds with high affinity and selectivity to human CXCR4 and exhibits a favorable dosimetry. [68Ga]Pentixafor-PET provides images with excellent specificity and contrast.  This non-invasive imaging technol. for quant. assessment of CXCR4 expression allows to further elucidate the role of CXCR4/CXCL12 ligand interaction in the pathogenesis and treatment of cancer, cardiovascular diseases and autoimmune and inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIStJF7qe9T7Vg90H21EOLACvtfcHk0lhSmS3wgGpkig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksFeis78%253D&md5=f71460418fb4564414bdbc1f098a4aa7</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.7150%2Fthno.11251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.11251%26sid%3Dliteratum%253Aachs%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DKeller%26aufirst%3DU.%26aulast%3DSchottelius%26aufirst%3DM.%26aulast%3DBeer%26aufirst%3DA.%26aulast%3DPhilipp-Abbrederis%26aufirst%3DK.%26aulast%3DHoffmann%26aufirst%3DF.%26aulast%3DSimecek%26aufirst%3DJ.%26aulast%3DGerngross%26aufirst%3DC.%26aulast%3DLassmann%26aufirst%3DM.%26aulast%3DHerrmann%26aufirst%3DK.%26aulast%3DPellegata%26aufirst%3DN.%26aulast%3DRudelius%26aufirst%3DM.%26aulast%3DKessler%26aufirst%3DH.%26aulast%3DSchwaiger%26aufirst%3DM.%26atitle%3DDisclosing%2520the%2520CXCR4%2520expression%2520in%2520lymphoproliferative%2520diseases%2520by%2520targeted%2520molecular%2520imaging%26jtitle%3DTheranostics%26date%3D2015%26volume%3D5%26spage%3D618%26epage%3D630%26doi%3D10.7150%2Fthno.11251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lapa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lückerath, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoene, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirbel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samnick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelzer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kropf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, K.</span><span> </span><span class="NLM_article-title">[<sup>68</sup>Ga]pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer-initial experience</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">9288</span><span class="NLM_x">–</span> <span class="NLM_lpage">9295</span><span class="refDoi"> DOI: 10.18632/oncotarget.7063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.18632%2Foncotarget.7063" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=9288-9295&author=C.+Lapaauthor=K.+L%C3%BCckerathauthor=M.+Rudeliusauthor=J.+S.+Schmidauthor=A.+Schoeneauthor=A.+Schirbelauthor=S.+Samnickauthor=T.+Pelzerauthor=A.+K.+Buckauthor=S.+Kropfauthor=H.+J.+Westerauthor=K.+Herrmann&title=%5B68Ga%5Dpentixafor-PET%2FCT+for+imaging+of+chemokine+receptor+4+expression+in+small+cell+lung+cancer-initial+experience&doi=10.18632%2Foncotarget.7063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7063%26sid%3Dliteratum%253Aachs%26aulast%3DLapa%26aufirst%3DC.%26aulast%3DL%25C3%25BCckerath%26aufirst%3DK.%26aulast%3DRudelius%26aufirst%3DM.%26aulast%3DSchmid%26aufirst%3DJ.%2BS.%26aulast%3DSchoene%26aufirst%3DA.%26aulast%3DSchirbel%26aufirst%3DA.%26aulast%3DSamnick%26aufirst%3DS.%26aulast%3DPelzer%26aufirst%3DT.%26aulast%3DBuck%26aufirst%3DA.%2BK.%26aulast%3DKropf%26aufirst%3DS.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DHerrmann%26aufirst%3DK.%26atitle%3D%255B68Ga%255Dpentixafor-PET%252FCT%2520for%2520imaging%2520of%2520chemokine%2520receptor%25204%2520expression%2520in%2520small%2520cell%2520lung%2520cancer-initial%2520experience%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D9288%26epage%3D9295%26doi%3D10.18632%2Foncotarget.7063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lapa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lückerath, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinlein, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monoranu, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linsenmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kropf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernestus, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löhr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, K.</span><span> </span><span class="NLM_article-title"><sup>68</sup>Ga-pentixafor-PET/CT for imaging of chemokine receptor 4 expression in glioblastoma</span> <span class="citation_source-journal">Theranostics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span><span class="refDoi"> DOI: 10.7150/thno.13986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.7150%2Fthno.13986" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=428-434&author=C.+Lapaauthor=K.+L%C3%BCckerathauthor=I.+Kleinleinauthor=C.+M.+Monoranuauthor=T.+Linsenmannauthor=A.+F.+Kesslerauthor=M.+Rudeliusauthor=S.+Kropfauthor=A.+K.+Buckauthor=R.+I.+Ernestusauthor=H.+J.+Westerauthor=M.+L%C3%B6hrauthor=K.+Herrmann&title=68Ga-pentixafor-PET%2FCT+for+imaging+of+chemokine+receptor+4+expression+in+glioblastoma&doi=10.7150%2Fthno.13986"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.7150%2Fthno.13986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.13986%26sid%3Dliteratum%253Aachs%26aulast%3DLapa%26aufirst%3DC.%26aulast%3DL%25C3%25BCckerath%26aufirst%3DK.%26aulast%3DKleinlein%26aufirst%3DI.%26aulast%3DMonoranu%26aufirst%3DC.%2BM.%26aulast%3DLinsenmann%26aufirst%3DT.%26aulast%3DKessler%26aufirst%3DA.%2BF.%26aulast%3DRudelius%26aufirst%3DM.%26aulast%3DKropf%26aufirst%3DS.%26aulast%3DBuck%26aufirst%3DA.%2BK.%26aulast%3DErnestus%26aufirst%3DR.%2BI.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DL%25C3%25B6hr%26aufirst%3DM.%26aulast%3DHerrmann%26aufirst%3DK.%26atitle%3D68Ga-pentixafor-PET%252FCT%2520for%2520imaging%2520of%2520chemokine%2520receptor%25204%2520expression%2520in%2520glioblastoma%26jtitle%3DTheranostics%26date%3D2016%26volume%3D6%26spage%3D428%26epage%3D434%26doi%3D10.7150%2Fthno.13986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Poschenrieder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schottelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaiger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of [<sup>68</sup>Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo—a comparison to [<sup>68</sup>Ga]pentixafor</span> <span class="citation_source-journal">EJNMMI Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="refDoi"> DOI: 10.1186/s13550-016-0227-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1186%2Fs13550-016-0227-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=27655427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A280%3ADC%252BC2svkt1Glsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=70&author=A.+Poschenriederauthor=M.+Schotteliusauthor=M.+Schwaigerauthor=H.+J.+Wester&title=Preclinical+evaluation+of+%5B68Ga%5DNOTA-pentixafor+for+PET+imaging+of+CXCR4+expression+in+vivo%E2%80%94a+comparison+to+%5B68Ga%5Dpentixafor&doi=10.1186%2Fs13550-016-0227-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22dR"><div class="casContent"><span class="casTitleNuber">22d</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo - a comparison to [(68)Ga]pentixafor</span></div><div class="casAuthors">Poschenrieder Andreas; Schottelius Margret; Wester Hans-Jurgen; Schwaiger Markus</div><div class="citationInfo"><span class="NLM_cas:title">EJNMMI research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70</span>
        ISSN:<span class="NLM_cas:issn">2191-219X</span>.
    </div><div class="casAbstract">BACKGROUND:  Due to its overexpression in a variety of tumor types, the chemokine receptor 4 (CXCR4) represents a highly relevant diagnostic and therapeutic target in nuclear oncology.  Recently, [(68)Ga]pentixafor has emerged as an excellent imaging agent for positron emission tomography (PET) of CXCR4 expression in vivo.  In this study, the corresponding [(68)Ga]-1,4,7-triazacyclononane-triacetic acid (NOTA) analog was preclinically evaluated and compared to the 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) parent compound [(68)Ga]pentixafor.  METHODS:  NOTA-pentixafor was synthesized by combining solid and solution-phase peptide synthesis.  The CXCR4 receptor affinities of [(68)Ga]pentixafor and [(68)Ga]NOTA-pentixafor were determined in competitive binding assays using the leukemic CXCR4-expressing Jurkat T-cell line and [(125)I]FC131 as the radioligand.  Internalization and cell efflux assays were performed using CXCR4-transfected Chem-1 cells.  Small-animal PET and biodistribution studies were carried out using Daudi-tumor bearing SCID mice.  RESULTS:  [(68)Ga]NOTA-pentixafor showed a 1.4-fold improved affinity towards CXCR4 (IC50).  However, internalization efficiency into CXCR4(+)-Chem-1 cells was substantially decreased compared to [(68)Ga]pentixafor.  Accordingly, small-animal PET imaging and biodistribution studies revealed a 9.5-fold decreased uptake of [(68)Ga]NOTA-pentixafor in Daudi lymphoma xenografts (1.7 ± 0.4 % vs 16.2 ± 3.8 % ID/g at 90 min p.i.) and higher levels of non-specific accumulation, primarily in the excretory organs such as the liver, intestines, and kidneys (2.3 ± 0.9 % vs 2.0 ± 0.3 % ID/g, 1.9 ± 0.8 % vs 0.7 ± 0.2 % ID/g, and 2.7 ± 1.1 % vs 1.7 ± 0.9 % ID/g, respectively).  CONCLUSIONS:  Despite enhanced CXCR4-affinity in vitro, the [(68)Ga]NOTA-analog of pentixafor showed reduced CXCR4 targeting efficiency in vivo.  In combination with enhanced background accumulation, this resulted in significantly inferior PET imaging contrast, and thus, [(68)Ga]NOTA-pentixafor offers no advantages over [(68)Ga]pentixafor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCTVJR05pgY4IRAdBLKY41fW6udTcc2eYJiRFqyVnKgrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svkt1Glsw%253D%253D&md5=426a0659c82874778a53f996688bda02</span></div><a href="/servlet/linkout?suffix=cit22d&amp;dbid=16384&amp;doi=10.1186%2Fs13550-016-0227-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13550-016-0227-2%26sid%3Dliteratum%253Aachs%26aulast%3DPoschenrieder%26aufirst%3DA.%26aulast%3DSchottelius%26aufirst%3DM.%26aulast%3DSchwaiger%26aufirst%3DM.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26atitle%3DPreclinical%2520evaluation%2520of%2520%255B68Ga%255DNOTA-pentixafor%2520for%2520PET%2520imaging%2520of%2520CXCR4%2520expression%2520in%2520vivo%25E2%2580%2594a%2520comparison%2520to%2520%255B68Ga%255Dpentixafor%26jtitle%3DEJNMMI%2520Res.%26date%3D2016%26volume%3D6%26spage%3D70%26doi%3D10.1186%2Fs13550-016-0227-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Portella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Luca, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Alterio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ierano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napolitano, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polimeno, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monfregola, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbieri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luciano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciarmiello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amodeo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scala, S.</span><span> </span><span class="NLM_article-title">Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e74548</span><span class="refDoi"> DOI: 10.1371/journal.pone.0074548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1371%2Fjournal.pone.0074548" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e74548&author=L.+Portellaauthor=R.+Vitaleauthor=S.+De+Lucaauthor=C.+D%E2%80%99Alterioauthor=C.+Ieranoauthor=N.+Napolitanoauthor=A.+Riccioauthor=M.+N.+Polimenoauthor=L.+Monfregolaauthor=A.+Barbieriauthor=A.+Lucianoauthor=A.+Ciarmielloauthor=C.+Arraauthor=G.+Castelloauthor=P.+Amodeoauthor=S.+Scala&title=Preclinical+development+of+a+novel+class+of+CXCR4+antagonist+impairing+solid+tumors+growth+and+metastases&doi=10.1371%2Fjournal.pone.0074548"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0074548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0074548%26sid%3Dliteratum%253Aachs%26aulast%3DPortella%26aufirst%3DL.%26aulast%3DVitale%26aufirst%3DR.%26aulast%3DDe%2BLuca%26aufirst%3DS.%26aulast%3DD%25E2%2580%2599Alterio%26aufirst%3DC.%26aulast%3DIerano%26aufirst%3DC.%26aulast%3DNapolitano%26aufirst%3DN.%26aulast%3DRiccio%26aufirst%3DA.%26aulast%3DPolimeno%26aufirst%3DM.%2BN.%26aulast%3DMonfregola%26aufirst%3DL.%26aulast%3DBarbieri%26aufirst%3DA.%26aulast%3DLuciano%26aufirst%3DA.%26aulast%3DCiarmiello%26aufirst%3DA.%26aulast%3DArra%26aufirst%3DC.%26aulast%3DCastello%26aufirst%3DG.%26aulast%3DAmodeo%26aufirst%3DP.%26aulast%3DScala%26aufirst%3DS.%26atitle%3DPreclinical%2520development%2520of%2520a%2520novel%2520class%2520of%2520CXCR4%2520antagonist%2520impairing%2520solid%2520tumors%2520growth%2520and%2520metastases%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De74548%26doi%3D10.1371%2Fjournal.pone.0074548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Di Maro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotta, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancaccio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Leva, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Pietra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ieranò, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napolitano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Alterio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siciliano, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sementa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomassi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotenuto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span> </span><span class="NLM_article-title">Exploring the N-terminal region of C-X-C motif chemokine 12 (CXCL12): Identification of plasma-stable cyclic peptides as novel, potent C-X-C chemokine receptor type 4 (CXCR4) antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">8369</span><span class="NLM_x">–</span> <span class="NLM_lpage">8380</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00695</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00695" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVagu7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8369-8380&author=S.+Di+Maroauthor=A.+M.+Trottaauthor=D.+Brancaccioauthor=F.+S.+Di+Levaauthor=V.+La+Pietraauthor=C.+Ieran%C3%B2author=M.+Napolitanoauthor=L.+Portellaauthor=C.+D%E2%80%99Alterioauthor=R.+A.+Sicilianoauthor=D.+Sementaauthor=S.+Tomassiauthor=A.+Carotenutoauthor=E.+Novellinoauthor=S.+Scalaauthor=L.+Marinelli&title=Exploring+the+N-terminal+region+of+C-X-C+motif+chemokine+12+%28CXCL12%29%3A+Identification+of+plasma-stable+cyclic+peptides+as+novel%2C+potent+C-X-C+chemokine+receptor+type+4+%28CXCR4%29+antagonists&doi=10.1021%2Facs.jmedchem.6b00695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists</span></div><div class="casAuthors">Di Maro, Salvatore; Trotta, Anna Maria; Brancaccio, Diego; Di Leva, Francesco Saverio; La Pietra, Valeria; Ierano, Caterina; Napolitano, Maria; Portella, Luigi; D'Alterio, Crescenzo; Siciliano, Rosa Anna; Sementa, Deborah; Tomassi, Stefano; Carotenuto, Alfonso; Novellino, Ettore; Scala, Stefania; Marinelli, Luciana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8369-8380</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors previously reported the discovery of a CXCL12-mimetic cyclic peptide (H-Arg-Ala-[Cys-Arg-Phe-Phe-Cys]-COOH (compd. 2))as selective CXCR4 antagonist showing promising in vitro and in vivo anticancer activity.  However, further development of this peptide was hampered by its degrdn. in biol. fluids as well as by its low micromolar affinity for the receptor.  Herein, extensive chem. modifications led to the development of a new analog (Ac-Arg-Ala-[DCys-Arg-Phe-Phe-Cys] -COOH (compd. 10)) with enhanced potency, specificity and plasma stability.  A combined approach of Ala-amino acid scan, NMR and mol. modeling unraveled the reasons behind the improved binding properties of (10) vs. (2).  Biol. investigations on leukemia (CEM) and colon (HT29 and HCT116) cancer cell lines showed that (10) is able to impair CXCL12-mediated cell migration, ERK-phosphorylation and CXCR4 internalization.  These outcomes might pave the way for the future preclin. development of (10) in CXCR4 overexpressing leukemia and colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpneAY14o5mFrVg90H21EOLACvtfcHk0lh2-kdl-tvlkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVagu7rN&md5=4dfb5d8ce770469fd7612f1aef2050c2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00695%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMaro%26aufirst%3DS.%26aulast%3DTrotta%26aufirst%3DA.%2BM.%26aulast%3DBrancaccio%26aufirst%3DD.%26aulast%3DDi%2BLeva%26aufirst%3DF.%2BS.%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DIeran%25C3%25B2%26aufirst%3DC.%26aulast%3DNapolitano%26aufirst%3DM.%26aulast%3DPortella%26aufirst%3DL.%26aulast%3DD%25E2%2580%2599Alterio%26aufirst%3DC.%26aulast%3DSiciliano%26aufirst%3DR.%2BA.%26aulast%3DSementa%26aufirst%3DD.%26aulast%3DTomassi%26aufirst%3DS.%26aulast%3DCarotenuto%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DScala%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26atitle%3DExploring%2520the%2520N-terminal%2520region%2520of%2520C-X-C%2520motif%2520chemokine%252012%2520%2528CXCL12%2529%253A%2520Identification%2520of%2520plasma-stable%2520cyclic%2520peptides%2520as%2520novel%252C%2520potent%2520C-X-C%2520chemokine%2520receptor%2520type%25204%2520%2528CXCR4%2529%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8369%26epage%3D8380%26doi%3D10.1021%2Facs.jmedchem.6b00695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Barlos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatzi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavropoulos, G.</span><span> </span><span class="NLM_article-title">2-Chlorotrityl chloride resin. Studies on anchoring of Fmoc-amino acids and peptide cleavage</span> <span class="citation_source-journal">Int. J. Pept. Protein Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span><span class="refDoi"> DOI: 10.1111/j.1399-3011.1991.tb00769.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1111%2Fj.1399-3011.1991.tb00769.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1917309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaK3MXltFGjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1991&pages=513-520&author=K.+Barlosauthor=O.+Chatziauthor=D.+Gatosauthor=G.+Stavropoulos&title=2-Chlorotrityl+chloride+resin.+Studies+on+anchoring+of+Fmoc-amino+acids+and+peptide+cleavage&doi=10.1111%2Fj.1399-3011.1991.tb00769.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">2-Chlorotrityl chloride resin.  Studies on anchoring of Fmoc-aminio acids and peptide cleavage</span></div><div class="casAuthors">Barlos, Kleomenis; Chatzi, Olga; Gatos, Dimitrios; Stavropoulos, George</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Peptide & Protein Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">513-20</span>CODEN:
                <span class="NLM_cas:coden">IJPPC3</span>;
        ISSN:<span class="NLM_cas:issn">0367-8377</span>.
    </div><div class="casAbstract">The esterification of 2-chlorotrityl chloride resin with 9-fluorenylmethoxycarbonyl (Fmoc) amino acids in the presence of EtN(CHMe2)2 is studied under various conditions.  High esterification yields are obtained using 0.6 equiv. Fmoc-amino acid/mmol resin in CH2Cl2 or ClCH2CH2Cl in 25 min at room temp.  The reaction proceeds without byproduct formation even in the case of Fmoc-Asn-OH and Fmoc-Gln-OH.  The quant. and easy cleavage of amino acids and peptides from 2-chlorotrityl resin using AcOH/CF3CH2OH/CH2Cl2 mixts. is accomplished within 15-60 min at room temp. while tert-Bu type protecting groups remain unaffected.  Under these exceptionally mild conditions, 2-chlorotrityl cations generated during the cleavage of amino acids and peptides from resin do not attack the nucleophilic side chains of tryptophan, methionine, and tyrosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ5Em66XBXF7Vg90H21EOLACvtfcHk0lhiKZ8N5og-oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXltFGjur4%253D&md5=2ac32b2f179e3b9e2a4977b6d7fa0aaa</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-3011.1991.tb00769.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-3011.1991.tb00769.x%26sid%3Dliteratum%253Aachs%26aulast%3DBarlos%26aufirst%3DK.%26aulast%3DChatzi%26aufirst%3DO.%26aulast%3DGatos%26aufirst%3DD.%26aulast%3DStavropoulos%26aufirst%3DG.%26atitle%3D2-Chlorotrityl%2520chloride%2520resin.%2520Studies%2520on%2520anchoring%2520of%2520Fmoc-amino%2520acids%2520and%2520peptide%2520cleavage%26jtitle%3DInt.%2520J.%2520Pept.%2520Protein%2520Res.%26date%3D1991%26volume%3D37%26spage%3D513%26epage%3D520%26doi%3D10.1111%2Fj.1399-3011.1991.tb00769.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Postma, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albericio, F.</span><span> </span><span class="NLM_article-title"><i>N</i>-Chlorosuccinimide, an efficient peptide disulfide bond-forming reagent in aqueous solution</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">14277</span><span class="NLM_x">–</span> <span class="NLM_lpage">14280</span><span class="refDoi"> DOI: 10.1039/c3ra43149e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1039%2Fc3ra43149e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1WitLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=14277-14280&author=T.+M.+Postmaauthor=F.+Albericio&title=N-Chlorosuccinimide%2C+an+efficient+peptide+disulfide+bond-forming+reagent+in+aqueous+solution&doi=10.1039%2Fc3ra43149e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">N-chlorosuccinimide, an efficient peptide disulfide bond-forming reagent in aqueous solution</span></div><div class="casAuthors">Postma, Tobias M.; Albericio, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">14277-14280</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel method has been developed for the efficient formation of peptide disulfide bonds under aq. conditions using N-chlorosuccinimide.  Complete disulfide bond formation is achieved in 15 min with solvent mixts. contg. water and acetonitrile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVpZCDqeEa37Vg90H21EOLACvtfcHk0lhiKZ8N5og-oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1WitLrI&md5=e7ee93d35b7e49782adaab43d1e23e19</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1039%2Fc3ra43149e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ra43149e%26sid%3Dliteratum%253Aachs%26aulast%3DPostma%26aufirst%3DT.%2BM.%26aulast%3DAlbericio%26aufirst%3DF.%26atitle%3DN-Chlorosuccinimide%252C%2520an%2520efficient%2520peptide%2520disulfide%2520bond-forming%2520reagent%2520in%2520aqueous%2520solution%26jtitle%3DRSC%2520Adv.%26date%3D2013%26volume%3D3%26spage%3D14277%26epage%3D14280%26doi%3D10.1039%2Fc3ra43149e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Postma, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albericio, F.</span><span> </span><span class="NLM_article-title"><i>N</i>-Chlorosuccinimide, an efficient reagent for on-resin disulfide formation in solid-phase peptide synthesis</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span><span class="refDoi"> DOI: 10.1021/ol303428d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol303428d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1ensw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=616-619&author=T.+M.+Postmaauthor=F.+Albericio&title=N-Chlorosuccinimide%2C+an+efficient+reagent+for+on-resin+disulfide+formation+in+solid-phase+peptide+synthesis&doi=10.1021%2Fol303428d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">N-Chlorosuccinimide, an Efficient Reagent for On-Resin Disulfide Formation in Solid-Phase Peptide Synthesis</span></div><div class="casAuthors">Postma, Tobias M.; Albericio, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">616-619</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Chlorosuccinimide is described as a widely applicable on-resin disulfide-forming reagent.  Disulfide bond formation was completed within 15 min in DMF.  This strategy was successfully used in the synthesis of oxytocin and a regioselective synthesis of an α-conotoxin.  Moreover, disulfide formation with N-chlorosuccinimide was found to be compatible with oxidn.-prone methionine and tryptophan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVYKBVLrDPILVg90H21EOLACvtfcHk0lhiKZ8N5og-oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1ensw%253D%253D&md5=1f7ded0192c4800d166a5ae309c00f94</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1021%2Fol303428d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol303428d%26sid%3Dliteratum%253Aachs%26aulast%3DPostma%26aufirst%3DT.%2BM.%26aulast%3DAlbericio%26aufirst%3DF.%26atitle%3DN-Chlorosuccinimide%252C%2520an%2520efficient%2520reagent%2520for%2520on-resin%2520disulfide%2520formation%2520in%2520solid-phase%2520peptide%2520synthesis%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D616%26epage%3D619%26doi%3D10.1021%2Fol303428d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Thiele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mungalpara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Våbenø, J.</span><span> </span><span class="NLM_article-title">Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">5313</span><span class="NLM_x">–</span> <span class="NLM_lpage">5329</span><span class="refDoi"> DOI: 10.1111/bph.12842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1111%2Fbph.12842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=25039237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVamt7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=5313-5329&author=S.+Thieleauthor=J.+Mungalparaauthor=A.+Steenauthor=M.+M.+Rosenkildeauthor=J.+V%C3%A5ben%C3%B8&title=Determination+of+the+binding+mode+for+the+cyclopentapeptide+CXCR4+antagonist+FC131+using+a+dual+approach+of+ligand+modifications+and+receptor+mutagenesis&doi=10.1111%2Fbph.12842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis</span></div><div class="casAuthors">Thiele, S.; Mungalpara, J.; Steen, A.; Rosenkilde, M. M.; Vabeno, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5313-5329</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The cyclopentapeptide FC131 (cyclo(-L-Arg1-L-Arg2-L-2-Nal3-Gly4-D-Tyr5-)) is an antagonist at the CXC chemokine receptor CXCR4, which plays a role in human immunodeficiency virus infection, cancer and stem cell recruitment.  Binding modes for FC131 in CXCR4 have previously been suggested based on mol. docking guided by structure-activity relationship (SAR) data; however, none of these have been verified by in vitro expts.  Exptl. Approach : Heterologous 125I-12G5-competition binding and functional assays (inhibition of CXCL12-mediated activation) of FC131 and three analogs were performed on wild-type CXCR4 and 25 receptor mutants.  Computational modeling was used to rationalize the exptl. data.  Key Results : The Arg2 and 2-Nal3 side chains of FC131 interact with residues in TM-3 (His113, Asp171) and TM-5 (hydrophobic pocket) resp.  Arg1 forms charge-charge interactions with Asp187 in ECL-2, while D-Tyr5 points to the extracellular side of CXCR4.  Furthermore, the backbone of FC131 interacts with the chemokine receptor-conserved Glu288 via two water mols.  Intriguingly, Tyr116 and Glu288 form a H-bond in CXCR4 crystal structures and mutation of either residue to Ala abolishes CXCR4 activity.  Conclusions and Implications : Ligand modification, receptor mutagenesis and computational modeling approaches were used to identify the binding mode of FC131 in CXCR4, which was in agreement with binding modes suggested from previous SAR studies.  Furthermore, insights into the mechanism for CXCR4 activation by CXCL12 were gained.  The combined findings will facilitate future design of novel CXCR4 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTJVv4tLiRYrVg90H21EOLACvtfcHk0ljPi6JtZcSLtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVamt7nE&md5=de979e35933c1b6566e6b4b43034e875</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Fbph.12842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12842%26sid%3Dliteratum%253Aachs%26aulast%3DThiele%26aufirst%3DS.%26aulast%3DMungalpara%26aufirst%3DJ.%26aulast%3DSteen%26aufirst%3DA.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26atitle%3DDetermination%2520of%2520the%2520binding%2520mode%2520for%2520the%2520cyclopentapeptide%2520CXCR4%2520antagonist%2520FC131%2520using%2520a%2520dual%2520approach%2520of%2520ligand%2520modifications%2520and%2520receptor%2520mutagenesis%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D5313%26epage%3D5329%26doi%3D10.1111%2Fbph.12842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Grieco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotenuto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiglia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zampelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patacchini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggi, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovero, P.</span><span> </span><span class="NLM_article-title">A new, potent urotensin II receptor peptide agonist containing a Pen residue at the disulphide bridge</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4391</span><span class="NLM_x">–</span> <span class="NLM_lpage">4394</span><span class="refDoi"> DOI: 10.1021/jm025549i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm025549i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4391-4394&author=P.+Griecoauthor=A.+Carotenutoauthor=P.+Campigliaauthor=E.+Zampelliauthor=R.+Patacchiniauthor=C.+A.+Maggiauthor=E.+Novellinoauthor=P.+Rovero&title=A+new%2C+potent+urotensin+II+receptor+peptide+agonist+containing+a+Pen+residue+at+the+disulphide+bridge&doi=10.1021%2Fjm025549i"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm025549i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm025549i%26sid%3Dliteratum%253Aachs%26aulast%3DGrieco%26aufirst%3DP.%26aulast%3DCarotenuto%26aufirst%3DA.%26aulast%3DCampiglia%26aufirst%3DP.%26aulast%3DZampelli%26aufirst%3DE.%26aulast%3DPatacchini%26aufirst%3DR.%26aulast%3DMaggi%26aufirst%3DC.%2BA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DRovero%26aufirst%3DP.%26atitle%3DA%2520new%252C%2520potent%2520urotensin%2520II%2520receptor%2520peptide%2520agonist%2520containing%2520a%2520Pen%2520residue%2520at%2520the%2520disulphide%2520bridge%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4391%26epage%3D4394%26doi%3D10.1021%2Fjm025549i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Fricker, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anastassov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darkes, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grujic, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idzan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrecque, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosi, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santucci, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, R. S. Y.</span><span> </span><span class="NLM_article-title">Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">588</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span><span class="refDoi"> DOI: 10.1016/j.bcp.2006.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2Fj.bcp.2006.05.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=588-596&author=S.+P.+Frickerauthor=V.+Anastassovauthor=J.+Coxauthor=M.+C.+Darkesauthor=O.+Grujicauthor=S.+R.+Idzanauthor=J.+Labrecqueauthor=G.+Lauauthor=R.+M.+Mosiauthor=K.+L.+Nelsonauthor=L.+Qinauthor=Z.+Santucciauthor=R.+S.+Y.+Wong&title=Characterization+of+the+molecular+pharmacology+of+AMD3100%3A+a+specific+antagonist+of+the+G-protein+coupled+chemokine+receptor%2C+CXCR4&doi=10.1016%2Fj.bcp.2006.05.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2006.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2006.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DFricker%26aufirst%3DS.%2BP.%26aulast%3DAnastassov%26aufirst%3DV.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DDarkes%26aufirst%3DM.%2BC.%26aulast%3DGrujic%26aufirst%3DO.%26aulast%3DIdzan%26aufirst%3DS.%2BR.%26aulast%3DLabrecque%26aufirst%3DJ.%26aulast%3DLau%26aufirst%3DG.%26aulast%3DMosi%26aufirst%3DR.%2BM.%26aulast%3DNelson%26aufirst%3DK.%2BL.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DSantucci%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DR.%2BS.%2BY.%26atitle%3DCharacterization%2520of%2520the%2520molecular%2520pharmacology%2520of%2520AMD3100%253A%2520a%2520specific%2520antagonist%2520of%2520the%2520G-protein%2520coupled%2520chemokine%2520receptor%252C%2520CXCR4%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D72%26spage%3D588%26epage%3D596%26doi%3D10.1016%2Fj.bcp.2006.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">DiPersio, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micallef, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolwell, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maziarz, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nademanee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span> </span><span class="NLM_article-title">Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin’s lymphoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4767</span><span class="NLM_x">–</span> <span class="NLM_lpage">4773</span><span class="refDoi"> DOI: 10.1200/JCO.2008.20.7209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1200%2FJCO.2008.20.7209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=19720922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGgtbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=4767-4773&author=J.+F.+DiPersioauthor=I.+N.+Micallefauthor=P.+J.+Stiffauthor=B.+J.+Bolwellauthor=R.+T.+Maziarzauthor=E.+Jacobsenauthor=A.+Nademaneeauthor=J.+McCartyauthor=G.+Bridgerauthor=G.+Calandra&title=Phase+III+prospective+randomized+double-blind+placebo-controlled+trial+of+plerixafor+plus+granulocyte+colony-stimulating+factor+compared+with+placebo+plus+granulocyte+colony-stimulating+factor+for+autologous+stem-cell+mobilization+and+transplantation+for+patients+with+non-Hodgkin%E2%80%99s+lymphoma&doi=10.1200%2FJCO.2008.20.7209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma</span></div><div class="casAuthors">DiPersio, John F.; Micallef, Ivana N.; Stiff, Patrick J.; Bolwell, Brian J.; Maziarz, Richard T.; Jacobsen, Eric; Nademanee, Auayporn; McCarty, John; Bridger, Gary; Calandra, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">4767-4773</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: This study evaluates the safety and efficacy of plerixafor (AMD3100), a CXCR4 antagonist, in mobilizing hematopoietic stem cells for autologous stem-cell transplantation in non-Hodgkin's lymphoma (NHL) patients.  Patients and Methods: This is a phase III, multicenter, randomized (1:1), double-blind, placebo-controlled study.  Patients with non-Hodgkin's lymphoma requiring an autologous hematopoietic stem-cell transplantation in first or second complete or partial remission were eligible.  Patients received granulocyte colony-stimulating factor (G-CSF; 10 μg/kg) s.c. daily for up to 8 days.  Beginning on evening of day 4 and continuing daily for up to 4 days, patients received either plerixafor (240 μg/kg) or placebo s.c.  Starting on day 5, patients began daily apheresis for up to 4 days or until ≥ 5 × 106 CD34+ cells/kg were collected.  The primary end point was the percentage of patients who collected ≥ 5 × 106 CD34+ cells/kg in 4 or fewer apheresis days.  Results: This report presents all data for all patients (n = 298) through 12 mo follow-up.  Eighty-nine (59%) of 150 patients in the plerixafor group and 29 (20%) of 148 patients in the placebo group met the primary end point (P < .001).  One hundred thirty-five patients (90%) in plerixafor group and 82 patients (55%) in placebo group underwent transplantation after initial mobilization.  Median time to engraftment was similar in both groups.  The most common plerixafor-assocd. adverse events were GI disorders and injection site reactions.  Conclusion: Plerixafor and G-CSF were well tolerated and resulted in a significantly higher proportion of patients with non-Hodgkin's lymphoma achieving the optimal CD34+ cell target for transplantation in fewer apheresis days, compared with G-CSF alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYjfnL3AIfbbVg90H21EOLACvtfcHk0ljPi6JtZcSLtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGgtbbI&md5=b2e30e8f1372875267ca61af49ee96cd</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1200%2FJCO.2008.20.7209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2008.20.7209%26sid%3Dliteratum%253Aachs%26aulast%3DDiPersio%26aufirst%3DJ.%2BF.%26aulast%3DMicallef%26aufirst%3DI.%2BN.%26aulast%3DStiff%26aufirst%3DP.%2BJ.%26aulast%3DBolwell%26aufirst%3DB.%2BJ.%26aulast%3DMaziarz%26aufirst%3DR.%2BT.%26aulast%3DJacobsen%26aufirst%3DE.%26aulast%3DNademanee%26aufirst%3DA.%26aulast%3DMcCarty%26aufirst%3DJ.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DCalandra%26aufirst%3DG.%26atitle%3DPhase%2520III%2520prospective%2520randomized%2520double-blind%2520placebo-controlled%2520trial%2520of%2520plerixafor%2520plus%2520granulocyte%2520colony-stimulating%2520factor%2520compared%2520with%2520placebo%2520plus%2520granulocyte%2520colony-stimulating%2520factor%2520for%2520autologous%2520stem-cell%2520mobilization%2520and%2520transplantation%2520for%2520patients%2520with%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2009%26volume%3D27%26spage%3D4767%26epage%3D4773%26doi%3D10.1200%2FJCO.2008.20.7209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Haribabu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sozzani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peiper, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horuk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyderman, R.</span><span> </span><span class="NLM_article-title">Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">28726</span><span class="NLM_x">–</span> <span class="NLM_lpage">28731</span><span class="refDoi"> DOI: 10.1074/jbc.272.45.28726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1074%2Fjbc.272.45.28726" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=28726-28731&author=B.+Haribabuauthor=R.+M.+Richardsonauthor=I.+Fisherauthor=S.+Sozzaniauthor=S.+C.+Peiperauthor=R.+Horukauthor=H.+Aliauthor=R.+Snyderman&title=Regulation+of+human+chemokine+receptors+CXCR4.+Role+of+phosphorylation+in+desensitization+and+internalization&doi=10.1074%2Fjbc.272.45.28726"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.45.28726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.45.28726%26sid%3Dliteratum%253Aachs%26aulast%3DHaribabu%26aufirst%3DB.%26aulast%3DRichardson%26aufirst%3DR.%2BM.%26aulast%3DFisher%26aufirst%3DI.%26aulast%3DSozzani%26aufirst%3DS.%26aulast%3DPeiper%26aufirst%3DS.%2BC.%26aulast%3DHoruk%26aufirst%3DR.%26aulast%3DAli%26aufirst%3DH.%26aulast%3DSnyderman%26aufirst%3DR.%26atitle%3DRegulation%2520of%2520human%2520chemokine%2520receptors%2520CXCR4.%2520Role%2520of%2520phosphorylation%2520in%2520desensitization%2520and%2520internalization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D28726%26epage%3D28731%26doi%3D10.1074%2Fjbc.272.45.28726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Mercurio, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomassi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaglione, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambery, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiuso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messere, A.</span><span> </span><span class="NLM_article-title">Switchable protecting strategy for solid phase synthesis of DNA and RNA interacting nucleopeptides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">11612</span><span class="NLM_x">–</span> <span class="NLM_lpage">11625</span><span class="refDoi"> DOI: 10.1021/acs.joc.6b01829</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.6b01829" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslGhtLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2016&pages=11612-11625&author=M.+E.+Mercurioauthor=S.+Tomassiauthor=M.+Gaglioneauthor=R.+Russoauthor=A.+Chamberyauthor=S.+Lamaauthor=P.+Stiusoauthor=S.+Cosconatiauthor=E.+Novellinoauthor=S.+Di+Maroauthor=A.+Messere&title=Switchable+protecting+strategy+for+solid+phase+synthesis+of+DNA+and+RNA+interacting+nucleopeptides&doi=10.1021%2Facs.joc.6b01829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Switchable protecting strategy for solid phase synthesis of DNA and RNA interacting nucleopeptides</span></div><div class="casAuthors">Mercurio, Maria Emilia; Tomassi, Stefano; Gaglione, Maria; Russo, Rosita; Chambery, Angela; Lama, Stefania; Stiuso, Paola; Cosconati, Sandro; Novellino, Ettore; Di Maro, Salvatore; Messere, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">11612-11625</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nucleopeptides are promising nucleic acid mimetics in which the peptide backbone bears nucleobases.  They can recognize DNA and RNA targets modulating their biol. functions.  To date, the lack of an effective strategy for the synthesis of nucleopeptides prevents their evaluation for biol. and biomedical applications.  Herein, we describe an unprecedented approach that enables the synthesis of cationic both homo and heterosequence nucleopeptides wholly on solid support with high yield and purity.  Spectroscopic studies indicate advantageous properties of the nucleopeptides in terms of binding, thermodn. stability and sequence specific recognition.  Biostability assay and laser scanning confocal microscopy analyses reveal that the nucleopeptides feature acceptable serum stability and ability to cross the cell membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLBpPY2vI5T7Vg90H21EOLACvtfcHk0lhYWbDQwp1xQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslGhtLvI&md5=0c184314f5da557b6fe6769b9f64940a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.6b01829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.6b01829%26sid%3Dliteratum%253Aachs%26aulast%3DMercurio%26aufirst%3DM.%2BE.%26aulast%3DTomassi%26aufirst%3DS.%26aulast%3DGaglione%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DChambery%26aufirst%3DA.%26aulast%3DLama%26aufirst%3DS.%26aulast%3DStiuso%26aufirst%3DP.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DDi%2BMaro%26aufirst%3DS.%26aulast%3DMessere%26aufirst%3DA.%26atitle%3DSwitchable%2520protecting%2520strategy%2520for%2520solid%2520phase%2520synthesis%2520of%2520DNA%2520and%2520RNA%2520interacting%2520nucleopeptides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2016%26volume%3D81%26spage%3D11612%26epage%3D11625%26doi%3D10.1021%2Facs.joc.6b01829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Wüthrich, K.</span> <span class="citation_source-book">NMR of Proteins and Nucleic Acids</span>; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1986</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1051%2Fepn%2F19861701011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&author=K.+W%C3%BCthrich&title=NMR+of+Proteins+and+Nucleic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1051%2Fepn%2F19861701011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1051%252Fepn%252F19861701011%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25BCthrich%26aufirst%3DK.%26btitle%3DNMR%2520of%2520Proteins%2520and%2520Nucleic%2520Acids%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D1986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Piantini, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorensen, O. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, R. R.</span><span> </span><span class="NLM_article-title">Multiple quantum filters for elucidating NMR coupling network</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">6800</span><span class="NLM_x">–</span> <span class="NLM_lpage">6801</span><span class="refDoi"> DOI: 10.1021/ja00388a062</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00388a062" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1982&pages=6800-6801&author=U.+Piantiniauthor=O.+W.+Sorensenauthor=R.+R.+Ernst&title=Multiple+quantum+filters+for+elucidating+NMR+coupling+network&doi=10.1021%2Fja00388a062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1021%2Fja00388a062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00388a062%26sid%3Dliteratum%253Aachs%26aulast%3DPiantini%26aufirst%3DU.%26aulast%3DSorensen%26aufirst%3DO.%2BW.%26aulast%3DErnst%26aufirst%3DR.%2BR.%26atitle%3DMultiple%2520quantum%2520filters%2520for%2520elucidating%2520NMR%2520coupling%2520network%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1982%26volume%3D104%26spage%3D6800%26epage%3D6801%26doi%3D10.1021%2Fja00388a062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Marion, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wüthrich, K.</span><span> </span><span class="NLM_article-title">Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of <sup>1</sup>H-<sup>1</sup>H spin-spin coupling constants in proteins</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span><span class="refDoi"> DOI: 10.1016/0006-291X(83)91093-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2F0006-291X%2883%2991093-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=6307308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaL3sXltVWkurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1983&pages=967-974&author=D.+Marionauthor=K.+W%C3%BCthrich&title=Application+of+phase+sensitive+two-dimensional+correlated+spectroscopy+%28COSY%29+for+measurements+of+1H-1H+spin-spin+coupling+constants+in+proteins&doi=10.1016%2F0006-291X%2883%2991093-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34bR"><div class="casContent"><span class="casTitleNuber">34b</span><div class="casTitle"><span class="NLM_cas:atitle">Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of proton-proton spin-spin coupling constants in proteins</span></div><div class="casAuthors">Marion, D.; Wuethrich, K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">967-74</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Two-dimensional correlated spectroscopy (COSY) is used for measurements of proton-proton spin-spin coupling consts. in protein 1H NMR spectra.  High digital resoln. along the frequency axis ω2 is achieved by placing the carrier frequency in the center of the spectrum, by using quadrature detection in both dimensions, and presenting the spectrum in the phase-sensitive mode.  Compared to other techniques for studies of spin-spin coupling consts., COSY provides greatly improved spectral resoln.  This is illustrated by expts. with H2O solns. of the small globular protein BUSI IIA (bull seminal inhibitor IIA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb5Hc_b_NcfrVg90H21EOLACvtfcHk0lhYWbDQwp1xQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXltVWkurY%253D&md5=0153273e1faf9425d8c6641d1451ed7c</span></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2883%2991093-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252883%252991093-8%26sid%3Dliteratum%253Aachs%26aulast%3DMarion%26aufirst%3DD.%26aulast%3DW%25C3%25BCthrich%26aufirst%3DK.%26atitle%3DApplication%2520of%2520phase%2520sensitive%2520two-dimensional%2520correlated%2520spectroscopy%2520%2528COSY%2529%2520for%2520measurements%2520of%25201H-1H%2520spin-spin%2520coupling%2520constants%2520in%2520proteins%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1983%26volume%3D113%26spage%3D967%26epage%3D974%26doi%3D10.1016%2F0006-291X%2883%2991093-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Braunschweiler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, R. R.</span><span> </span><span class="NLM_article-title">Coherence transfer by isotropic mixing: application to proton correlation spectroscopy</span> <span class="citation_source-journal">J. Magn. Reson.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span><span class="refDoi"> DOI: 10.1016/0022-2364(83)90226-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2F0022-2364%2883%2990226-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaL3sXks1eju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1983&pages=521-528&author=L.+Braunschweilerauthor=R.+R.+Ernst&title=Coherence+transfer+by+isotropic+mixing%3A+application+to+proton+correlation+spectroscopy&doi=10.1016%2F0022-2364%2883%2990226-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Coherence transfer by isotropic mixing:  application to proton correlation spectroscopy</span></div><div class="casAuthors">Braunschweiler, L.; Ernst, R. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Magnetic Resonance (1969-1992)</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">521-8</span>CODEN:
                <span class="NLM_cas:coden">JOMRA4</span>;
        ISSN:<span class="NLM_cas:issn">0022-2364</span>.
    </div><div class="casAbstract">A new mechanism of coherence transfer is proposed which is useful for 2-dimensional correlation spectroscopy in liqs.  Cross-peaks are generated between all members of a coupled spin network leading to 4 most complete correlation diagram.  The scheme produces net coherence transfer and can be arranged to create pure absorption mode spectra with peaks of pos. intensity.  A new type of 2-dimensional correlation NMR expt. is illustrated.  After a prepn. pulse the spin system is allowed to evolve freely under the (assumed) weak coupling Hamiltonian in terms of single spin modes.  For the mixing process the Hamiltonian is modified to a form which is dominated by the full isotropic coupling terms.  The coherence of the spins is periodically exchanged during the mixing time and is obsd. during the detection period again under the unperturbed Hamiltonian.  Illustrative examples of 2-dimensional correlated spectra with and without relayed peaks are shown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo25_GwCJe3XrVg90H21EOLACvtfcHk0lghWE9mI_rO9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXks1eju7c%253D&md5=693eaaee37b0224796b7d9e3403759c6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2F0022-2364%2883%2990226-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-2364%252883%252990226-3%26sid%3Dliteratum%253Aachs%26aulast%3DBraunschweiler%26aufirst%3DL.%26aulast%3DErnst%26aufirst%3DR.%2BR.%26atitle%3DCoherence%2520transfer%2520by%2520isotropic%2520mixing%253A%2520application%2520to%2520proton%2520correlation%2520spectroscopy%26jtitle%3DJ.%2520Magn.%2520Reson.%26date%3D1983%26volume%3D53%26spage%3D521%26epage%3D528%26doi%3D10.1016%2F0022-2364%2883%2990226-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Jeener, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, R. R.</span><span> </span><span class="NLM_article-title">Investigation of exchange processes by two-dimensional NMR spectroscopy</span> <span class="citation_source-journal">J. Chem. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">4546</span><span class="NLM_x">–</span> <span class="NLM_lpage">4553</span><span class="refDoi"> DOI: 10.1063/1.438208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1063%2F1.438208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaL3cXkvFOqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1979&pages=4546-4553&author=J.+Jeenerauthor=B.+H.+Meierauthor=P.+Bachmannauthor=R.+R.+Ernst&title=Investigation+of+exchange+processes+by+two-dimensional+NMR+spectroscopy&doi=10.1063%2F1.438208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of exchange processes by two-dimensional NMR spectroscopy</span></div><div class="casAuthors">Jeener, J.; Meier, B. H.; Bachmann, P.; Ernst, R. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4546-53</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">A new general technique for the investigation of exchange processes in mol. systems is proposed and demonstrated.  Applications comprise the study of chem. exchange, of magnetization transfer by inter- and intramol. relaxation in liqs., and the spin diffusion and cross-relaxation processes in solids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC2mejjZuTKbVg90H21EOLACvtfcHk0lghWE9mI_rO9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXkvFOqtw%253D%253D&md5=014ee72eb4b37485dbaec604ede8d3b3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1063%2F1.438208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.438208%26sid%3Dliteratum%253Aachs%26aulast%3DJeener%26aufirst%3DJ.%26aulast%3DMeier%26aufirst%3DB.%2BH.%26aulast%3DBachmann%26aufirst%3DP.%26aulast%3DErnst%26aufirst%3DR.%2BR.%26atitle%3DInvestigation%2520of%2520exchange%2520processes%2520by%2520two-dimensional%2520NMR%2520spectroscopy%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1979%26volume%3D71%26spage%3D4546%26epage%3D4553%26doi%3D10.1063%2F1.438208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Bartels, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billeter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guentert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wüthrich, K.</span><span> </span><span class="NLM_article-title">The program XEASY for computer-supported NMR spectral analysis of biological macromolecules</span> <span class="citation_source-journal">J. Biomol. NMR</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><span class="refDoi"> DOI: 10.1007/BF00417486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1007%2FBF00417486" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=1-10&author=C.+Bartelsauthor=T.+Xiaauthor=M.+Billeterauthor=P.+Guentertauthor=K.+W%C3%BCthrich&title=The+program+XEASY+for+computer-supported+NMR+spectral+analysis+of+biological+macromolecules&doi=10.1007%2FBF00417486"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2FBF00417486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00417486%26sid%3Dliteratum%253Aachs%26aulast%3DBartels%26aufirst%3DC.%26aulast%3DXia%26aufirst%3DT.%26aulast%3DBilleter%26aufirst%3DM.%26aulast%3DGuentert%26aufirst%3DP.%26aulast%3DW%25C3%25BCthrich%26aufirst%3DK.%26atitle%3DThe%2520program%2520XEASY%2520for%2520computer-supported%2520NMR%2520spectral%2520analysis%2520of%2520biological%2520macromolecules%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D1995%26volume%3D6%26spage%3D1%26epage%3D10%26doi%3D10.1007%2FBF00417486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Sargent, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwyzer, R.</span><span> </span><span class="NLM_article-title">Membrane lipid phase as catalyst for peptide-receptor interactions</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">5774</span><span class="NLM_x">–</span> <span class="NLM_lpage">5778</span><span class="refDoi"> DOI: 10.1073/pnas.83.16.5774</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1073%2Fpnas.83.16.5774" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=5774-5778&author=D.+F.+Sargentauthor=R.+Schwyzer&title=Membrane+lipid+phase+as+catalyst+for+peptide-receptor+interactions&doi=10.1073%2Fpnas.83.16.5774"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1073%2Fpnas.83.16.5774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.83.16.5774%26sid%3Dliteratum%253Aachs%26aulast%3DSargent%26aufirst%3DD.%2BF.%26aulast%3DSchwyzer%26aufirst%3DR.%26atitle%3DMembrane%2520lipid%2520phase%2520as%2520catalyst%2520for%2520peptide-receptor%2520interactions%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1986%26volume%3D83%26spage%3D5774%26epage%3D5778%26doi%3D10.1073%2Fpnas.83.16.5774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Grieco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancaccio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotenuto, A.</span><span> </span><span class="NLM_article-title">Conformational study on cyclic melanocortin ligands and new insight into their binding mode at the MC4 receptor</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3721</span><span class="NLM_x">–</span> <span class="NLM_lpage">3733</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.05.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2Fj.ejmech.2011.05.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=3721-3733&author=P.+Griecoauthor=D.+Brancaccioauthor=E.+Novellinoauthor=V.+J.+Hrubyauthor=A.+Carotenuto&title=Conformational+study+on+cyclic+melanocortin+ligands+and+new+insight+into+their+binding+mode+at+the+MC4+receptor&doi=10.1016%2Fj.ejmech.2011.05.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.05.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.05.038%26sid%3Dliteratum%253Aachs%26aulast%3DGrieco%26aufirst%3DP.%26aulast%3DBrancaccio%26aufirst%3DD.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26aulast%3DCarotenuto%26aufirst%3DA.%26atitle%3DConformational%2520study%2520on%2520cyclic%2520melanocortin%2520ligands%2520and%2520new%2520insight%2520into%2520their%2520binding%2520mode%2520at%2520the%2520MC4%2520receptor%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D3721%26epage%3D3733%26doi%3D10.1016%2Fj.ejmech.2011.05.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit39b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mollica, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotenuto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limatola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costante, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinnen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieretti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsodi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samavati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zador, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benyhe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Novel cyclic biphalin analogue with improved antinociceptive properties</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1032</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span><span class="refDoi"> DOI: 10.1021/ml500241n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500241n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1032-1036&author=A.+Mollicaauthor=A.+Carotenutoauthor=E.+Novellinoauthor=A.+Limatolaauthor=R.+Costanteauthor=F.+Pinnenauthor=A.+Stefanucciauthor=S.+Pierettiauthor=A.+Borsodiauthor=R.+Samavatiauthor=F.+Zadorauthor=S.+Benyheauthor=P.+Davisauthor=F.+Porrecaauthor=V.+J.+Hruby&title=Novel+cyclic+biphalin+analogue+with+improved+antinociceptive+properties&doi=10.1021%2Fml500241n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Cyclic Biphalin Analogue with Improved Antinociceptive Properties</span></div><div class="casAuthors">Mollica, Adriano; Carotenuto, Alfonso; Novellino, Ettore; Limatola, Antonio; Costante, Roberto; Pinnen, Francesco; Stefanucci, Azzurra; Pieretti, Stefano; Borsodi, Anna; Samavati, Reza; Zador, Ferenc; Benyhe, Sandor; Davis, Peg; Porreca, Frank; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1032-1036</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two novel opioid analogs have been designed by substituting the native D-Ala residues in position 2,2' of biphalin with two residues of D-penicillamine or L-penicillamine and by forming a disulfide bond between the thiol groups.  The so-obtained compd. 9 contg. D-penicillamines showed excellent μ/δ mixed receptor affinities (K i δ = 5.2 nM; K i μ = 1.9 nM), together with an efficacious capacity to trigger the second messenger and a very good in vivo antinociceptive activity, whereas product 10 was scarcely active.  An explanation of the two different pharmacol. behaviors of products 9 and 10 was found by studying their conformational properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomcpAB9Zk-1bVg90H21EOLACvtfcHk0lgmR4mG6JZcrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtbnJ&md5=5bb0b213b04bddfed5f835c4cf307f5b</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1021%2Fml500241n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500241n%26sid%3Dliteratum%253Aachs%26aulast%3DMollica%26aufirst%3DA.%26aulast%3DCarotenuto%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DLimatola%26aufirst%3DA.%26aulast%3DCostante%26aufirst%3DR.%26aulast%3DPinnen%26aufirst%3DF.%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DBorsodi%26aufirst%3DA.%26aulast%3DSamavati%26aufirst%3DR.%26aulast%3DZador%26aufirst%3DF.%26aulast%3DBenyhe%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DNovel%2520cyclic%2520biphalin%2520analogue%2520with%2520improved%2520antinociceptive%2520properties%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1032%26epage%3D1036%26doi%3D10.1021%2Fml500241n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Arimont, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Graaf, C.</span><span> </span><span class="NLM_article-title">Structural analysis of chemokine receptor–ligand interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">4735</span><span class="NLM_x">–</span> <span class="NLM_lpage">4779</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01309</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01309" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1Sjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4735-4779&author=M.+Arimontauthor=S.+L.+Sunauthor=R.+Leursauthor=M.+Smitauthor=I.+J.+P.+de+Eschauthor=C.+de+Graaf&title=Structural+analysis+of+chemokine+receptor%E2%80%93ligand+interactions&doi=10.1021%2Facs.jmedchem.6b01309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Analysis of Chemokine Receptor-Ligand Interactions</span></div><div class="casAuthors">Arimont, Marta; Sun, Shan-Liang; Leurs, Rob; Smit, Martine; de Esch, Iwan J. P.; de Graaf, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4735-4779</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review focuses on the construction and application of structural chemokine receptor models for the elucidation of mol. determinants of chemokine receptor modulation and the structure-based discovery and design of chemokine receptor ligands.  A comparative anal. of ligand binding pockets in chemokine receptors is presented, including a detailed description of the CXCR4, CCR2, CCR5, CCR9 and US28 X-ray structures, and their implication for modeling mol. interactions of chemokine receptors with small-mol. ligands, peptide ligands, and large antibodies and chemokines.  These studies demonstrate how the integration of new structural information of chemokine receptors with extensive structure-activity relationship and site-directed mutagenesis data facilitates the prediction of the structure of chemokine receptor-ligand complexes that have not been crystd.  Finally a review of structure-based ligand discovery and design studies based on chemokine receptor crystal structures and homol. models illustrates the possibilities and challenges to find novel ligands for chemokine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQjIDUCY7fubVg90H21EOLACvtfcHk0lgmR4mG6JZcrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1Sjs78%253D&md5=7a4e23ff0f003157e4416ad0caf7517d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01309%26sid%3Dliteratum%253Aachs%26aulast%3DArimont%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.%2BL.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DSmit%26aufirst%3DM.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26atitle%3DStructural%2520analysis%2520of%2520chemokine%2520receptor%25E2%2580%2593ligand%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4735%26epage%3D4779%26doi%3D10.1021%2Facs.jmedchem.6b01309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Kaiser, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colescott, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossinger, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, P. I.</span><span> </span><span class="NLM_article-title">Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span><span class="refDoi"> DOI: 10.1016/0003-2697(70)90146-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2F0003-2697%2870%2990146-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=5443684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaE3cXhtVWjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1970&pages=595-598&author=E.+Kaiserauthor=R.+L.+Colescottauthor=C.+D.+Bossingerauthor=P.+I.+Cook&title=Color+test+for+detection+of+free+terminal+amino+groups+in+the+solid-phase+synthesis+of+peptides&doi=10.1016%2F0003-2697%2870%2990146-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides</span></div><div class="casAuthors">Kaiser, Emil; Colescott, R. L.; Bossinger, C. D.; Cook, P. I.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">595-8</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">A rapid color test is described for detecting ≥5 micromoles free terminal amino group/g in the reaction mixt. from solid-phase peptide synthesis according to R. B. Merrifield (1968).  After washing the solid phase with CH2Cl2, a 10-20 mg sample of the resin peptide is treated with 2-3 drops each of the following reagents: 500 mg ninhydrin/10 ml EtOH; 80 g PhOH/ 20 ml EtOH; and 20 ml 0.001M KCN dild. to 100 ml with pyridine.  The mixt. is heated 2-5 min at 100°.  The development of an intense blue color on the beads and in the soln. (except that terminal proline or terminal β-benzyl aspartate gave a brown or red-brown color) is a pos. result.  In the absence of untreated terminal amino groups, the beads remained white and the soln. yellow (neg. result).  The formation of pale blue beads and a light green soln. was a slightly pos. result.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE5EMxGtKGTrVg90H21EOLACvtfcHk0lgmR4mG6JZcrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXhtVWjur0%253D&md5=c6caf0b6e42136c56e24a1df93a63f3f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2870%2990146-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252870%252990146-6%26sid%3Dliteratum%253Aachs%26aulast%3DKaiser%26aufirst%3DE.%26aulast%3DColescott%26aufirst%3DR.%2BL.%26aulast%3DBossinger%26aufirst%3DC.%2BD.%26aulast%3DCook%26aufirst%3DP.%2BI.%26atitle%3DColor%2520test%2520for%2520detection%2520of%2520free%2520terminal%2520amino%2520groups%2520in%2520the%2520solid-phase%2520synthesis%2520of%2520peptides%26jtitle%3DAnal.%2520Biochem.%26date%3D1970%26volume%3D34%26spage%3D595%26epage%3D598%26doi%3D10.1016%2F0003-2697%2870%2990146-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Hancock, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battersby, J. E.</span><span> </span><span class="NLM_article-title">A new micro-test for the detection of incomplete coupling reactions in solid-phase peptide synthesis using 2,4,6-trinitrobenzenesulphonic acid</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span><span class="refDoi"> DOI: 10.1016/0003-2697(76)90034-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2F0003-2697%2876%2990034-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1976&pages=260-264&author=W.+S.+Hancockauthor=J.+E.+Battersby&title=A+new+micro-test+for+the+detection+of+incomplete+coupling+reactions+in+solid-phase+peptide+synthesis+using+2%2C4%2C6-trinitrobenzenesulphonic+acid&doi=10.1016%2F0003-2697%2876%2990034-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2876%2990034-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252876%252990034-8%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DW.%2BS.%26aulast%3DBattersby%26aufirst%3DJ.%2BE.%26atitle%3DA%2520new%2520micro-test%2520for%2520the%2520detection%2520of%2520incomplete%2520coupling%2520reactions%2520in%2520solid-phase%2520peptide%2520synthesis%2520using%25202%252C4%252C6-trinitrobenzenesulphonic%2520acid%26jtitle%3DAnal.%2520Biochem.%26date%3D1976%26volume%3D71%26spage%3D260%26epage%3D264%26doi%3D10.1016%2F0003-2697%2876%2990034-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Güntert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mumenthaler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wüthrich, K.</span><span> </span><span class="NLM_article-title">Torsion angle dynamics for NMR structure calculation with the new program DYANA</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span><span class="refDoi"> DOI: 10.1006/jmbi.1997.1284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1006%2Fjmbi.1997.1284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=9367762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaK2sXmvFymtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1997&pages=283-298&author=P.+G%C3%BCntertauthor=C.+Mumenthalerauthor=K.+W%C3%BCthrich&title=Torsion+angle+dynamics+for+NMR+structure+calculation+with+the+new+program+DYANA&doi=10.1006%2Fjmbi.1997.1284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Torsion angle dynamics for NMR structure calculation with the new program DYANA</span></div><div class="casAuthors">Guntert, P.; Mumenthaler, C.; Wuthrich, K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">283-298</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">The new program DYANA (DYnamics Algorithm for Nmr Applications) for efficient calcn. of three-dimensional protein and nucleic acid structures from distance constraints and torsion angle constraints collected by NMR expts. performs simulated annealing by mol. dynamics in torsion angle space and uses a fast recursive algorithm to integrate the equations of motions.  Torsion angle dynamics can be more efficient than mol. dynamics in Cartesian coordinate space because of the reduced no. of degrees of freedom and the concomitant absence of high-frequency bond and angle vibrations, which allows for the use of longer time-steps and/or higher temps. in the structure calcn.  It also represents a significant advance over the variable target function method in torsion angle space with the REDAC strategy used by the predecessor program DIANA.  DYANA computation times per accepted conformer in the "bundle" used to represent the NMR structure compare favorably with those of other presently available structure calcn. algorithms, and are of the order of 160 s for a protein of 165 amino acid residues when using a DEC Alpha 8400 5/300 computer.  Test calcns. starting from conformers with random torsion angle values further showed that DYANA is capable of efficient calcn. of high-quality protein structures with up to 400 amino acid residues, and of nucleic acid structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSScNysHFGa7Vg90H21EOLACvtfcHk0lhckgVDDeUa8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvFymtbw%253D&md5=403b201ea5726641fc0aea34969de69a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1997.1284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1997.1284%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25BCntert%26aufirst%3DP.%26aulast%3DMumenthaler%26aufirst%3DC.%26aulast%3DW%25C3%25BCthrich%26aufirst%3DK.%26atitle%3DTorsion%2520angle%2520dynamics%2520for%2520NMR%2520structure%2520calculation%2520with%2520the%2520new%2520program%2520DYANA%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D273%26spage%3D283%26epage%3D298%26doi%3D10.1006%2Fjmbi.1997.1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Maple, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinur, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagler, A. T.</span><span> </span><span class="NLM_article-title">Derivation of force fields for molecular mechanics and dynamics from ab initio energy surface</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">5350</span><span class="NLM_x">–</span> <span class="NLM_lpage">5353</span><span class="refDoi"> DOI: 10.1073/pnas.85.15.5350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1073%2Fpnas.85.15.5350" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1988&pages=5350-5353&author=J.+Mapleauthor=U.+Dinurauthor=A.+T.+Hagler&title=Derivation+of+force+fields+for+molecular+mechanics+and+dynamics+from+ab+initio+energy+surface&doi=10.1073%2Fpnas.85.15.5350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1073%2Fpnas.85.15.5350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.85.15.5350%26sid%3Dliteratum%253Aachs%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DDinur%26aufirst%3DU.%26aulast%3DHagler%26aufirst%3DA.%2BT.%26atitle%3DDerivation%2520of%2520force%2520fields%2520for%2520molecular%2520mechanics%2520and%2520dynamics%2520from%2520ab%2520initio%2520energy%2520surface%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1988%26volume%3D85%26spage%3D5350%26epage%3D5353%26doi%3D10.1073%2Fpnas.85.15.5350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Pettersen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couch, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenblatt, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrin, T. E.</span><span> </span><span class="NLM_article-title">UCSF Chimera - A visualization system for exploratory research and analysis</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span><span class="refDoi"> DOI: 10.1002/jcc.20084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1002%2Fjcc.20084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=15264254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1605-1612&author=E.+F.+Pettersenauthor=T.+D.+Goddardauthor=C.+C.+Huangauthor=G.+S.+Couchauthor=D.+M.+Greenblattauthor=E.+C.+Mengauthor=T.+E.+Ferrin&title=UCSF+Chimera+-+A+visualization+system+for+exploratory+research+and+analysis&doi=10.1002%2Fjcc.20084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">UCSF Chimera-A visualization system for exploratory research and analysis</span></div><div class="casAuthors">Pettersen, Eric F.; Goddard, Thomas D.; Huang, Conrad C.; Couch, Gregory S.; Greenblatt, Daniel M.; Meng, Elaine C.; Ferrin, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1605-1612</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The design, implementation, and capabilities of an extensible visualization system, UCSF Chimera, are discussed.  Chimera is segmented into a core that provides basic services and visualization, and extensions that provide most higher level functionality.  This architecture ensures that the extension mechanism satisfies the demands of outside developers who wish to incorporate new features.  Two unusual extensions are presented: Multiscale, which adds the ability to visualize large-scale mol. assemblies such as viral coats, and Collab., which allows researchers to share a Chimera session interactively despite being at sep. locales.  Other extensions include Multalign Viewer, for showing multiple sequence alignments and assocd. structures; ViewDock, for screening docked ligand orientations; Movie, for replaying mol. dynamics trajectories; and Vol. Viewer, for display and anal. of volumetric data.  A discussion of the usage of Chimera in real-world situations is given, along with anticipated future directions.  Chimera includes full user documentation, is free to academic and nonprofit users, and is available for Microsoft Windows, Linux, Apple Mac OS X, SGI IRIX, and HP Tru64 Unix from http://www.cgl.ucsf.edu/chimera/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmD4M5S0cPbVg90H21EOLACvtfcHk0lhckgVDDeUa8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D&md5=944b175f440c1ff323705987cf937ee7</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20084%26sid%3Dliteratum%253Aachs%26aulast%3DPettersen%26aufirst%3DE.%2BF.%26aulast%3DGoddard%26aufirst%3DT.%2BD.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DCouch%26aufirst%3DG.%2BS.%26aulast%3DGreenblatt%26aufirst%3DD.%2BM.%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DFerrin%26aufirst%3DT.%2BE.%26atitle%3DUCSF%2520Chimera%2520-%2520A%2520visualization%2520system%2520for%2520exploratory%2520research%2520and%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1605%26epage%3D1612%26doi%3D10.1002%2Fjcc.20084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, E. Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mol, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenalti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handel, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structures of the CXCR4 chemokine receptor in complex with small molecule and cyclic peptide antagonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">1066</span><span class="NLM_x">–</span> <span class="NLM_lpage">1071</span><span class="refDoi"> DOI: 10.1126/science.1194396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1126%2Fscience.1194396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=20929726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1066-1071&author=B.+Wuauthor=E.+Y.+T.+Chienauthor=C.+D.+Molauthor=G.+Fenaltiauthor=W.+Liuauthor=V.+Katritchauthor=R.+Abagyanauthor=A.+Broounauthor=P.+Wellsauthor=F.+C.+Biauthor=D.+J.+Hamelauthor=P.+Kuhnauthor=T.+M.+Handelauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structures+of+the+CXCR4+chemokine+receptor+in+complex+with+small+molecule+and+cyclic+peptide+antagonists&doi=10.1126%2Fscience.1194396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists</span></div><div class="casAuthors">Wu, Beili; Chien, Ellen Y. T.; Mol, Clifford D.; Fenalti, Gustavo; Liu, Wei; Katritch, Vsevolod; Abagyan, Ruben; Brooun, Alexei; Wells, Peter; Bi, F. Christopher; Hamel, Damon J.; Kuhn, Peter; Handel, Tracy M.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6007</span>),
    <span class="NLM_cas:pages">1066-1071</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chemokine receptors are crit. regulators of cell migration in the context of immune surveillance, inflammation, and development.  The G protein-coupled chemokine receptor CXCR4 is specifically implicated in cancer metastasis and HIV-1 infection.  Here we report five independent crystal structures of CXCR4 bound to an antagonist small mol. IT1t and a cyclic peptide CVX15 at 2.5 to 3.2 angstrom resoln.  All structures reveal a consistent homodimer with an interface including helixes V and VI that may be involved in regulating signaling.  The location and shape of the ligand-binding sites differ from other G protein-coupled receptors and are closer to the extracellular surface.  These structures provide new clues about the interactions between CXCR4 and its natural ligand CXCL12, and with the HIV-1 glycoprotein gp120.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeofqcIJsBzLVg90H21EOLACvtfcHk0ljBJHF5GqnKqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahurnM&md5=2d39cc2cff4adce72e63f427e568e35d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1126%2Fscience.1194396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1194396%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DB.%26aulast%3DChien%26aufirst%3DE.%2BY.%2BT.%26aulast%3DMol%26aufirst%3DC.%2BD.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DWells%26aufirst%3DP.%26aulast%3DBi%26aufirst%3DF.%2BC.%26aulast%3DHamel%26aufirst%3DD.%2BJ.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DHandel%26aufirst%3DT.%2BM.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructures%2520of%2520the%2520CXCR4%2520chemokine%2520receptor%2520in%2520complex%2520with%2520small%2520molecule%2520and%2520cyclic%2520peptide%2520antagonists%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1066%26epage%3D1071%26doi%3D10.1126%2Fscience.1194396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirado-Rives, J.</span><span> </span><span class="NLM_article-title">Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">11225</span><span class="NLM_x">–</span> <span class="NLM_lpage">11236</span><span class="refDoi"> DOI: 10.1021/ja9621760</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9621760" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaK28XmtlOitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=11225-11236&author=W.+L.+Jorgensenauthor=D.+S.+Maxwellauthor=J.+Tirado-Rives&title=Development+and+testing+of+the+OPLS+all-atom+force+field+on+conformational+energetics+and+properties+of+organic+liquids&doi=10.1021%2Fja9621760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids</span></div><div class="casAuthors">Jorgensen, William L.; Maxwell, David S.; Tirado-Rives, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">11225-11236</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and testing of the OPLS all-atom force field for org. mols. and peptides are described.  Parameters for both torsional and nonbonded energetics have been derived, while the bond stretching and angle bending parameters have been adopted mostly from the AMBER all-atom force field.  The torsional parameters were detd. by fitting to rotational energy profiles obtained from ab initio MO calcns. at the RHF/6-31G*//RHF/6-31G* level for more than 50 org. mols. and ions.  The quality of the fits was high with av. errors for conformational energies of less than 0.2 kcal/mol.  The force-field results for mol. structures are also demonstrated to closely match the ab initio predictions.  The nonbonded parameters were developed in conjunction with Monte Carlo statistical mechanics simulations by computing thermodn. and structural properties for 34 pure org. liqs. including alkanes, alkenes, alcs., ethers, acetals, thiols, sulfides, disulfides, aldehydes, ketones, and amides.  Av. errors in comparison with exptl. data are 2% for heats of vaporization and densities.  The Monte Carlo simulations included sampling all internal and intermol. degrees of freedom.  It is found that such non-polar and monofunctional systems do not show significant condensed-phase effects on internal energies in going from the gas phase to the pure liqs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhGotSev_b1LVg90H21EOLACvtfcHk0ljBJHF5GqnKqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtlOitrs%253D&md5=fef2924a69421881390282aa309ae91b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fja9621760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9621760%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DMaxwell%26aufirst%3DD.%2BS.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520the%2520OPLS%2520all-atom%2520force%2520field%2520on%2520conformational%2520energetics%2520and%2520properties%2520of%2520organic%2520liquids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D11225%26epage%3D11236%26doi%3D10.1021%2Fja9621760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Maier, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasavajhala, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickstrom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmerling, C.</span><span> </span><span class="NLM_article-title">ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3696</span><span class="NLM_x">–</span> <span class="NLM_lpage">3713</span><span class="refDoi"> DOI: 10.1021/acs.jctc.5b00255</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00255" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFequ7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=3696-3713&author=J.+A.+Maierauthor=C.+Martinezauthor=K.+Kasavajhalaauthor=L.+Wickstromauthor=K.+E.+Hauserauthor=C.+Simmerling&title=ff14SB%3A+improving+the+accuracy+of+protein+side+chain+and+backbone+parameters+from+ff99SB&doi=10.1021%2Facs.jctc.5b00255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB</span></div><div class="casAuthors">Maier, James A.; Martinez, Carmenza; Kasavajhala, Koushik; Wickstrom, Lauren; Hauser, Kevin E.; Simmerling, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3696-3713</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. mechanics is powerful for its speed in atomistic simulations, but an accurate force field is required.  The Amber ff99SB force field improved protein secondary structure balance and dynamics from earlier force fields like ff99, but weaknesses in side chain rotamer and backbone secondary structure preferences have been identified.  Here, we performed a complete refit of all amino acid side chain dihedral parameters, which had been carried over from ff94.  The training set of conformations included multidimensional dihedral scans designed to improve transferability of the parameters.  Improvement in all amino acids was obtained as compared to ff99SB.  Parameters were also generated for alternate protonation states of ionizable side chains.  Av. errors in relative energies of pairs of conformations were under 1.0 kcal/mol as compared to QM, reduced 35% from ff99SB.  We also took the opportunity to make empirical adjustments to the protein backbone dihedral parameters as compared to ff99SB.  Multiple small adjustments of φ and ψ parameters were tested against NMR scalar coupling data and secondary structure content for short peptides.  The best results were obtained from a phys. motivated adjustment to the φ rotational profile that compensates for lack of ff99SB QM training data in the β-ppII transition region.  Together, these backbone and side chain modifications (hereafter called ff14SB) not only better reproduced their benchmarks, but also improved secondary structure content in small peptides and reprodn. of NMR χ1 scalar coupling measurements for proteins in soln.  We also discuss the Amber ff12SB parameter set, a preliminary version of ff14SB that includes most of its improvements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgntnN9ES97rVg90H21EOLACvtfcHk0ljBJHF5GqnKqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFequ7rN&md5=7b803577b3b6912cc6750cfbd356596e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00255%26sid%3Dliteratum%253Aachs%26aulast%3DMaier%26aufirst%3DJ.%2BA.%26aulast%3DMartinez%26aufirst%3DC.%26aulast%3DKasavajhala%26aufirst%3DK.%26aulast%3DWickstrom%26aufirst%3DL.%26aulast%3DHauser%26aufirst%3DK.%2BE.%26aulast%3DSimmerling%26aufirst%3DC.%26atitle%3Dff14SB%253A%2520improving%2520the%2520accuracy%2520of%2520protein%2520side%2520chain%2520and%2520backbone%2520parameters%2520from%2520ff99SB%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2015%26volume%3D11%26spage%3D3696%26epage%3D3713%26doi%3D10.1021%2Facs.jctc.5b00255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Dickson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madej, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skjevik, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teigen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, R. C.</span><span> </span><span class="NLM_article-title">Lipid14: the amber lipid force field</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">865</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span><span class="refDoi"> DOI: 10.1021/ct4010307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct4010307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Wgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=865-879&author=C.+J.+Dicksonauthor=B.+D.+Madejauthor=A.+A.+Skjevikauthor=R.+M.+Betzauthor=K.+Teigenauthor=I.+R.+Gouldauthor=R.+C.+Walker&title=Lipid14%3A+the+amber+lipid+force+field&doi=10.1021%2Fct4010307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid14: The Amber Lipid Force Field</span></div><div class="casAuthors">Dickson, Callum J.; Madej, Benjamin D.; Skjevik, Age A.; Betz, Robin M.; Teigen, Knut; Gould, Ian R.; Walker, Ross C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">865-879</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The AMBER lipid force field has been updated to create Lipid14, allowing tensionless simulation of a no. of lipid types with the AMBER MD package.  The modular nature of this force field allows numerous combinations of head and tail groups to create different lipid types, enabling the easy insertion of new lipid species.  The Lennard-Jones and torsion parameters of both the head and tail groups have been revised and updated partial charges calcd.  The force field has been validated by simulating bilayers of six different lipid types for a total of 0.5 μs each without applying a surface tension; with favorable comparison to expt. for properties such as area per lipid, vol. per lipid, bilayer thickness, NMR order parameters, scattering data, and lipid lateral diffusion.  As the derivation of this force field is consistent with the AMBER development philosophy, Lipid14 is compatible with the AMBER protein, nucleic acid, carbohydrate, and small mol. force fields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo60Ks38bQOe7Vg90H21EOLACvtfcHk0liP4MI5DB7MUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Wgt70%253D&md5=6efe3346bab426a93016d10418b6957a</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fct4010307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct4010307%26sid%3Dliteratum%253Aachs%26aulast%3DDickson%26aufirst%3DC.%2BJ.%26aulast%3DMadej%26aufirst%3DB.%2BD.%26aulast%3DSkjevik%26aufirst%3DA.%2BA.%26aulast%3DBetz%26aufirst%3DR.%2BM.%26aulast%3DTeigen%26aufirst%3DK.%26aulast%3DGould%26aufirst%3DI.%2BR.%26aulast%3DWalker%26aufirst%3DR.%2BC.%26atitle%3DLipid14%253A%2520the%2520amber%2520lipid%2520force%2520field%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2014%26volume%3D10%26spage%3D865%26epage%3D879%26doi%3D10.1021%2Fct4010307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, D. A.</span><span> </span><span class="NLM_article-title">Automatic atom type and bond type perception in molecular mechanical calculations</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span><span class="refDoi"> DOI: 10.1016/j.jmgm.2005.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2Fj.jmgm.2005.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=16458552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1Gis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=247-260&author=J.+Wangauthor=W.+Wangauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Automatic+atom+type+and+bond+type+perception+in+molecular+mechanical+calculations&doi=10.1016%2Fj.jmgm.2005.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Automatic atom type and bond type perception in molecular mechanical calculations</span></div><div class="casAuthors">Wang, Junmei; Wang, Wei; Kollman, Peter A.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-260</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">In mol. mechanics (MM) studies, atom types and/or bond types of mols. are needed to det. prior to energy calcns.  The authors present here an automatic algorithm of perceiving atom types that are defined in a description table, and an automatic algorithm of assigning bond types just based on at. connectivity.  The algorithms have been implemented in a new module of the AMBER packages.  This auxiliary module, antechamber (roughly meaning "before AMBER"), can be applied to generate necessary inputs of leap-the AMBER program to generate topologies for minimization, mol. dynamics, etc., for most org. mols.  The algorithms behind the manipulations may be useful for other mol. mech. packages as well as applications that need to designate atom types and bond types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqizj6F18nBYbVg90H21EOLACvtfcHk0liP4MI5DB7MUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1Gis7g%253D&md5=8031a21d2784d5dea12e70868522aa61</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2005.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmgm.2005.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DAutomatic%2520atom%2520type%2520and%2520bond%2520type%2520perception%2520in%2520molecular%2520mechanical%2520calculations%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2006%26volume%3D25%26spage%3D247%26epage%3D260%26doi%3D10.1016%2Fj.jmgm.2005.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieplak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornell, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model</span> <span class="citation_source-journal">J. Phys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">10269</span><span class="NLM_x">–</span> <span class="NLM_lpage">10280</span><span class="refDoi"> DOI: 10.1021/j100142a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/j100142a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaK3sXlvVyqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1993&pages=10269-10280&author=C.+I.+Baylyauthor=P.+Cieplakauthor=W.+Cornellauthor=P.+A.+Kollman&title=A+well-behaved+electrostatic+potential+based+method+using+charge+restraints+for+deriving+atomic+charges%3A+the+RESP+model&doi=10.1021%2Fj100142a004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model</span></div><div class="casAuthors">Bayly, Christopher I.; Cieplak, Piotr; Cornell, Wendy; Kollman, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">10269-80</span>CODEN:
                <span class="NLM_cas:coden">JPCHAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-3654</span>.
    </div><div class="casAbstract">The authors present a new approach to generating electrostatic potential (ESP) derived charges for mols.  The major strength of electrostatic potential derived charges is that they optimally reproduce the intermol. interaction properties of mols. with a simple two-body additive potential, provided, of course, that a suitably accurate level of quantum mech. calcn. is used to derive the ESP around the mol.  Previously, the major weaknesses of these charges have been that they were not easily transferably between common functional groups in related mols., they have often been conformationally dependent, and the large charges that frequently occur can be problematic for simulating intramol. interactions.  Introducing restraints in the form of a penalty function into the fitting process considerably reduces the above problems, with only a minor decrease in the quality of the fit to the quantum mech. ESP.  Several other refinements in addn. to the restrained electrostatic potential (RESP) fit yield a general and algorithmic charge fitting procedure for generating atom-centered point charges.  This approach can thus be recommended for general use in mol. mechanics, mol. dynamics, and free energy calcns. for any org. or bioorg. system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRAz3o6S1gOrVg90H21EOLACvtfcHk0liP4MI5DB7MUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlvVyqsLs%253D&md5=e65c6a556ffc174df4f327687912a0bd</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fj100142a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fj100142a004%26sid%3Dliteratum%253Aachs%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DCieplak%26aufirst%3DP.%26aulast%3DCornell%26aufirst%3DW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DA%2520well-behaved%2520electrostatic%2520potential%2520based%2520method%2520using%2520charge%2520restraints%2520for%2520deriving%2520atomic%2520charges%253A%2520the%2520RESP%2520model%26jtitle%3DJ.%2520Phys.%2520Chem.%26date%3D1993%26volume%3D97%26spage%3D10269%26epage%3D10280%26doi%3D10.1021%2Fj100142a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, J. A.,  Jr.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, N. J.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas, Ö.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J.</span>Gaussian 09, revision <span class="NLM_edition">D.01</span>; <span class="NLM_publisher-name">Gaussian, Inc.</span>: <span class="NLM_publisher-loc">Wallingford, CT</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+J.+Frisch&author=G.+W.+Trucks&author=H.+B.+Schlegel&author=G.+E.+Scuseria&author=M.+A.+Robb&author=J.+R.+Cheeseman&author=G.+Scalmani&author=V.+Barone&author=B.+Mennucci&author=G.+A.+Petersson&author=H.+Nakatsuji&author=M.+Caricato&author=X.+Li&author=H.+P.+Hratchian&author=A.+F.+Izmaylov&author=J.+Bloino&author=G.+Zheng&author=J.+L.+Sonnenberg&author=M.+Hada&author=M.+Ehara&author=K.+Toyota&author=R.+Fukuda&author=J.+Hasegawa&author=M.+Ishida&author=T.+Nakajima&author=Y.+Honda&author=O.+Kitao&author=H.+Nakai&author=T.+Vreven&author=J.+A.+Montgomery&author=J.+E.+Peralta&author=F.+Ogliaro&author=M.+Bearpark&author=J.+J.+Heyd&author=E.+Brothers&author=K.+N.+Kudin&author=V.+N.+Staroverov&author=R.+Kobayashi&author=J.+Normand&author=K.+Raghavachari&author=A.+Rendell&author=J.+C.+Burant&author=S.+S.+Iyengar&author=J.+Tomasi&author=M.+Cossi&author=N.+Rega&author=N.+J.+Millam&author=M.+Klene&author=J.+E.+Knox&author=J.+B.+Cross&author=V.+Bakken&author=C.+Adamo&author=J.+Jaramillo&author=R.+Gomperts&author=R.+E.+Stratmann&author=O.+Yazyev&author=A.+J.+Austin&author=R.+Cammi&author=C.+Pomelli&author=J.+W.+Ochterski&author=R.+L.+Martin&author=K.+Morokuma&author=V.+G.+Zakrzewski&author=G.+A.+Voth&author=P.+Salvador&author=J.+J.+Dannenberg&author=S.+Dapprich&author=A.+D.+Daniels&author=%C3%96.+Farkas&author=J.+B.+Foresman&author=J.+V.+Ortiz&author=J.+Cioslowski&author=D.+J.+Fox&title=Gaussian+09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DM.%2BJ.%26jtitle%3DGaussian%252009%26pub%3DGaussian%252C%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Phillips, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gumbart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajkhorshid, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chipot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skeel, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kale, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulten, K.</span><span> </span><span class="NLM_article-title">Scalable molecular dynamics with NAMD</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1781</span><span class="NLM_x">–</span> <span class="NLM_lpage">1802</span><span class="refDoi"> DOI: 10.1002/jcc.20289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1002%2Fjcc.20289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=16222654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=1781-1802&author=J.+C.+Phillipsauthor=R.+Braunauthor=W.+Wangauthor=J.+Gumbartauthor=E.+Tajkhorshidauthor=E.+Villaauthor=C.+Chipotauthor=R.+D.+Skeelauthor=L.+Kaleauthor=K.+Schulten&title=Scalable+molecular+dynamics+with+NAMD&doi=10.1002%2Fjcc.20289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Scalable molecular dynamics with NAMD</span></div><div class="casAuthors">Phillips, James C.; Braun, Rosemary; Wang, Wei; Gumbart, James; Tajkhorshid, Emad; Villa, Elizabeth; Chipot, Christophe; Skeel, Robert D.; Kale, Laxmikant; Schulten, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1781-1802</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">NAMD is a parallel mol. dynamics code designed for high-performance simulation of large biomol. systems.  NAMD scales to hundreds of processors on high-end parallel platforms, as well as tens of processors on low-cost commodity clusters, and also runs on individual desktop and laptop computers.  NAMD works with AMBER and CHARMM potential functions, parameters, and file formats.  This article, directed to novices as well as experts, first introduces concepts and methods used in the NAMD program, describing the classical mol. dynamics force field, equations of motion, and integration methods along with the efficient electrostatics evaluation algorithms employed and temp. and pressure controls used.  Features for steering the simulation across barriers and for calcg. both alchem. and conformational free energy differences are presented.  The motivations for and a roadmap to the internal design of NAMD, implemented in C++ and based on Charm++ parallel objects, are outlined.  The factors affecting the serial and parallel performance of a simulation are discussed.  Finally, typical NAMD use is illustrated with representative applications to a small, a medium, and a large biomol. system, highlighting particular features of NAMD, for example, the Tcl scripting language.  The article also provides a list of the key features of NAMD and discusses the benefits of combining NAMD with the mol. graphics/sequence anal. software VMD and the grid computing/collab. software BioCoRE.  NAMD is distributed free of charge with source code at www.ks.uiuc.edu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7fq_yG00T1rVg90H21EOLACvtfcHk0lgnqW8S0HOGUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbJ&md5=189051128443b547f4300a1b8fb0e034</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20289%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DJ.%2BC.%26aulast%3DBraun%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DGumbart%26aufirst%3DJ.%26aulast%3DTajkhorshid%26aufirst%3DE.%26aulast%3DVilla%26aufirst%3DE.%26aulast%3DChipot%26aufirst%3DC.%26aulast%3DSkeel%26aufirst%3DR.%2BD.%26aulast%3DKale%26aufirst%3DL.%26aulast%3DSchulten%26aufirst%3DK.%26atitle%3DScalable%2520molecular%2520dynamics%2520with%2520NAMD%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2005%26volume%3D26%26spage%3D1781%26epage%3D1802%26doi%3D10.1002%2Fjcc.20289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Ballesteros, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span> </span><span class="NLM_article-title">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span> <span class="citation_source-journal">Methods Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span><span class="refDoi"> DOI: 10.1016/S1043-9471(05)80049-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=10.1016%2FS1043-9471%2805%2980049-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=366-428&author=J.+A.+Ballesterosauthor=H.+Weinstein&title=Integrated+methods+for+the+construction+of+three-dimensional+models+and+computational+probing+of+structure-function+relations+in+G+protein-coupled+receptors&doi=10.1016%2FS1043-9471%2805%2980049-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span></div><div class="casAuthors">Ballesteros, Juan A.; Weinstein, Harel</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Neurosciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">366-428</span>CODEN:
                <span class="NLM_cas:coden">MENEE5</span>;
        ISSN:<span class="NLM_cas:issn">1043-9471</span>.
    </div><div class="casAbstract">A review, with 135 refs., on approaches that can be used to resolve the apparent ambiguities that burden the pharmacol. testing of G protein-coupled receptor (GPCR) models, based on the integration of structural information about the receptor, about mutants, and about the changes induced by ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfENoRspqa7LVg90H21EOLACvtfcHk0lgnqW8S0HOGUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D&md5=d3f99e9d07cea245a770f3f099bc8cc7</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS1043-9471%2805%2980049-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-9471%252805%252980049-7%26sid%3Dliteratum%253Aachs%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26aulast%3DWeinstein%26aufirst%3DH.%26atitle%3DIntegrated%2520methods%2520for%2520the%2520construction%2520of%2520three-dimensional%2520models%2520and%2520computational%2520probing%2520of%2520structure-function%2520relations%2520in%2520G%2520protein-coupled%2520receptors%26jtitle%3DMethods%2520Neurosci.%26date%3D1995%26volume%3D25%26spage%3D366%26epage%3D428%26doi%3D10.1016%2FS1043-9471%2805%2980049-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OE0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OE0','PDB','3OE0'); return false;">PDB: 3OE0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OJT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OJT','PDB','5OJT'); return false;">PDB: 5OJT</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i27"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01062">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_26802"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01062">10.1021/acs.jmedchem.7b01062</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Analytical data for the studied peptides; NMR resonance assignments of <b>19</b>; NOE derived upper limit constraints of <b>19</b>; Cα carbons rmsd of <b>19</b> along the MD production run (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01062/suppl_file/jm7b01062_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Model of <b>19</b> at the CXCR4 binding site (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01062/suppl_file/jm7b01062_si_002.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01062/suppl_file/jm7b01062_si_001.pdf">jm7b01062_si_001.pdf (398.9 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01062/suppl_file/jm7b01062_si_002.pdb">jm7b01062_si_002.pdb (185.34 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB code is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OJT">5OJT</a> for the NMR structure of <b>19</b>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01062&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-23%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01062%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01062" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0f6b4ffd4248d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
